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ABSTRACT 
A method for measuring human platelet Angiotensin 
II (All) binding was validated, and characterisation 
studies involving 67 non-pregnant subjects were 
performed. Platelets were found to possess high 
affinity binding sites . with many of the 
characteristics of receptors. No correlation was 
found between platelet All binding and the rise in 
intracellular free calcium after ex vivo All infusion, 
thus formal validation of the binding sites as 
receptors was not achieved. 
In 25 non-pregnant subjects, there was an inverse 
co.rrelation between p l a t e ~ e t t All binding and 
simultaneously measured plasma All (P<0.02). In 10 
ovulatory subjects, platelet All binding diminished in 
the luteal phase of the menstrual cycle (P<0.02). 
In a pilot cross-sectional study of platelet All in 
normotensive pregnancy, incorporating 125 
pregnant/postnatal patients, platelet All b i n d i ~ g g was 
significantly lower in 1st trimester patients as 
compared to non-pregnant subjects (P<O.OOl). Platelet 
All binding remained low throughout pregnancy. Higher 
values, approximating to the non-pregnant level, were 
found 6 weeks postnatally. 
These findings were confirmed in a longitudinal 
study .of 30 pregnant women, with a diminution in 
platelet All binding being suggested by 5-8 weeks 
gestation (p- 0.02). Inverse correlations in 
pregnancy between platelet All"' binding and the 
components of the renin-angiotensin system were found 
(P<O.Ol). There were also significant correlations 
between platelet All binding and the levels of serum 
sodium, urea and osmolality (P<O.Ol). 
When platelet All binding was measured in 67 
patients wi th established hypertension in pregnancy, 
binding in patients with pregnancy induced 
hypertension (PIH) was· significantly higher than in 
normotensive primigravidae (P<O.OOOl). No differences 
in binding were found in the puerperium. 
In a prospective comparison of platelet All binding 
and the All sensitivity· test in predicting the 
development of PIH, involving 34 subjects, platelet 
All binding was a more effective discriminant t ~ a n n any 
o.f the parameters derived ~ r o m m the All sensitivity 
test. There was a significant. correlation between 
platelet All binding and the slope of the curve 
relating the d i a ~ t o l i c c pressor response to infused All 
(P<O.Ol). 
Firs t of all, 
Broughton Pipkin 
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Chapter 1. 
THE INTRODUCTION. 
The following introduction provides a background 
to the studies included in this thesis. There are two 
reasons for considering hypertension in pregnancy in 
the first section. The importance of developing a 
suitable screening test is established from the onset, 
in addi tion, defining the various terms relating to 
hypertension in pregnancy facilitates their use in 
subsequent chapters. The renin-angiotensin system is 
fundamental to the thesis, and is thus considered in 
Section 2. Section 3 considers the renin-angiotensin 
system in normotensive and hypertensive pregnancy. A 
general review of receptor and· binding site theory in 
general follows, (Section 4), which examines. some of 
the concepts used in Section 5 ° (Angiotensin II binding 
sites in vascular tissue). The introduction is 
completed by three sections concernit:lg plate.1ets: 
morphology and'. behaviour (Section 6), changes in 
normotensive and hypertensive pregnancy (Section 7) 
and finally, the rationale for the use ofplat.elets as 
a model for vascular smooth muscle "(Section 8). 
Section 1. 
HYPERTENSIVE DISORDERS OF PREGNANCY. 
The first definite reference to pre-eclampsia is 
The pre-Hippocratic 
No. 523, contains the 
the onset of drowsy 
bad; such cases are 
probably Greek in origin. 
"Coacae Praenotiones" , XXXI, 
aphorism: 'In pregnancy, 
headaches with heaviness is 
perhaps liable to some sorts of 
[cited by Chesley, 1978a]. 
fits at the same time' 
. 
In the ensuing centuries a ,legion of possible 
aetiologies, treatments, and preventative measures 
have been proposed, such ,that Zwiefel [1916], termed 
pre-eclampsia 'the d i s ~ a s e e of t h e o r i e ~ ' . . Before this 
thesis proceeds to add further to the myriad of such 
proposals, . this chapter contains a discussion of 
classifications, incidences, predisposing factors, 
mortality statistics, and the possible screening tests 
of the hypertensive disorders of pregnancy. 
Definition and classification. 
The hypertensive disorders of pregnancy, formerly 
called 'toxaemias of pregnancy', comprise, several 
diseases and syndromes associated with high blood 
pressure. No toxin has been identified in the blood, 
thus the term "toxaemia" is an ambiguous, misnomer. 
Indeed, the unknown aetiology of m a ~ y y of the 
hypertensive diseases of pregnancy has led to clinical 
signs such as hypertension and proteinuria, not merely 
diagnosing disease, but defining it. A disease cannot 
be defined precisely by clinical signs, and as 
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discussed below, this has resulted in a lack of 
uniformity between authors. 
a) Hypertension. 
Carefully controlled prospective studies of blood 
pressure throughout pregnancy have been performed by 
MacGillivray, Rose and Rowe [1969] and, Chesley 
[1978b]. These showed that the trend of blood 
pressure was to fall during the second trimester 
followed by a rise in the third trimester, with 
diastolic blood pressure increasing substantially more 
than systolic pressure as the. pregnancy advanced. 
The main failing in both s t u d i ~ s s was an absence of 
blood pressure readings before pregnancy, the unproven. 
assumption being made that blood pressure six weeks 
post delivery was equivalent to that p r i o ~ ~ to 
pregnancy. 
Hypertension' has been categorised using either an 
absolute threshold or an increment from the baseline 
in the first half of pregnancy. Various aQsolute 
thresholds have been set, including values as low as 
125/75 mmHg. [Chesley, 1976] with some authors only 
using a diastolic pressure limit [e.g. Nelson, 1955]. 
Chesley [1976] found increased perinatal mortality 
rates when the blood pressure exceeded 125/75 mmHg •• 
However, as ",Redman [1987] noted, just because the 
group with a diastolic pressure of 75 mmHg. or more 
includes a relatively greater number of individuals 
with abnormal pregnancies does not justify·, labelling 
the whole group as abnormal; doing S9 confuses 
epidemiological and clinical conc'epts. A commonly 
used dividing 'line, and that adopted by the American 
College of Obstetricians and Gynecologists, is 140/90 
mmHg. [Hughes, 1972]. This arbitrary value has the 
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advantage of being approximately the mean diastolic 
blood pressure plus two standard deviations after 35 
weeks gestation, [MacGillivray, Rose and Rowe, 1969]. 
Further justification for using 90 mmHg. as the 
diastolic threshold for identification of an abnormal 
group may be claimed by noting that the point of 
inflection in relation to increasing 
mortality is found at this level [Friedman 
1977], although Redman's criticism again 
perinatal 
and Neff, 
applies. 
Tervila, Goecke and Timonen [1973] advocated the 
retention of the systolic value in the definition, 
noting that in a series of 4404 patients, systolic 
blood pressure provided a closer correlation with 
perinatal mortality, low apgar s ~ o r e s , , and small for 
dates babies, ~ h a n n diastolic recordings. 
. 
An inherent bias in using a threshold l ~ v e l l alone, 
such as a diastolic pressure of 90mmHg., as specified 
by Nelson [1955], is that individuals whose pressures 
rise from 85 mmHg are grouped with individuals who had 
baseline levels of 70 mmHg or less." The two groups 
may represent different p o p u l a ~ i o n s ; ; some authors 
categorising the former as chronic' hypertension 
[Redman, 1987]. To counter this bias, the d e f i ~ i t i o n n
of the American College of Obstetricians and 
Gynecologists is based on a systolic p r e s ~ u r e e of at 
least 140 mmHg or an increment of at least 30 mmHg or 
a diastolic'" pressure ot' at least 90 mmHg or' an 
increment of at least 15 mmHg (Hughes, 1972]. 
However, MacGillivray [1983] found a diastolic 
pressure increment of 15 mmHg in 72.9% of normal 
primigravid pregnancies. Even if the i n c ~ e m e n t t were 
to be raised to 20 mmHg., a study 'from this centre, 
found a rise of 20 mmHg in the diastolic pressure of 
26% of 500 consecutive normal primigravid pregnancies 
[Broughton Pipkin and Symonds, unpublished datal. 
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Wha tever arbitrary threshold is chosen, there are 
problems in using it to divide a continuously 
distributed variable such as arterial pressure. This 
leads to patients with essential hypertension being 
regarded as having a discrete disease state, rather 
than being at the upper end of a continuous spectrum. 
It is incorrect for some authors to disregard such 
patients [e.g. Nelson, 1955], and for others to 
consign them to a separate category [e.g. Chesley, 
1978b]. However, as some authors found an increased 
incidence of pre-eclampsia in such patients [Harley, 
1966], there would seem to be little alternative •. 
A . specific difficulty ~ n c ( ) u n t e r e d d when measuring 
blood pressure in pregnant women, is the necessity of 
using the 4th Korotko.v sound for diastolic pressure. 
Raftery and Ward [1968] demonstrated that in'healthy 
young. women, the 5th sound correlated better with 
diastolic pressure recorded directly from the right 
brachial artery. However, in pregnancy, use of the 
5th sound results i ~ ~ large skewing of data due to the 
finding of the 5th Korotkov sound at zero cuff 
pressure in some pregnant women [MacGillivray, Rose 
and Rowe, 1969]. 
The difficulty in diagnosing hypertension is 
compounded by a necessity.to standardise the technique 
of measurement, and by random and s y ~ t e m a t i c c
variations in blood pressure. Factors such as 
posture influence it, blood pressure being lowest when 
the patient is lying in the left lateral position; the 
blood pressure being measured in' her -right arm 
[Wichman, Ryden and Wichman, 1984]. The position of 
the arm relative to the heart also affects recordings, 
each centimetre of vertical height above or below the 
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level of the heart being equivalent to a difference in 
pressure of 0.7 mmHg. [Murnaghan, 1987]. A detailed 
description of the conditions of measurement in this 
study is included in the methods chapter, (p. 112). 
The spontaneous variability of blood pressure in 
hypertensive pregnant women has long been appreciated 
[Wiessner, 1899]. In addition, Murnaghan, Mitchell 
and Ruff [1980] demonstrated that in 16 normotensive 
patients, blood pressure varied with the circadian 
rhythm, values being highest during the afternoon and 
early evening. Under stressful conditions, Sleight, 
Fox, Lopez and Brooks [1978] found that a rise in 
blood pressure could', be evoked. This latter factor 
. 
may well be responsible for many of the elevated blood 
pressure recordings noted when patients visiJ; their 
obstetricians. 
Such factors can be reduced by averaging a large 
number' of readings, and in certain definitions high 
values are" only accepted if confirmed after a time 
i n t e r v ~ l , , for example 24 hours [Nelson, 1955]. In 
clinical practice this has the disadvantage of 
excluding the most acute and seriolls cases who are 
delivered shortly after admission. 
Finally, it, must be remembered that elevated 
arterial resistance is a more fundamental feature of 
pre-eclampsia than hypertension [Ginsburg and ~ u n c a n , ,
1967]. The latter is only a useful screening test as 
the cardiac output is usually constant. 
To paraphrase Redman [1987], hypertension is a 
difficult to measure, artificial concept, w'ith large 
sampling, errors, and it is not the cardiovascular 
abnormality of primary interest in the pathogenesis of 
- 5 -
pre-eclampsia. To this could be added the difficulty 
in setting the arbitrary thresholds. 
b) Proteinuria. 
Most authors have incorporated proteinuria in the 
definition of pre-eclampsia [e.g. Nelson, 1955, 
Hughes, 1972, Chamberlain, 1981, Davey, 1985, Rubin, 
1988], although some only incorporate it in 'severe' 
pre-eclampsia. As discussed above, there are problems 
in using clinical signs to define the disease, and 
eclampsia has been described in the absence of 
proteinuria [Sibai, McCubbin, Anderson, Lipshitz·and 
Dilts, 1981]. Nevertheless, in two large prospective 
~ t u ~ i e s s of 13,000 patients an,d of 41,000 patients, 
Page and Chris tianson [1976] and Naeye and Friedman 
(1979] found that when significant proteinuria was 
present, the outcome of the pregnancy, as assessed by 
the perinatal mortality, was inversely proportional to 
the degree of proteinuria. Both studies assessed 
proteinuria on random urine samples, and can be" 
criticised accordingly. Even in severe cases of ,pre-
eclampsia, the degree, of proteinuria may fluctuate 
widely over any 24 hour period [Gant and Worley, 
1980a]. More precise quantitation using 24 hour urine 
collections is desirable, although may be more 
difficult to achieve in clinical practice; it may be 
necessary to deliver a patient within a few hours of 
admission. 
e) Oedema. 
Oedema was formerly regarded as one of the 
diagnostic signs of pre-eclampsia' [Nelson, 1955]. 
However,in a prospective study of 83 patients, 
moderate oedema was found in 80% of 'normotensive 
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pregnancies [Robertson, 1971]. Moreover, Robertson 
found a similar incidence of hypertension among women 
with no oedema and amongst those with early or late 
onset oedema. Indeed, in a series of over 4,000 
patients, Tervila, Goecke and Timonen [1973] found 
that the presence of oedema tended to improve the 
fetal prognosis. 
d) Hyperurieaemia. 
An elevated serum urate measurement has been 
suggested as a specific diagnostic feature of pre-
eclampsia [Rubin, 1988]. R e d m ~ n , , Beilin, Bonnar and 
Wilkinson [1976] found that .... in a study of 332 
hypertensive pregnant patients, plasma urate l e v e l ~ ~
were a better i n d i ~ a t o r r of fetal prognosis than blood 
pressure. However; Breckenridge [1966] had previously 
noted serum u r ~ ~ e e to be frequently raised in essential 
hypertension, finding hyperuricaemia in 58% of 
patients under treatment for hypertension at the 
Hammersmith Hospital. Uric acid is filtered through 
the glomeruli, but is primarily excreted t h r ~ u g h h the 
tubules and in 71 male patients with borderline and 
established hypertension, s e r u ~ ' ' uric acid 
concentrations correlated inversely with renal blood 
flow per square metre of body surface [Messerli, 
Frohlich, Dreslinski, Suarez and Aris timuno, 1980]. 
Raised serum urate levels are probably better regarded 
not as a diagnostic or ,specific feature of pre-
eclampsia, but as a sensitive indicator of impaired 
renal function and renal blood flow. 
e) Renal biopsy findings. 
A specific renal lesion has been described in pre-
eclampsia. Details of the pathological. changes are 
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outside the scope of this text [see McCartney, 1964, 
Lindheimer, Chesley, Taylor, Spargo and Katz, 1987], 
but the major changes occur in the glomeruli, which 
become large and swollen but not hypercellular. 
McCartney [1964] performed renal biopsies on 62 
carefully selected p r i m i g r a ~ i d d patients, all known to 
be clinically normal in early pregnancy, who developed 
hypertension, proteinuria and oedema in the third 
trimester. Examination of the biopsies revealed that 
only 44 had the renal lesion of pre-eclampsia. 
Similar results were obtained by Fisher, Luber, 
Spargo, Spargo and Lindheimer [1980], from 104 
primigravid hypertensive patients, with both stud,ies 
finding that amongst muitiparous hypertensive patients 
the ~ e n a l l lesion occurred much less commonly. Such 
data underscore the difficulty i ~ ~ making a clinical 
diagnosis, of" the hypertensive complications of 
pregnancy on clinical criteria alone. 
There are further problems' in defining and 
classifying hypertensive disorders of pregnancy. For 
instance, with regard to the time of onset of pre-
eclampsia, some definitions set a c u t ~ o f f f time of 20 
weeks [e.g. Gant and Worley, 1980a], others 24 weeks 
[e.g. Hughes, 1972], and others 26 weeks [e.g. Nelson, 
1955]. There seems little basis for choosing anyone 
of these above another, indeed pre-eclampsia has been 
described prior to 20 weeks [Sibai, Abdelia and 
Taylor, 1982], often in conjunction with a molar 
pregnancy. 
Nevertheless, 
definitions to 
there 
allow 
is a need for provisional 
different investigators to 
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compare their experiences. Detailed below are the 
definitions used in this study, which are felt on 
balance to be the most appropriate. 
Pregnancy induced hypertension (PIB). 
An arterial blood pressure of 140 mmHg. or greater, 
and a diastolic blood pressure of 90 mmHg. or greater, 
occurring in a previously normotensive woman after the 
twentieth week of pregnancy. At least two such blood 
pressure recordings must be obtained,. on consecutive 
occasions, 24 hours apart. There should be no history 
of chronic renal disease or essential hypertension. 
Pre-eclampsia. 
Pregnancy induced ~ y p e r t e n s i o n n with the addition of 
significant proteinuria, significant proteinuria being 
the excretion of at least 0.3 gm of protein in a 24 
hour urine collection, in the absence of a urinary 
tract infection. 
Eclampsia. 
The Occurrence of convulsions in a patient with 
pre-eclampsia, in the absence of a history of 
epilepsy •. 
Essential hypertension. 
The presence of a blood pressure of at least 140/90 
mmHg., either before the twentieth week of pregnancy, 
or after three months post delivery. 
- 9 -
Incidence. 
Largely due to differences in definitions, 
incidences of pregnancy induced hypertension vary 
markedly, with estimations of up to 25% of pregnancies 
having been made [Chamberlain, 1981]. In data from 
this centre, using identical definitions to those 
above, Symonds [1979] found an incidence of pregnancy 
induced hypertension of 10.3% amongst primigravidae. 
The incidence was of a similar order in a study by 
MacGillivray et. ale [1969], who found an incidence 
amongst Aberdeen primigravid patients of 8.9% over a 
. two year period, using diagnostic thresholds of . at 
least 0.25 gm/litre proteinuria and at least 140/90 
mmHg. blood pressure recordings. Hall and Campbell 
[1986], again studying the p o p u l a t i o ~ ~ in Aberdeen, 
found little challge in incidence over· the last three 
decades. 
Predisposing f ~ c t o r s . .
In 1694 Mauriceau observed that nulliparous women 
were more likely to develop eclampsia than mUltiparous 
women [cited by Chesley, 1978c]. ·'In the British 
Perinatal Mortality Survey the incidence of 'moderate 
and s e v e ~ e ' ' pre-eclampsia in primigravidae was 13.5% 
as compared with 7.1% in multigravidae [Taylor, 1988]. 
Campbell, MacGillivray and Carr-Hill [1985] suggested 
that an abortion, either t,herapeutic or spontaneous, 
confers a protective effect, only if it occurs 'in the 
second trimester. Following a first trimester 
abortion, the subsequent incidence of pre-eclampsia 
approximated to that of the other nulliparous 
patients. 
- 10-
The association of increased maternal age and both 
pre-eclampsia and eclampsia is consistent [e.g. 
Nelson, 1955], with the morbidity being reflected in 
the ages of maternal deaths caused by eclampsia/pre-
eclampsia in England and Wales [HMSO, 1982-84]. Over 
a maternal age of 35 years, a dramatic increase in 
maternal deaths occurs. At the other end of the age 
spectrum, there is a disparity' of opinion. Certain 
studies, [e.g. Vollman, 1970] suggest an increased 
incidence in girls in their early teens, but ·this has 
not been found in other studies [ e . g ~ ~ Nelson, 1955]. 
These conflicting results may be explained by the 
difficulty in making comparisons with the early 
teenage group, due to the high incidence of concealed 
pregnancy and 'poor antenatal care, affecting both the· 
observed incidence and the presentation of the 
disease. 
Over a century ago, a familial history of the 
disease was suggested [Elliot J 1873]. However, it is 
only in the 'last thirty years that research has 
focussed on this aspect; principally due to the 
persistent and dedicated work of Leon Chesley. His 
. recent analysis of data co.llected 'Over a 49 year 
period concerned the incidences of pre-eclampsia and 
eclampsia in 147 s ~ s t e r s , , 248 daughters, 74 
granddaughters and 131 daughters-in-law of women who 
had eclampsia [Chesley and Cooper, 1986]. The 
observed incidences fitted ~ l o s e l y y with a single gene 
model with the frequency of the putative gene' being 
0.25. Other studies have confirmed a genetic and 
familial predisposition. Arngrimsson, Bjornsson, 
Geirsson, Bjornsson, Walker and Snaedal [1990] found a 
pattern of inheritance through . three or four 
generations in 94 families from the homogenous island 
population of Ie'eland, whi,ch could fit either a single 
- 11 -
recessive gene model or a dominant model with 
incomplete penetrance. 
It must be recognised that this conclusion relates 
to severe pre-eclampsia or eclampsia occurring in 
primigravidae. The disease is also very common in 
conditions associated with hyperplacentosis (multiple 
gestation, hydatidiform mole, diabetes, etc.) 
[Chesley, 1978c], and the single gene hypothesis would 
not explain this. 
There must be other compounding factors involved in 
the genesis of pre-eclampsia. A detailed review of 
possible factors is beyond the remit of ~ h i s s thesis. 
Suffice to say, that s ~ g g e s t i o n s s include a fetal sex-
linked factor, (MacGillivray [1983] finding an excess 
of male infants), low socioeconomic c l a ~ s s
[Chamberlain, "1981], maternal obesity [Hall and 
Campbell, 1986], maternal smoking, (a protective 
"effect [Chamberlain, 1981]), non-caucasian ethnic 
origin [Taylor, 1988], and even an association with 
unsettled weather [Chesley, 1978c]. 
Mortality. ~ , ,
The British Births Survey 1970 studied 16,815 women 
who had babies in one week [Chamberlain, Phillip, 
Howlett and Masters, 1978]. In cases of 'severe pre-
eclampsia', (this approximated to the definition of 
pre-eclampsia "above), the perinatal mortality rate 
increased to 34/1000 from the normal rate of 19/1000. 
However, the rate was normal or even slightly lower 
in cases of 'mild or moderate pre-eclampsia', (this 
approximated to the definition Qf PIH' above). 
Tervila, Goecke, and Timonen [1973] found a similar 
pattern in 4404 cases from Helsinki and Wurzburg, 
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reporting no effect on perinatal mortality from either 
hypertension alone, or hypertension and oedema. When 
proteinuria was also present, the perinatal mortality 
rose from 24/1000 to 65/1000. Should eclampsia ensue, 
recent figures of up to 216/1000 have been reported 
[Taylor, 1988]. 
Hypertensive disorders of pregnancy have remained 
the most common cause of maternal mortality in England 
and Wales, over recent decades [HMSO, 1982-84]. In 
the triennium 1982-84 there were 25 maternal deaths 
(13.5/million), 14 of which resulted from eclampsia. c 
Prevention of PIH. 
The treatment of established PIH i ~ ~ outside the 
. scope of this ~ e x t . . However, if PIH and pre-e'Clampsia 
could be prevented, eclampsia would not develop. 
Worley [1984] recommends· a management plan of rest, 
regular out-patient attendance, and early 
hospitalisation, aimed at those 'patients who are at an 
increased risk of developing hypertension in 
pregnancy. Nakamura, Ito, Matsui, Yoshimura, Kawasaki 
and Maeyama [1986] advocated a low salt diet for such 
patients. Recent work has suggested prophylactic 
benefits of both low-dose aspirin administration 
[Beaufils, Uzan, Donsimoni and Colau, 1985] and fish 
oil administration [Secher and Olsen, 1990]. 
Moreover, botb clinical experience and investigation 
[Gan t and Worley, 1980b] , provide evidence tha t a 
prophylactic reduction in physical activity may 
forestall PIH. (These concepts are discussed in 
greater detail in Chapter 9, p. 245.) The difficulty 
is in differentiating between t h o s e ' ~ h o o a r ~ ~ and will 
remain normal, 'and those those who appear normal but 
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will later develop PIH. To this end, a number of 
possible tests have been investigated, including: 
a) The angiotensin sensitivity test. 
This investigation is discussed in more detail in 
section 3, (p. 50). Gant, Daley, Chand, Whalley and 
Macdonald [1973] reported that primigravid women who 
la ter developed PIH in the same pregnancy showed an 
increased pressor response to infused angiotensin II. 
Although subsequent studies found substantial false 
positive rates [e.g. Oney and Kaulhausen, 1982, 
N a k a m ~ r a , , Ito, Ma'tsui, Yoshimura, Kawasaki and 
MaeyalI!.a, 1986] , this tes t is regarded as the mos t 
discriminatory available. , However, it is a time 
consuming procedure, and requires the placement of an 
intravenous 
throughout, 
the general 
cannula and' the presence of a clinician 
. 
thus rendering ~ t t unsuitable for screening 
population. 
b) The roll-over test. 
Gant, Chand, Worley, Whalley, Crosby and Macdonald 
[1974) described what later became known as the roll-
over test. They reported that an increase of > 20 
mmHg. in the diastolic blood pressure, when the 
patient was turned from the left lateral to the supine 
position, predicted' the development of subsequent 
hypertension in 15 out of 16 women tested at between 
,'. 
28 and 32 weeks gestation. Unfortunately subsequent 
reports have indicated that the test is less 
satisfactory, with Tunbridge and Donnai [1983] finding 
a false negative rate of 19% and false positive rate 
of 80%. Dekker, Makovitz and Wallenburg [1'990] found 
a false positive rate of 67% and they concluded that 
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the roll-over test was of no value in the prediction 
of PIH. 
There are several flaws in the test. Some patients 
have unusually low diastolic blood pressures in the 
left lateral position «45mmHg.), this can create a 
false positive result when the value is compared with 
the reading in the supine position [Phelan, 1977]. 
Furthermore, markedly differing results from the same 
patient are found when the test is' performed on a 
biweekly basis [Phelan, 1977]. Despite the fact that 
the test is simple to perform and requires only time 
and personnel rather than elaborate equipment, it has 
rightly found little place in routine obstetric 
practice. 
c) Forearm venous tone. 
In a cross-sectional study, Stainer, Morrison, 
Pickles and Cowley U0986] found that women with PIH 
were venoconstricted in the forearm, when compared 
with normotensive pregnant women. The authors suggest 
that measurement of venous tone may have potential as 
a screening test for PIH. However, the number of 
women studied was small, with only 11 PIH patients, 
(two of whom were- in their second pregnancies). 
Moreover the degree of overlap was such that only one 
value of the PIH group lay outside the normal range. 
A prospective study by the same group demonstrated 
similar resulOt's, with differences in forearm" venous 
tone occurring at least six weeks before the diagnosis 
of PIH [Stainer, 1989]. Patient number was again 
small, (33 primigravidae, of whom 7 developed PIH) , 
and overlap was again present. '. -Al though time-
consuming, and requiring both temperature control and 
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sophisticated equipment, the technique merits further 
study. 
d) Platelet count. 
Redman, Bonnar and Beilin [1978] suggested that 
platelet count might be helpful in monitoring high 
risk pregnancies. They found· that a reduction in 
platelet count occurred early in the development of 
pre-eclampsia, being detectable about seven weeks 
prior to delivery. However, the study group 'chosen 
were mUltiparous women with chronic hypertension, in 
'whom a diagnosis of superimposed pre-eclampsia cannot 
be made with ease. The chosen method of diagnosing 
pre-eclampsia was that of an e l e ~ a t i o n n in plasma 
urate, which as discussed above, is better regarded as 
an indicator of impaired renal function. In addition, 
the variation in counts between patients was such that 
no importance could be attached to a single low 
reading. As discussed in section 6 (p. 104), a 
reduced platelet count is found in only a minority of 
. patients with pre-eclampsia, thus platelet counts 
cannot be regarded as a good screening test. 
e) Prostacyclin synthesis. 
As reviewed in section 3 (p. 52), diminished 
prostacyclin production may be a factor enhancing 
angiotensin I ~ ~.. pressor sensitivity in patients with 
severe PIH. . In a small study, Fitzgerald, Entman, 
Mulloyk and FitzGerald [1987] found elevated levels·of 
2,3 -dinor-6-keto-prostaglandin F1 alpha (a stable 
urinary metabolite of prostacyclin) in patients who 
subsequently developed PIH. Moreover, in" the same 
patients, they found no difference in the results of 
the angiotensin sensitivity test betweerf those women 
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who developed PIH and those who remained normotensive. 
In another small study [Schaffer, Rakhit, Martin, 
Hanie, Sibia, Ross, Dunton and Douglas, 1990], 
elevated urinary thromboxane : 2,3 -dinor-6-keto-
prostaglandin F1 alpha ratios were found in patients 
with severe PIH. A complex method was used in these 
studies, involving gas chromatography-mass 
spectrometry. Evaluation of potential as a screening 
test would require study of a larger population with a 
more easily applied method such as radioimmunoassay. 
f) Doppler ultrasound. 
Doppler ultrasound scanning is, becoming an' 
increasingly controversial technique, (e.g reviewed by 
Neilson [1987]), and detalled discussion is beyond the 
s c o p ~ ~ of this thesis. However, the possibility of. 
identifying changes in perfusion in advance of 
clinical signs prompted Campbell, Pearce, Hackett, 
C9hen-Overbeek and Hernandez [1986] to perform Doppler 
studies of maternal arcuate arteries. They studied 
126 women at 16-18 weeks gestation, and found a higheF 
subsequent incidence of PIH in women with abnormal 
waveforms. The very high incidence (40%) of abnormal 
waveforms demonstrated in this series may be spurious, 
and suggests that the normal ranges obtained initially 
were inappropriate for the general population. In 
contrast, a recent controlled study of Doppler' 
uteroplacental waveforms in untreated cases of PIH, 
.... ." 
demonstrated no difference from the normotensive 
controls [Hanretty, Whittle and Rubin, 1988]. 
Although the method of obtaining the waveform has been 
criticized [Pearce and MacParland, 1988], it was 
apparent that markedly different waveforms" could be 
obtained from the utero-placental vessels, a finding 
which probably relates to the focal' nature of 
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placental pathology in PIH. The value of the 
technique as a screening procedure is thus as yet 
unproven. 
At present, none of the above methods are widely 
used to screen the general pregnant population, in 
order to select those at risk of developing PIR. 
This thesis involves a study of human platelet 
angiotensin II binding, including the potential use of 
the technique as a marker and indeed. screening tes t 
for PIH. 
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section 2. 
THE RENIN-ANGIOTENSIN SYSTEM. 
In 1898 Tigerstedt and Bergman demonstrated that a 
kidney extract exerted a potent pressor response when 
injected into a rabbit, and they termed the active 
, subs tance renin. Since this time the renin-
angiotensin system has been closely associated with 
efforts to understand the regulation of blood 
pressure. This section presents a' brief overview of 
the present state of knowledge' of the renin-
angiotensin system" concentrating on a n g i o ~ e n s i n n II 
(All). Unless stated the section considers data from 
human studies. 
The renin-angiotensin system is summarised in 
Figure 1.1. 
Angiotensinogen. 
Angiotensinogen is the circulating alpha2 globulin 
from which enzyme renin cleaves the decapeptide 
angiotensin I. Chromatographic studies by Gordon and 
Sachin [1977] suggested a mUltiplicity of forms. 
Subsequent characterisation studies [Campbell, 
Bouhnik, C o e ~ y , , Menard -and Corvol, 1985]. have 
indicated that all forms stem from a single precursor 
of molecular weight 46,000. The higher m ~ l e c u l a r r
weight forms are believed to be either aggregates or 
combinations with other proteins. T h ~ ~ higher 
molecular weight forms increase p r o g ~ e s s i v e l y y as a 
proportion of the total angiotensinogen throughout 
pregnancy [Tetlow and, Broughton Pipkin, 1986]. 
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Figure 1.1. 
The renin-angiotensin system. 
'. 
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Fyhrquist, Rosenlof, Gronhagen-Riska, Hortling and 
Tikkanen [1985] noted immunological similarities 
between erythropoietin and angiotensinogen, and 
suggested that angiotensinogen might be a 
precursor of erythropoietin. However, these results 
have not been confirmed, and removal of contaminants 
using fast protein liquid chromatography, indicated 
that the substances were unrelated [Rosenlof, 1986]. 
A detailed review of the sources and regulation of 
angiotensinogen production is provided by Reid, Morris 
and Ganong [1978]. In summary, the majority of the 
angiotensinogen . in the circulation is synthesised in 
the liver. Oestrogens increase angiotensinogen 
production, as does the administration of ACTH, 
certain corticosteroids, and All itself. The ability 
of corticosteroids to i n c r e a ~ e e angiotensinogen 
production is related to glucocorticoid rather than to 
mineralocorticoid activity. Thus plasma levels are 
elevated in patients with Cushing's syndrome but not 
in patients with 'primary aldosteronism [Krakoff, 
1973]. 
Renin. 
Renin is an aspartyl ,proteinase that cleaves the 
Leu-Val bond from the aspartic acid end of 
angiotensinogen to release angiotensinogen I (Figure 
1.1) • Renin exis ts in various forms. Morris and 
Lumbers [1972] ' ~ t u d y i n g g amniotic fluid, suggested that 
proteinases activated an inactive form. 
Renin is primarily synthesised and stored in a 
specialised part of the nephron, the', juxtaglomerular 
apparatus, a complex of vascular and tubular elements 
located at the hilum of the glomerulus, (Figure 1.2). 
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The major components of the juxtaglomerular apparatus 
are the afferent and efferent arterioles and the 
macula densa, a specialised tubular area that marks 
the transition from the loop of Henle to the distal 
tubule. The afferent arteriole contains specialised 
cells known as the juxtaglomerular cells. These 
cells, which are the site of synthesis, storage, and 
release of renin, contain myofibrils, characteristic 
of vascular smooth muscle, and a well developed 
endoplasmic reticulum and Golgi membranes, 
characteristic of endocrine cells. The vascular and 
tubular elements of the juxtaglomerular apparatus are 
innervated· by adrenergic nerves. More detailed 
description . of the anatomy of the juxtaglomerular 
apparatus may be found elsewhere [Keeton and C a m ~ b e l l , ,
1981]. 
" ...... "Enctoth.1IaI calla 
Juatagtom.""tar c.tla 
AFFERENT ARTERIOLE DISTAL'TUBULE 
Figure 1.2. The anatomical relationship .. of the 
juxtaglomerular apparatus [Keeton and 'Campbell, 1981]. 
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Renin release is controlled by interacting renal 
and extrarenal factors. Tobian, Tomboulian and 
Janecek [1959] perfused isolated rat kidneys, and 
noted degranulation of juxtaglomerular cells in 
association with increased perfusion pressure. This 
led Tobian to propose the 'stretch' receptor 
hypothesis, whereby a high renal perfusion pressure or 
renal (afferent arteriolar) vasodilation stretches the 
walls of the afferent arterioles. The juxtaglomerular 
cells are thus stretched, resulting in decreased renin 
release. Subsequent criticism of the· theory has 
stemmed from the observation by various workers that 
either s'ystemic or renal arterial renin release was 
usually associated with renal vasodilation. Many of 
these studies .[e.g. Cowley and Guyton, 1972] were 
performed on anaesthetised animals, and are difficult 
to interpret in view of the redu7ed renal blood flow 
and increased renin release induced by anaesthesia per 
.!! [Keeton and Campbell, 1981]. However, further 
studies on conscious chronically cannulated dogs [e.g. 
Gutmann, Tagawa, Haber and Barger, 1973] confirmed the 
previous. findings. It must be assumed that 
intravascular pressure rather than the radius of the 
afferent arteriole is the factor inducing 'stretch', 
i.e that a baroreceptor mechanism is present. 
Evidence derived from animal studies suggests that 
changes in the rate of delivery of sodium [Vander and 
Miller, 1964] and chloride [Kptchen, Golla and Luke, 
1978] to the d i s t ~ l l tubule are detected by the macula 
densa, and signal reciprocal changes in renin release. 
The sympathetic nervous system also plays an important 
role in the control of renin release. In an elegant 
study of the innervation of the juxtaglomerular 
apparatus, Johnson, Davis and Witty [1971] stimulated 
isolated renal nerves in anaesthetised dogs, having 
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given an intrarenal infusion of papaverine. The 
increased renin release noted, was thus in the absence 
of a functional macula densa, or any change in renal 
blood flow. Other factors that alter renin secretion 
include potassium, vasopressin, and All, all of which 
inhibit secretion. The control of renin release has 
been extensively reviewed [Davis and Freeman, 1976, 
Reid, Morris and Ganong, 1978, Keeton and Campbell, 
1981]. 
Whilst the majority of renin is renal in origin, it 
is known to be synthesised in a variety of extrarenal 
tissues, notably those of the genital t r a c t ~ ~ Symonds, 
Stanley and Skinner [1968] described the production of 
renin by in vitro cultures of chorion and uterine 
muscle. Immunohistochemical te.chniques have shown the 
p + e s ~ n c e e of cells containing renin granules clustering 
in the interarteriolar tissue in human myometrium 
adjacent to the endometrium [Johnson, Johnson, Ronan 
and Craven, 1984]. Renin has also been identified in 
brain tissue from several species [e.g. Phillips, 
1987], lending support to the suggestion of an 
intrinsic brain renin-angiotensin system, (see p. 29). 
Renin is measured in the plasma either in the form 
of plasma renin activity (PRA) or plasma renin 
concentration (PRC). The former measures the rate of 
generation of angiotensin I (AI) under constant 
conditions of pH and t e m p e r a t u ~ e e and in the presence 
of inhibitors of converting enzyme and angiotensinase. 
PRC measures the maximal AI generation obtained in the 
presence of excess heterologous (sheep) substrate. 
Under certain condi tions the subs tra te may be . the 
limiting factor in the generation of .At [Skinner, 
Lumbers and Symonds, 1969] thus PRC provides a truer 
measurement of enzyme concentration. 
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Angiotensin I (AI). 
AI is of little biological activity and is rapidly 
converted to All [Peach, 1977]. The enzyme 
responsible for this conversion is converting enzyme 
(ACE). 
Angiotensin Converting Enzyme (ACE). 
ACE is a non-specific carboxypeptidase that cleaves 
dipeptides from many synthetic or natural substrates, 
including bradykinin, as demonstrated by Yang, Erdos 
and Levin [1970], who found ACE to be i d ~ n t i c a l l to 
kinase II. 
The primary site of functional All production. 
outside pregnancy is the lung, morphological and 
immunological studies originally performed on rabbit 
tissues, having indicated that ACE is. -predominantly 
localised in the luminal surface of the endothelial 
cells which line blood vessels [Caldwell, S ~ e g a l , , HSu,' 
Das and Soffer, 1976]. However, using high 
performance liquid chromatography Miyazaki, Okunishi, 
Nishimura and Noboru [1984] found ACE activity in 
blood vessels of other tissue beds, in d i f f e r e n ~ ~
species. In addition, ACE activity has been 
demonstrated in fetal membranes, placenta and amniotic 
fluid [Warren, Craven and Symonds, 1984]. 
Angiotensin II (All). 
The octapeptide All is the physiologically active 
component of the renin-angiotensin system. . The 
various actions of the hormone are considered in more 
detail below. 
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Cardiovascular effects. 
In 1941, Hill and Andrus first presented evidence 
from in vitro experiments with animal tissues that All 
possessed a direct positive inotropic myocardial 
effect. The vast majority of subsequent studies, 
performed using dog heart-lung preparations, perfused 
cat and rabbit hearts, isolated cat and dog papillary 
muscles, and isolated atria from cats and rabbits, 
have consistently confirmed a positive inotropic 
action of All (e.g. Dempsey, McCallum and Kent and 
Cooper, 1971, Freer, Pappano, Peach, Bing, McLean, 
Vogel and Sperelakis,1976, reviewed by Peach, 1977]. 
One study (Downing a1;1d Sonnenblick; 1963] concluded 
that there was no consistent inotropic effect when cat 
myocardial preparations were continuously infused with 
All, yet .these conclusions were based on only three 
such preparations. 
The majority of workers have found that the 
administration of All to animals with intact 
baroreceptor reflexes results in a bradycardia [e.g. 
Page and Olmstead, 1961, Brod, Hejl, Hornych, Jirka, 
Slechta and Burianova, 1969, reviewed by Peach, 1977]. 
However, Ismay, Lumbers and Stevens [1979] studying 
conscious sheep, found that the bradycardia· evoked 
when blood pressure was raised by All was less marked 
than when the same increase in blood pressure· was 
produced by phenylephidrine. Mor"eover, Mueller, 
Gregory, Giannelli and Ayres [1?70] found no change in 
heart rate when Ali infusion studies were performed "on 
10 post heart-surgery patients. Both Ismay et. al., 
and Lumbers, McCloskey and Potter [1979] suggested 
that All inhibited vagal discharge to the heart; . the 
latter group recording the effect of All. on action 
potentials in single cardiac efferent fibres dissected 
from the vagus nerves of dogs. 
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In all species studied, the blood pressure response 
to intravenously injected All begins within about ten 
seconds, and is characterised by a sharp rise in both 
systolic and diastolic pressures, the increase in 
diastolic pressure being the greater [Peach, 1977]. 
Very low doses induce a slow progressive rise in 
arterial pressure that may require days to develop, 
however, infusions that cause an immediate pressor 
response tend to result in tachyphlaxis over a period 
of several hours [e.g. Dickinson and Lawrence, 1963, 
Day, McCubbin and Page, 1965]. There are several 
components to the pressor response to All. Direct 
influences of the central and sympathetic nervous 
systems are discussed below, however the major 
c o m p o n ~ n t t results from direct vasoconstriction in 
several vascular beds, the splanchnic, renal, and skin 
beds being the most sensitive [Br<;>d; Hejl, Hornych, 
Jirka, Slechta "and Burianova, 1969, Reid, 1985]. Brod 
et. ale [1969] infused 9 subjects intravenously with 
All, finding little change in forearm" muscle blood 
flow, as compared to markedly reduced skin and renal 
blood flow. Paradoxical ~ o r o n a r y y vasodilation induced 
by All has been reported in rabbits [Needleman, 
Marshall and Sobel, 1975], and has been shown to be 
due to stimulation of the synthesis of a prostaglandin 
E2-like substance. An underlying vasoconstrictor 
effect was unmasked by the administration of the 
prostaglandin synthetase blocking agent, indomethacin. 
Interaetion with sympathetic nervous system. 
There is good evidence that the vasoconstrictor 
effects of All and sympathetic nerve activity 
interact. For example, Zimmerman [1962] demonstrated 
that sympathectomy in dogs reduced the" pressor ,effect 
of All. Conversely, All may 'modify the 
vasoconstrictor effect of sympathetic activity. AII-
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induced potentiation of the contraction of sympathetic 
smooth muscle has been reported by many groups 
[reviewed by Peach, 1977]. 
Nicholls, Espiner, Miles, Zwiefler and Julius 
[1981] infused normal human subjects with All in doses 
from 0.5 to 4.0 ng/Kg/min and raised plasma All 
concentrations to as high as 100 pg/ml (normal range 
up to 35 pg/ml in man) without any significant effect 
on the plasma catecholamine level, suggesting no 
adrenal medullary effect of such physiological peptide 
concentrations. They also found unchanged plasma 
catecholamine concentrations in hypertensive patients 
given the converting enzyme inhibitor captopril at a , 
dose which lowered the. plasma All levels from 22 to ~ ~
pg/ml. Furthermore, during All-induced hypertension, 
(20 ng/Kg/min for six days), in unanaesthetised dogs, 
, 
there was only a transient increase in arterial 
adrenaline level after four hours of infusion, 
[Carroll, Lohmeier and Brown,. 1983]. Measurement of 
the adrenal noradrenaline secretion rate indicated no 
increased release from the adrenal. 
However, there are inherent flaws in the above 
studies. Measuremen t of uns t.imula ted ca techolamine 
levels will not have been sufficiently sensitive to 
detect relatively small changes in adrenergic 
transmitter release due to All-induced facilitation, 
especially with the less specific measurement methods 
available in the early 1980s. In addition, 
baroreceptor reflexes due to blood pressure changes 
w o ~ l d d tend to counteract the effect of All on 
transmitter release. In contrast, concentrations of 
30-1000 pg/ml All produced consistent fa,cilitation of 
adrenergic responses in isolated preparations without 
compensa tory mechariisms [Zimmerman, Gomer and Liao, 
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1972, Ackerly, Blumberg and Peach, 1976]. 
Furthermore, in the isolated rat kidney, endogenously 
formed All enhanced pressor responses and transmitter 
release during renal adrenergic nerve stimulation when 
AI was infused [Boke and Malik, 1983]. 
The mechanism by which All enhances sympathetic 
vasoconstriction is controversial. 'Some investigators 
[e.g. Kiran and Khairallah, 1969] have concluded that 
the peptide directly stimulates adrenergic nerve 
terminals to release noradrenaline. However, in Kiran 
and Khairallah's work, the concentration of All, 
necessary to produce significant effects in the 
perfused rabbi t ',aortae was high, (20 ug/ml) • The ", 
majority of other studies have indicated that All 
interferes with the inactivation of synaptic 
n o r a d r e n a l i n ~ ~ by inhibi ting the neuronal uptake 
process for the amine [reviewed by Peach, 1977]. 
There is also evidence from studies of guinea pig 
atria a d r e ~ e r g i c . . nerve endings' that- ')!·II stimulates 
n6radrenaline synthesis by enhancing hydroxylation of 
tyrosine [Roth, 1972]. 
Central actions. 
The blood-brain barrier excludes polar molecules, 
such as A I I ~ ~ from most parts of the brain. However, 
in the rat, systemically administered radiolabelled 
All was found to have a specific, high affinity uptake 
in the circumventricular orgaIls, small areas of the 
brain that lack'8 blood-brain barrier [Van H o u t ~ n , ,
Schiffrin, Mann, Posner and Boucher, 1980]. A 
detailed discussion of whether the actions elicited by 
centrally administered All can be explained solely on 
the basis of an interaction at the circumventricular 
organs, or whether ,a separate brain renin-angiotensin 
system exists, is outside the remit of this thesis. 
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In summary, although certain studies question the 
presence of All in the brain, (for example Semple, 
Wacrae and Morton [1980] suggested that much of the 
immunoreactive "All" found in human cerebrospinal 
fluid was an immunoassay artifact), the demonstration 
of many of the components of the renin-angiotensin 
system [reviewed by Phillips, 1987], and the wide 
variety of responses obtained, (discussed below), on 
injecting All into the central nervous system has led 
the majority of authors to support the existence of an 
intrinsic· brain system [e.g. Reid, 1979, Ganong, 
1984]. 
The major central actions of All include the 
control of hypovolaemia, the , c y ~ l i c c regulation of 
reproductive hormones, and possible neurotransmitter 
effects. 
Water intake is elevated in conditions which 
elevate the renin-angiotensin system; for example, 
water deprivation, renal artery constriction, 
administration of i s o p r ~ t e r e n o l l [Severs and Summy-
Long, 1975]. Fitzsimons and Simons [1969] 
demonstrat·ed that All infused intravenously caused 
rats to drink, the effect being greater after 
nephrectomy. Moreover, when All was injected or 
infused into the anterior diencephalon, the minimal 
dose sufficient to cause 'water-replete rats to drink 
was at least 1000 times s ~ a l l e r r than the minimal 
intravenous dose [Epstein, Fitzsimons and Rolls, 
1969]. Dose response studies in the dog, indicate 
that drinking responses can be elicited by low doses 
of intravertebral and intracarotid All, which produce 
elevations in plasma All levels that ,are within the 
physiological range [Reid, Brooks, Rudolph and Keil, 
1982]. Reid et. ale [1982] estimated that the 
- 29-
threshold plasma All level necessary to induce 
drinking in the dog was in the range 108-449 pg/m1; 
with plasma concentrations in the lower half of - the 
range being commonly found in hypovolaemic states. 
With the caveat that the effects of the endogenous 
hormone are not necessarily those of exogenous 
infusion doses, it seems reasonable to conclude, that 
in animals at least, the dipsogenic effect is a 
physiological one. 
The first evidence for a central pressor effect of 
All was obtained from isolated head perfusion studies 
in dogs [Bickerton and Buckley, 1961]. Subsequently, 
dose response studies in dogs demonstrated that 
pressor responses could also be elicited by 
intravertebral or intracarotid infusion of .AII in 
doses that p r o d u ~ e e elevations in concentration within 
the p h y s i o l o g i 6 ~ 1 1 range, (the threshold being a plasma 
All level below 100pg/m1) [Reid eta a1., 1982]. This 
dose dependant effect has been demonstrated by 
numerous independent groups and in several species 
i n c 1 u d ~ n g g man [e.g. Falcon, Phillips, Hoffman and 
Brody, - 1978, Unger, Rascher, Schuster, Pav10vitch, 
Schomig, Dietz and Ganten, 1981, Ganong, 1984]. 
Comparison of the dose response curves for 
administration of intravertebra1 and intracarotid All 
in dogs, with the dose response curve for intravenous 
All, suggested that centrally mediated effects 
constituted a significant comp?nent of the increase in 
blood pressure produced by intravenous All [Reid 'eta 
a1., 1982]. 
Some groups demonstrated relatively marked 
increases in plasma vasopressin with low doses of All 
administered directly into the cerebral ventricles 
[e.g. Ramsay, Kei1, Sharpe andShinsakoJ 1978], 
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whereas others failed to show any increase [Reid et. 
al., 1982]. Regrettably, many authors neglected to 
take their use of anaesthetic agents into account. 
Certain anaesthetic agents may increase vasopressin 
secretion, whilst others abolish it [Padfield and 
Morton, 1976]. When analysis is confined to studies 
on conscious animals, the variation in the dose of 
systemically administered All requ,"red to stimulate 
vasopressin secretion may reflect difficulties in 
vasopressin assays [e.g. Phillips, 1987]. In human 
studies, Padfield and Morton [1976] found that plasma 
levels of vasopressin only increased at 
supraphysiological levels of All, (at approximately 
200pg/ml), and concluded that All is unlikely to 
affect vasopressin concentrations in physiological 
situations. However, vasopressin is suppressed by 
elevations in blood pressure, and All i ~ ~ a p r e ~ s o r r
agent. Thus "the role of All may be greater than 
predicted by results from exogenous infusions. 
Phillips [1987] suggested that the central effects 
of All included the control of sodium balance. All 
infused into the third ventricle has been shown to 
cause rats to drink large quantities of 2.7% sodium 
chloride [Fluharty and Epstein,1983]. Furthermore, a 
natriuresis has been demonstrated, following 
intraventricular injections of All, in rats, dogs, and 
goats [Brooks and Malvin, 1982, Reid, 1984]. However, 
the studies quoted above were on animals, with large 
doses of exogenous hormone elevating All 'to 
supraphysiological levels. Coghlan, ConSidine, 
Denton, Fei, Leksell, McKinley, Muller, Tarjan, 
Weisinger and Bradshaw [1981] argued against a role 
for All in this situation, finding that the All 
antagonist saralasin did not alter the sodium intake 
of sodium deficient' sheep. 
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In animal studies, All has been shown to increase 
ACTH secretion when administered into the carotid 
arteries, or into the cerebral ventricles, [Ramsay, 
Keil, Sharpe and Shinsako, 1978, Reid et. aI, 1982]. 
These studies were flawed in that increased ACTH 
secretion was inferred from changes in plasma 
corticosteroid concentration, ignoring any direct 
action of All on the adrenal cortex. Nevertheless, 
when isolated pituitary cells were treated with All, 
radioimmunoassay measurements of ACTH increased [Vale, 
Vaughan, Smith, Yamamoto, Rivier and Rivier, 1983]. 
Since ACTH modulates the aldosterone stimulatory 
effect of All at the adrenal cortex, (discus$ed 
below), a delicate amplification system seems to 
exist. 
There is evidence that All has a fUnctional 
interrelationship wfth the hypothalamo-pituitary s e ~ ~
hormone axis. In oestrogen primed, ovariectomised 
rats, intraventricular All increased plasma 
luteinising hormone (LH) levels, whereas intravenous 
All had no effect [Steele, Gallo and Ganong, 1985]. 
Moreover, in the presence of oestrogen and 
progesterone, whilst intravenous saralasin or 
enalapril (an ACE inhibitor) did not affect the LH 
surge during proestrus in rats, intravenous 
administration prevented the surge [Pellicer, Palumbo, 
DeCherney and Naftolin, 1988]. All stimulates 
noradrenaline secretion, (discussed below), which is 
known to. stimulate LH secretion, thus this could .be 
either a direct or an indirect effect. In contrast, 
prolactin and growth hormone secretion by the anterior 
pituitary were selectively inhibited by 
intraventricular All [Steele et. al., c 1985]., The 
physiological significance of these findings was not 
assessed, the doses'of All being much higher than both 
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physiological levels, and the levels used to elicit 
drinking [Severs and Summy-Long, 1975]. 
The influence of the sex hormones on All binding is 
considered in a later section, (p. 83). 
The final central nervous system function of All is 
the stimulation and interaction with neuro-
transmitters. Electrophysiological studies have shown 
All to act as a neurotransmitter, being able to excite 
neurons at doses of 10-12 M and being found in 
synaptic terminals [Pavovcik and Phillips, 1984]. All 
increases catecholamine production in the brain, with 
intraventricular All increasing noradrenaline turnover' 
in the" circumventricular organs without changing the 
dopamine turnover [Summners and Phillips, 1983]. 
Peripheral All administration has been found to 
increase the serotonin content of the dog 
hypothalamus, brainst,em and·. pineal gland [Nahmod, 
Finkielman,' Benarroch and Pirola, 1978]. Interactions 
with opiods such as enkephalins and endorphins have 
also been suggested [Haulica, Petrescu, Stratone, 
Branisteanu, Rosca, Neamtu and Slatineanu, 1982]. 
Aldosterone secretion. 
All in vivo is a specific stimulus to aldosterone 
secretion within the physiological range. The 
sensitivity threshold in humans ,varies from 0.3 to 1.0 
ng All/Kg/min in fndividuals consuming 100-200 mEq 'of 
sodium [Hollenberg, Chenitz, Adams and Williams, 
1974]. When endogenous All is low, a low sodium diet 
increased the sensitivity and magnitude of the 
response to All by up to threefold [Hollenberg et. 
al., 1974]. The infusion rate of 0.3 ng All/Kg/min 
. did not produce a measurable change in the pl,asma All 
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level, suggesting that the sensitivity of the 
glomerular cell was greater than that of the technique 
used to measure All. Potassium loading also increased 
the maximum output of aldosterone in response to All 
infusion [Hollenberg, Williams, Burger and Hooshmand, 
1975]. With prolonged infusion, a decrease in 
aldosterone secretion occurred, which may be a 
secondary effect of potassium depletion [Ames, 
Borkowski, Sininski and Laragh, 1965]. In vitro 
studies using human tissue are few. Moreover, due to 
the profound effect of dietary sodium and potassium 
intake in vivo and in vitro, human studies are 
d i f f i c ~ l t t to interpret in view of the lack of control 
of these critical variables. Nevertheless, when 
normal human adrenal cells w e r ~ ~ used, the response was 
similar to that reported in vivo i.e. the All response 
was modified by dietary sodium intake [Williams and 
Braley, 1977]. Cells obtained from aldos t ~ r o n o m a s s
tend to have an increased sensitivity to sodium and 
All and a much greater aldosterone output, primarily 
because of an increased rate of conversion of 
corticosterone to a ~ d o s s terone [Williams and Braley, 
1977]. 
The biochemical mechanism whereby All s timula tes 
aldosterone synthesis is complex. Aldosterone 
synthesis is regulated at two steps; an early step 
involving the conversion of cholesterol to 
pregnenolone which is therefore common to many 
steroids, and a s p ~ c i f i c c later step, the conversion 'of 
corticosterone to aldosterone (Muller, 1971]. To 
study these two regulated steps Campbell, Brady and 
Gomez-Sanchez [1986] used an inhibitor of3 beta-
hydroxy steroid dehydrogenase, cyanoketone to block 
. , 
the further metabolism of pregnenolone. Using this 
. method in isolated adrenal cells from rats, they found 
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that All stimulated pregnenolone synthesis in a 
concentration related manner; at higher concentrations 
it also stimulated the second step. 
The control of steroid secretion by All may differ 
across species. There is evidence for this in the 
response of fasciculata cells to All. Studies of rat 
and normal human cells give no indication that All 
stimulates secretion [Hollenberg et. al., 1974, 
Williams and Braley, 1977]. However, in bovine and in 
pathological human tissue, All stimulates cortisol 
production [Kojima, Kojima and Rasmussan, 1986]. The 
implication of these findings in terms of All 
stimulated aldosterone secretion are uncertain, but ,., 
lead to caution in the interpretations made from 
animal studies. 
Prostaglandins have also been proposed as 
regulators of adrenal steroidogenesis [e.g. Kostis, 
DeFelice and Pianko, 1987], and Campbell et. al. 
[1986]·found that PGE2 stimulated aldosterone 
synt?esis by activating the early step. Furthermore, 
indomethacin, at a concentration that inhibited the 
synthesis of p r o ~ t a g l a n d i n s , , reduced by 48% the 
stimulation of aldosterone 'synthesis by All. 
Indomethacin, like PGE2' acted only on the early 
biosynthetic step [Campbell et. al., 1986]. This data 
thus provides support for a role for prostaglandins in 
All induced steroidogenesis. 
" 
There is a complex interrelationship between the 
renin-angiotensin system and prostaglandin synthesis. 
Various prostaglandins have been found to affect the 
r e n i n ~ a n g i o t e n s i n n system, with p r o s t a g l a n d i ~ s s E1; E2' 
A1' D2' 12' G2' H2 and arachidonic acid all being 
,found to stimulate renin release, whereas PGF2 1 
a pha 
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. inhibits renin release [Keeton and Campbell, 1981]. 
In addition, direct intrarenal All infusion has been 
shown in dogs, to evoke release of a PGE2-like 
substance, [McGiff, Crowshaw, Terragno and Lonigro, 
1970]. Indomethacin administration has been shown to 
block the intrarenal formation of PGE2' and to enhance 
both the renal vasoconstrictor and the overall 
systemic pressor response to All [Aiken and Vane, 
1973, Negus, Tannen and Dunn, 1976]. Consideration of 
the relationship between All and prostaglandins in 
pregnancy, follows in the next section, (p. 44). 
Renal actions. 
All exerts a number of effects on the kidneys. 
Indirect actions of All occur via three mechanisms 
discussed above; increased perfusion pressure due to 
peripheral vasoconstriction, incre.ased sodium 
'reabsorption and potassium secretion from stimulated 
aldosterone secretion, and the actions of All-induced 
catecholamines. 
Direct effects of All include: 
1) A potent feedback inhibition of renal renin release 
[Vander and Geelhoed, 1965]. 
2) A potent vasoconstricting effect on renal vascular 
smooth muscle, especially on the efferent arterioles. 
This results in increased renal perfusion pressure, 
decreased renal blood flow, and enhanced reabsorption 
due to a reduction in both per,icapillary hydrostatic 
pressure and colloid pressure, [these changes are 
reviewed in detail by Mendelsohn, 1985a]. 
3) Increased tubular reabsorption of sodium (in the 
proximal convoluted tubule) [reviewed by Humphreys and 
Lin, 1988]. 
4) The interaction with renal prostaglandin synthesis 
. discussed above. In addition All infusion c:auses a 
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reduction in prostaglandin-mediated cAMP production by 
mesangial cells, resulting in contraction of the cells 
[Ichikawa and Brenner, 1984]. 
An intact renin-angiotensin system is crucial to 
the autoregulation of renal blood flow and glomerular 
filtration rate, (GFR). When Hall, Guyton, Jackson, 
Coleman, Lohmeier and Trippodo [1977] reduced renal 
perfusion pressure in dogs with' high plasma renin 
concentration, autoregulation of renal blood flow and 
GFR was maintained. . However, when converting enzyme 
inhibi tors were infused, the GFR fell. This effect 
has been encountered in patients with bilateral renal. 
artery stenosis, where the renin-angiotensin system 
has ~ a i n t a i n e d d the GFR in spite. of low perfusion' 
pressures. The addition of captopril has induced 
functional renal insufficiency in some of these 
patients [Hricik, Browning, Kapelman,Goorno, Madias 
and Dzau, 1983]. 
Angiotensin III (AlII). 
The heptapeptide AlII is the first product of 
degradation of All, (Figure 1.1). It is All minus' 
aspartic acid that is removed by aminopeptidase 
hydrolysis. With the exception of the adrenal cortex, 
where AlII seems to be more potent than All in the 
conversion of cholesterol to aldosterone, AlII 
manifests all the activity of All but is a less potent 
pressor agent, and its concen1:ration is much lower 
than All in .humanplasma [reviewed by Kostis et. a l ~ , ,
1987]. 
The following section moves on to a more specific 
consideration of the renin-angiotensin system in 
normal and in hypertensive pregnancies .• 
- 37-
.' 
Section 3. 
THE RENIN-ANGIOTENSIN SYSTEM IN NORMAL AND IN 
HYPERTENSIVE PREGNANCIES. 
The renin-angiotensin system in normal pregnancy. 
Two important features dominate the changes that 
occur in the renin-angiotensin sys tem in· pregnancy. 
The first is the increase in plasma concentrations of 
angiotensinogen, renin and angiotensin II (All). The 
second is a diminution in sen$itivity to infused and 
presumably to circulating All. 
Helmer and Judson [1967] first demonstrated the 
marked increase· in angiotensinogen in pregnancy. They 
found an elevation in plasma levels of angiotensinogen 
in 22 women in normal pregnancy. The administration 
of oestrogens to 7 pregnant women caus$d an increase 
in angiotensinogen similar to that found in p ~ e g n a n c y , ,
from which Helmer and Judson concluded that the 
changes of pregnancy were oestrogen induced. There is 
general agreement that the plasma concentration of 
angiotensinogen increases during pregnancy [reviewed 
by Broughton Pipkin, 1988]. Derkx, Stuenkel, 
Schalekamp, Visser, Huisveld and Schalekamp' [1986], 
studying a larger group of women, confirmed that 
o e s t r o g e n - c o n t a i n i ~ g g oral contraceptive pills induc·ed 
similar changes. Tetlow and Broughton Pipkin [1986] 
examined the relative proportion of high and low 
molecular weight substrates in normal pregnancy using 
gel filtration chromatography. They found that the 
proportion of high. molecular weight angiotensinogen 
was linearly correlated with gestational age. rising 
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from approximately 5% to 15% through gestation, 
although no attempt was made to identify whether the 
high molecular weight forms were polymers of 
angiotensinogen, or protein bound forms of low 
molecular weight angiotensinogen. 
Increases in plasma renin activity (PRA) and plasma 
renin concentration (PRC) have also been demonstrated. 
Brown, Davies, Doak, Lever and Robertson [1963], in a 
cross-sectional study of 38 patients, found a rise in 
PRA, with a peak at 16 weeks gestation. Although 
Genest, de Champlain, Veyrat, Boucher, Tremblay, 
Strong, Koiw and Marc-Aurele [1965] also found 
elevated PRA in pregnancy, the peak values they 
reported were much later in the pregnancy. Nei ther 
group measured angiotensinogen, and the differences 
may reflect either small sample size or the difficulty 
in using a measurement that may be limited by 
available angiotensinogen. The consensus from· more 
recent studies is that PRA rises until 28-30 weeks 
gestation, and then diminishes towards term [e.g. 
Oats, Broughton Pipkin, S y m o ~ d s s and Craven, 1981, 
Karlberg, Ryden and W i c h m a n ~ ~ 1984, reviewed by 
Broughton Pipkin, 1988]. 
The data of Oats et. ale [1981], obtained from a 
longi tudinal study of 18 primigravid patients, 
demonstrated a rise in PRC throughout gestation, with 
a level 2-3 t i m e ~ ~ that seen ·in non-pregnant women 
being attained. This study also recorded serial 
measurements of angiotensin-converting enzyme, finding 
a highly significant increase after 30 weeks 
gestation. 
Massani, Sanguinetti, Gallegos and Raimondi [1967] 
found that plasma All levels in normotensive pregnant 
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patients were increased as compared to non-pregnant 
women, although the numbers in their study, nine and 
seven respectively, were small. Cross-sectional data 
suggests a progressive rise to term [Gordon, Symonds, 
Wilmhurst and Pawsey, 1973, Weir, Brown, Fraser, 
Lever, Logan, McIlwaine, Morton, Robertson and Tree, 
1975], with Weir et. ale finding no correlation 
between plasma All and either PRC or angiotensinogen. 
However, in one longitudinal study of primigravidae, 
All levels rose in the first trimester, reaching a 
maximum at mid-gestation [Oats, 1982]. 
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Figure 1.3 Proportional increments of the components 
of the Renin-angiotensin system in pregnancy. Non 
pregnant values form the reference point. Data: from 
various authors quoted above; figure: modified 
version from Broughton Pipkin [1988]. 
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Most studies of angiotensinase activity in 
pregnancy, although small in subject number, have 
indicated a progressive rise throughout pregnancy 
[e.g. Talledo, Rhodes and Livingstone, 1967, Tapia, 
Johnson and Strong, 1972]. This may explain the 
smaller increase, in proportional terms, of plasma All 
as compared to plasma renin and plasma angiotensinogen 
concentrations, (Figure 1.3) [Broughton Pipkin, 1988]. 
The increased angiotensinase activity has been 
suggested as a possible explanation of the diminution 
in pressor response to All, (see below). 
Chinn and Dusterdieck [1972] calculated that in 
normotensive adult women, All was usually present in 
concentrations only just below those capable of 
affecting arterial blood pressure. As discussed 
, . 
above, the concentration of All is elevated in normal 
pregnancy. 
from the 
However, the pregnant woman is protected 
potential hypertensive effects of the 
increased concentration. 
Abdul-Karim and Assali [1961] first demonstrated 
that the pressor response of 12 subjects to a standard 
intravenous dose of angiotensin (5ug), was 
significantly less when tested pre- as compared to 
postpartum. The pressor response of 4 non-pregnant 
subjects was similat" to that found in the postpartum 
studies. This diminution in pressor sensitivity 
appears to be specific to All.. Chesley, Talledo, 
Bohler and Zuspan [1965] and Lumbers [1970] confirmed 
the relative insensitivity to All in pregnancy, yet 
,< .' 
found that the pressor response to noradrenaline was 
essentially the same in pregnant and non-pregnant 
women. In a semi-longitudinal study, principally of 
Afro-American women, Gant, Daley, Chand, Whalley and 
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Macdonald [1973] found that the diminution was 
apparent by 8 weeks gestation, and reached a maximum 
at 16 to 18 weeks gestation, falling slowly to term 
thereafter. 
Kaplan and Silah [1964] devised a clinical test to 
separate renovascular hypertension from other forms of 
hypertension, based on the assumption that patients 
with increased endogenous levels of All (renovascular 
hypertension) required greater doses of exogenous All 
to.achieve a given pressor response because of prior 
receptor occupancy. The componen ts of the renin-
angiotensin system increase at a similar gestation to 
that at which reduced pressor sensitivity to All has 
been n ~ t e d d [e.g. Karlberg, Ryden and Wichman; 1984], 
and Talledo, Rhodes and Livingstone [1966] suggested 
. .. 
that t a c h y p h y l ~ x i s s in. response to raised All 
concentration ,"-as the cause of the diminished pressor 
response. However, no association between threshold 
dose and endogenous All was found in 22 women in the 
second trimester of pregnancy, in whom infusion 
s t u d i e ~ ~ were performed [Broughton Pipkin, HUnter, 
Turner' and O'Brien, 1984]. Furthermore, Gant, Chand, 
Whalley and Macdonald [1974] found that suppression of 
basal activity of the renin-angiotensin system by 
acute volume expansion with normal saline had no 
effect On the dose of All required to evoke a 20 mmHg 
diastolic blood p r ~ s s u r e e rise in pregnant subjects, 
despite enhancing pressor responsiveness in non-
pregnant women. The rapid infusion of an equal amount 
of 5% saline, did, however, result in a diminution in 
pressor response to All in p r e g n a n ~ ~ patients, w i ~ h h a 
similar decrease in PRA. These, results suggest that 
the principal determinant of pressor response is 
responsiveness of the vessels themselves, rather than 
alterations in activity of the renin-angiotensin 
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system or alterations in plasma volume. There have 
been several suggestions of mechanisms whereby vessel 
responsiveness is altered. 
Contraction 
muscle are 
and relaxation of 
controlled through 
vascular smooth 
variations in 
cytoplasmic calcium ion concentration. The calcium 
control of the actinomysin system is the final common 
pathway by which neurotransmitters, hormones and 
vasoactive drugs normally exert their short term 
influences on vascular tone [Johansson, 1981] 
(discussed further in Section 5, p. 86). Studies in 
isolated smooth muscle cells with calcium sensitive 
dyes confirm that activation is associated with 
i n c ~ e a ~ e d d intracellular calcium [ F ~ y , , Shlevin,.Granger 
and Taylor, 1979]. Although little is known about 
intracellular ionic concentration in the pregnant 
human, a cross-sectional study demonstrated that in 
platelets, cells with many of the characteristics of 
smooth muscle cells, (see Section 8), intracellular 
free calcium rises in pregnancy [Kilby, Broughton 
Pipkin, Cockbill, Heptinstall and Symonds, 1990]. 
Such changes would be expected to cause increased 
rather than decreased responsiveness. 
Another candidate implicated in the diminution of 
the pressor response is progesterone. In seven women 
with pregnancy i n ~ u c e d d hypertension, who had lost 
their refractoriness to All, (see below), an infusion 
of 5 alpha-dihydroprogesterone was associated with the 
restoration of refractoriness to the pressor effects 
of All [Everett, Worley, Macdonald and Gant, 1978]. 
. . 
Moreover, in five pregnant women in whom pressor 
sensitivity was increased by indomethacin, (see 
below), infusion of 5 alpha-dihydroprogesterone 
similarly restored refractoriness. Such data is 
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consistent with the view that a progesterone 
metabolite is important in maintaining normal blood 
pressure in pregnancy. However, Chesley and Tepper 
[1967] found that progesterone administration to non-
pregnant women did not blunt the All pressor response, 
although the renal response to All was diminished, 
whilst oestrogen administration had no effect. 
Curiously, whilst the dose of 300 mg / day 
progesterone administered by Chesley and Tepper 
approximates to the quantity of hormone secreted in 
pregnancy, the dose of 0.45 mg / day ethinyl 
oestradiol used, is considerably less than that found 
in pregnancy. One further difficulty in relating the 
diminished pressor response found in pregnancy to 
changes in s.teroid concentrations is the specific 
nature of the diminished response. Any effect of 
steroids, and indeed of changes in intracellular free 
. 
calcium, would be expected to have a general effect on 
vascular responsiveness to vasoconstrictors. 
The complex inter-relationship between vasodilator 
prostanoids and All has been previously· discussed, 
(Section 2, p. 35). Speroff,· Haning and Ewaschuk 
[1976] demonstrated that in pregnant monkeys, acute 
elevation of blood pressure by All was associated with 
a significant increase in the release of prostaglandin 
E from the uterus. This increase was associated with 
increased uterine" artery blood flow. Although 
Terragno, Terragno, Pacholxzyk and McGiff [1974] in 
the pregnant dog, and Venuto, O'Dorisio, Stein and 
Ferris [1975] in the pregnant rabbit, found diminished 
uterine artery blood flow following the administration 
of the prostaglandin synthetase inhibitor, 
indomethacin, Speroff" et. al. [1976] did not i ~ ~ t i a l l y y
find this. However, when they substituted alternative 
anaesthetic agents for the cardiovascular stimulant 
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sodium pentabarbital, their results concurred with 
those from other species [Speroff, Haning and Levin, 
1977]. 
In addi tion to playing a role in the control of 
uterine blood flow, the increase in plasma 
prostaglandins found in pregnancy [reviewed by Ferris, 
1988], may be responsible for the reduced All 
sensitivity, with increased All required in pregnancy 
to overcome antagonism caused by increased synthesis 
of vasodilator prostaglandins. Broughton Pipkin, 
Hunter, Turner and O'Brien [1982] examined the effect 
of p r o s t a g l a n ~ i n n E2 on the pressor response to 
exogenous All ;in 22 pregnant women in mid-trimester, 
and in 10 non-pregnant contrQl subjects. 
Prostaglandin E2 diminished the diastolic blood 
'" pressure response in both groups without altering the 
basal blood, pressure, the effect being significant 
only in the pregnant group. Furthermore, indomethacin 
has been shown to enhance the systemic pressor 
response to All in pregnancy [Everett, Worley, 
Macdonald and Gant, 1978]. 
Another possible candidate as regulator of the All 
pressor response in pregnancy is atrial natriuretic 
peptide (ANP). ANP antagonises All-induced arterial 
contractility in vitro to a greater extent than 
noradrenaline-induced contrac til'i ty [Kleinert, Maack, 
Atlas, Januszewicz, Sealey and Laragh, 1984]. 
Moreover, the majority of studies, (all cross-
sectional), suggest increased levels of ANP in 
pregnancy [e.g. Thomsen, Storm, Thamsbor,g, deNully, 
Bodker and Skouby, 1988, Miyamoto, Shimokawa, Sumioki, 
Touno and N a k a n o ~ ~ 1988, Merkouris, ~ i l l e r , ,
Catanzarite, Rigg, Quirk and Vesely, 1990]. One 
dissenting study was that· of Hirai, Yaniahara, 
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Nakayama, Ishibashi and Yamaji [1988]. Hirai et. ale 
found that although there was a gradual increase in 
ANP levels as pregnancy progressed, the mean 
concentrations were not significantly different from 
those of the non-pregnant women. They noted both the 
wide range in pregnancy, (12.5-137 pg/ml), and the 
marked overlap between groups, criticising the small 
sample size of other studies. However, the study of 
Hirai et. ale was also cross-sectional, and the 
statistical tests used appear to ignore the skewed 
nature of the data. 
Both Gant, Chand, Whalley and Macdonald [1974], 
s t u d y i ~ g g the effect·of acute volume expansion, and 
Broughton Pipkin et. ale [1982], studying the effect 
of prostaglandin E 2 ~ ~ found different results w ~ e n n non-
pregnant as compared to .pregnant subjects were used. 
The control of· vascular responsiveness in pregnancy 
may well be complex, w i t h ' ~ e v e r a l l factors important. 
One further suggestion, particularly pertinent to 
this thesis is that these factors mediate their effect 
via alterations in All receptor concentrations. This 
would then be an effect specific to All, rather than a 
general effect, as would be caused by changes in 
intracellular calcium, anatomical effects on 
-
structure, or the dilutional effect of the increased 
blood volume in p r e g ~ a n c y . .
Aguilera and Catt [1981] demonstrated that in rat 
vascular smooth muscle tissue, conditions associated 
with reduced vascular· sensitivity to All,. such. as 
sodium restriction, were also associated with 
diminished All receptor concentrations. Prior to this 
thesis, there has been no reported work on human All 
receptor changes in pregnancy. However, studies of 
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rabbit mesenteric vascular tissue, indicate reduced 
All receptor concentrations in pregnancy [Brown and 
Venuto, 1986]. Furthermore, both increases in 
endogenous All and progesterone infusions, have been 
found to reduce All receptor concentrations; the 
former in rat vascular smooth muscle tissue [Brunner, 
Chang, Wallach, Sealey and Laragh, 1972], the latter 
in rat uterine smooth muscle tissue [Schirar, Capponi 
and Catt, 1980]. A more detailed discussion of All 
receptors follows in Section 5. 
The renin-angiotensin system in hypertensive 
pregnancy. 
Section 1 contains a detailed review of many of the 
aspects of pregnancy induced hypertension (PIH), 
including deta-iled definitions of PIH and pre-
eclampsia (PE). Discussion of the aetiology of PIH is 
outside the scope -of this thesis, however, 
hyperfunction of the renin-angiotensin system has been 
suggested as a possible contributory cause for 20 
years [Massani, Sanguinetti, Gallegos and Raimondi, 
196.1]. This has led to study of the components of the 
renin-angiotensin system in PIH. 
The plasma concentration of angiotensinogen does 
not appear to change markedly in hypertensive 
pregnancies [e.g. Tapia, Johnson and Strong, 1972, 
reviewed by Broughton Pipkin, 1988]. However, 
Tewksbury and Dart [1982] reported that the proportion 
of high molecular weight a n g i o t e n s i n o g e ~ . . increased 
from 16% to 28% in pregnancies complicated by PIH. 
The true molecular weight of the high molecular. weight 
angiotensinogen is unknown. Gordon and Sachin [1977] 
obtained an estimate using gel filtration under 
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denaturing conditions, finding a value of 350,000 to 
500,000. However the method they employed only yields 
valid estimates if the shape ,of all the proteins 
studied, standards and unknowns, are the same and 
there is no evidence that this criterion 
Whether such a difference in the 
was met. 
form of 
angiotensinogen is of functional importance has yet to 
be assessed. 
There are conflicting reports in the literature 
regarding PRA and PRC in patients with PIH. Some 
authors suggest a relative increase relative to 
normotensive pregnancies [e.g. Symonds, Broughton 
Pipkin and Craven, 1975], some no c h a n g ~ ~ [e.g. Brown, 
Davies, Doak, L e v e ~ , , Robertson and Trust, 1966, 
Gallery, Stokes, Gyory, Rowe,and Williams, 1980], a n ~ ~
others a decrease [e.g. Weir, Brown, Fraser, 
. .. 
Kraszewski, Lever, McIlwaine, Morton, Robertson and 
Tree, 1973,' Symonds and Andersen, 1974]. In many of 
the studies, the range of variation within the group 
was greater than the difference between the groups 
[e.g. Brown et. a1., 1966]. Possible e,xp1anations of 
these discrepancies are legion. The lack of 
standardization of collection procedures may have been 
responsible for at least part of the conflict. 
Changes of pos ture have been shown to have a marked 
> effect on PRA in pregnancy [Weinberger, Petersen, Herr 
and Wade, 1973] • ., Rowe, Gallery and Gyory [1979] 
demonstrated how commonly used collection and handling 
procedures could inadvertently result in 
cryoactivation of renin, the effect being much greater 
in pregnant as compared to non-pregnant women. 
Gallery et. a1. [1980] suggested that 'variation in 
sodium intake was important. Different criteria for 
inclusion into the various studies were usea. For 
example, Symonds and Andersen [1974] demonstrated the 
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pitfalls of ignoring parity [e.g. Weir et. al., 1973], 
finding that changes in PRA and PRC levels were 
completely different in primigravid and multigravid 
women. Despite the difficulties in drawing any 
conclusions, there does seem to be some consensus that 
in severe, proteinuric PIH, PRA is suppressed [Symonds 
and Andersen, 1974, Karlberg, Ryden and Wichman, 
1984]. 
Studies of plasma All levels in PIH·· have also 
produced confusing data. In a small series, Massani, 
Sanguinetti, Gallegos and Raimondi [1967] found no 
significant differences in plasma All levels in 
hypertensive as compared to normotensive pregnancies. 
The bioassay they used would not hav$ distinguished 
between angiotensins I and II, and there was no 
matching of gestational a g ~ . . On balance, it appears 
reasonably certain that in pre-eclampsia, 'All levels 
are diminished, even in the face of a contracted 
plasma volume [Weir et.al., 1973, Pedersen, Aalkjaer, 
Christensen, Christensen, Danielsen, Johannesen, 
Kornerup, Leyssac, Mulvany and Rasmussen, 1984]. In 
mild late-onset PIH there may be activation of the 
renin-angiotensin system, significantly elevated 
levels of All having been found [Symonds et. al., 
1975, Symonds and Broughton Pipkin, 1978]. 
Interpretation of the study by Symonds et. al. [1975] 
is'eased by their exclusion of niultigravid women, and 
by ,the careful control of posture at the time of 
sampling which they ensured • 
. Such changes in angiotensinogen, reni,n. and All, 
with marked overlap between groups demoristrated in 
each of the above studies, are unlikely to a c c o ~ n t t for 
the pronounced changes in All sensitivity, (see 
below). This does not negate a significant role for 
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the renin-angiotensin axis in the development or 
aggravation of PIH; changes may occur at a cellular 
level. 
Alterations in pressor sensitivity to All in women 
with PIH are well documented. In 1968, Talledo, 
Chesley and Zuspan demonstrated that pre-eclamptic 
patients showed increased sensitivity to infusions of 
All as compared to normotensive pregnant women. Since 
then several prospective studies have been performed. 
In 1973, Gant, Daley, Chand, Whalley and Macdonald 
reported that primigravid women who later developed 
PIH in the same pregnancy,. showed an increased 
vascular sensitivity to All a.s early as the 18th to 
22nd weeks of gestation. Their series contained 192 
patients, mostly .Afro-American teenagers, between 13 
and 17 years old." 91% of the subjects who needed more 
than 8ng of All/kg/min, (on at least one occasion 
between 28 and 32 weeks gestation), to elicit an 
increase in diastolic blood pressure of at least 20 
mmHg, remained normotensive throughout the pregnancy; 
Conversely, only 9% of the women who later .developed 
PIH had not shown an· increased sensitivity to All. 
There are problems in relating· the results of Gant et. 
al. to other populations, Gant et. al. reported the 
incidence of PIH in the Dallas population as 37.5%, 
well above the incidence found in our centre of 
approximately 10% [Symonds, 1979]. The youth and 
lower socio-economic status of the Afro-American 
popula tion, as well as the tendency of negroes to 
hypertension may have been predisposing factors in the 
etiology of PIH and pre-eclampsia, and thus may have 
influenced the data obtained. Teenagers have been 
suggested as suffering more frequently from 
hypertensive disorders in pregnancy [Vollman, 1970]. 
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Oney and Kaulhausen [1982] also investigated the 
prospective value of such studies in the early 
diagnosis of hypertensive disorders in pregnancy. 
They tested an unselected European population, 
performing an All infusion on 231 normotensive 
primigravid women between 28 and 32 weeks gestation. 
They confirmed the high predictive value of a negative 
test, (0.954), but found a high false positive rate, 
(approximately 50%). Similar results were obtained by 
Nakamura, Ito, Matsui, Yoshimura, Kawasaki and Maeyama 
[1986] in a smaller study of 48 Asian women of mixed 
parity, and by Dekker, Makovitz and Wallenburg [1990] 
in a study of 90 nulliparous European women. The mean 
effective pressor dose of All in the three very 
different Afro-American, European and Asian 
populations differed minimally, suggesting that race 
is not a major factor in d e t e r m ~ n i n g g v ~ s c u l a r r
. reactivity to All. 
One dissenting report is that of M o r r i s ~ ~ O'Grady, 
Hamilton and Davidson [1978]. They examined a small 
group of young primigravid pa.tients, testing them each 
week from the 29th to the ·32nd week of pregnancy. 
They found a false positive rate of 93% and a false 
negative rate of 17%, concluding that All infusions 
were an unreliable screening tes t. However, there 
were methodological differences in this study. Rather 
than using a sphygmomanometer -to measure arterial 
blood pressure, Morris et. ale used a Doppler 
ultrasound device. For unknown reasons, they could 
not establish a constant baseline diastolic pressure. 
Therefore they calculated basal diastolic blood 
pressure from the average of two 30 minuti·periods in 
the left lateral recumbent position. 
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Sensi tivi ty to infused All is regarded as one of 
the better predictors of whether PIH will develop 
later in the pregnancy [e.g. Wallenburg, Dekker, 
Makovitz and Rotmans, 1986]. However, the test is 
impractical as a screening test for the general 
population, taking several hours to perform, and 
requiring both medical supervision and the placement 
of an intravenous cannula. 
These findings are complemented by the observation 
that specific hyper-responsiveness to All has been 
documented in isolated small arteries taken from the 
omentum of women with proteinuric PIH [Aalkjaer, 
Johannesen,Pedersen, Rasmussen and Mulvany, 1984]. 
The cause of such altered pressor sensitivity to 
-PIH is .unknown.. In a cross-sectiona'! study comparing 
intracellular free calcium ion concentrations in women 
with established PIH and normotensive pregnant women, 
Kilby, Broughton Pipkin, Cockbill, Heptinstall and 
Symonds [1990] found increased levels in women with 
PIH. . However, as discussed above, there are 
difficulties in relating such calcium ion changes to 
altered pressor sensitivity, not least the elevated 
levels found in pregnancy [Kilby et. al., 1990]. One 
attractive hypothesis is that the diminished 
. production of vasodilator prostanoids in severe PIH is 
a major factor e n h a ~ c i n g g pressor sensitivity to All. 
A fall in the stable metabolite of prostacyclin, 6-
keto-PGFlalpha' has been reported to occur early in 
pre-eclampsia [pedersen, Christensen, Christensen, 
Johannesen, Kornerup, Kristensen, Lauritsen, Leyssac, 
Rasmussen and Wohlert, 1983]. Indeed, · F i t z g e r ~ · l d , ,
Entman, Mulloyk and FitzGerald [1987] identified an 
'at risk' cohort during the first trimester, ~ n n the 
basis of urinary 6-keto-PGlalpha excretion. Lower 
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levels of prostacyclin synthesis has also been 
reported in the umbilical vessels of the babies of 
pre-eclamptic women [reviewed by Ferris, 1988]. 
Broughton Pipkin [1988] speculated that in women 
with PIR, altered sensitivity to All might be due to 
changes in All binding. Prior to this thesis no 
formal examination of All receptor number or avidity 
in human pregnancy appears to has been performed, and 
there is no spontaneous disease nor experimentally 
induced condi tion in animals tha t has general 
acceptance as a model of pre-eclampsia. 
Before discussing All receptors at greater length, 
the next section considers the theory of receptors in 
general. 
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Section 4. 
RECEPTOR THEORY. 
One of the earliest proponents of the concept of 
receptors was Paul Ehrlich, a German physician, 
biologist and chemist. He was concerned with 
antibodies against bacterial toxins and snake venoms, 
and postulated that antitoxins were essentially free 
receptors which combined with the toxin, thereby 
preventing combination with the receptors of the 
cells. Ehrlich summarised his emphasis on the binding 
of drugs to receptors: 'If the law is .. true in 
chemistry that corpora non agunt nisi liguida, then 
for chemotherapy the principle is true. that corpora 
non agunt nisi fixata (substances do not act unless 
bound)' [Ehrlich, 1913]." 
Receptor theory is crucial to this thesis, thus 
before All receptors in particular are reviewed, 
there follows a brief discussion of conceptual models 
of drug-receptor interactions. 
Many pharmacological and physiological observations 
support the hypothesis that drugs and hormones produce 
their effects by interacting in' a 'specific way with 
some component of a living cell. This component, 
which is likely to be either an enzyme or a site on 
the cell membrane, is called a receptor. 
One analogy for the action of a drug on" a receptor 
is that of a lock," (the receptor), and key, (the 
drug). This image was first proposed by Emil Fischer 
in 1894 for the action of enzymes, where the lock is 
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the active centre of the enzyme, and the key is the 
substrate. In that this is a mechanistic view of a 
chemical combination, the analogy is crude; 
nevertheless, some valid implications are conveyed. 
The drug 'unlocks' the response, moreover, the 
specificity of the 'locks' as far as the 'keys' are 
concerned is only relative; the lock-may be turned by 
a different number of keys, and so a series of 
chemically related drugs may have the same action. In 
addition, the lock may be 'jammed', i.e. the response 
may be blocked by an appropriate substance [Fischer, 
1894]. 
Application of the Law of· Mass Action: The Occupation 
Theory. 
-Any detailed conclusions about drug-receptor 
interactions must rest on information derived from 
studies of the kinetics of drug action or of dose 
response curves. The .kinetics of drug 'ac tion, 
however, when measured on isolated tissues, are likely 
to depend ~ n n the rate of diffusion of the drug to the 
receptors, 'on the rate of reaction of the drug with 
the receptors, and on the rate of response of the 
cells to the drug-receptor reaction. These problems 
may arise even when :responses are measured on single 
cells [Mackay, 1966]. Analyses of drug-receptor 
interactions t h e r e ~ o r e e tend to be based on dose 
response curves measured under equilibrium conditions, 
so that complicated kinetic factors are eliminated. 
The responses obtained are then assumed to correspond 
to an equilibrium, or steady state, o c c u p a t ~ o n n of .. the 
receptors, to which the law of mass action may be 
applied. 
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The simplest assumption about the formation of a 
drug-receptor complex is that it can be expressed as a 
chemical reaction: 
Drug + Receptor ~ ~ Drug-receptor complex 
with the complex producing a biological response of 
magnitude E, proportional to the amount of the 
complex, where kl and k2 represent the forward and 
reverse rate constants,thus: 
D + R 
and E -
where q is a proportionality constant. 
According to the law of mass action, the rate of 
forward reaction is given by ki[D][R], and the rate of 
the reverse reaction is given by k2[DR]. 
At equilibrium, the rates of association and 
d i s s o c i ~ t i o n n are equal:k1[D][R] - k2[DR] 
therefore: 
- K - [D][R] [DR] (1) 
where K is the dissociation constant, also known as 
the Michaelis-Menten constant. The affinity of the 
drug for the receptor is given by 11K • 
The total number of receptors, Rt, 
the receptors involved in forming the 
the free receptors, thus: [R] -
substituting for [R] in equation (1): 
is the sum' of 
complex, plus 
[Rt] - [DR] 
[D]([Rtl - [DR]) [D ] K -
This may be rearranged to the form: 
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[DR] = 
lRfJ 
(2) 
K 
If Em is the maximal response of which the system 
is capable, obtained when all the receptors are 
occupied: 
Em - q[Rt] 
therefore: 
E = 
-a& Em 
and therefore: 
E 
-
Em [ D ~ ~ (3) K + [ J 
This is the familiar h y p e ~ b o l i c c function in which E 
- 0 when [D] 
- 0, and E approaches Em when [D] becomes 
very large. When half maximal response is obtained: 
E . [ D ~ ~ - 1 -Em K +DJ --z 
so that the concentration of D required for a half-
maximal response is equal to K. 
The derivation of equation (3) is identical to that 
of the classical Michaelis-Menten equation, which 
gives the velocity v of an enzyme reaction as a 
function . of the substrate concentration [S], the 
enzyme-substrate dissociation constant K , and the 
maximum velocity V : 
v 
-
V 
K 
Three critical assumptions, which underlie the 
derivation or usual application of e q u ~ t i o n n (3) are as 
follows: 
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a) Response is proportional to receptor occupancy. 
The receptor theory of drug activity was first 
postulated by Clark [1926a], and simply states that 
the intensity of a pharmacological effect is directly 
proportional to the number of receptors occupied by 
the drug. In the case of e n z y m e - s ~ b s t r a t e e and enzyme-
inhibitor interactions, since the observed response is 
derived directly by the concentration of enzyme bound 
substrate or inhibitor, this assumption is soundly 
based. However, with respect to drug effects in 
general, the assumption may not be correct, and 
alternatives to the 'occupation theory' are considered 
,below. 
b) One drug molecule combines with one" receptor site. 
This is the simplest reaction mechanism, from which 
equation (3) (and .also the M i c h a e l i s - M e ~ t e n n treatment) 
is derived. 
c) A negligible fraction of the total drug is 
combined. In equation (3) this enables the term [D], 
" the . uncombined drug, to· be replaced by [Dt] , the 
. total drug concentration. A .system in which this 
assumption is true, is said to be operating in zone A 
[Straus and Goldstein, 1943]. In experiments where 
binding ~ s s actually measured, as in equilibrium 
dialysis, uncombined drug is ~ e t e r m i n e d d and equation 
(3) can be used rigorously. However, when' a 
biological response is the criterion of effect, only 
the total amount of the drug added to the system is 
known. 
If equation (3) is inverted , the equation of a 
straight line is obtained: 
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1 
,-
= K x 1 + 1 
Em m Em 
(4) 
When reciprocal response magnitudes, l/E, are 
plotted against reciprocal doses, l/[D], (actually 
l/[Dt], as explained above when discussing the zone A. 
assumption), the slope is K/Em, . and the intercept 
l/Em. This procedure is known as the double 
reciprocal or Lineweaver-Burk plot [Lineweaver and 
Burk, 1934]. Increasing drug concentrations are to 
the left, so that the y-axis is at l/[D] - 0, 
corresponding to infinite drug concentration, where 
all receptors are occupied.. ,The y intercept gives 
l/Em. Since the slope, given by equation. (4), is 
K/Em, K can be obtained by estimating the slope: but 
an easier method is to extend the line downwards and 
to the left, as shown in Figure 1.4. The x- intercept 
is -[l/K]. 
liE 
2/Em 
1/Em 
./ .. , 
.' 
......... 
-[11K) 11K . 1/[0]. 
Figure 1.4 The double reciprocal plot. 
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Another very useful linear transformation often 
used when interpreting binding data is the Scatchard 
plot [Scatchard, 1949]. Equation (1) states that: 
K = [ O ~ ~ [R] DR] 
If n is the number of binding' si tes per protein 
molecule, and 
the system, 
binding sites, 
P the molar concentration of protein in 
then nP, the total concentration of 
is equal to [DR] + [R], and: 
nP[O] - [OR][O] = K[OR] 
(K+[O])[OR] = nP[O] 
If r is the number of moles of drug bound per· moles . 
of total protein, then: 
r - [OR] -' n [ o ~ ~
-p- . (R + D]) 
therefore: Kr + r[O] - n[D] 
'and therefore: r 
-
-r + n 
m Lr Lr 
Thus plotting r/[O] against r should yield a 
straight line with two intercepts, n (on the x axis) 
and n/K(on the y axis), hence K is obtained.. An 
example of this approach is shown in Figure 1.5. In 
this example, the dissociation constant of the 
platelet angiotensin II binding in one representative 
subject is shown, in an experiment examining the 
'effect of reducing unlabelled angiotensin II on 
specific binding, (Gee p. 129). 
A useful feature of this type of graph is that if 
there are distinct sets of' binding sites with 
different affinities, two or more line segments may be 
distinguishable [Klotz and Hunston, 1971].- Figure 1.6 
illustrates this type of plot for the binding of 
acetylcholine to a proteolipid extracted from an 
acetylcholine-sensitive tissue. There is one binding 
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Figure 1.S. 
Scatchard analysis of the results 
platelet angiotensin II specific 
from one 
binding 
competition study (see Chapter 3, p. 129). 
Figure 1.6. 
Scatchard analysis of acetylcholine binding to a 
proteolipid extracted from electroplax tissue of 
the electric eel. From De Robertis, Lunt and La 
Torre [1971]. 
Figure 1.5. 
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si te wi th high affinity and about ten other sites 
where the binding is much weaker [De Robertis, Lunt 
and La Torre, 1971]. 
It should be pointed out that analysis by Scatchard 
plots was originally developed for sys tems where 
soluble ligands interact with one or more 
independent binding sites on a soluble macromolecule. 
Such a model may not hold for particulate membrane 
receptors with extremely high affinity. In some 
cases, for example radio-labelled cholera toxin, 
binding can occur at concentrations well below the 
dissociation constant, K, of the compound [Henderson, 
1973]. 
Alternatives to the Occupation theory. 
a)Efficacy (Intrinsic Activity). 
After Clark proposed the theory [1926a], loopholes 
were discovered. With certain series of ,drugs, for 
example alkyltrimethylammonium"" compounds tested on 
guinea pig ileum [Stephenson, 1956], a maximal 
response was never achieved even at extremely high 
doses. The biological effect did not appear to follow 
the law of mass action, nor did it seem to be 
dependent on the affinity of the drug for the 
receptors. 
Ariens [1954] and Stephenson [1956] proposed 
modifications to the occupation theory in an attempt 
to explain such anomalous factors. They visualised 
the drug-receptor interaction as being a two 0" step 
phenomenon: 
1. Complexation of the drug with its receptor. 
2. Production of the effect. 
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Affinity of the drug for the receptor alone is not 
sufficient. The compound must also have what Ariens 
described as intrinsic activity. The Ariens-
Stephenson idea considers the ability of the drug 
receptor-complex to produce a biological effect. 
Their modification brings in the concept of agonists 
and antagonists, which are thought·- to have a strong 
affinity for the receptor and a tendency to form a 
complex. However, only the agonist gives rise to the 
stimulus and has intrinsic activity. 
Since the biological effect of a drug at a given 
dose would be determined both by the extent of 
receptor Q.ccupancy, (determined by affinity), and by 
the intrinsic activity or e f f i ~ a c y , , it follows that 
according to this theory equal biological responses 
need not imply equal degrees of receptor occupancy, 
and maximal re'sponses may vary from drug to drug. . 
b) Spare receptors. 
Much of the data on drug-receptor interactions is 
based on studies of smooth or striated muscle. There 
are many steps between a drug interacting. with a 
receptor and the contraction of the muscle; namely 
changes in ion fluxes, depolarisation, intracellular 
release of calcium, etc. It is certainly plausible 
that the limiting factor may not be the total number 
of receptors, but rather One or more of the 
intervening processes. Hence a maximal response would 
be obtained with only a fraction of the receptors 
occupied. Certain anomalous effects, not readily 
explained by the occupation theory led to the 
formation of this alternative known as the spare 
receptor hypothesis [Stephenson, 1956, Ariens, Van 
Rossum and Koopman, 1960]. 
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The 'atropine anomaly' is typical of such effects 
[Clark, 1926b]. Acetylcholine reduces the amplitude 
of contraction of the frog heart. If the heart is 
treated with a small dose of atropine and then 
retested with acetylcholine, a ten-fold increment· in 
atropine concentration necessitates a ten-fold 
increase in acetylcholine dosage to' achieve the same 
response as previously. At all atropine 
concentrations the same maximum response could be 
elicited, provided the acetylcholine concentration was 
high enough. 
According to the occupation theory, when maximal 
response was obtained in the presence of atropine, the 
receptors should be fully occupied by acetylcholine 
molecules, with the atropine molecules ,displaced. 
Thus, if the t,issue w ~ s s removed from a high a tropine 
and acetylcholine concentration, then replaced in a 
solution without atropine, and finally in solution 
without atropine o ~ ~ acetylcholine, the heart should 
have regained the original sensitivity to 
acetylcholine.' In fact, the decreased sensitivity 
produced by atropine persists. With repeated 
washings, the atropine effect diminishes only very 
slowly, but the rate of washout is the same whether or 
not acetylcholine is present. The antagonism, which 
is apparently competitive, is at the same time almost 
irreversible, and not affected oy the presence of the 
agonist. 
This phenomenon is explained by the spare receptor 
concept. The affinity of acetylcholine, for the 
.. 
receptors is assumed to be low, but maximal response 
is obtained when only·a small fraction of the receptor 
pool is occupied. Supposing that when 0.01' of the 
total number of receptors, n, combine with 
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acetylcholine to cause maximal response, 99% of the 
receptors are • spare' • If atropine irreversibility 
blocks 90% of the receptors, leaving O.ln available 
for interaction. 10% occupancy is now required to 
produce maximal response, thus a much higher 
acetylcholine concentration is necessary. 
c) Rate theory. 
Instead of attributing excitation to the occupation 
of receptors by drug molecules, the rate theory 
attributes it to the process of occupation, each 
association between a drug molecule and a receptor 
providing one quantum of excitation [Paton, 1961]. 
The magnitude of a response is proportional to the 
rate at: which drug molecules associate with r.eceptor 
sites. 
Efficacy, or intrinsic'activity, is no longer an ad 
hoc constant, but is defined by the rate constant for 
association of drug ~ o l e c u l e s s with receptors, kl' 
which may differ from drug to drug. The distinction 
between an agonist and an antagonist is defined by the 
value of k2' the rate constant of dissociation. If 
the k2 is large, then the rate of dissociation of the 
complex will be high, making free receptor sites 
available at a high rate. Such drugs are agonists. 
However, if the k2 is small, the drug-receptor complex 
is stable, and f r e ~ ~ receptor sites become avaIlable 
only infrequently, with little excitation and only 
weak agonist action. The persistent occupancy of the 
si tes by such a drug reduces the number of sites 
available to an agonist, so that the. drug behaves as 
an antagonist. For all drugs, the potency is 
described by the equilibrium dissociation constant 
k2/kl which as usual describes the affinity of the 
drug for the receptor. 
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Ra te theory explains the 
antagonists first stimulate 
finding that 
then block as 
some 
the 
stimulation fades. One example is nicotine,· which 
initially excites the autonomic ganglion cell, then 
blocks it, so that it no longer responds to various 
agonists. The stimulation is a consequence of the 
initial associations between drug molecules and 
receptors, which proceed at a high rate, as all 
receptor sites are vacant [Goldstein, Aronow and 
Kalman, 1974]. 
Rate theory also accounts for a phenomenon known as 
f . ~ d e , , in which an agonis t causes an immediate peak 
response that fades off to a lower plateau at 
equilibrium. The theory predicts such behaviour for 
all agonists, .since the initial rate of combination is 
bound to be higher than the even tual rate at steady 
state. However, numerous instances are known in which 
fade is not observed at all, with responses following 
those predicted by occupation theory, e.g. the action 
of the cholinomimetic drug nor arecoline on guinea-pig 
atrial tissue tBieger, Kruger-Thiemer, Lullmann and 
Ziegler, 1970]. 
d) Allosteric effects. 
The interpretations presented above were attempts 
to find a c o n s i s t ~ n t t explanation of the observed 
phenomenon of partial agonism. The recognition of the 
general importance of allosterism in metabolic 
regulation has been accompanied by the realization 
that allosteric transitions (induced c o n f ~ r m a t i ~ n a l l
changes) playa major role in the action "of drugs on 
membrane bound receptors [Belleau, 1964, and Changeux, 
Thiery, Tung and Kittel, 1967] 
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Recent observations indicate that substrate and 
inhibitor may combine at different sites and yet 
influence each others affinity for a receptor by 
inducing configurational changes in the receptor. 
Figure 1.7 [Koshland, 1964] suggests one possibility. 
A, Band C represent a flexible active site, which 
assumes an active form under the' influence of a 
substrate molecule. An inhibitor of a different shape 
combining at a different site could impede the 
subs tra te-induced change. In the model shown, the 
inhibition might seem competitive, if the affinity of 
substrate or inhibitor for their respective sites was 
diminished by the combination of the other with its 
site. 
Figure 1.7. The ef'rect of an inhibitor on a flexible 
active site [Koshland, 1964]. 
Studies with cholinergically innervated cells from 
the electric eel provide experimental e v i d e n c ~ ~ of an 
allosteric effect [Changeux and Podleski, 1968]. When 
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data was obtained on the relationship between the 
extent of depolarisation and the concentration of 
cholinergic agonists, a systematic departure from the 
law of mass action was observed. Changeux and 
Podleski [1968] proposed that the acetylcholine 
receptor exists in two interconvertable states, a 
depolarized state (D) with a higher affinity for 
agonists, and a polarized state (p) with a higher 
affinity for antagonists. The membrane potential is 
governed by the relative proportions of the two 
states. An agonist selectively complexes with the (D) 
state, shifting the equilibrium in that direction. An 
antagonist selectively complexes with the (p) state' 
preventing the shift to the (D) state. Low i n t r i n s i c ~ ' '
activity of a partial agonist would be determined by' 
its ability to .complex with either state,: but with a 
preferential' ~ f f i n i t y y for the (D) state. Thus, 
differences in maximal response can be explained, for 
regardless of how high the concentration of such a 
drug was, it would hold a definite proportion of the 
" 
receptors in the inactive (p) state. 
e) Mobile or floating receptor model. 
The two-state, model outlined above, depicting a 
concerted conformational change of the receptor, 
implies a restricted association between an ionophore 
and the ligand recognition s i ~ e . . The 'mobile' or 
'floating' r e c e p t o r ~ m o d e l , , developed simultaneously in 
a number of laboratories [e.g. De Haen, 1976, Jacobs 
and Cuatrecasas, 1976, and Boeynaems and Dumont, 
1977], proposes that a hormone-receptor complex may 
interact with a number of 'effector' substituents in 
the plane of the membrane. The above workers observed 
that a number of receptor-specific agonists, (e.g. 
catecholamines, prostaglandins, glucagon, ACTH) , could 
independently stimulate adenylate cyclase in a cell 
- 67-
such as the adipocyte. The manner of the response was 
indicative of a unique adenylate cyclase enzyme 
responding in a complex way to a variety of hormonal 
stimuli. Rather than supposing that all of the 
receptors clus ter around the cyclase enzyme complex, 
(this very large complex, which would be visible at 
the electron microscope level, has not been observed), 
this model proposes that each independent receptor 
moiety can freely compete for the effector, (adenylate 
cyclase), in the plane of the membrane. Moreover, 
observations with fluorescent-labelled antibodies 
directed at cell surface constituents has demonstrated 
that membrane molecules can diffuse freely in the 
plane of the membranes [Frye and Edidin, 1970]. 
Figure 1.8. The mobile or floating receptor model. 
Using the example of insulin, the;, receptor (R), 
changes its conformation (R'). The hormone-receptor 
complex interacts with two separate membrane effector 
molecules, (E and El) [Hollenberg, 1985]. 
- 68-
The model has been generalised to accommodate a 
variety of receptor systems, the concept of receptors 
as freely diffusable membrane constituents that, on 
binding to a ligand, can interact with other freely 
diffusable membrane effectors, is illustrated in 
Figure 1.8. 
These speculative interpretations are discussed in 
order to emphasise the many possible ways of looking 
at the rather complex. phenomena associated with drug 
actions on membrane bound receptors. All the theories 
discussed suffer from the same weakness. In the 
absence of concrete physicochemical evidence of drug 
receptor interactions they remain inconclu'sive. The 
simple law of mass action d e ~ c r i p t i o n n including the 
occupation theory, adequately describe a large number 
o,f I n t e r ~ c t i o n s s in which the: receptor is a soluble 
macromolecule. '. The known phenomenon of allosterism 
illuminates' the mechanism of action of a further 
set of drugs. What remains is a special class of 
receptors that appear to be integrally bound to 
membranes. These sometimes yield anomalous kinetic 
data not readily explained by simple law of mass 
action theory. It seems likely .that real 
understanding will have to await further progress in 
the isolation of membrane-bound receptors. 
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Section 5. 
ANGIOTENSIN II BINDING SITES IN VASCULAR TISSUE. 
Angiotensin II (All) is known to produce effects on 
target tissues such as the adrenal gland, brain, 
kidney and myocardium, (see Section 2 - The renin-
angiotensin system). Receptors for the peptide have 
been identified in each of these tissues, and their 
characteristics and function have been extensively 
reviewed by Aguilera, Schirar, Baukal and Catt [1980], 
Capponi, Aguilera, Fakunding and Catt [1981], and 
Mendelsohn [1985]. Discussion of the localisation and 
binding properties of All receptors in these organs is 
beyond the scope of this thesis, and instead. this 
section' concentrates on All binding in vascular 
tissue. Throughout this section, the use of the term 
receptor relates to cellular binding sites which 
demonstrate both the characteristics· of ·'a hormonal 
response, (see below), and a correlation between 
binding site occupancy and a target cell response. In 
tissues, such as human platelets, where binding of All 
does not fulfil these criteria, (see p. 79), the term 
binding site is used. 
The study of All receptors in vascular tissue has 
been complicated by the small amount of smooth muscle 
in such tissue, and by the difficulty in obtaining 
suitable membrane preparations for the study of 
receptor regulation. However, All binding has been 
studied in preparations from other smooth muscle 
tissues including the uterus and the bladder, and in 
human platelets. The properties of All receptors in 
smooth muscle of nonvascular origin have been shown to 
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be generally similar to those found in vascular tissue 
[Aguilera and Catt, 1981]. In particular, All 
receptors in both the rat uterus and bladder smooth 
muscle demonstrate a parallel negative regulatory 
influence of sodium restriction to that found in the 
rat mesenteric artery [Capponi et. al., 1981, Aguilera 
and Catt, 1981]. Likewise, All binding sites on human 
platelets have been found to resemble All receptors in 
vascular tissue in the response to alterations in the 
endogenous renin-angiotensin system [Moore and 
Williams, 1981, Moore, Taylor and Williams, 1984, 
Ding, Kenyon and Semple, 1985]. All binding studies 
in the above tissues are thus discussed, although the 
limitations of using All binding both in p l ~ t e l e t s s and 
in nonvascular smooth muscle as models of vascular 
smooth muscle All binding must be recognised. The 
rationale of the use of -platelet All binding as a 
model of myocyte All binding is further discussed in 
section 8 (p. 108). 
Identification and localisation. 
The earliest observations on All binding in 
vascular tissues demonstrated specific binding of 
radiolabelled All to rabbit aortic strips [Lin and 
Goodfriend, 1970] and to subcellular fractions of 
rabbit aorta [Devynck, 'Pernollet and Meyer, 1973] and 
guinea pig aorta [Le Morvan and .Paliac, 1975]. These 
binding sites were of relatively low affinity, (15-50 
nM), in comparison to circulating levels of All, (10-
100 pM), and may not be representative of All 
receptors in resistance vessels. Moreover, 
contractile responses to All in the·. 'aorta; a 
fibroelastic, conductive type vessel, differ from 
those in muscular resistance type vessels [Altura and 
Altura, 1970]. More recently, All receptors have been 
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identified 
mesenteric 
Alexander, 
Murray and 
in particulate fractions derived from rat 
arterial arcades [Gunther, Gimbrone and 
1980a, Aguilera and Catt, 1981, Mcqueen, 
Semple, 1984], small muscular vessels 
representative of resistance vasculature and highly 
sensitive to All [Bohr and Urchida, 1967]. These were 
found to be of higher affinity, «1 "nM), as discussed 
further below. 
The first evidence of specific binding of All to 
uterine tissue was provided by Lin and Goodfriend 
[1970] in the rat, and the presence of uterine All 
receptors has subsequently been demonstrated in 
several species [Schirar, Capponi and Catt, 1980, 
Siddiqi, Koenig and Clarke, 1986]. Specific binding 
of All to human platelets was first demonstrated by 
Moore and W i l l ~ a m s s [1981]. 
Autoradiographic analysis following intracardiac 
injection of tritiated All in rats showed nuclear 
localisation in myocardial and vascular smooth muscle, 
suggesting a direct interaction of the hormone at a 
nuclear level [Robertson and Khairallah, . 1971]. 
Recent support for the concept of nuclear receptors is 
provided by Re and co-workers, who suggested that All 
migh t also in terac t directly wi th the nucleus. They 
'demonstrated binding of All to a rat liver 
nucleoprotein, following incubation of rat liver 
nuclei with radiolabelled All [Re, Visard, Brown and 
Bryan, 1984]. The problem of how All might reach this 
site in intact cells is unresolved, but one attractive 
possibility is that the hormone is internalise4 by 
receptor mediated endocytosis [Pastan and"Willingham, 
1981]. 
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However, localisation of the receptors on the 
plasma membrane has been directly demons tra ted 
biochemically. Analysis of microsomal membranes 
prepared from homogenates both of rabbit aorta, and of 
rat myometrium, by differential centrifugation and 
density gradient fractionation demonstrated that 
binding sites for tritiated All copurify with marker 
enzymes of the plasma membrane, such as adenylate 
cyclase [Devynck et. al., 1973]. Purified microsomal 
membranes solubilised with deoxycholate retain their 
ability to bind triti"ated All [Devynck, Pernollet, 
Meyer, Fermandjian, Fromageot and Bumpus, 1974]. 
Photoaffinity labelling, in which a photosensitive 
ligand" is covalently coupled to binding sites prior to 
solubilisation and fractionation, has confirmed the 
receptor localisation on the plasma membrane, ·using 
dog uterine t i ~ s u e e [Capponi and Catt, 1980]. Electron 
microscope autoradiography of" cultured rabbit aorta 
smooth muscle cells also demonstrated that the initial 
site of interaction of All was at the plasma membrane 
[ ~ a g l i n , , Stukenbrok, Joyce and Jamieson, 1987]. The 
latter technique demonstrated varying receptor density 
amongs t cells in the popula tion, ranging from cells 
that were heavily labelled to those with virtually no 
label. This implies that All receptor expression may 
be limited to a certain progeny within the cell 
population or be a function of their stage within the 
cell cycle. 
Characterisation. 
The hormone - receptor interaction :Ls" the "first 
step of a chain of cellular responses leading to the 
hormonal response. A hormone receptor is a p a ~ t i c u l a r r
cellular component possessing the dual function of 
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recognition and stimulation. For the interaction of a 
hormone with a cellular binding site to be considered 
to correspond to a receptor interaction, it should 
fulfil the criteria of a hormonal response; exhibiting 
specificity, high affinity, reversibility and 
saturability. 
Specificity of All receptors in the rabbi t aorta 
was demonstrated by the absence· of any effect of 
phentolamine, methylsergide, and diphenhydramine, at 
doses that completely abolished the vasoconstrictor 
effect of noradrenaline, 5-hydroxytryptamine, and 
histamine, respectively [Rioux, P a ~ k k and Regoli, 
1973]. Rioux et. al. [1973] also demonstrated that 
the myotropic effect of All was similarly unchanged in 
the presence of indomethacin, which significantly 
reduced the myotropic effect of prostaglandin E2. 
The structural requirements for binding of All have 
been extensively investigated. Both Gunther, Gimbron7 
and Alexander [1980a] and Mcqueen, Murray. and S e m p l ~ ~
[1984] found that in rat mesenteric artery tissue, the 
discrimination between the affinities·· for angiotensin 
I, II, and III, and angiotensin analogues, was 
consistent with the pressor activity of these p e p t i d e ~ ~
[Bumpus, Khairallah, Arakawa, Page and Smeby, 1961, 
Carey, Vaughan, Peach and Ayres, 1978] • In 
particular, angiotensin I (AI) had virtually no effect 
on the binding of tracer All. 
In similar studies using uterine tissue from dogs 
and using human platelets, little difference was found 
between the affinities of All and a n g ~ o t e n s i I i i III 
(AlII) [Gregory and Aguilera, 1981, Moore and 
Williams, 1981]. This seems to disagree with the 
affinities expected from pharmacological studies; 
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during All and AlII infusions in man, the heptapeptide 
evokes only 15-30% of the pressor effect of All [Carey 
et. al., 1978]. However, Gregory and Aguilera [1981] 
suggested that similar affinities should be expected, 
providing evidence that responses to infusion of the 
peptides relate to differences in degradation rates. 
Binding sites of high affinity have been found in 
rat mesenteric arteries [e.g. Gunther, Gimbrone and 
Alexander, 1980a, Mcqueen, Murray and Semple, 1984]. 
The apparent dissociation constant Kd of 1 nM found by 
Gunther et. ale [1980a] suggested a lower affinity 
than that found by Mcqueen et. ale [1984] of 19-74 pM, 
although the observed concentrations of binding sites 
were s i ~ i l a r , , (54 and 80 fmol/mg of membrane protein 
respectively). The latter group suggested that 
degradat"ion of tracer All might explain the different 
dissociation constants found. Mcqueen et. ale [1984] 
encountered, extensive degradation that could not be 
inhibited without adversely affecting b i ~ d i n g g
capacity, necessitating the use of non-linear 
regression methods for the analysis of radioligand 
binding data. The lower affinity for the All receptor 
reported by Gunther et. ale [1980a] may have been due 
to unrecognised tracer All degradation. If the 
experimental results of Mcqueen et. ale [1984] are 
. analysed without compensation for tracer degradation, 
(e.g. by Scatchard a n a l y s ~ s ) , . . the calculated 
dissociation constant is in the region of 1 nM. 
High affinity binding for All has also been 
demonstrated in uterine tissue, (e.g. in the rat, Kd: 
1 nM [Schirar, Capponi and Catt, 1980]), .. and in human 
platelets, Kd: 0.1 ~ ~ 0.3 nM [e.g. Moore and Williams, 
1981, Ding, Kenyon and Semple, 1984] •. 
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The concentration of All binding sites on platelets 
deserves additional comment. A maximal level of 
approximately 10 receptor sites per platelet has 
consistently been found [e.g. Moore and Williams, 
1981, Mann, Sis and Ritz, 1985, Ding, Kenyon and 
Semple, 1985a]. Assuming 1 mg of platelet membrane 
protein per 10 cells [Alexander, Cooper and Handin, 
1978], the platelet, with 10 fmol All bound / mg 
protein, has 20% of the binding site density reported 
in uterine smooth muscle (45 fmol/mg) and vascular 
smooth muscle (57 fmol/mg) [Aguilera, Hauger and Catt, 
1978, Gunther, Gimbrone and Alexander, 1980b]. 
Scatchard analyses of data derived from steady-
state binding and binding-inhibition experiments have" 
often indicated the presence of two populations of" 
binding sites, with ,differing affinities [e.g.' 
"Chevillotte, Devynck, Fyhrquist, Meyer, Rouzaire-
Dubois and Worcel, 1975, Mcqueen, Murray and Semple, 
1984, Moore and Kwok, 1987] •. The significance of" the 
low affinity binding sites is controversial. In most 
cases the l o ~ ~ affinity" sites have been considered 
physiologically insignificant, part of non-specific 
binding, or simply overlooked. Chevillotte et. ale 
[1975] and Mcqueen et. ale [1984] argued that it was 
unlikely that the low ,affinity binding sites were 
- involved in any response to All, as their low 
affinities would prDbably not permit interactions with 
All at physiological concentrations, (10-100 pM). 
However, Moore and Kwok [1987] found that in rat 
uterine tissue, the value of the dissociation constant 
obtained by photoaffinity labelling was two o r d e ~ s s of 
magnitude larger than that obtained for the high 
affinity membranous All binding sites. They suggested 
that the low affinity binding sites represent the 
native 'resting' receptors, and that the high affinity 
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Photo-affinity labelling has been used to 
of the determine the physical characteristics 
receptor. 
shown to 
molecular 
dodecy1 
All receptors in the dog uterus have been 
consist of two species with a relative 
mass value of 126 and 64 kDa. On sodium 
sulfate polyacrylamide (SDS) gel 
electrophoresis under reducing condi.tions, Capponi and 
Catt [1980] observed a single band of 68 kDa. All 
receptors in rat liver and adrenal glomeru10sa 
membranes have also been studied. There seems to be 
general agreement that the All receptor is composed of 
two, (or perhaps four), subunits, each of a relative 
molecular mass near 68 kDa [Mendelsohn, 1985]. This ,. 
is consistent with the suggestion above, that one or 
more disu1phide bonds are essential bridges in the 
receptor molecule. 
Whilst the - techniques above are useful tools in 
characterising the All receptor, they have not 
resulted ,in its purification 'to homogeneity. Recently 
it was hypothesised that there is a molecular 
recogni tion code in which peptide ligands and their 
receptor binding sites can be encoded by complementary 
nucleotide sequences [Bost, Smith and Blalock, 1985]. 
Elton, Dion, Bost, Opari1 and Blalock [1988] 
demonstrated the use of this hypothesis in the 
purification of the All receptor. They found that a 
peptide, specified"by RNA complementary to the mRNA. of 
All, competed specifically with radio1abe11ed All for 
All binding sites on rat adrenal membranes. 
Furthermore, they used an antibody to the 
complementary peptide to immunoaffinity-puri.fy a 
protein which specifically bound radio1abe11ed All. 
The complete validation of peptide hormone binding 
sites as receptors that mediate the biological actions 
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of the ligand requires that a correlation be made 
between binding site occupancy and an appropriate 
target-cell response. Indirect evidence for such a 
correlation is obtained from binding-inhibition 
studies of All and its analogues, as detailed above. 
In addition, a direct relationship between binding and 
muscle contraction was shown by Baudouin, Meyer and 
Worcel [1971] whilst studying the specific binding of 
tritiated All to rabbit aorta. 
Several studies have attempted to determine whether 
the low All binding site density on platelets is 
sufficient to evoke.some cellular response. Poplowski, 
[1970] and Ding, MacIntyre, Kenyon and Semple [1?85] 
~ a v ~ ~ suggested that All added ~ o o platelet suspensions 
enhanced the aggregation response to adrenaline, and 
Haller, Ludersdorf, Lenz, Distler and Philipp [1987] 
found that All ' i n c r ~ a s e d d intracellular free calcium in 
platelets. The suggestion that the physiological 
action of All on platelets may be as an enhancer of 
the actions of other hormones rather than as a primary" 
effector, may explain the lower concentration of. All 
. binding sites on platelets as compared to vascular 
tissue (discussed above). As yet, no attempt at 
correlating any cellular responses with platelet 
binding site concentrations has been made. 
Regulation. 
The sensitivity of vascular tissues to All changes 
in response to certain regulatory factors, and such 
changes are thought to be accompanied by parallel All 
receptor variations: 
a) Cireulating All level. 
Kaplan and Silah [1964] observed an inverse 
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relationship between the level of endogenous 
circulating All in humans and the pressor effect 
resulting from the injection of synthetic All. 
Furthermore, when the plasma All level in rats was 
lowered by nephrectomy, Brunner, Chang, Wallach, 
Sealey and Laragh [1972] demonstrated an enhanced 
pressor effect of exogenous All. 
Gunther, Gimbrone and Alexander [1980b] 
demonstrated that All receptor concentrations in rat 
mesenteric arteries were regulated by circulating All 
levels. Increased levels of All induced by sodium 
restriction resulted in significantly decreased 
receptor concentration, w h e r ~ a s s inhibition of All 
formation ~ y y an AI converting enzyme inhibitor, SQ-
14,225, had the opposite effect. Renin did not appear 
to play a role, as the increase in. plasma .renin 
activity (PRA)-in sodium depleted rats was associated 
with decreased receptor concentration, whilst an even 
greater increase in PRA in sodium depleted rats given 
SQ-14,225, (due to loss of feedback inhibition of 
renin release by endogenous All), was accompanied by 
increased receptor density. Moreover, Schiffrin, 
Gutkowska and Genest [1984] showed a diminution in the 
number of rat mesenteric artery All receptors when the 
hormone was infused, the dissociation constant being 
. unaffected. 
Previous studies of the regulation of All smooth 
muscle receptors had used uterine membrane fractions, 
and yielded conflicting results. Devynck, Pernollet, 
Macdonald, Mathews, Raisman and Meyer [1978] reported 
increased All binding in sodium depleted·orOats, whilst 
Aguilera, Hauger and Catt [1978] found a 40% decrease. 
Although the reasons for this discrepancy are·unclear, 
it illustrates the difficulty in extrapolating binding 
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data from the uterus, a tissue which does not respond 
to physiological concentrations of All, to vascular 
smooth muscle. 
In human pIa tele t studies, resul ts demons tra ting 
that significant All binding changes inversely 
correlate with changes in plasma All levels [Moore, 
Taylor and Williams, 1984, Ding, Kenyon and Semple, 
1985] were obtained by alteration of dietary sodium. 
b) Sodium balance. 
The results of variations in sodium balance on the 
pressor effect of All ar"e well established, with 
sodium deficiency causing a decrease in pressor 
responsiveness to All, in ~ o t h h the rat 
IBrunner ,Chang , Wallach, Sealey and Laragh, 1972], and 
"in vascular tissue from d9gs [Oliver and Cannon, 
1978]. In the latter study, altered sodium balanc'e 
had little "effect on the pressor responses to other 
vasoactive hormones such as catecholamines [Oliver and 
Cannon, 1978]. 
The selective nature of this effect suggested a 
specific mechanism for the changing All sensitivity. 
In addition to the studies above, Aguilera and Catt 
[1981] found that sodium restriction and loading were 
accompanied by significant decreases and increases, 
respectively, in r",at mesenteric artery All receptors. 
Furthermore, during' altered sodium intake, no 
alterations in alpha- or beta- adrenoreceptors were 
found. 
As discussed in section 2, s o d i u ~ ~ depletion 
increases All production by stimulating renin release, 
and the elevated levels of All may well account for 
sodium induced changes in All receptor "concentration. 
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c) Mineralocorticoids. 
Schiffrin, Gutkowska and Genest [1984] found that 
the decrease in rat mesenteric artery All receptor 
concentration when All was infused, did not occur at 
the highest infusion dose, (200ng/Kg/min). Moreover, 
only at this dose did they find a significant increase 
in plasma aldosterone. When deoxycorticosterone was 
infused, an increase in the number of All receptors 
was noted. Increased vascular All receptor 
concentrations have also been shown after infusion of 
aldosterone into rats ex vivo, and after the addition 
of aldosterone to cultured rat mesenteric artery cells 
in vitro [Schiffrin, Franks and Gutkowska, 1983]. 
Whether these results, which have yet· to be 
confirmed in human studies, have any physiological 
implications is uncertain. However, they suggest that 
mineralocorticolds may have an up-regulating action on 
vascular All receptors. 
d) Cations and guanine nucleotides. 
C a t ~ o n s s have been shown to influence the binding of 
All to receptors in a wide variety of tissues, 
including the adrenal.cortex, aorta, renal glomerulus, 
cerebellar cortex and liver [Wright, Alexander, 
Ekstein and G i m b ~ o n e , , 1982]. No consistent pattern of 
cation effect has emerged, even when vascular tissue 
alone is considered. Gunther,. Alexander and Gimbrone 
[1980a], Wright et. ale [1982], and McQueen, M u r ~ a y y
and Semple [1984] found that the divalent cations 
Mn+2, Mg+2, and Ca+2 increased All binding 
concentrations in rat mesenteric artery fractions, 
whereas the chelating agents EDTA and ··.EGTA had an 
inhibiting effect. . In contrast, Devynck and Meyer 
[1976] demonstrated that Ca+2 and Mg+2 decreased All 
binding concentrations in the rabbit aorta. The 
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significance of these differences is unclear, but they 
sugges t that All receptors may vary in their 
biochemical nature from tissue to tissue, and even 
from blood vessel to blood vessel. In addition to a 
possible alteration in the concentration of All 
receptors, an Mn+2 induced increase in receptor 
affinity has been demonstrated [Wright et. al., 1982]. 
Guanine nucleotides have been found to inhibit All 
binding [Devynck and Meyer, 1976]. Wright et. ale 
[1982] noted that in rat mesenteric artery tissue, the 
sensitivity of All binding to inhibition by· guanine 
nucleotides was greatly reduced when endogenous, 
divalent cations were chelated by EDTA. They 
postulated, the existence of receptor associated 
cation-sensitive sites, and suggested that a complex 
interplay with guanine nucleotides .regulates All 
binding. 
e) Sex steroids. 
Uterine contractility is modulated by oestrogen and 
progesterone, and oestrogen ~ a s s been shown to increase 
rabbit uterine alpha-adrenergic and oxytocin receptors 
[Williams and Lefkowitz, 1977, Nissenson, Flouret and 
Hechter, 1978]. In 1980, Schirar, Capponi and Catt 
found that during the rat and rabbit .ovarian cycles, 
. changes in the concentrations of uterine All receptors 
were directly proportional to· changes in the se7um 
levels of oestradiol. After ovariectomy, the density 
of All receptors was found to decrease as a function 
of time elapsed from surgery, reaching 50% of the 
control v a ~ u e s s 8 days after castration.. Furthermore, 
s h o r t ~ t e r m m infusion of oestradiol caused ~ ~ ~ r o g r ~ s s i v e e
increase in All receptor concentration, reaching a 
maximum of four- to six-fold above control values at 
36 hours. Progesterone infusion for 7 days caused 
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uterine All receptor numbers to diminish by 93%. No 
effects of steroids on the affinity of All receptors 
were detected. 
In pregnant rabbits and pregnant women, there is a 
sus tained rise in circulating All levels despite a 
fall in systemic blood pressure [Lee, Oakes, Lam and 
Hobel, 1982, Karlberg, Ryden and Wichman, 1984]. 
During pregnancy in both species, there is an 
attenuated vasoconstrictor response to exogenously 
infused All [Abdul-Karim and Assali, 1961, Donker, Min 
and Venuto, 1983]. 
'. During pregnancy in both rats and sheep, a 
diminution in the number of uterine All receptors has 
been shown, [Schirar, Capponi and Catt, 1980, Siddiqi, 
Koenig and Clarke,· 1986]. Schirar found t ~ a t t infusion 
of the converting-enzyme inhibitor SQ-14;225 did not 
mOdify uterine All receptor concentration, indicating 
that these changes were unrelated to plasma All 
levels. 
Brown and Venuto [1986] demonstrated that the 
concentration of mesenteric artery All receptors was 
lower in pregnant than nonpregnant rabbits, and 
suggested that the decrease in receptors was related 
to the associated elevation of endogenous All. Paller 
[1984] had previously found no All receptor changes 
during pregnancy in rats. However, Paller [1984] used 
nonvascular bladder smooth' muscle tissue. In 
addition, it is particularly inappropriate to compare 
findings in the pregnant rats with those in other 
species. It has been suggested that the " r ~ s i s t a ~ c e e in 
pregnancy to the pressor action of All that is 
observed in humans [Abdul-Karim and Assali, 1961] and 
in rabbits [Donker, Min and Venuto, 1983], does not 
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occur in rats [Fowler, Johnson, Kurz, Ki1joi1, Love 
and Payne, 1981]. If this is the case, altered All 
receptor concentrations in pregnant rats would be 
surprising. 
As yet, there have been no reports regarding 
platelet All binding site changes in pregnancy. 
Mode of action. 
The activation mechanism of All in smooth muscle 
appears to be independent of cyclic nucleotide 
formation. Penit, Faure and Jard [1983] demonstrated 
that All did not modify the cyclic AMP content of rat 
aortic smooth muscle cells ~ n p r i m a r y y culture. This 
lack of response was not due to major impairment of 
the adeny1ate cyclase system, because a definite 
response to beta-adrenergic stimulation was found. 
The action of All is, however, 'ca1cium dependant. 
Reduction of extracellular calcium concentration has 
been shown to abolish. the contractile responses of rat 
uterine tissue to All [Freer, 1975]. Freer [1975] 
also noted that the calcium blocking agent, verapami1, 
prevented All-induced uterine contractions. Another 
calcium channel blocker, nitrendipine, has been found 
to reduce All pressor responsiveness in pregnant sheep 
[Lawrence and Broughton Pipkin. 1986]. 
Gaining 
which All 
muscle has 
structural 
vessels. 
" 
insight into the biochemical mechanism by 
mediates its effect in vascular smooth 
been difficult, in part because of the 
and cellular heterogeneity' of .. blood 
Several workers [e.g. Penit et. a1., 1983, 
Brock, Alexander, 
1985, Alexander, 
Ekstein, Atkinson and Gimbrone, 
Brock, Gimbrone and Rittenhouse, 
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1985] have used cultured vascular smooth muscle cells, 
which express functional All receptors, to provide a 
homogeneous population of intact cells in sufficient 
numbers for biochemical analysis. 
Using the calcium-sensitive fluorescent indicator 
quin 2, Brock et. ale [1985] demonstrated that All 
caused a rapid increase in cytosolic free calcium in 
cultured rat aortic smooth muscle cells, the increase 
being dependant on the mobilisation of intracellular 
calcium and the influx of extracellular calcium. In 
similar tissue culture, Alexander et. ale [1985] 
subsequently found that All stimulated the breakdown 
of phosphatidylinosi tol bisphosphate and··.the 
generation of inositol triphosphate •. The time course 
of the inositol triphosphate formation was comparable 
. . 
to that. of the. All induced cytosolic free calcium 
increase. Inositol triphosphate has been shown to 
cause a rapid release of calcium, probably from the 
sarcoplasmic .reticulum [Smith, 'Smith and Higgins, 
1985], which triggers the contraction of smooth muscle 
by . activating a calmodulin dependant protein kinase 
that phosphorylates a light chain of smooth muscle 
myosin [Adelstein and Eisenberg, 1980]. Anderson, 
Gimbrone and Alexander [1981] had previously shown 
that All increased phosphorylation of the myosin light 
chain in cultures of smooth muscle cells derived from 
rat mesenteric arteries. 
Although such a mechanism describes one possible 
mode of action of All, it is almost certainly an 
oversimplification. For example, recent work by 
Vallega, Canena, Berk, Brock and Alexander [1988], 
again using cell cultures, indicated that All 
. regulated the activity of a vascular smooth muscle 
sodium ion - hydrogen ion exchange mechanism. The 
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authors also suggested that an All induced 
a1ka1inisation may activate a sodium ion - calcium ion 
exchange; a mechanism for cytoso1ic calcium 
homoeostasis. 
Information regarding the mode of action and 
regulation of vascular smooth muscle All receptors is 
constantly increasing, aided by the use of accessible 
tissue models. A discussion of the tissue model used 
in this thesis, platelets, now follows. 
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Section 6. 
PLATELETS: MORPHOLOGY AND BEHAVIOUR. 
Guilio Bizzozero was probably the first person to 
observe platelets in the circulating blood of intact 
animals. In 1882 he coined the term 'blut plattchen' 
and described the changes that platelets undergo when 
exposed to a foreign surface. These studies and 
subsequent work suggested that the platelet is almost 
solely responsible for the white thrombus that p l u g ~ ~ a 
small vascular puncture [ ~ i z z o z e r o , , 1882, cited, by 
Wintrole" 1985]. 
The behaviour of platelets is .central. to the 
thesis, thus' there follows a discussion of platelet 
morphology and action. 
Platelets are the smallest of the formed elements 
of blood, with a diameter ~ f f 2-3 microns. Normally, 
approximately 250,000 are present per pl (range 
150,000 - 350,000) [Majerus, 1987]. Platelets are 
formed from megakaryocyte cytoplasm, prior to release 
into the circulation from the bone marrow [Majerus, 
1987]. They remain viable in vivo for about 9 days, 
and m i c r o s c o p i ~ a l l y y they appear as flat discs (Figure 
1.9). The shape of a platelet is labile; for example, 
exposure of platelets to the anticoagulant EDTA turns 
the disc shape into a 'spiny sphere' [Holmsen, 1972]. 
This shape change is the first response of the 
platelet to almost any stimulus, and, has re'sulted in 
criticism of work with platelets which have been 
handled, washed, or stored for long periods of time 
[Holmsen, 1972]. 
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Figure 1.9. 
Scanning electron micrograph of human platelets drawn 
directly into fixative. 
[Hovig, 1970] 

Morphology. 
Platelets can be considered as having three zones, 
the peripheral, the Sol-gel and the organelle zones. 
A detailed discussion of platelet morphology is 
outside the limits of this text, but is extensively 
discussed, amongst others by Holmsen [1972], Gerrard 
and White [1976], Shattil and' Bennett [1980], and 
White, Clawson and Gerrard [1981]. The brief review 
below concentrates on the peripheral zone, consisting 
of the membranes and closely associated structures, as 
All binding sites have been found to be membrane bound 
[Capponi and Catt, 1980] (see p. 73). 
The peripheral zone ,is ,. made up of three structural 
domains, the exterior coat, t ~ e e unit membrane, and the 
submembrane region. It includes an i n t r ~ c a t e e system 
of channels continuous with the plasma membrane, the 
open canalicular system [White et. al., 1981]. The 
surface area exposed to surrounding plasma is thus 
much greater than expected, and in this sense the 
platelet resembles' a sponge [Adelson, Rheingold and 
Crosby, 1961]. 
The exterior coat, or fluffy coat, is about 50 nm 
thick, and runs all around the platelet. Human 
platelets can be stained with dyes such as lanthanum 
nitrate, ruthenium red, and alcian blue, all revealing 
a heavy glycocalyx on platelets, thicker, alld more 
dense, than the surface coats of other blood cells 
[O'Brien, 1970]. When Schiff's stain is used, three 
characteristic bands of glycoprotein are demonstrated; 
I, II and III. These correspond to molecular weights 
of approximately 155,000, 135,000 and' 100,000 
respectively [Mills, 1981). These three major 
glycoprotein classes can be subdivided on' the basis of 
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affinity for plant lectins, and by the relative 
intensity of radio-labelling [e.g. Nurden and Caen, 
1978]. With a combination of these techniques, as 
many as 15 different glycoproteins have been 
identified. These glycoproteins act as receptors for 
stimuli, triggering platelet activation, and as 
discussed below, deficiencies of certain receptors may 
lead to disordered platelet function. 
Under the electron microscope, the unit membrane 
appears as a triple layered structure with a thickness 
of about 8 nm, in common with all cell membranes 
[ ~ o v i g , , 1968]. However, this three layered structure. 
i ~ ~ a . specific, ·repeatable artifact originating from. 
fixation procedures, and any such biological membrane 
should be regarded as a conglomerate of lipid and 
. . 
protein molecules in constant movement relative to 
each other [Hoimsen, 1972]. 
Lying beneath the unit membrane is the third 
component of the peripheral zone, the sub-membrane 
r ~ g i o n . . Electron microscopy has shown this region to 
contain a relatively regular system of filamentous 
elements [White, 1969]. Functionally, the sub-
membrane filaments are thought to cooperate in 
maintaining.platelet discoid shape, playa role in the 
extrusion and stabilisation of pseudopods, and 
interact with other elements of the platelet 
contractile m , ~ c h a n i s m m to effect platelet cohesion and 
clot retraction [White et. al., 1981]. 
The Sol-gel zone is the matrix of the cytoplasm of 
the p l a t e l e t ~ ~ Near the surface, a microtubular system 
provides a cytoskeleton which maintains the discoid 
shape of the platelet. This system consists of a 
bundle of 8-24 circular profiles, each ~ p p r o x i m a t e l y y
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25 nm in diameter, the major protein being tubulin. 
Microfilaments constitute a second system of fibres in 
this zone. These filaments are approximately 5 nm in 
diameter, with actin being the major proteinaceous 
component [White et. al., 1981]. Pronounced changes 
occur in the Sol-gel zone when the platelet is 
activated. The randomly dispersed cytoplasmic 
organelles are moved into a tightly packed mass in the 
central region of the platelet where they are 
encircled by microtubules and a tight fitting web of 
microfilaments [Gerrard and White, 1976]. 
Understanding of the third zone, the organelle 
zone, increased with the development of electron 
~ i c r o s c o p y . . Mitochondria, and at least three distinct 
types of secretory granules hl!-ve been demonstrated 
[Brenton-Gorius and Guichard, 1975].. Alpha granules 
contain coagulation factors, such as beta 
thromboglobulin and platelet factor 4, (both heparin 
neutralising factors), fibrinogen,. factor V, and von' 
Willebrand factor. Another type of secretory granule 
in platelets is t e ~ m e d d the dense body. This organelle 
contains calcium and magnesium ions, ATP, ADP, and 
smaller amounts of other. nucleotides plus several 
vasoactive hormones, particularly serotonin. A third 
secretory granule is the lysosome, which contains 
hydrolase enzymes, similar to those found in other 
cells. 
,'. 
Any consideration of platelet anatomy must include 
the membrane systems, the dense tubular system and the 
open canalicular system. The dense tubular system is 
thought to be analogous to the sarcoplasmic reticulum 
of smooth muscle cells [Gerrard and W h i t ~ , , 1976], 
being the site where calcium, important for triggering 
contractile events, is, sequestered 'and released 
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[O'Rourke, Halenda, Zavoico and Feinstein, 1985]. 
Also, it is the site where enzymes involved in 
prostaglandin synthesis are localised. The surface 
connected open canalicular system is made up of 
membranous channels providing access to the interior 
for plasma-borne substances, and an egress route for 
substances released by storage granules [White et. 
al., 1981]. 
Platelet binding sites. 
In recent years, the exterior coat of the platelet 
has .been found to contain many high affinity binding 
sites. The concept of a platelet receptor being, an 
externally orientated membrane protein, accessible in 
the intact cell, that demonstrates specificity, high 
affinity and satur4bility, and that interacts 
reversibly with" the agonist, forming a complex, which 
then initiates a measurable intracellular response, 
has been discussed previously in Sections 4 and 5. 
The f'irst receptor to be discussed is historically 
the first one identified, adenosine diphosphate (ADP). 
In 1972, Born found that at low concentrations, (0.1 _ 
0.5 pM), ADP induced human platelets to change shape. 
ADP also i n d u ~ e s s platelet aggregation and antagonises 
adenylate cyclase stimulation [Haslam, 1973]. 
The methods used to' study the ADP receptor 
illustrate the difficulties of platelet receptor 
characterisation and isolation. The most traditional 
technique, that of directly measuring the binding of 
radiolabelled ADP to intact platelets, is not 
applicable, as ADP is hydrolysed by 'platelet membrane 
phosphatases [Born and Feinberg, 1975]. A second 
approach, measuring the binding of ADP' to isolated 
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membranes [Nachman and Ferris, 1974], is also not 
valid because membrane preparations expose both 
proteins that were externally orientated and proteins 
found on the cytoplasmic face. 
Bennett, Colman and Colman [1978] reported the use 
of f1uorosu1fony1benzoyl adenosine (FSBA), as a 
specific analogue for ADP. Washed intact platelets 
incubated with [3H]-FSBA' showed concentration-
dependent covalent incorporation of radioactivity and 
concomitant inhibition of shape change. When platelet 
membranes prepared from the platelets exposed to [3H]_ 
FSBA were subjected to SDS gel electrophoresis, a 
single radioactive peak corresponding to a relative 
molecular weight (Mr ) of 100 kd w a ~ ~ found. 
As discussed below, adrenaline is a powerful 
. 
inducer of platelet aggregation. The effect of 
adrenaline on human platelets can be abolished by 
alpha-receptor blocking agents such as 
dihydroergotamine and phentolamine. Using a variety 
of such agents, allied to computer modelling 
techniques, Hoffman, De Lean, Wood, Schoken and 
Lefkowitz [1979] demonstrated that. the receptor 
involved was the alpha-2, presynaptic type. Motulsky, 
Shattil, and Insel [1980] successfully characterised 
alpha-2 adrenergic receptors on human platelets, 
finding a dissociation constant (Kd) of 2.7 nM. This 
receptor has .. , since been' purified 80,000-fold to 
apparent homogeneity, using a five-step chromographic 
procedure, and is a single polypeptide, (Mr - 64 kd) 
[Regan, Nakata, DeMarinis, Caron and Lefkowitz, 1986]. 
Moreover, using a partial amino acid sequence from the 
purified receptor as a guide, the alpha-2 ~ d r e n e r g i c c
receptor has been cloned and expressed [Kobilka, 
Matsui, Kobi1ka, Yang-Feng, Francke, Caron, Lefkowitz 
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and Regan, 1987]. 
Fibrinogen binding studies have suggested that 
there are 45,000 fibrinogen binding sites per 
platelet, and using a monoclonal hybridoma antibody, 
immunoaffinity chromatography has isolated the binding 
site from a detergent-solubilised platelet membrane 
extract [McEver, Baenziger and Majerus, 1982]. This 
method has the disadvantage that it is not possible to 
separate intracellular and plasma membranes. Using 
gel filtration chromatography, Jennings and phillips 
[1982] found the fibrinogen binding site to be a 
dimeric glycoprotein w i ~ h h the relative molecular 
weights of the subunits being 125 kd and' 95 kd. The 
fibrinogen binding site, ,designated glycoprotein IIb-
IlIa, has been shown to bind to purified human 
fibrinogen [Nachman and Leung, 1982]. The formation 
of the glycoprotein lIb-IlIa fibrinogen complex was 
calcium dependent, fibrinogen specific, saturable and 
inhibited by specific amino acids. The binding site' 
has also been shown to bind platelet contractile 
proteins [Phillips, Jennings and E d w a r d ~ , , 1980]; thus 
suggesting a model in which lIb-IlIa serves a linking 
func tion by binding fibrinogen to its extracellular 
portion and binding platelet contractile proteins to 
its intracellular portion. 
Glanzmann' s thrombasthenia, a congenital platelet 
disorder, is . .characterised by mucocutaneous bleeding 
with absent or reduced platelet aggregation [Majerus, ' 
1987]. Direct binding studies of monoclonal 
antibodies to fibrinogen binding sites, indicate an 
absence of binding in such patients, with 50% levels 
in obligate heterozygotes [McEver, B a e n ~ i g e r r and 
Majerus, 1980].' 
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However, fibrinogen binding sites should not 
strictly be regarded as receptors, as the interaction 
of fibrinogen with glycoprotein lIb-IlIa does not 
occur on an intact cell but requires prior stimulation 
of the platelet, for example by AOP [Colman, 1990]. 
The definition of a platelet receptor also excludes 
another of the well-understood platelet reactions. 
The autosomal recessive disease, Bernard-Soulier 
syndrome, has been shown to result from an absence of 
binding sites for von Willebrand factor (vWF) an 
integral factor in the blood coagulation cascade. 
Binding studies using purified radiolabelled vWF have 
confirmed the presence of platelet binding sites ,> in 
normal, individuals, but not in Bernard-Soulier 
patients [Kao, Pizzo and McKee, 1979]. Furthermore, a 
deficiency of glycoprotein Ib can ,be" d e m o ~ s t r a t e d d in 
such patients' using SOS electrophoresis [Nurden and 
Caen, 1975]. However, the interaction of .vWF with vWF 
binding sites can occur in metabolically inert 
platelets, (treated with' formaldehyde). The 
agglutination which results, does 'thus not require a 
measurable intracellular 'response [Colman, 1990]. 
High affinity binding sites, (Kd - 0.3 nM), for 
thrombin have been found [Harmon a,nd Jamieson, 1985], 
although the receptor has not yet been isolated. 
Similarly, although s t u d ~ e s s using a radiolabelled 
thromboxane A ~ ~ antagonist have demonstrated high 
affini ty, saturable and reversible binding to human 
platelet membranes [Saussy, Mais, Burch and Halushka, 
1986], isolation and characterisation of the receptor 
is awaited. In addition, Schafer, C ~ o p e r , , O'Hara and 
Handin [1979] have identified high affinity binding 
sites for prostaglandin 12 and 02 .inplatelet 
. particulate fractions. 
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Perhaps no receptor for a platelet agonist has been 
as controversial as that for collagen. No fewer than 
nine binding sites on the platelet surface have been 
promulgated as the platelet collagen receptor. One 
possibility is glycoprotein IIIb, Tandon, Kralisz and 
Jamieson [1989] having recently demonstrated that this 
protein inhibits aggregation. and shape change 
stimulated by collagen, without inhibiting platelet 
aggregation stimulated by thrombin, ADP or adrenaline. 
Amongst polypeptide platelet high affinity binding 
sites demonstrated have been those for vasopressin (Kd 
1 nM) [Thibonnier and Roberts, 1985], for atrial 
natriuretic peptide [Schiffrin, Deslongchamps and 
Thibault, 1986], an.d I:ls discussed previously (p. 75), 
for angiotensin II [Ding et. al., 1984]. 
Platelet function. 
In the circulation, platelets are freely floating 
cells that do not adhere to each other or to vascular 
endothelium.. However, when platelets are exposed to a 
non-endothelial surface, they adhere and spread to the 
surface. In this process, the platelet shape changes 
dramatically from a disc to a spiny sphere with long 
fine filopodia [Holmsen, 1972]. The process of 
adhesion requires the presence of von Willebrand 
factor, and other plasma factors, such as fibrinogen 
[George, N u r d e ~ ~ and Phillips, 1985]. 
Most of the platelets that accumulate at sites of 
injury do not adhere directly to subendothelial 
structures but rather to each other •... This process of 
platelet-platelet adherence is called aggregation. 
Platelet aggregation has been studied .in vitro by 
measuring the aggregation of stirred platelet 
- 96-
suspensions by monitoring changes in optical density 
using a modified spectrophotometer [e.g. Macfarlane 
and Mills, 1975]. Platelet aggregation can be 
triggered by several physiological agents, the mos t 
important of which are ADP and thrombin. Other 
potential agonists include collagen, adrenaline, 
vasopressin, serotonin, thromboxane A2 and platelet 
activating factor [Shattil and Bennett, 1980]. ADP, 
serotonin and thromboxane A2 are released from the 
platelet during degranulation, thus they produce 
positive feedback and cascade platelet activation. 
Aggregation results in secretion of the contents of 
platelet granules, which as discussed ~ ~ o v e , ,
stimulates further aggregation. When the granules are 
condensed in the centre of the cell following 
contraction of the microtubular circumferential band, 
the .granular m ~ m b r a n e s s fuse with the membranes of the 
surface-connected open canalicular system [Stenberg, 
Shuman, Levine and Bainton, 1984]. Secretion is thus 
analogous to squeezing a sponge. 
The above events require calcium [Holmsen, 1972]. 
It is thought that the aggregating agents bind to 
platelet· surface binding sites, and that this then 
triggers release of calcium from the dense tubular 
s y s t e m ~ ~ When platelets are stimulated, for example by 
thrombin, the intracellular free calcium levels have 
been shown to <rise by at least tenfold, as measured 
with the fluorescent indicator Quin-2 [Rink, Smith and 
Tsien, 1982]. The role of intracellular free calcium 
in initiating platelet activity has been studied in a 
series of experiments which demonstrated that varying 
thresholds of intracellular free calcium elevation 
produced various platelet responses. R e ~ a t i v e l y y low 
thresholds of elevation of intracellular free calcium 
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resulted in platelet shape change and myosin light 
chain phosphorylation, the latter being required for 
platelet contraction [Simpson, Hallam and Rink, 1984]. 
Platelet aggregation has been shown to occur at higher 
thresholds of elevation [Rink and Hallam, 1984]. Even 
higher thresholds of elevation of intracellular free 
calcium result in secretory exocytosis [Rink and 
Hallam, 1984], liberation of arachidonic acid 
[Pollock, Rink and Sage, 1987] and thromboxane A2 
production [Pollock, Rink and Irvine, 1986]. 
The next chapter considers the changes in platelet 
morphology and behaviour that occur in normotensive 
and hypertensive pregnancy. 
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Section 7. 
PLATELET CHANGES IN 
NORMOTENSIVE AND HYPERTENSIVE PREGNANCY. 
Normotensive pregnancy. 
Several investigators have studied the platelet 
count in pregnancy, with conflicting results. One of 
the problems in assessing the platelet studies during 
pregnancy relates to the definition of normal 
pregnancy. Moreover platelet counting t e c h n ~ q u e s s ha·ve 
differed between reports, as has study design, with 
instances of cross sectional d a ~ a a having been compared 
d ~ r e c t l y y ~ i t h h results from longitudinal studies. 
O-Brien [1976], Fay, Hughes and Farron [1983], and 
Sill a ~ d d Lind [1985], all showed a small fall in 
platelet count towards term. In a small cross-
sectional study, O'Brien [1976] found a significant 
progressive decrease in platelet count. The study by 
Fay et. al. [1983] analysed the results from over two 
thousand patients. However, the study design was also 
c ~ o s s - s e c t i o n a l , , and patient· selection criteria were 
unclear. Furthermore, the fall in platelet number 
which occurred from 32 weeks gestation, was not 
significant when compared to non-pregnant values. 
Sill and Lind [1985] reported a fall in the platelet 
count towards term from a longitudinal study of 26 
normotensive patients. However, there was 
considerable variation in p l a t e l e ~ · · count· within 
individuals, and the apparent fall in the group as a 
whole was accounted for by a considerable fall in a 
few individuals. 
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In contrast, in four longitudinal studies, where 
care was taken to exclude patients with pregnancy 
induced hypertension, no change in platelet count was 
found [Fenton, Saunders, and Cavill, 1977, Tygart, 
McRoyan, Spinnato, McRoyan and Kitay, 1986, Pekonen, 
Rasi, Ammala, Viinikka and Ylikorkala, 1986 and 
Marumoto, Kaibara and Murata, 1988], with Fenton et. 
al. [1977] stressing the considerable variation in the 
platelet counts of normal women. 
It seems reasonable to conclude that any reduction 
in platelet count is minimal. In view of the 40% 
increase.in plasma volume induced by normal pregnancy, 
platelet mass must thus increase considerably. 
Mean platelet volume (MPV) and platelet 
distribution width (PDW) h ~ v e e been used as indices of 
bone marrow h a e m o p ~ e t i c c activity; Letsky [1985] having 
demonstrated that platelets become progressively 
smaller with age. A g a i ~ , , differing results. have been 
obtained. Fay et. ale [1983] noted an increase in the 
MPV in the last ·month of pregnancy with the PDW 
increasing progressively. Sill and Lind [1985] 
confirmed the progressive rise in the PDW, but found 
that the MPV increased throughout the third trimester. 
Tygart et. ale [1986] found the MPV to be unchanged. 
Marumoto et. ale [1988] demonstrated a decrease in MPV 
from 20 to 31 weeks gestation with a marked increase 
from 38 to 41" weeks gestation. Although all the 
authors collected their samples in EDTA, none of them 
give venepuncture details. Holmsen [1972] amongst 
others, has emphasised the importance of collection 
and handling techniques. Any diffe.rences .may have 
produced .. the discrepancies, which probably also 
reflect differences in the populations studied. 
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Both Wallenburg and Van Kessel [1978] and Rakoczi, 
Tallian, Bagdany and Gati [1979] have studied platelet 
life-span in healthy pregnant and non-pregnant women. 
Both studies were cross-sectional, with relatively 
small numbers, (between nine and nineteen), in each 
group. Their methods involved the use of aspirin to 
inhibit the platelet cyclo-oxygenase system and allow 
the calculation of platelet survival curves. Although 
the mean platelet life spans were marginally shorter 
in the pregnant women, the differences were not 
significant. Pekonen et. al. [1986] confirmed these 
results in a longitudinal study of 17 patients. The 
increased platelet mass and unaltered platelet life 
span suggested a pregnancy-induced increase in the 
total p l a t e l e ~ ~ turnover. 
Measurement of secretory products released from 
platelets, into the plasma is a further means of 
examining platelet activity in pregnancy. In both 
cross sectional [Douglas, Shah, Lowe, Belch, Forbes 
and Prentice, 1982], and longitudinal studies [Pekonen 
e t. a ~ . , , 1986], pregnancy resul ts in an increase in 
plasma beta-thromboglobulin levels. Contradictory 
measurements of serum thromboxane B2' (the stable 
metabolite of thromboxane A2)' have been obtained. 
Koullapis, Nicolaides, Collins, Rodeck and Campbell 
[1982] and Pekonen et. al. [1986] did not find 
elevated levels in pregnapcy, the former being a 
" cross-sectional study involving 141 u n c o m p l i ~ a t e d , ,
normotensive pregnancies. Ylikorkala and Viinikka 
[1980] had previously demonstrated a rise with 
gestation, in a small cross-sectional study. One 
explanation of this difference lies in-the production 
of . thromboxane a2 by tissues other than platelets, 
such as the placenta and amnion [Ylikorkala and 
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Makila, 1985], and again collection and handling 
techniques may be important. 
Despite an extensive literature search, no studies 
of pregnancy induced changes in platelet plasma 
membrane binding sites have been found, apart from a 
study of alpha 2 adrenoreceptors in the puerperium 
[Metz, Stump, Cowen, Elliott, Gelder and Grahame-
Smith, 1983]. The principal finding of the study was 
that the number' of platelet alpha 2 adrenoreceptors 
fell after childbirth. In rabbit uterine tissue, 
oestrogen has been shown to increase alpha adrenergic 
receptors [Williams and Lefkowitz, 1917], and Metz ei. 
~ l . . [1983] suggested that a r e d u c t i o n ~ i n n oestrogen ~ n d d
progesterone affected ·the number' of receptors. 
However, they were unable to show a direct 
relationship between binding characteristics and serum 
steroid levels in either the ante-partum or the post-
partum samples. 
Platelet aggregation in response to various agents 
alters during pregnancy. Yamazaki, Motomiya, 
Kikutani, Sakakibara, Watanebe, Namuta and Noguchi 
[1979] assessed platelet" aggregation, utilising 
platelet rich plasma and using the light-transmission 
method mentioned in the previous section (p. 97). 
They found that platelet aggregation induced by ADP 
and adrenaline occurred more frequently in pregnant 
~ ~ . 
women, as compared to non-pregnant women. One of the 
inherent problems of using platelet rich plasma, is 
that the platelet yield may not be representative of 
the original platelets. This problem, considered 
again in Chapter 2 (p. 121), may". be particularly 
important' in pregnancy [Burgess-Wilson, Morrison and 
Heptinstall, 1986]. 
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Hypertensive pregnancy. 
There have been many studies of the circulating 
platelet count in pre-eclampsia and pregnancy induced 
hypertension (PIH) [e.g. Howie, 1977, Trudinger, 1976, 
Rakoczi, Tallian, Bagdany and Gati, 1979, Gibson, 
Hunter, Neame and Kelton, 1 9 8 ~ , , Pekonen et. al., 
1986]. The majority of these observers found a 
reduction in the number of circulating platelets, but 
comparisons be tween studies are made ex tremely 
difficult by the varying definitions used. For 
instance, whereas Rakoczi et. al. [1979] defined 
severe pre-eclampsia as a rise in diastolic blood· 
pressure of 20 mmHg. with proteinuria i ~ ~ excess of 0.5 
gm/day, Pekonen et. al. [1986] regarded the 
diagnostic criteria for severe pre-eclampsia as 
proteinuria above 5 gm/day and/or blood pressure 
. 
repeatedly above 160/110 mmHg. Pekonen et. al. [1986] 
were one of the few groups to show no reduction in 
platelet count. This. may be explained in part by 
their active management of pre-eclamptic patients, 
with three-quarters of pre-eclamptic patients being 
delivered prior to 35 weeks gestation, possibly before 
the platelet count diminished. Gibson et. al. [1982] 
found that the reduction in platelet number only 
occurred in about 20% of cases, and the sample size in 
the study of Pekonen et. al. [1986] (n = 16), may have 
been too small to detect any change. Moreover, 
Wallenburg [1987] demonstrated that platelet counts, 
even in patients with severe disease, show marked day 
to day variation. 
An increased platelet consumption. in ·PIH was 
suggested. by Giles and Inglis [1981]. In general 
large platelets (macrothrombocytes) arft immature 
platelets, and they found an increase in. the mean 
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platelet volume in a cross-sectional study of over 500 
patients with PIH. Rakoczi et. ale [1979] had 
previously demonstrated reduced platelet survival in 
pre-eclamptic patients, using the non-radioisotopic 
method described above. Unfortunately, the value of 
the non-isotopic method is limited in such patients. 
The technique relies upon a stable platelet count 
throughout the test, unfortunately not often the case 
in pre-eclampsia. This factor, and differing 
populations, may account for the contrasting results 
of Pekonen et. ale [1986], who found that platelet 
survival in pre-eclampsia was unchanged. 
The ~ e s u l t s s of in ·vitro platelet aggregation 
studies are conflicting. H o w i ~ , , yrentice and McNicol 
[1971] found decreased ADP-induced platelet 
aggregation in pre-eclamptic patients, unlike patients 
with non-proteinuric PIH and with essential 
hypertension, in whom platelet aggregation was 
unchanged. Similarly, this group· demonstrated a 
decrease in arachidonic acid induced aggrega tion in 
the pre-eclamptic p a t i ~ n t s s [Whigham, Howie, Drummond 
and Prentice, 1978]. Inglis, S t u a r t ~ ~ George and 
Davies [1982] showed unchanged ADP-induced platelet 
aggregation in pre-eclamptic patients. In a study 
from this centre, Morrison, Crawford, Macpherson and 
Heptinstall [1985] found increased platelet 
aggregation in patients with PIH. The concentration 
<' 
of arachidonic acid needed to induce aggregation and 
release reaction was reduced, particularly in those 
patients who were hyperuricaemic. 
Possible explanations for such discrepancies are 
legion. The studies are all cross-sectional. Whigham 
et. ale [1978] and Morrison et. ·al. [1985] included 
patients of mixed parity. Howie et. ale [1971] 
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failed to comment on parity. Almost a third of the 
patients studied by Morrison et. ale [1985] were 
taking labetolol, an alpha- and beta-adrenergic 
antagonist with known effects on platelet aggregation 
[Anfossi, Trovati, Lanzio, Mularoni, Massucco and 
Emanuelli, 1988]. Late pregnancy controls were poorly 
matched in the study by Howie et. ale [1971], platelet 
counts varying markedly between groups. However, as 
in previous comparisons, the most important factors in 
the differences shown are the problems 'associated with 
the use of platelet rich plasma, (discussed above), 
and the various definitions of PIH and pre-eclampsia. 
Patients included in the study of Howie et. ale [1971] 
may have had the disease more severely, as patients 
wi th blood pressures up to 190/125 mmHg, and 'reduced 
birthweights were noted. If their patients had 
concurrent intrav,ascular .coagulation, this could had 
resulted in removal of the more active platelets from 
the circulation. 
A study 'by Louden, Heptinstall, Broughton Pipkin, 
Mitchell and Symonds [1989] also from this centre, 
examined whole blood platelet aggregation in 27 
patients with PIH, using definitions identical to 
those used in this thesis. Arachidonic acid-induced 
platelet aggregation was found to be increased only in 
patients with non-proteinuric PIH, whereas adrenaline 
and ADP induced aggregation. was increased in both the 
.-
non-proteinuric PIH and the pre-eclamptic g r o u p s ~ ~
Platelet activity as assessed by plasma beta-
thromboglobulin concentration" was found to be 
elevated in patients with PIH, by both'Inglis et. ale 
[1982], in a well-structured study with a carefully 
matched control group, and by Pekonen e t . ~ a l . . [1986], 
with an increase in levels as compared to normotensive 
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pregnancies being demonstrated. 
During the second trimester, in the spiral arteries 
supplying the placenta, platelet aggregates can be 
demonstrated between the trophoblast cells that form 
the intimal lining of the vessels [Sheppard and 
Bonnar, 1974]. Howie [1977] demonstrated that in pre-
eclamptic patients, platelet serotonin levels were 
lower than those found in non-pregnant and normal 
pregnant controls. The explanation suggested for this 
finding was that platelet emboli' occur in the 
microcirculation in pre-eclampsia, and that the 
platelets release some of their serotonin. C h a n g ~ s s of 
pIa tele t behaviour may be of special importance· in 
~ e l a t i o n n to the diminished placental blood flow "that 
appears to be a prerequisite for the development of 
pre-eclampsia. In pregnancies complicated by severe 
growth retardation, extensive atheromatous lesions 
full of fibrin and lipid-laden cells are found, 
producing occlusion of the spiral arteries [Sheppard 
and Bonnar, 1976]. 
Ylikorkala and Makila [1985] argued t h a t ~ ~ the 
platelet-vascular changes pathognomonic for pre-
eclampsia could be explained by an imbalance between 
locally produced and acting prostaglandins, • 
pros tacyclin and thromboxane A2' wi th the imbalance 
tilted towards the vasoconstrictor, platelet 
aggrega ting ~ c c tions of thromboxane A2' produced by 
platelets. Support for this theory is provided by 
Koullapis , Nicolaides, Collins, Rodeckand Campbell 
[1982], who found significantly higher plasma levels 
of thromboxane B2' (the stable. metabolite of 
thromboxane A2)' in 19 patients o(mixed parity with 
PIH. Pekonen et. ale [1986] found increased 
thromboxane B2 levels in patients with pre-eclampsia, 
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although the increases were not significant. 
In the studies included in this thesis, platelets 
have been used as a model for vascular myocytes. The 
next and final section of the introduction briefly 
considers the rationale for this model. 
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Section 8. 
THE RATIONALE FOR THE USE OF PLATELETS AS A MODEL FOR 
VASCULAR MYOCYTES 
In this thesis, platelet All binding sites are used 
as a model for studying smooth myocyte All binding 
sites. Both platelets and smooth myocytes are cells 
that depend upon excitation-contraction coupling 
mechanisms for their actions and bear many 
resemblances both physiologically and 
pharmacologically. 
Both types of cell contain a .contractile system 
composed of an actin-myosin complex [Pollard, Thomas 
and Niederman, 1974], although studies using electron 
microscopy suggest that the platelet myosin filament 
is relatively short with fewer cross-links which might 
thus form a limiting fact'or in the contractile force 
generated [Hinssen, .D'Haese, Small and Sobieszek, 
1978]. 
The presence of membranous high affinity binding 
sites has been demonstrated in both platelets and 
vascular myocytes, with intracellular changes being 
affected by r e ~ e p t o r r media·ted signal transduction. 
One such example is the adrenoreceptor. Both alpha-1 
and alpha-2 adrenoreceptors have been identified in 
vascular smooth muscle [Bylund and U'Pritchard, 1983, 
Van Zwieten, Van Meil and Timmermans, 1981]. As 
described above (p. 93), platelet alpha-2 
adrenoreceptors have been fully isolated and 
characterised [Motulsky et. al.,· 1980]. ~ ~ Moreover, 
washed platelets loaded with the fluorescent indicator 
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Quin-2 have been demonstrated to show an elevation in 
intracellular free calcium when incubated with 
adrenaline. This effect was inhibited by the addition 
of yohombine, suggesting a direct involvement of the 
alpha-2 receptor in the modulation of intracellular 
free calcium [Erne, Mittelholzer, Burgisser, Fluckiger 
and Buhler, 1984]. A similar adrenoreceptor mediated 
increase in intracellular free calcium had previously 
been demonstrated in rabbit vascular smooth muscle 
tissue [Cauvin, Loutzenhiser, Hwang and Van Breeman, 
1982]. 
The isolation of high affinity All binding sites.in 
both vascular smooth muscle [e.g. Gunther et. al., 
1 9 ~ O a ] , , and in platelets [e.g •. Moore and Williams, 
1981], has been discussed in Section. 5. (p. 75). In 
both tissues, alterations in the endogenous renin-
angiotensin system produce significant changes in All 
binding which inversely correlate with changes in 
plasma All levels [Gunther et. al., 1980b, Moore et. 
al., 1984]. 
In response to drugs, similarities between changes 
in platelet behaviour and changes in vascular tone 
have been described. Catecholamines cause both 
vasoconstriction and platelet aggregation [Cameron and 
Ardlie, 1982] whereas drugs that cause vasodilation, 
such as sodium nitroprusside, inhibit platelet 
aggregation [ L ~ v i n , , Weksler and Jaffe, 1982] •. In a 
study using 26 normal volunteers, Cowley, Stainer, 
Cockbill and Heptinstall [1984] demonstrated a close 
correlation between maximal cold-induced 
plethysmography and the threshold concentration of 
arachidonate required 
response in vitro. 
prostacyclin infusion. 
in induce a pro-aggregatory 
Five subjects underwent a 
This decreased the maximal 
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cold-induced vasoconstrictor response and increased 
the threshold concentration of arachidonate to induce 
an aggregatory response. Cowley et. al. [1984] 
suggested that the reactivity of both platelets and 
blood vessels depends up on cyclic AMP levels. 
There are thus many similarities between platelets 
and myocytes. However, the changes which platelets 
undergo in normotensive and hypertensive pregnancy are 
complex and extensive. Such changes will inevitably 
provide an important caveat when any pregnancy-induced 
alterations in binding are considered. 
-110-
Chapter 2. 
METHODS. 
This thesis encompasses several different studies 
of platelet angiotensin (All) binding. Before 
considering these in turn, this chapter will discuss 
the methods common to all the studies, and describe 
some experiments performed to validate the techniques 
used. A detailed list of laboratory reagents and 
disposable equipment may be found in Appendix A. 
a) Solutions. 
Modified 199 medium: lL of 199. medium was 
supplemented with 7 S ~ 9 9 mg MgS04' 10S.S mg CaC12, 2g 
glucose, 1.46 g EDTA and 5 g bovine s e r ~ m m albumin to 
give a solution containing (in mmo1/1):.· Na+ 145; ~ + +
3.S; Ca+2 2.54; Mg+2 1.lS; S ~ 4 - 2 2 1.lS; HC03- 24.9; C1-
. 12-S; P04-3 1.lS; glucose 11.1; EDTA 5; 0.5% (w/v) 
bovine serum albumin, pH 7.4. 
T ~ i s - H C 1 1 buffered saline : 0.6 g Tris and 0.5 g 
bovine serum albumin were added to 100 m1 of normal 
saline to give a solution containing 50 mmo1 Tris-
HC1/154 mmo1/1 NaC1, 0.5% (w/v) bovine serum albumin, 
pH 7.35. 
These solutions were stored at 4'C. 
Ptha1ate solution : 395 m1 of dibuty1 ptha1ate 
(specific gravity 1.046) was mixed with 105 m1 diony1 
ptha1ate (specific gravity 0.970) to produce 500 m1 of 
a solution with a specific gravity of 1.030. 
This solution was stored at room temperature. 
b) Patient Selection. 
Patient selection criteria for each study are 
discussed in relevant subsequent chapters, 
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However, no patient had any evidence of essential 
hypertension, chronic renal disease, or diabetes, and 
all the pregnancies were singletons. All subjects 
gave informed consent to inclusion in a clinical 
trial, including consent to venepuncture. Patients 
gave written consent prior to infusion studies. 
Ethical approval for all the studies described in the 
thesis was obtained from the hospital ethical 
committee. 
c) Blood Pressure. 
Blood pressure measurements were performed by 
auscultation and standard sphygmomanometry, in 
accordance with the proposals submitted to the 
International Society for the Study of Hypertension in 
Pregnancy [Davey and MacGillivray, 1986]. In 
particular, all patients were carefully p o s i t i o n e ~ ~ o ~ ~
their right -'side with-a 15-30' tilt and the cuff 
applied-to the right upper arm at the same level as 
the heart. The rate of cuff deflation was restricted 
to 10 mmHg in 5 seconds. The systolic pressure was 
taken at the first Korotkov sound and the diastolic 
pressure at the fourth Korotkov sound,- (see p. 4), 
both being recorded to the nearest 5 mmHg. All blood 
pressure recordings were performed by the same 
observer. 
d) Venepuncture. 
Platelets may be activated at the point of 
venepuncture; as the vessel wall is damaged, sub-
endothelial surfaces are exposed, and prostaglandins 
may be rapidly released. Care was thus exercised in 
venepuncture technique to avoid unnecessary trauma. 
It was not possible to quantify the artefactual 
activation which may have occurred as -a result of 
exposure of the blood to a series of foreign surfaces, 
-112-
before mixture with anticoagulant, but the importance 
of standardised venepuncture techniques has been 
stressed [Saniabadi, Lowe, Madlick, Spowart, Shaw, 
Barbenel and Forbes, 1986]. A 19 gauge needle was 
thus employed to allow free flow of 35 ml of blood to 
pass from the venepuncture site in the antecubital 
fossa into a polypropylene syringe. A tourniquet was 
used to effect venous stasis, and the skin was 
prepared with a Medi-Swab. A traumatic venepuncture 
resulted in the disposal of the sample, followed by a 
new attempt in the opposite arm. 
Blood was transferred from the syringe to the 
following t u b ~ s : :
17.2 ml for platelet All b i n d i ~ g , , estimation into 
two 10 ml graduated polypropylene tubes, each 
containing 1 ml of the a n ~ i c o a g u l a n t t 3.13% (w/v) 
trisodium citrate dihydrate, which is isotonic with 
human blood, and 400 pl of acetyl salicylic acid (25 
mmol/l). 
10 ml for plasma All, p l ~ s m a a renin substrate (PRS), 
and plasma renin concentration (PRe) assay into a 
polypropylene' tube containing 250 ul o-phenanthroline 
(25 mmol/l) and 250 ul diaminoethanetetra-acetic acid 
(EDTA) (125 mmol/l). 
2 ml for ~ ~ l l l blood count estimation into a glass 
EDTA vacutainer tube. 
5 ml for serum urea and electrolytes, osmolarity, 
urate and creatinine estimation into a glass additive-
free vacutainer tube. 
The samples were gently mixed by inversion. The 
samples for platelet All binding and'for All, PRS and 
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PRC estimation, were placed in ice and transferred to 
the laboratory for immediate assay. 
e) Preparation of platelets. 
An initial, platelet count was made, (Ariane-5 
platelet counter, ABX, Montpe11ier, France.) 
Platelet preparation as described by Ding, Kenyon 
and Semple [1984], was initially attempted. This 
involved layering blood onto an iso-osmotic solution 
of Perco11 (154 mmo1/1 NaC1; specific gravity 1.06). 
After centrifugation (400g, 5 minutes, 4'C, using an 
MSE Coo1spin 2 ·centrifuge), the upper p 1 a t e 1 e t - r ~ c h h
layer equal to the volume of added blood was aspirated 
with a 1iquipipette, washed with an equal volume of 
modified medium 199 and centrifuged, (1000g, 10 
minutes, 4'C). This was r ~ p e a t e d d ~ h r e e e times with the 
platelet-rich iayer resuspended in 15 m1 of modified 
medium 199 each time. The final aspirate was 
suspended' in 5-6 m1 of medil.Jm and the suspension 
filtered through 20pm nylon gauze. The platelet count 
in the concentrate was then counted, using the Ariane-
5 counter. 
However, using the above method, the recovery of 
platelets from whole blood (platelet yield) was 
consistently below 10% ,in 10 consecutive samples. 
This figure is . ~ e l 1 1 below the 60% achieved by Ding et. 
a1. [1984]. The reason for this discrepancy is 
unclear, but may have been due to the author's 
inability produce a discrete layer of blood on the 
perco11 solution. 
An alternative method of platelet preparation was 
thus subsequently used throughout the studies included 
in this thesis. This ,method, described below, is 
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similar to that used by Mann, Sis and Ritz [1985] when 
studying platelet All binding, and was already being 
used in ongoing platelet studies in this centre. 
After an initial platelet count, platelet rich 
plasma (PRP) was prepared by centrifugation, (160g, 20 
minutes, 4 fC). The supernatant PRP was filtered 
through 20 pm nylon gauze, prior to being adjusted to 
pH 6.4 with O.lM citric acid; 1 u/ml apyrase being 
added. Apyrase was used as a 250 u/ml ,stock solution 
in 154 mmol/l NaCl, and stored at _20fC. The 
platelets were pelleted by centrifugation," (400g, 20 
minutes, 4'C), and resuspended in modified medium 199. 
The platelet' concentration in a small portion of the 
suspension w a ~ ~ measured, (after being dilute,d 1:9, see 
p. 121), and the volume of medium adjusted to give a 
platelet concentration of 106/)11. Leucocyte and 
. 
erythrocyte contamination was checked using a 'Minos 
STE counter (ABX). 
Both methods involve centrifugation, which may 
cause ~ h e e formation of aggregates of the most active 
sub-population of platelets, which would be discarded 
with the red and white blood cells. Platelet loss of 
between 20 and 40% has been recorded, with the 
suggestion that the platelets lost may have been those 
with the greatest metabolic activity [Corash and 
Gralnick, 1974]. 
" 
f) Platelet All binding studies. 
The physiological concentration of All in the 
plasma of many species is in the order of 10-100 pM, 
(see p. 27). One problem found when' studying the 
binding of the hormone at such low concentrations, is 
the necessity to use a radioactive hormone of high 
specific activity. This is usually achieved by 
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introducing atoms of radioactive iodine into the 
molecule. However, the iodination of All results in a 
loss of biological activity, the potency of the 
iodinated All diminishing with each iodine atom [Lin, 
Ellis, Weisblum and Goodfriend, 1969]. The 
substitution of hydrogen by tritium neither provokes 
major structural changes, nor pe;turbs the biological 
activity of the hormone [Morgat, Hung and Fromageot, 
1970]. However, the specific activities obtained are 
much lower than those· of the iodinated hormone. Thus 
either physiological concentrations of the iodinated 
hormone must be used, producing sub-optimal 
interaction with the receptor; or pharmacological 
concentrations of the tritiated h o r ~ . ~ n e , , which 
interacts normally with the receptor. I ~ ~ fact, both 
labelled peptides have been. satisfactorily employed 
for quantitative binding studies on All receptors, and 
there are surprisingly few areas of discrepancy 
between . results obtained with the two tracers-
[Capp.oni, Aguilera, Fakunding and Catt, 1981]. 
Previous studies of All binding on platelets have u s e d ~ ~
·125I - AII [Moore and Williams, 1981, Ding, Kenyon and 
Semple, 1984, Mann, Sis. and Ritz, 1985], and the· 
method detailed below is essentially that'of Ding et. 
ale [1984], with only minor modifications. 
125I _AII (specific activity 74 TBq/mmol) was stored 
at -20'C in Tris-buffered s ~ l i n e e at a concentration of 
300 pmol/l. To prevent damage by freezing and 
thawing, the 125I - AII was stored in 200 pI aliquots, 
this quantity being only sufficient for the assay of 
one sample. Unlabelled All was stored in 20 pI 
aliquots at -20'C at a concentrati0l?-' of 1 ··mg/ml in 
saline. . Each day, an aliquot was thawed at room 
temperature, and added to 700 )11 Tris buff.ered saline, 
to give a final concentration of 25 pmol/l. 
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Six portions (200pl) of the platelet concentrate 
were each incubated with 25 )11 of 125I - AII (300 
pmol/l) in polypropylene tubes in a Grant shaking 
water bath (Grant Instruments, Cambridge, England). 
To three of these portions, an excess of unlabelled 
All (25 pI, 25 pmol/l), was added prior to the 
incubation. To the other three portions, 25)11 Tris-
buffered saline was added. The final concentration of 
125I - AII was thus 30 pmol/l. 
After incubation at 26'C for 90 minutes, platelets 
were separated from the 199 medium, by centrifuging 
100 pI portions of, the incubation mixture in 400.)11 
microcentrifuge t u b ~ s s containing 200 pI of the mixture 
of pthalate esters. A Beckman m i ~ r o , c e n t r i f u g e e
(Beckman, U.S.A.) was used, at 12,000g for 30 seconds. 
The microcentrifuge tubes were immediately frozen in a 
mixture of acetone and solid CO2, the latter being 
produced from a cylinder of compressed gas using a 
Snow pack C02 pellet maker (Jencons Scientific-Ltd., 
Leighton Buzzard, England). The frozen 
microcentrifuge tubes were then cut with a tube cutter 
(Rostfret Sollingen, West Germany), just below the 
oil-water interface'. The lower portion of the tube, 
containing the platelet pellet, was. then counted as 
the 'bound' hormone, and the upper portion of. the 
tube, containing the supernatant, was counted as 
• free' hormone, using an LKB Wallac 1275 mini-gamma 
~ ~ , 
counter. The non-specific binding was defined as the 
amount of All bound to platelets in the presence of 
excess unlabelled All. Values of platelet All binding 
discussed subsequently have been corrected for non-
specific binding, which ranged from' ,10-40% "of total 
binding ... 
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g) Biochemical and haematological quantification of 
serum and urine samples. 
Plasma concentrations of renin (PRC), renin 
substrate (PRS), and All were measured by 
radioimmunoassay [Poulsen and Jorgensen, 1974, 
Broughton Pipkin and Symonds, 1977, Craven and 
Symonds, 1978]. Reproducibility.of these methods, as 
measured by replicate assays, were: 
PRC 5.6% intra-assay, 10.7% inter-assay. 
PRS 9.2% intra-assay, 15.3% inter-assay. 
All 4.0% intra-assay, 11.1% inter-assay. 
A full blood count estimation was performed on ~ h e e
EDTA sample in the Haematology Department using a 
Coulter S Plus 4 automated blood counter (Coulter 
Company, U.S.A.). 
The clot ted·' blood sample for serum urea and 
electrolytes, urate, osmolality and creatinine 
estimation was sent to. the. Department of Clinical 
Chemistry. A 24 hour urine sample, consisting of all 
urine passed in a 24 'hour period, following early 
morning voiding, was delivered to the same department. 
Serum urea and electrolytes, urate, osmolality and 
creatinine estimations ,were performed using a Kodak 
700XR Ekatachem analyser. The reproducibility of 
these assays is summarised in Appendix B. The 
corresponding urinary estimations were performed'using 
an SMA continuous flow analyser. Urinary total 
protein concentration was measured by the method of 
salicyl-sulphonic acid turbidity. 
h) Statistical Analysis. 
Guidance was received from Mr. P. ~ H . . Riley, 
statistical advisor to the University of Nottingham, 
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from the earliest stages of the project. Data was 
stored on the University Mainframe computer, in a form 
appropriate for use of the Statistical Package for the 
Social Sciences [SPSS-X, 1988]. Unless otherwise 
stated, medians and 25th and 75th centi1es have been 
quoted as estimates of central tendency and scatter, 
respectively, and non-parametric' statistics have been 
employed. (When the sample size is below 10 the range 
rather than the 25th and 75th centi1es has been 
quoted.) Non-parametric statistics were used because 
the data for many of the parameters measured was found 
to be significantly skewed, and is in accord with the 
statistical advice received. Consistent use of non-
parametric testing is appropriate for such data, 
because no a s s ~ m p t i o n n is made regarding data 
distribution. For paired data, the Wilcoxon matched 
pairs s i g n e ~ - r a n k s s test has been used. For unpaired 
data, the M a n n ~ W h i t n e y y U test has been used. Whe+e 
other types of analysis have been performed, this will 
be clearly explained in the text. 
In o r d e ~ ~ to allow for multiple comparisons amongst 
groups, P<O.Ol rather than P<O.OS has been taken, 
throughout the thesis, as the level indicating 
statistical significance. 
The results of the studies presented in the 
subsequent chapters" have been tabulated. In order to 
aid interpretation of the data, many of the results 
have also been presented as figures. This duplication 
was deliberate. Graphical interpretation of the data 
was reproduced by a Macintosh SE micro-computer with 
laser printer, and all diagrams and tables have been 
produced by the author. 
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Validation of the methods. 
Unless stated otherwise, in the following 
validatory experiments, all the subjects were non-
pregnant females, who were normotensive and had no 
history of renal, metabolic or cardiovascular disease. 
No subject was taking any medication. 
Platelet preparation. 
a) Platelet count. 
Venous blood from six subjects, taken for platel.et 
All binding site assay, was repeatedly c o ~ ~ t e d d using 
the Ariene-5 platelet counter. The coefficients of 
variation when four platelet .count estimations were 
p ~ r f o r m e d . . on each sample ranged from 0.2 - 1.9%, 
median : 1.0%." When the same procedure was performed 
using the prepared platelet concentrate, the 
coefficients of variation· ranged from 0.5 - 18.2%, 
median : 5.1%. However, following dilution with the 
Minoton solution, (see below), these values fell to a 
range of 0.3 - 2.1%, median: 1.2%. 
Figure 2.1 demonstrates the effect of diluting the 
~ r i g i n a l l whole blood sample wi th normal saline; the 
platelet count was found to decrease linearly in 
proportion to the dilution4 However, this linear 
relationship was not found at the highest 
concentrations of the prepared platelet suspension, 
(Figure 2.2). The platelet suspension was diluted 
with Minoton, a proprietary isotonic salt solution, 
(ABX, Montpellier , France). At the. high platelet 
concentrations, well above physiological levels, the 
Ariene-5 counter consistently underestimated the 
platelet concentration. In the subsequent studies, 
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Figure 2.1. 
Platelet counts obtained when whole blood samples 
were diluted with normal saline. 
These results were from three subjects, with mean +/-
SEM of triplicate readings plotted. 
Figure 2.2. 
Platelet counts obtained when whole blood samples 
were diluted with minoton solution. 
These results were from three subjects, with mean +/-
SEM of triplicate readings plotted. 
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b) Platelet distribution curve. 
in order to 
1:9 dilution 
As discussed above, (see p. 102 and p. 115), it has 
been suggested that the use of, platelet rich plasma 
selects a particular platelet population [Corash and 
Gralnick, 1974]. The use of the Ariene-5 platelet 
counter allows comparison of the platelet volume 
distribution curves of the whole blood sample with 
that of the final platelet concentrate. Figure 2.3 
illustrates a example from one representative non-
pregnant subject. 
When the distribution curves of the whole blood 
samples and the platelet concentrate were compared in 
six representatlve non-pregnant. female subjects, using 
the non-parametric Wilcoxon matched-pairs signed-rank 
test, no significant difference was found in any of 
the subjects, (p- 0.3 - 0.8). 
c) Purity of sample. 
Leucocyte and erythrocyte contamination was checked 
in 20 platelet concentrates using a Minos STE counter, 
(ABX). Contamination with leucocytes was < 1%, (1-5 x 
103/pl), and no erythrocytes were detected. This low 
level of contamination is .important in view of the 
~ ~
finding that All receptors are present in greater 
numl?ers on leucocytes than on platelets [Moore and 
Williams, 1981]. 
Binding Assay. 
In the following validatory experiments, 52 ml of 
blood was taken from each non-pregnant female subject. 
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Figure 2.3. 
Platelet Distribution curves. 
This figure illustrates the platelet distribution 
curves obtained from whole blood and from the final 
platelet suspension, from one representative non-
pregnant subject. 
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This was collected into six 10 ml polypropylene tubes, 
each containing 1 ml trisodium citrate, (3.13% w/v), 
and 400 pI acetylsalicylic acid, (2.5 mmol/l). 
a) Platelet concentration. 
125I - AII , was incubated with platelet 
concentrations of 1 x 106 cells/pI, 7.5 x 105 
cells/pI, 5 x 105 cells/pI, and 2.5 x 105 cells/ pI, 
at 26 Ie for 90 minutes. There was a direct, linear 
relationship between cell concentration and specific 
binding, (Figure 2.4a). In each of four experiments 
the correlation coefficients relating to specific 
binding and platelet concentration were > 0.9, 
although at 'a concentration of 2.5 x 105 cells/pi, 
binding was consistently underestimated. Non-specific 
binding was also related to the platelet 
concentration, (Figure 2.4b). 
In subsequent experiments throughout this thesis, 
if there were insufficient platelets to adjust the 
concentration to 106 cells/pI, the quoted value of 
specific b.inding was obtained by multiplying the 
concentration of specific binding found by 
106/platelet concentration. If there were 
insufficient platelets to adjust to a concentration of 
at least 5 x 105 cells/pl, the experiment was 
abandoned. 
b) pH. 
In five experiments, ,the platelet suspension was 
divided into five portions, and the pH of the 
resulting portions adjusted to between 6.9 - 7.8. The 
platelets were then incubated with 1 2 5 I ~ A I I I at 26 Ie 
for 90 minutes. The effect of pH on specific binding 
is illustrated in Figure 2.5. When the pH ·rose above 
7.4, platelet All binding declined, although a 
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Figure 2.4. 
The effect of varying platelet concentration on 
specific and on non-specific platelet All binding. 
These results were from four subjects, with mean +/-
SEM of triplicate assays plotted. 
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Figure 2.5. 
The effect of varying pH on platelet All binding. 
These results were from five subjects, with mean +/-
SEM of triplicate assays plotted. The incubation 
time was 90 min and the incubation temperature was 
26'C. 
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significant difference was only attained at a pH of 
7.8 (P<0.01, Wilcoxon matched-pairs signed-ranks 
test). 
c) Incubation time. 
In assessing the time course of binding, 125I - AII 
(30 pmol/l) was incubated with platelets at 26 'c, the 
equilibrium being stopped by centrifugation at varying 
time intervals. Figure 2.6 demonstrates the results 
of five experiments.' Platelet All binding increased 
rapidly for 30 minutes, then more slowly between 30 
and 90 minutes. There was a plateau from 90 to 150 
minutes when binding remained relatively ~ o n s t a n t . .
In subsequent experiments. incubation time was 90 
minutes. However, on o ~ c a s i o n s , , in order to 
f a c i l i t ~ t e e the processing of more than one sample, 
this time period was extended to 120 minutes. 
T ~ e e experiments were repeated at a concentration of 
15 pmol/l 125I - AII , in order to derive dissociation 
'rate constants (Kd) from kinetic data using two 
concentrations of ligand (see p. 130). 
d) Temperature. 
Incubation temperature was assessed by incubating 
, portions of the platelet suspension in five different 
shaking water b ~ t h s , , the temperature in the water 
baths varying from 16 'c to 37 'C. The concentration 
of 125I - AII was 30 pmol/l, the pH 7.4 and the 
incubation time 90 minutes. The results of four 
experiments are shown in Figure 2.7. There was 
significantly greater platelet All binding (P<O.Ol) at 
22 'c and 26 'c, than at 16 'c, 30 'c, or 37 'C. In 
subsequent experiments, the incubation temperature was 
26 'C. 
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Figure 2.6 • 
. The effect of varying incubation time on platelet All 
binding. 
These results were from four subjects, with mean +/-
SEM of triplicate assays plotted. The concentration 
of 125I - A11 was 30 pmol/l. The incubation 
temperature was 26'C and the pH was 7.4. 
Figure 2.7. 
The effect of varying incubation temperature on 
platelet All binding. 
These results were from four subjects, with mean +/-
SEM of triplicate assays plotted. The incubation 
time was 90 min and the pH was 7.4. 
Figure 2.6 
100 
t a c 
" C 80 :s 
Co) 
:;:: 
'u 
CD 
a. 80 
th 
c; 
f E >< 
f 
co 
E 40 
'0 
#. 
20 
o o - ~ - - ~ ~ - - r - ~ - - r - - - ~ ~ ~ ~ ~ ~ ~ - - ~ ~ - - - - ~ - - - - ~ - - - - - T - - ~ ~
o 1 5 30 45 60 75 90 105 120 135 150 
Incubation time (minutes) 
Figure 2.7 
100 
90 
a 
c 
" 
80 
C 
-:s 
Co) 70 
:;:: 
U 80 !. 
th 
c; 50 
E 
>< 40 co 
E 
'0 30 
#. 20 
10 
0 
10 20 30 40 
Temperature (OC) 
Work by both Moore and Williams [1981] and Ding, 
Kenyon and Semple [1984], suggests that it is 
difficult to separate the effects of incubation time 
and temperature on platelet All binding. It is likely 
that at 16 'c, platelet All binding had yet to attain 
maximal levels. At 37 'c both groups, [Moore and 
Williams, 1981, Ding et. a1., - 1984], found that 
varying incubation times resulted in a short plateau 
period when platelet All binding was constant. Ding 
et. a1. [1984] found that at 37 'c, platelet All 
binding declined progressively after 30 minutes. 
e) Stability. 
In five experiments, following preparation of the 
platelet suspension, t ~ e e binding assay was delayed for 
60 minu tes , at varying tempera tures. There was a 
marked reduction in platelet All binding at ea,ch 
temperature', wIth median diminutions in platelet All 
binding of- 82% at -20'C, 63% at 4'C, and 68% at 16'C. 
-In subsequent experiments there was no delay between 
platelet preparation and the binding assay. 
f) Enzyme inhibition. 
Enzymatic degradation of 125I - AII occurs in many 
tissues, including vascular smooth muscle [Gunther, 
Gimbrone and Alexander, 1980b]. This precludes ~ h e e
study of binding sites at equilibrium unless 
appropriate e n z y m ~ ~ inhibitors' are added. Mann" Sis 
and Ritz [1985], when studying platelet All binding, 
found that without the addition of the enzyme 
inhibitor bacitracin (lmg/ml) there was a considerable 
loss of measurable binding. However, t h ~ ~ incupation 
temperature in the experiments of Mann et. al. [1985] 
was 37'C. To determine whether the addition of an 
enzyme inhibitor was necessary at an incubation 
temperature of 26'C, the platelet suspension from six 
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subjects was divided into two portions, with one half 
being incubated with bacitracin (lmg/ml) and the other 
half without bacitracin (90 min incubation at pH 7.4, 
26'C). 
The results of these experiments are illustrated in 
Figure 2.8. The median value of platelet All binding 
in the samples without bacitracin added was the same 
as that of the samples incubated with bacitracin (3.1 
fmol/109 cells). The addition of bacitracin did not 
significantly alter platelet All binding (P>0.3, 
Wilcoxon matched-pairs signed-ranks test), thus in 
subsequent experiments it was not added. 
g)-Blood donation. 
In_an effort to study the effect of alterations in 
platelet populations on platelet All binding, blood 
was taken from-six subjects both immediately prior to, 
and one week following, the donation of approximately 
500ml blood at the Nottingham Blood Transfusion 
Centre. The subjects were all male (in order to avoid 
any effect of the menstrual c y c l ~ , , see p. 141) and had 
a median age of 28 years (range 18-42). All the 
subjects were normotensive, and none was taking any 
medication. 
Prior to the blood donation, the median values of 
the platelet parameters were as - follows: platelet 
count· 214 x f09/L (range 187-321), mean platelet 
volume (MPV) 8.2 fl (range 7.7-8.5) and platelet 
distribution width (PDW) 15.7 (range 14.8-16.5). 
Following the blood donation, there was no significant 
change in the platelet count (204 x·- .109 /L, -·185-309, 
P>0.5, Wilcoxon matched-pairs signed-ranks test). 
There _ ~ e r e , , however, changes in MPV (9.1 £1, 8.2-9.9, 
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Figure 2.8. 
The effect of the enzyme inhibitor bacitracin in 
platelet All binding. 
/' 
Figure 2.9. 
Platelet All binding immediately prior to, and one 
week following, blood donation. 
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P= 0.04) and in PDW (16.9, 16.2-17.8, P= 0.03) which 
approached significance. 
The changes in platelet All binding are illustrated 
in Figure 2.9. Despite the alterations in platelet 
parameters, the values of platelet All binding after 
the blood donation (median 2.7 fmol/109 cells) were 
not significantly different from those obtained prior 
to blood donation (median 2.6 fmol/109 cells, P>0.4, 
Wilcoxon matched-pairs signed-ranks test). 
Quantification of inter-assay and intra-subject 
variation. 
a) Inter-assay variation of platelet All binding 
assay. 
-
The method described above entails performing 
triplicate binding assays on every blood sample. Each 
month, the coefficient of variation found in the 
triplicate assays was calculated for the first 20 
samples. The values' ranged from 10% - 18% (median 
13.5%), and were, dependant' on the particular study 
I 
being performed. 'When analysis was confined to non-
pregnant subjects, the lowest value of 10% was 
obtained. However, as would be expected, greater 
variation was found in s a m p ~ e s s from pregnant women, in 
whom lower values of p1atelet All binding were 
demonstrated. 
This inter-assay variation confirmed the need for 
triplicate assays, if necessary at a lower platelet 
concentration. 
b)' Intra-subject variation of platelet All binding 
assay. 
Six samples of blood were taken from each of five 
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subjects, (including the author), over a fourteen day 
period. All the subjects were male, in order to avoid 
any menstrual effect, ( see p. 141). The coefficient 
of variation ranged from 17% - 42% (median 27%). 
However the ranking of the subjects, (highest 
concentration of platelet All binding to lowest 
concentration of platelet All binding) , remained 
constant on all bar one of the six occasions. 
When this assessment of intra-subject variation was 
repeated after a further nine months experimentation 
similar results were obtained (median coefficient. of 
variation 25%, range 11%-40%). 
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Chapter 3. 
CHARACTERISATION OF PLATELET All BINDING SITES. 
This chapter is the first of six chapters 
describing studies of platelet All binding. At the 
end of each chapter there is a brief discussion 
relating to the experiments described in that 
particular chapter. The thesis 'then concludes with a 
General Discussion. 
As discussed in the Introduction (p. 79), for the 
interaction of a hormone 'with a cellular binding site 
to be considered to correspond to a receptor 
interaction, it should fulfil the criteria of·· a 
hormonal response; exhibiting specificity., high 
affini ty, reversibility and saturabi1i ty •... The 
complete validation of peptide hormone binding sites 
as receptors which mediate the biological actions of 
the ligand requires that a c o r r e 1 ~ t i o n n be made between 
receptor occupancy and an appropriate target-cell 
response. The purpose of the experiments detailed 
below was to establish whether the All binding sites 
found on platelets had the characteristics of 
receptors. 
Study sample. 
Unless otherwise stated, all the subjects in the 
studies below were non-pregnant female members .of the 
medical and nursing staff aged between 18 and 43 
years. All subjects were normotensive and had no 
history of renal, metabolic or cardiovascular disease. 
No pa tien t was taking any medica tion, including the 
oral contraceptive pill. 52 m1 of'· blood was taken 
from each patient, the subsequent methodology being as 
described on page 112. 
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Saturation studies. 
The platelet suspensions from 5 subjects were 
divided into seven portions, and these were incubated 
with varying concentrations of 125I - AII • Figure 3.1 
illustrates the relationship between specific All 
binding and increasing concentrations of the labelled 
peptide, the plateau of the curve demonstrating 
saturability of the binding sites. 
Scatchard analysis, (see p. 60), of specific 
binding results from the 5 saturation curves showed 
linear plots with a mean equilibrium· dissociation 
constant (Kd) (+/- SEM) of 2.57 +/- 0.97 x 10-10 
mol/I, thus d e m o n s t r a ~ i n g g that the binding sites were 
of high affinity. Figure 3.2 shows a Scatchard plot 
from one representative saturation study. 
Competition studies. 
The platelet suspensions from 5 subjects were again 
divided into seven portions, h o w e v e ~ , , for these 
experiments each portion was incubated' with a fixed 
concentration of 125I - AII and increasing 
concentrations of unlabelled All. Figure 3.3 
illustrates the results of these studies. S i g n i f i c a ~ t t
displacement of the label was noted at concentrations 
of unlabelled All as low as 5 x 10-11 .mol/l, 
(P<O.Ol). At a concentration of 2.5 x 10-8 mol/I, 97% 
of the specific binding had been displaced. Scatchard 
analysis of these results gave a Kd of 1.41 +/- 0.7 x 
10-10 mol/I, again demonstrating high affinity. 
Figure 3.4 shows a Scatchard plot from one 
representative competition study. 
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Figure 3.1. 
Saturation study. 
This figure illus tra tes the effect of altering the 
concentration of radiolabelled Angiotensin II on 
specific binding. 
These results were from five subjects, with the mean 
+/- SEM of triplicate readings plotted. 
Figure 3.2. 
Scatchard analysis of saturation study results. 
The results of one representative non-pregnant 
subject are shown. 
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Figure 3.3. 
Competition study. 
This figure illustrates the effect of altering the 
concentration of unlabelled Angiotensin II on 
specific binding. 
These results were from five subjects, with the mean 
+/- SEM of triplicate readings plotted. 
Figure 3.4. 
Scatchard analysis of competition study results. 
The results of one representative non-pregnant 
subject are shown. 
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Figure 3.5. 
Kinetic data obtained using two concentrations of 
ligand. 
These results were from at least three subjects at 
each concentration of 125I - AII, with the mean +/- SEM 
of triplicate readings plotted. 
Figure 3.6. 
All binding expressed as the natural log of the 
proportion of binding at various times rela ti ve to 
the binding at equilibrium. 
Competition studies were also attempted using 
platelet suspensions from pregnant women. All 
subjects were primiparous, taking no medication except 
iron preparations and were in the third trimester 
(median gestational age 34 weeks). However, many of 
these women had low or undetectable levels of platelet 
All binding, making characterisation studies 
difficult. In order to perform successful competition 
studies on 5 patients, these studies were attempted in 
12 subjects. The median value of platelet All binding 
in these subjects was 8.0 fmol/l09 cells. Scatchard 
analysis indicated that the binding sites were of high 
affinity, with a Kd of 2.5 +/-. 0.7 x 10-10 mol/I, 
which did not dif.fer significantly from that of the 
non-pregnant subjects. 3 of the 5 subjects 
subsequently developed pregnancy-induced hypertension. 
Kinetic studies. 
. The effect of varying incubation time upon specific 
binding has been discussed in the validation of the 
method, (p. 123). These experiments were repeated in 
a further 4 subjects, (although in one subject no 
binding could be detected), with the concentration of 
125I - AII 15 pmol/l instead of 30 pmol/l, (Figure 3.5). 
Forward (Kl) arid reverse (K_l) rate constants were 
calculated by a method free of assumptions made in the 
fitting of binding results to the appropriate rate 
equations [Gunther, Gimbrone and Alexander, 1980a]. 
This method, which is derived in full in Appendix C, 
calculates Kl and K_1 as follows: 
K1 - '" S - S' 
Do' - Do 
and 
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Figure 3.5. 
Kinetic data obtained using two concentrations . of 
ligand. 
These results were from at least three subjects at 
each concentration of 125I - AII , with the mean +/- SEM 
of triplicate readings plotted. 
Figure 3.6. 
All binding expressed as the natural log of the 
proportion of binding at various times relative to 
the binding at equilibrium. 
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where Sand S' are the slopes obtained by expressing 
All binding as the natural logarithm of the proportion 
of binding at various times (B) relative to binding at 
equilibrium (Beq), (see Figure 3.6), and Do and Do' 
are the initial concentrations of 12SI - AII • Using 
this equation, Kl was calculated to be 2.0 x 108 
mol/sec/l and K_l was 2.8 x 10-2 mol/sec/l. A 
dissociation constant Kd of 1.4 x 10-10 mol/l was thus 
obtained. 
Specificity studies. 
To determine ligand specificity of the binding 
sites, competition curves were prepared using various 
angiotensin analogues as the unlabelled hormone (see· 
Figure 3.7). In this analysis, Des-Aspl angiotensin. 
II (AlII) was equipotent" w i t ~ ~ All, followed by' 
[Sar1 ,Ala8] angiotensin '11, with angiotensin I (AI) 
found to be the least potent peptide. 
Dissociation Studies. 
Unlabelled All, at a concentration of 2S pmol/l, 
was added to platelet suspensions which had been 
preincubated with 12SI - AII at 26 'c for 90 minutes. 
Figure 3.8 demonstrates the diminution in platelet All 
binding f o l l o ~ , i n g g the addition of the excess of 
unlabelled hormone. The binding was thus found to be 
reversible. 
Correlation with cell response studies. 
No attempt at correlating a cellular response with 
platelet All binding site concentration has previously 
been reported. As discussed in the Introduction (p. 
8S), a possible mechanism by which the vascular 
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Figure 3.7. 
Competitive binding by analogues of All for 125I - AI I 
binding sites. 
Experiments with each peptide were performed using at 
least three subjects'. The mean of triplicate 
readings has been plotted. 
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Dissociation study. 
The effect of adding excess unlabelled All following 
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These results were from three subjects, with the mean 
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smooth muscle cell All binding site exerts its effect 
is via an increase in intracellular free calcium 
([Ca+2]i). Moreover, platelets have homologous 
intracellular mechanisms for the mobilisation of 
[Ca+2]i [O'Rourke, Halenda, Zavoico and Feinstein, 
1985]. All has been found to"increase [Ca+2]i in 
platelet suspensions from non-pregnant women [Haller, 
Ludersdorf, Lenz, Distler and Philipp, 1987], and 
pregnant subjects [Haller, Oeney, Hauck, Distler and 
Philipp, 1989], although the concentration of All 
necessary to elicit an increase was higher than that 
described in experiments with vascular smooth muscle 
[Alexander, B'rock, Gimbrone and Rittenhouse, 1985]. 
The relationship. between platelet All binding.and 
the All-induced rise in platelet [Ca+2]i was therefore 
investigated •. Experiments were performed in vitro, 
'- . 
with the addition of All to platelet suspensions, and' 
ex vivo, with platelets obtained from primiparous 
subjects before and after they were infused with 
intravenous All. The subjects were in the third 
trimester of pregnancy, when levels of platelet 
[Ca+2]i have been found to be at their highest [Kilby, 
Broughton Pipkin, Cockbill, Heptinstall and Symonds,. 
1990]. 
The in vitro"and ex vivo studies were performed on 
six subjects 'and on thirteen subjects respectively; 
their details are summarised in Table 3.1. No woman 
was known to be suffering from renal, metabolic or 
cardiovascular disease. All the subje.cts were studied 
during their first pregnancy and no'patient in any 
group was taking any medication bar iron and vitamin 
supplements. All subjects were receiving ad libitum 
sodium intake and had normal serum urea, creatinine, 
and electrolyte estimations. 
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Table 3.1. 
Each study group comprised subjects in the third 
trimester of their first pregnancy. 
quoted (range). 
In vitro group 
(n - 6) 
Maternal age (years) 25 (17-28) 
Gestation (weeks) 33 (29-34) 
Diastolic B.P. (mmHg) 68 (64-74) 
Systolic B.P. (mmHg) 120 (115-125) . 
Platelet count (103/pl) 160 (114-225) 
In vitro studies. 
. 
Medians are 
Ex vivo group 
(n - 13) 
25 (21-28) 
32 (28-33) 
70 (50-85) 
110 (100-125) 
211. (127-333) 
'. 
. Platelet All binding was measured as described in 
Chapter 2. Platelet [Ca+2]i was measured, with the 
fluorescent indicator fura-2 being added to prepared 
platelet suspensions [Kilby, Broughton Pipkin, 
Cockbill, Heptinstall and Symonds, 1990]. 
Platelet [Ca+2]i was measured immediately after the 
addi tion of All, at concen tra tions ranging from 2 x 
10-6 ~ o l / l l to 2x 10-12 mol/l, to the platelet 
preparations of each subject. 
Quantitative measurement of platelet [Ca+2]i 
indicated a basal concentration of 111 (97-122) nM. 
On stimulation with All, no change in fluorescence was 
elicited in any -of the subjects, even at the highest 
doses of .• All. The median value of platelet All 
binding was found to be 3.1 (0-21.4) fmol/l09 cells. 
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Ex vivo studies. 
An initial venous blood sample was obtained from an 
indwelling cannula (Venflon 19 G) in an antecubital 
vein, prior to an All infusion,· using the protocol 
described by Broughton Pipkin, Hunter, Turner and 
O'Brien [1982]. (A brief description of this protocol 
is included in Chapter 8, p. 220). A second blood 
sample was obtained at the end of the third infusion 
step, at a dose of 16ng All/kg/min. The platelet All 
binding assay and the platelet [ca+2]i.estimation were 
performed on the initial samples and the platelet 
[Ca+2]i estimation on the second sample, as described 
above. 
Platelet [Ca+2]i in the blood samples taken prior 
to All infusion was 115 (range 89-126) nM. 
Measurement of platelet [Ca+2]i following the All 
. . . 
infusion indicated a statistically significant AII-
induced rise in concentration (P(O.Ol, Wilcoxon 
·matched-pairs signed-ranks test), to 138 (103-154) nM. 
The increase was found in 12 of the 13 subjects 
(Figure 3.9). 
The median value of platelet All binding, 
determined prior to the infusion was 2.0 (0-15.4)· 
fmol/109 cells. The All infusion caused a rise in the 
plasma All concentration from 43.2 (10.9-100) .pM to 
130.0 (13.3-300.0) pM. 
There was no significant correlation between 
platelet All binding and the rise in platelet [Ca+2]i 
(P>0.2, Spearman correlation coefficient), as 
illustrated in Figure 3.10, although the trend was 
positive. Furthermore, there was 
between the rise in platelet (ca+2 ]i 
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no correlation 
and ei ther the 
Figure 3.9. 
Platelet intracellular free calcium levels, before 
and immediately following All infusion. 
There was a significant rise in the levels of 
intracellular free calcium (P<O.Ol). 
Figure 3.10. 
The All-induced rise in platelet intracellular free 
calcium plotted against platelet All binding. 
No significant correlation 
parameters was found (R = 
correlation coefficient). 
between these two 
0.36, P>0.2,Spearman 
Figure 3.9 
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initial plasma All concentration or the rise in plasma 
All level (P>0.5, in each case). 
Infusion studies. 
To test the effect of acute changes in the plasma 
All level on platelet All binding, All infusion 
studies were performed using 9 non-pregnant and 32 
pregnant subjects. 
As above, an initial venous blood sample was 
obtained from an indwelling cannula prior to an All 
infusion [Broughton Pipkin et. a1., 1982]. A second 
blood sample was obtained at the end. of the third 
infusion step, at a, dose of 4ng All/kg/min when the 
subjects were non-pregnant .and 16ng All/kg/min w h ~ n n
the subjects were pregnant. Platelet All binding and 
, . 
plasma All levels were measured in both blood samples. 
Non-pregnant subjects. 
These subjects fulfilled the criteria·' described 
above (p. 128) and in addition, were all studied 
between days 5-9 of the menstrual c y c 1 e ~ ~ Their median 
age was 28 years (range 18-43). 
The All infusion caused a rise in the plasma All 
level from a median value' of 15.4 pM (9.9-28.8) to 
52.3 pM (34.5-107.7). The change in platelet All 
binding from a median value of 4.9 fmo1/109 cells to a 
median value of 4.0 fmo1/109 cells is illustrated in 
Figure 3.11. The change in platelet All binding was 
not significant (P>0.4). 
Pregnant subjects. 
None of the pregnant subjects was known to be 
suffering from renal, metabolic or cardiovascular 
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Figure 3.11. 
The effect of All infusion on platelet All binding in 
non-pregnant subjects. 
Figure 3.12. 
The effect of All infusion on platelet All binding in 
pregnant subjects. 
The median values are indicated by the horizontal 
bars. 
Figure 3.11 
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disease. All the subjects were primiparous 
were taking any medication bar iron and 
supplements. All subjects were receiving ad 
and none 
vitamin 
libitum 
sodium intake and had normal serum urea, creatinine, 
and electrolyte estimations. The median age of the 
subjects was 24 years (21-24) and the median 
gestational age was 32 weeks (31-32). All subjects 
were normotensive when the infusion studies were 
performed (median systolic blood pressure 117 mmHg., 
114-121, median diastolic blood pressure 65 mmHg., 61-
69). 
The All infusion. caused a rise in the plasma All 
level from a media.n value of 8.2 pM (3.2-60.0) to 
120.1 pM (40.5-205.0). The change in .platelet All 
binding from a median value of 2.6 fmol/l09 cells to a 
median 'value of 2.5 fmol/l09 cells. is illustrated in 
Figure··3.12. As in the non-pregnant subjects, this 
change in platelet All binding was not significant 
(P>0.5). 
Discussion. 
These results indicate that human platelets possess 
a single class of high affinity, specific, saturable 
and reversible binding sites. Moreover, the 
validation exper'iments des'cribed in the previous 
chapter found platelet All binding to be time, 
temperature and pH dependent. Previous findings 
[Moore and Williams, 1981, Ding, Kenyon and Semple, 
1984, Mann, Sis and Ritz, 1985] have therefore been 
confirmed. The difficulty in performing 
characterisation ~ t u d i e s s using platelets from pregnant 
subjects has been alluded to above. The median value 
of the five pregnant subjects in whom competition 
studies were possible is well above the median values 
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in the third trimester, determined in both the cross-
sectional and longitudinal studies (see Chapter 5, p. 
153, and Chapter 6, p. 171). That three of the five 
patients subsequently developed pregnancy-induced 
hypertension is further evidence that these women may 
be unrepresentative of the normotensive pregnant 
population. 
Three different methods, performed on different 
subjects, indicated that the value of the dissociation 
constant Kd was between 1.40 - 2.57 x 10-10 mol/l. 
The fact that similar binding site affinities were 
found for both radiolabelled All and for the native 
hormone, (i.e the 125I - AII saturation curve and the 
competitive displacement studies), suggests that-
iodination of the hormone did not alter its binding to_ 
platelets, thus j u s t i f y i ~ g g its u ~ e e as a radiolabelled 
tracer. In this regard, the platelets resembled rat 
mesenteric artery tissue, which also binds iodinated 
and unlabelled All equally _[Gunther, Gimbrone -and 
Alexander, 1980a].-
The values of the dissociation constant found were 
in close agreement with those found previously in 
human platelets, 1.2 - 3.0 x'10-10 mol/l, [Moore and 
Williams, 1981, Ding, Kenyon and Semple, 1984, Mann, 
Sis and Ritz, 1985]. The 'affinity of the platelet 
binding sites were also of a similar order to those 
reported in animal vascular smooth muscle [e.g. in rat 
mesenteric artery tissue, McQueen, Murray and Semple, 
1984, discussed in the Introduction, p. 75]. 
There was, however, a disparity noted between these 
results and previous work, when the dissociation study 
was considered. As illustrated in Figure 3.8, the 
diminution in binding found following the addition of 
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excess unlabelled All, ceased after one hour. This 
contrasts with the results of Ding et. al. [1984] and 
Mann et. al. [1985], indeed, the latter group found 
that even after six hours the rate of the reduction in 
binding levels had not slowed. Following the 90 
minute incubation with 125I - AII only, clumps of 
platelet aggregates were visible. It was thus 
anticipated that the addition of the unlabelled All 
would only partially displace the radiolabelled 
peptide. The differing findings of the above workers 
may reflect varying degrees of platelet aggregation, 
although the method of platelet preparation used by 
Mann et. al. [1985] was similar to that used in this 
thesis, with the production of platelet rich plasma a ~ ~
an intermediate step. The possibility that in our 
studies there was breakdown of the unlabelled All 
cannot be discounted. 
In a small sample of primiparous subjects in the 
third trimester of pregnancy, an All-induced rise i ~ ~
platelet [Ca+2]i in the ex vivo situation was 
demonstrated. However, in contrast to the work of 
Haller, Oeney, Hauck, Distler and Philipp [1989], no 
increase in platelet [Ca+2]i was f ~ u n d , , on addition o ~ ~
All to platelets in vitro, using either physiological 
or pharmacological concentrations of All. Our 
findings were I:oncordan t wi th an earlier in vi tro 
study in non-pregnant subjects [Lechi, Lechi, 
Bonadonna, Sinigaglia, Corrandini, Polignano, Arosio, 
Covi and Detogni, 1987]. The methodology used in this 
study was similar but not identical to that used by 
the Haller" group. Centrifugation was ""'used to prepare 
the platelet suspensions and the more contemporary 
indicator fura-2 used to measure platelet [ca+2]i' 
allowing a reduction in the intracellular 
concentration of indicator and thus reducing any 
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buffering of the calcium signals. The response found 
by Haller et. ale [1987] was present only in a very 
narrow concentration band (10-7 to 10-6mol/l), and it 
is possible that the concentration steps used in this 
study were too large to identify the steep peak of 
response. 
However, the results of the ex vivo data clearly 
demonstrate a rise in platelet [ca+2]iafter infusion 
'of All. The increase in platelet [Ca+2]i in the ~ ~
vivo studies was smaller than that demonstrated by 
Haller et. ale [1989], and lower than the transient 
calcium signals measured in smooth muscle cells 
[Brock, Alexander, ",Ekstein, Atkinson and Gimbrone, 
1985]. ,The relatively smaller effect of ,All ex vivo 
may be . explained by the low number of All binding 
sites on platelets as compared to smooth muscle cells 
[Aguilera, Hauger and Catt, 1978, Gunther, Gimbrone 
and Alexander 1980b] (discussed in the Introduction, 
p. 76). 
The results demonstrated no correlation between 
platelet All binding and the rise in platelet[Ca+2]i 
after ex vivo infusion of All, although an underlying 
trend was apparen t. Formal validation of the high 
affinity platelet All binding sites as receptors has 
thus not been achieved. 
An All-induced enhancement of the platelet 
aggregation response to adrenaline has been. noted 
[Poplawski, 1970, Ding, MacIntyre, Kenyon and Semple, 
1985] • Condi tions caus ing vasocons t'ric tion tend to 
produce parallel increases in platelet aggregation 
[e.g ... Cowley, Stainer, Cockbill and Heptinstall, 
1984]. Vascular smooth muscle constriction has been 
shown to be related to vascular smooth muscle cell All 
-139-
binding [Baudouin, Meyer and Worce1, 1971], thus an 
attempt to correlate All enhancement of platelet 
aggregation with platelet All binding might be 
fruitful. 
The results of the All infusion studies are in 
accord with those of Moore, Taylor and Williams 
[1984], who also found that short term increases in 
plasma All did not alter platelet All binding. The 
regulation of platelet All binding will be "discussed 
in subsequent chapters. 
In conclusion, the characterisation studies provide 
strong evidence that the platelet All binding sites 
are receptors. However, until a correlation between 
levels of binding and a biological response i$ 
- -demonstrated, they cannot strictly be regarded as 
such. 
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Chapter 4. 
MENSTRUAL STUDY. 
Changes in platelet All binding associated 
with the menstrual cycle. 
This chapter will describe the results from fifteen 
nulliparous, normotensive non-pregnant female 
volunteers during the follicular and luteal phases of 
the menstrual cycle. Changes in the renin-angiotensin 
system associated with the menstrual cycle are well 
established, with increased levels in the luteal phase 
of plasma renin concentration (PRC) [Brown, Davies, 
Lever and Robertson, 1964], plasma renin activity 
(PRA) [Skinner, Lumbers and Symonds, 1969] and plasma 
angiotensin II (All), concentration [Sundsfjord and 
Aakvaag, 1970] having been found. As discussed in 
chapter l-(section 5 p. 79), regulation of platelet 
All binding by changes in plasma All concentration has 
been suggested ~ M o , o r e , , Taylor and Williams, 1984, 
Ding, Kenyon and Semple, 1985]. It was thus decided 
to measure platelet All binding in both the follicular 
and luteal phases of the menstrual cycle in a small 
sample of women. 
Study sample. 
Fifteen nulliparous, normotensive Caucasian women 
were investigated between days 5-9 of the menstrual 
cycle (follicular phase) and on day 21 (luteal phase). 
All subjects had either not been taking h o ~ m o n a l l
contraception for at least six months (40%) or had 
never taken this medication (60%). Subjects had no 
recent history of m e n s t ~ u a l l disorder, and had regular 
periods. All subjects were normotensive and had no 
history of renal, metabolic or cardiov'ascular disease. 
No subject was taking any medication. All subjects 
were r ~ c e i v i n g g sodium intake ad libitum and had normal 
serum urea, creatinine and electrolyte estimations. 
Their ages, body weights and blood pressures are 
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summarised in Table 4.1. In view of the small sample 
size, the range of values are quoted rather than the 
25th and 75th centiles. 
The fifteen women were divided on the basis of 
serum progesterone levels into those with ovulatory 
(n-10) and anovulatory (n-5) cycles. As discussed 
below, a rise in serum progesterone level from <5 
nmol/l at days 5-9 to >30 nmol/l at day 21 was 
adjudged to indicate· ovulation. The changes in 
serum progesterone levels are illustrated in Figure 
4.2. 
1) The ovulatory subgroup_ 
The ten women had a median" age of 26 years. The 
median body weight for the. follicular phase was 
~ 1 . 5 k g . . .All individuals were normotensive, the median 
follicular pha"se blood pressure being 117/75 mmHg. 
Neither body weight (P>0.3) nor blood pressure (P>0.4) 
changed significantly in· the luteal phase (Wilcoxon 
matched-pairs signed-ranks test). 
2)The anovulatory subgroup_ 
The five women had a median age of 21 years. The 
median body weight for the follicular phase was 61.7 
~ g . . All individuals were normotensive, the median 
follicular phase blood pressures being 110/60 .mmHg. 
Again, no significant changes in either body weight 
(P>0.5) or blood pressure (P>0.5) were noted in the 
phases of the menstrual cycle. 
There were no significant differen·ces between the 
ovula tory and anovula tory subgroups when comparisons 
of age· (P>0.4), body weight ( P > 0 ~ 5 ) , , systolic blood 
pressure (P>O.l) and diastolic blood pressure (P>O.l) 
were made (Mann-Whitney Utest). 
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Table 4.1. 
Demographic data for the sample of non-pregnant women 
investigated during the menstrual cycle. 
At the end of the study, 10 women were considered to 
have ovulatory cycles and 5 were considered to have 
anovulatory cycles. 
Median values (range) are quoted. 
Table 4.2. 
Hormonal data from the sample of non-pregnant women 
investigated during the menstrual cycle. 
Median values (range) are quoted. 
The lower limit of· detection of the serum 
progesterone assay was 2.0 nmol/l. In the 
statistical analysis performed, values reported as 
<2.0 nmol/l have been deemed to be 2.0 nmol/l. 
Table 4.1. 
OVULATORY ANOVULATORY 
Follicular Luteal· Follicular· Luteal 
Age 26 * * " 21 * * 
(years) (20-42) (20-35) 
Weight 61.5 61.8 61.7 61.8 
(Kg) (49.9-94.2) (50.2-94.0) (58.5-81.7) (59.0-81.7) 
Systolic blood 117 118 110 108 
pressure (mmHg.) (100-130) (105-130) _ O , , ~ 0 - 1 2 0 ) ) (100-115) 
Diastolic blood 75 75 60 70 
pressure (mmHg.) (60-80) (60-80) (50-70) (55-80) , 
Table 4.2. 
OVULATORY ANOVULATORY 
Follicular Luteal .Follicular Luteal 
Progesterone <2.0 56.0 <2.0 8.0 
(nmoIlL) «2.0-4.0) (32.0-75.0) «2.0-<2.0) «2.0-11.5) 
Angiotensin II 9.4 16.5 29.1 15.6 
':.' 
(pg/ml) (2.9-26.9) (3.6-42.1 ) (6.7-67.5) (12.6-66.2) 
P.R.C. 1.6 4.9 1.8 2,.1 
(ng Allhr/ml) (0.5-3.4) (1.3-6.7) (0.1-2.0) (0.2-2.5) 
P.R.S. 1.2 1.1 1.0 1.0 
(ug AI Iml) , (0.7-2.4) (0.5-3.2) (0.4-1.1 ) (0.2-1.0) 
40 mI. of venous blood was taken on each occasion, 
as previously described (chapter 2, p. 112). In 
addition to platelet All binding, serum urea and 
electrolytes, All, plasma renin substrate (PRS), 
plasma renin concentration (PRC), and progesterone 
estimations were performed using "the methods detailed 
in Chapter 2. 
Results. 
1) Platelet All binding. 
Figure 4.1 summarises the changes in p l a t e l ~ t t All 
binding. 
In the ovu,latory subjects, there was a diminution 
in binding in the luteal phase of the cycle in nine of 
the ten women. The fall in platelet All binding, from 
a median ~ a l u e e of 11.2 (0.7-29.5) fmol/l09 cells at 
··days 5-9 to a median value of 3.6 (0.0-20.4) fmol/109 
cells' at day 21, approached significance (P(0.02, 
Wilcoxon matched-pairs signed-ranks test). 
An increase in platelet All binding was found in 
two of the five subjects deemed to be anovulatory. 
The change in ·binding, froin a median value of 8.8 
(1.9-10.6) f m ~ l / 1 0 9 9 cells at days 5-9 to a median 
value of 0.0 (0.0-13.7) fmol/109 cells, was not 
significant (P>0.5). 
.. 
There were no significant differences between the 
ovulatory and' the anovulatory subgroups when 
comparisons of platelet All binding in the follicular 
(P>0.5) and luteal (P>0.4) phase of the menstrual 
cycle were made (Mann-Whitney Utest). 
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Figure 4.1. 
Changes in platelet All binding 
menstrual cycle in ovulatory 
subjects. 
associated with the 
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and in anovulatory 
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2) Hormonal data. 
Table 4.2 summarises the changes in serum 
progesterone, All, PRe and PRS. 
There was a significant increase in the serum 
progesterone levels in the ovulatory subgroup from the 
follicular phase to the luteal phase (P<O.Ol, Wilcoxon 
matched-pairs signed-ranks test). In the anovulatory 
subgroup, the increase in serum progesterone levels 
was not significant (P>O.l). There was a 
significantly greater increase in the serum 
progesterone l e v e ~ s s in the ovulatory subgroup as 
compared to the ~ n o v u l a t o r y y subgroup (P(O.Ol, Mann-
Whitney U test) •. Figure 4.2 illustrates .the changes 
in s e ~ u m m progesterone levels. 
In t h ~ ~ o v u l ~ t o r y y subjects, there was a significant 
rise in both plasma All (P<O.05, Wilcoxon matched-
pairs signed ranks test) and PRe (P(O.OS) from the 
follicular 
significant 
to the 
change 
luteal phase. 
in PRS. In 
There was no 
the anovulatory 
subjects there were no significant changes from the 
follicular to the 1uteal phase, in plasma All, PRe or 
PRS. A significant difference in the change in plasma 
All, but not in PRe or PRS, was shown in these 
subjects as c ~ m p a r e d d with- the ovulatory s u ~ g r o u p p
(P(O.OS, Mann-Whitney U test). Figure 4.3 illustrates 
the changes in plasma All, PRe and PRS. 
3) Platelet data. 
Table 4 ~ 3 3 summarises the changes in platelet count, 
mean platelet volume and platelet distribution width. 
None of the parameters changed significantly from the 
follicular to the luteal phase of the cycle, in either 
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Figure 4.2. 
Serum progesterone concentrations in the follicular 
and luteal phases of the menstrual cycle. 
A rise in the serum progesterone concentration from 
<5 nmol/l at days 5-9 to >30 nmol/l at day 21 was 
adjudged to indicate ovulation. 
Figure 4.3. 
Changes in plasma All, PRC and PRS associated with 
the menstrual cycle in ovulatory and anovulatory 
subjects •• 
Figure 4.2. 
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Table 4.3. 
Platelet data from the sample of non-pregnant women 
investigated during the menstrual cycle. 
Median values (range) are quoted. 
Table 4.4. 
Biochemical data from the sample of non-pregnant 
women investigated during the menstrual cycle. 
Median values (range) are quoted. 
Table 4.3. 
OVULATORY ANOVULATORY 
Follicular Luteal Follicular Luteal 
Platelet count 224 235 227 210 
( x 109 IL) (168-346) (160-344) (174-252) (153-221) 
Mean platelet volume 7.7 8.1 7.9 7.6 
(f I) (6.9-9.3) (6.9-9.7) (6.8-8.0) (7.3-8.2) 
Platelet distribution 16.4 '16.3 15.1 15.1 
,"o/-; .' 
width (14.4-17.9) (14.4-17.5) (14.7-16.2) (14.4-16.4) 
Table 4.4. 
OVULATORY ANOVULATORY 
Follicular luteal Follicular luteal 
Sodium 140 139 140 '141 
(mmolll) (139-146) (137-142) (139-141) (138-143) 
Potassium 4.2 4.1 4.5 3.9 
(mmolll) (3.5-5.3) (3.3-4.5) (4.1-5.1) (3.7-4.7) 
Urea . 4.1 4.3 4.2 4.1 
(mmoI/L) (2.8-5.6) (2.9-5.9) (2.8-5.1) (2.5-5.0) 
Creatinine 83 79 76 76 
(ymol/L) (69-98) (56-98) (73-87) (45-91) 
Urate 180 196 218 224 
(umoIlL) (167-257) (167-245) (198-296 ) (207-306) 
-
Osmolality 285 280 281 281 
(Osm/Kg) (278-298) (274-288) (278-288) (275-285) 
the ovulatory or the anovulatory subgroup (P>O.3, 
Wilcoxon matched-pairs signed ranked test). There 
were no significant differences between the ovulatory 
and the anovulatory subgroups (P>O.4, Mann-Whitney U 
test). 
4) Biochemical data. 
Table 4.4 summarises the changes in . serum sodium, 
potassium, urea, creatinine, urate and osmolarity. 
The only significant change from the follicular to the 
luteal phase was found in the ovulatory subgroup; ,a 
significant decrease in serum osmolarity was noted 
(P<O.Ol, Wilcoxon matched-pairs signed-ranks test). 
For all other c·omparisons P>O.05. There were no 
significant differences between the ovulatory and 
anovulatory subgroups ( P > O . ~ , , Mann-Whitney U test). 
Discussion. 
The main problem in interpreting this study lies in 
the small number of anovulatory patients studied. The 
logistics of recruitment were not easy, given the 
strict entry criteria and the amount of laboratory 
time required for each patient. Thus the possibility 
of incorrect acceptance o ~ ~ the Null Hypothesis for 
lack of any ~ t a t i s t i c a l l y ' ' significant difference 
between the groups must be recognised. However, 
although the sample size was small, this prospective 
study has demonstrated a significant diminution in 
platelet All binding in the luteal phase of ovulatory 
menstrual cycles in nulliparous,. normotensive women, 
with the median value of platelet All binding 
decreasing by 69%. 
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Significant increases in both All and PRC were 
found in the ovulatory subgroup, with the 75% increase 
in the median plasma All concentration in the luteal 
phase being very similar to the 76% increase 
previously reported by Sundsfjord and Aakvaag [1970]. 
In the luteal phase of ovulatory cycles, progesterone 
from the corpus luteum causes a net loss in. both 
sodium and water from the renal tubules, due to the 
increase in glomerular filtration rate and the 
natriuretic effects of progesterone [Oparil, Erlich 
and Lindheimer, 1975]. As discussed in the 
introduction (section 2), . these changes are at least 
partially compensated for by activation of the renin-
angiotensin system and its effects on renal tubular 
sodium h a n d l ~ n g . . The observed rise in ~ R C C in the 
ovulatory patients (Table 4.2) is consistent with this 
hypothesis. As discussed above, increases in both PRC 
. 
and plasma r-enin ac ti vi ty have previous ly been 
demonstrated [Brown, Davies, Lever and Robertson, 
1964, Skinner, Lumbers and Symonds, 1969]. Our data 
are also concordant with these physiological changes 
in that the serum electrolytes were unaffected by the 
changes in serum progesterone. The significant fall 
in serum osmolarity found in the luteal phase of 
ovulatory subjects is probably due to the effects of 
the progesterone surge and changes in sensory volume 
receptors, changes which extend into pregnancy if 
implantation occurs [Davison, 1980]. 
Increases in plasma All concentrations consequent 
upon dietary sodium restriction have previously been 
found to cause a reduction in plateiet All binding 
[Moore, Taylor and Williams, 1984, Ding, Kenyon and 
Semple,' 1985], thus the increased plasma All 
concentrations in the .luteal phase provide one 
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possible explanation for the diminution in platelet 
All binding. 
The influence of sex steroid hormones on platelet 
All binding has yet to be studied. However, as 
discussed in the introduction (section 5 p. 83), rat 
and rabbit uterine All receptor concentrations respond 
in a dose-dependent manner to steroid administration 
[Schirar, Capponi and Catt, 1980]. Schirar et. ale 
[1980] found that progesterone infusion caused an 
increase in uterine All receptor concentrations 
whereas oestradiol injection resulted in a· decrease. 
As previously discussed (p. 71), uterine All. receptors 
share ~ a n y y characteristics with platelet All binding 
sites, and steroid hormone regulation of platelet All 
binding is another possibility •. 
. . 
The majorit-y of studies of platelet behaviour 
during the different phases of the menstrual cycle 
suggest. increased platelet reactivity· in the luteal 
phase. Zahavi, Dreyfuss, Kalef and Soferman [1973] 
demons tra ted an increase in the pro-aggrega tory 
effects of ADP, and recent data from this centre has 
i n d i c a ~ e d d that prostaglandin E2-induced platelet rich 
plasma aggregation is increased in the third week of 
the menstrual cycle [Hughes, Broughton Pipkin, 
Heptinstall, personal commuriication]. One cause of 
the increased reactivity may be the elevated levels of 
plasma All in the luteal phase of the cycle, Poplawski 
[1970] having found that All enhanced the pro-
aggregatory effects of both ADP and adrenaline, 
although it did not exert any direct . effect itself. 
The alterations in platelet behaviour may themselves 
diminish the availability of cell surface binding 
sites, and thus compromise the use of platelets as a 
model of vascular smooth muscle cells. 
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In all cases a quantitative measure of ovulation 
was obtained. Diagnosis is in practice presumptive, 
based on luteal progesterone production. The critical 
level has been reported variously as between 9 and 30 
nmo1/1 [reviewed by Hull, Savage, Bromham, Ismail and 
Morris, 1982], the wide range be'ing at least partly 
due to inconsistency between cycles in 'normal' women. 
There is disagreement about the definition of the very 
term 'ovulation', which in clinical practice, and 
indeed most research studies, is based on indirect 
evidence of ovulation. The best proof of ovulation is 
subsequent pregnancy, thus using 21 untreated 
singleton conception cycles, Hull e t ~ ~ ale [1982] found 
that the critical progesterone level in a single 
mid1utea1 serum sample was 28 nmo1/1, this being the 
lower 95 % confidence limit. Their lowest o b s ~ r v e d d
value was 27 nmol/l. To allow for assay variation' 
they suggested that a' value of 30 nmo1/1 be taken as 
indicating ovulation. This value is in accord with 
that established in our own laboratory [Wood, Groom, 
Moore, Ratcliffe and Selby, 1985]. 
The importance of quantitative evidence of 
ovulation is underlined by the fact that all the 
subjects studied had normal, regular menstrual cycles, 
yet 5 out of 15 were anovulatory. Thus in studies of 
platelets in tht! menstrual cycle where confirmation 
was not obtained, (e.g. platelet aggregation in the 
menstrual cycle [Yamazaki, Motomiya, Kikutani, 
Sakakibara, Watanebe, Namuta and Noguchi, 1979]), the 
sample group may contain a h e t e r o g e ~ e o u s s group of 
ovula tory and anovulatory women. Urif ortuna tely , a 
preliminary study-of changes in the pressor response 
to A I ~ ~ during the menstrual cycle also failed to 
document evidence of ovulation [Broughton Pipkin and 
O'Brien, personal communication]. Thus although an 
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overall diminution in pressor response was found 
during the luteal phase, there can be no certainty 
that this was related to ovulation. 
In view of the above finding of reduced platelet 
All binding in the luteal phase of the cycle, in all 
subsequent studies, non-pregnant subjects have. been 
studied between days 5-9 of the menstrual cycle. 
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Chapter 5. 
CROSS-SECTIONAL STUDY. 
Platelet All binding in normotensive and 
hypertensive pregnancy. 
Prior to this study, there was no information 
concerning platelet angiotensin II (All) binding in 
pregnancy. Although less powerful than prospective 
longitudinal studies, cross-sectional studies are 
frequently used in pregnancy to" provide preliminary 
data. It was thus decided to perform a 'pilot' cross-
sectional study, in order to assess whether a 
longitudinal study, following a cohort of women 
, 
through pregnancy, would be justified. 
Study' sample. 
A total of 175 women were studied, with.25 subjects 
in each group. 
a) Normotensive patients. 
25 primiparous patients in each trimester were 
recruited randomly' from the antenatal clinic, the 
exception to this being 18 of the 25 subjects 
inves.tigated in the first trimester' who were studied 
prior to a termination of pregnancy (under Clause 2, 
Abortion Act, 1967). 25 patients were studied on the 
postnatal ward, 24 hours after their first pregnancy. 
A further 25 patients were recruited randomly from the 
postnatal clinic, six weeks following their ·first 
pregnancy, in 18 cases delivery having been by 
caesarean section. Data for comparison was o b t a i ~ e d d
from 25 nulliparous volunteers at days 5-9 of the 
menstrual cycle. No woman was known to be suffering 
from renal, metabolic or cardiovascular disease. No 
subject was taking any medication except iron 
supplementation. The pregnancies of all 
pregnant/postnatal patients remained normotensive 
throughout, with no patient having any proteinuria 
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detectable on routine 'dipstick' testing. All 
subjects were receiving sodium intake ad libitum and 
had normal serum urea, creatinine and electrolyte 
estimations. The median ages, gestational ages, 
subject weights and both systolic and diastolic blood 
pressures are summarised in Table 5.1. 
The median gestational ages of the trimester 
samples were 10.0, 18.0 and 33.0 weeks respectively. 
In all cases the gestational ages were confirmed by an 
ultrasound scan performed at approximately 18 weeks 
gestation. With the exception of maternal age in the 
first trimester group, which was significantly lower 
than that of any other group (P(O.Ol), ~ h e r e e were no 
significant differences in maternal ·age (P>O.l), 
systolic blood pressure (P>O.l), or diastolic blood 
pressure .(P>O.OS), between any of the 'normotensive' 
groups (Mann-Whitney U test). Maternal weight 
increased in pregnancy, the difference from the non-
. pregnant control group reaching a significant level by 
the third trimes ter (P(O. 001) • Ma ternal weight was 
also significantly greater in the group studied six 
weeks post delivery as compared to the. non-pregnant 
control group (P(O.Ol). 
b) Hypertensive patients. 
25 p r i m i p a r o u ~ ~ patients in the third trimester of 
pregnancies complicated by pregnancy-induced 
hypertension (PIH), as defined by Davey and 
MacGillivray [1987] (discussed further in the 
introduction, section 1, p. 9), were. also studied. 
These patients were subdivided in lf patients with 
non-proteinuric PIH and 14 with proteinuric PIH or 
pre-eclampsia, with respect to the presence or absence 
of • significant proteinuria' ( >0. 3g/24 hour urine 
collection), illustrated in figure 5.1. All samples 
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Table 5.1. 
Demographic details of the normotensive pregnant and 
non-pregnant patients. 
Median values are shown, with the interquartile range 
in brackets. 
, 
} 
Table 5.1 
Non- 1 st trimester 2nd trimester 3rd trlm.ester I 24hrs PN 6/52 PN 
Gestation * * 10.0 1S.0. 33.0 * * * * 
(weeks) (9.5-12.0) (16.0-21.0) (29.5-3S.0) 
Age 26 20 25 25 25 25 
(years) (24-29) (1S-23) (21-2S) (21-2S) (21-2S) (22-27) 
Weight 59.8 60.6 67.5 73.0 6S.7 69.2 
(Kg) . (57.6-66.1) (56.3-65.0) (60.0-70.6) (66.0-81.0) (60.5-71.7) (62.5-77.5) 
SystOliC blood 110 110 115 110 120 120 
pressure (mmHg.) (104-123) (110-120) (110-120) (110-123) (110-120) (110-120) 
.. 
Diastolic blood 70 70 70 7n 70 70 
pressure (mmHg.) (70-75) (60-70) (70-70) (65-75) (70-S0) (70-80) 
Figure 5.1. 
Quantitative urinary protein content 
hypertensive primigravid patients. 
in the 
Median values are shown, with the interquartile range 
marked. 
The PIH group have been subdivided into non-
proteinuric PIH patients (n=ll) and patients with 
pre-eclampsia (n=14) on the basis of significant 
proteinuria (>0.3g / 24hours). The overall data from 
the PIH group and the subdivided data are shown. 
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were taken prior to any antihypertensive medication 
being commenced. No woman was known to be suffering 
from renal, metabolic or cardiovascular disease. The 
subjects with PIH were followed up in the postnatal 
period and all patients were normotensive wi th no 
proteinuria at six weeks post delivery. 
The maternal ages, gestational ages, maternal 
weights, systolic and diastolic blood pressures, 
gestational ages at delivery and infant birthweights 
. of this group are summarised in Table 5.2, gestational 
age again being confirmed by ultrasound scan. Both 
the systolic and diastolic blood pressures of the PIH 
group were by definition elevated as compare9 to those 
of the normotensive third trimester patients (Figure 
5.2), the differences being significant (P<O.001, 
Mann-Whitney U test). There were no significant· 
. --
differences in blood pres sur. between those patients 
with non-proteinuric PIH and those with p r e - ~ c l a m p s i a a
(P>O.5). There were no significant differences 
between any of the groups when comparisons of 
gestational age (P>O.1), maternal age (P>O.1) and 
maternal weight (P>O.05) were made. Gestational age 
at delivery was significantly earlier in the PIH group 
than in the normotensive third trimester patients 
"\ (P(O.001), no significant difference being found 
between the non-proteinuric PIH patients and- the 
patients with pre-eclampsia (P<O.1). Differences in 
infant birthweight between the normotensive· and the 
PIH third trimester groups approached significance 
(P-O.012), the difference being s i g n i ~ i c a n t t when the 
pre-eclamptic group were compared wi th both the non-
proteinuric patients (P(O.01) and the normotensive 
group (P(O.01). 
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Table 5.2. 
Demographic details of the normotensive and 
hypertensive third trimester patients. 
Median values are shown, with the interquartile range 
in brackets. 
The PIH patients have been subdivided on the basis of 
significant proteinuria. The overall data from the 
PIH group and the subdivided data are shown, with the 
normotensive subjects included for comparison. 
Table 5.2 
, 
3rd trimester PIH Non-protelnurlc PIH Pre-eclampsia 
n=25 n=25 n=11 n=14 
Gestation 33.0 36.0 38.0 35.0 
(weeks) (29-38) (33-38) (36-38) (32-38) 
Age ·25 ·24 23 24 
(years) (21-28) (19-27) (18-27) (20-28) 
Weight 73.0 79.5 83.5 79.3 
(Kg) (66.0-81.0) (71.8-86.7) (66.8-95.8) (72.7-86.0) 
Systolic blood 110 145 145 145 
pressure (mmHg.) (110-123) (140-150) (140-150) (143-155) 
Diastolic blood 70 95 97 95 
pressure (mmHg.) (65-75) (95-100) (95-100) (95-100) 
Gestation at 40.0 38.0 38.0 37.0 
delivery (weeks) (39.5-40.5) (36.8-38.0) (37.0-39.0) (35.0-38.5) 
Blrthwelght 3.30 2.94 3.10 2.63 
(Kg) (2.99-3.53) (2.31-3.31) (2.54-3.34) '(2.10-3.51) 
~ t . , . .
.) 
Figure 5.2. 
Diastolic and systolic blood pressures of the 
normotensive and hypertensive third trimester 
pregnant patients. 
Median values are shown, with the interquartile range 
marked. 
The PIH group have been subdivided on the basis of 
significant proteinuria. The overall data from the 
PIH group and the subdivided data are shown, with the 
normotensive subjects included for comparison. 
Figure 5.2. 
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Platelet Angiotensin II (All) binding data. 
a) Normotensive patients. 
The median value of platelet All binding in the 
non-pregnant female volunteer group was 9.0 fmol/l09 
cells, these data not being normally distributed and 
with marked individual variability being found (see 
Figure 5.3). 
Kruskal-Wallis analysis of variance indicated a 
significant effect of pregnancy on platelet All 
binding (P<O.OOOl). There was significantly lower 
platelet All binding in the first trimester group (2.7 
fmol/109 cells, P<O.OOl, Mann-Whitney U test) as 
compared' to the non-pregnant control group, .with an 
apparent . reduction in variability. In four women no 
p l a t e l e ~ a A I I I binding could be detected at this time, 
an observation "not made in the non-pregnant control 
group. As illustrated in Figure 5.3 the median value 
of platelet All binding remained low in the groups of 
second trimester women (3.3 fmol/109 cells), third 
trimester women (2.3 fmol/109 cell,s), and in those 
studied 24 hours after delivery (1.3 fmol/109 cells), 
with no significant differences between any of these 
groups (P>O.l). There was significantly higher 
binding in the women studied six weeks after delivery 
(9.0 fmol/109" cells, P < O ~ O l ) ) as compared to those 
studied 24 hours after delivery, with values similar 
to those in the non-pregnant control group. 
b) Hypertensive patients. 
The median value of platelet All "binding in the 25 
PIB patients was 6.0 fmol/109 cells (Figure 5.4). 
Median platelet All binding thus fell by 33% in the 
PIH patients by comparison with the non-pregnant 
control group, whereas in the normotensive third 
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Fiaure 5.3 
Figure 5.3 
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trimester group, median platelet All binding fell by 
74%. Binding was significantly higher in the PIH 
group than in the normotensive third trimester 
patients (P<O.OOl, Mann-Whitney U test). Platelet All 
binding in the 14 patients with pre-eclampsia (6.7 
fmol/109 cells) was significantly higher than in the 
normotensive pregnant patients (P<O.Ol) but was not 
significantly higher than in the 11 patients with non-
proteinuric PIH (5.0 fmol/109 cells, P>O.l). Platelet 
All binding was higher in the patients with non-
proteinuric PIH as compared to the normotensive 
pregnant group although the difference did not reach 
significant l e v e l ~ ~ (P>0.05). 
Hormonal data 
a)" Normotensive patients. 
The median values of plasma angiotensin II (All), 
plasma renin concentration (PRe) and plasma renin 
substrate (PRS) are summarised in Table 5.3. 
Kruskal-Wallis analysis of yariance indicated a 
significant effect of pregnancy on all three hormone 
estimations, with P<O.Ol in each case. 
The median plasma All concentration was 6.7 pg/ml 
in the non-pre'gnant group '(Figure 5.5). Higher All 
levels were found in the first trimester group, and 
the difference became significant by the second 
trimester (P<O.Ol, Mann-Whitney U test). Levels of 
the peptide continued to rise with pregnancy, reaching 
a maximum in the third trimester (Figure 5.5). There 
was a reduction ". in All levels in the samples taken 24 
hours' after delivery, with the levels at six weeks 
post-delivery being significantly lower than those of 
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Table 5.3 
Hormonal data from the normotensive pregnant and ~ ~
pregnant patients. 
Median values are shown, with the interquartile range 
in brackets. 
Table 5.3 
1 st trimester 2nd trimester 3rd trimester 24hrs PN 6/52 PN 
Angiotensin II 6.7 11.0 14.0 19.3 , . 14.1 7.0 
(pg/ml) (3.4-12.0) (4.5-30.0) (10.0-21.0) (12.7-31.6) (5.9-31.8) (3.5-34.1 ) 
P.R.C. 0.9 2.3 3.2 2.8 1.9 1.0 
(ng Al/hr/ml) (0.7-1.6) (1.3-3.4) (2.1 .. 4.7) (1.5 .. 3.8) (1.2-3.5) (0.6-1.4) 
P.R.S. 1.2 1.3 1.9 2.5 2.0 1.3 
(ug AI/ml) (1.1-1.6) (1.1-2.0) (1.2 .. 2.6) (2.1 .. 4.2) (1.2-2.5) (1.0-1.7) 
the third trimes ter group (P<O. 01) and approximating 
to those of the non-pregnant control group. 
Increased values of PRe and PRS were also found in 
pregnancy (Table 5.3, Figure 5.5). The values of PRe 
were significantly higher in the'first trimester group 
as compared with the 
(P<O.OOl, Mann-Whitney 
non-pregnant 
U test). 
control group 
. There were no 
significant differences between the three trimesters 
or at 24 hours after delivery (P>0.05). However, the 
values found six weeks postnatally were significantly 
lower than those 24 hours after delivery (P<O.Ol). 
The rise in PRS became significant by the second 
trimester (P<O.Ol). Significant changes in PRS were 
found between the third trimester and 24 hours after 
delivery (P<O.Ol), and between 24 hours and six w e e ~ s s
after delivery ( P < O . O ~ ) . . - Va1qes of both PRe and PRS 
at six weeks after delivery approximated to those of 
the non-pregnant control group. 
b) Hypertensive patients. 
The median values of All, PRe and PRS are 
summarised in Table 5.4. 
The values of plasma All in the 25 PIH patients 
were significantly higher than those of the non-
pregnant contrp1 group (P<O.Ol Mann-Whitney U . test), 
but did not differ significantly from the normotensive 
third trimester patients (P>O.l) (Figure 5.6). Plasma 
All levels were higher in the 11 patients with non-
proteinuric PIH than in the 14 patients with pre-
eclampsia, although the difference w a ~ ~ not significant 
(P>O.l). 
Similar patterns were demonstrated when levels of 
PRe and PRS were considered (Figure 5.6). There were 
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Figure 5.5. 
Plasma angiotensin II (All), plasma renin substrate 
(PRS), and plasma renin concentration (PRC) in the 
normotensive pregnant and non-pregnant patients. 
Median values are shown, with the interquartile range 
marked. 
The concentrations of all three hormones were 
significantly elevated in pregnancy. 
Figure 5.6. 
Plasma angiotensin 
(PRS), and plasma 
normotensive and 
pregnant patients. 
II (All), plasma renin substrate 
renin concentration (PRC) in the 
hypertensive third trimester 
Median values are shown, with the interquartile range 
marked. 
The PIH patients have been subdivided on the basis of 
significant proteinuria. The overall data from the 
PIH group and the subdivided data are shown, with the 
normotensive subjects included for comparison. 
Figure 5.5. 
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Table 5.4. 
Hormonal data from the normotensive and hypertensive 
third trimester patients. 
Median values 'are shown, with the interquartile range 
in brackets. 
The PIH patients have been subdivided on the basis of 
significant proteinuria. The overall data from the 
PIH group and the subdivided data are shown, with the 
normotensive subjects included for comparison. 
Table 5.4 
3rd trimester PIH Non-p.roteinurlc PIH Pre-eclampsia 
n=25 n=25 n=11 n=14 
Angiotensin II 19.3 15.6 21.6 12.1 
(pg/ml) . (12.7-31.6) (9.8-48.2) (11.9-51.2) (8.7-41.8) 
P.R.C. 2.8 1.9 2.4 1.7 
(ng AI/hr/ml) (1.5-3.8) (1.1-3.2) (1.3-4.3) (0.9-2.5) 
P.R.S. 2.5 2.1 2.4 1.9 
(ug AI/ml) (2.1-4.2) (1.6-2.8) : (1.9-3.5) (1.3-2.4) 
significantly higher levels of both hormones in the 25 
PIH patients as compared to the non-pregnant control 
group (P(0.01). There were no significant differences 
between any of the pregnant groups, although when the 
values of PRS were considered, the differences between 
the PIH group and the normotensive third trimester 
group (P .... 0.03) and between those patients with pre-
eclampsia and those with non-proteinuric PIH (P-0.04) 
approached significance. 
Correlation between platelet All binding and hormone 
concentrations. 
In the non-pregnant control group there were 
inverse correlations between platelet All binding and 
both plasma All (Spearman correlation coefficient rs -
-0.48, P-0.015) and" PRS (rs - -0.44, P-0.027) which 
approached significance. The relationship between 
platelet All binding and plasma .AII is illustrated in 
Figure 5.7. 
of the groups of pregnan t and pos tna tal 
was any significant correlation between 
All binding and either Allor PRS found. 
In none 
patients, 
platelet 
Spearman correlation coefficients for All ranged from 
-0.31 to +0.22"and those for PRS ranged from -0.11 to 
+0.20. Even when platelet All binding was considered 
in relation to plasma All in the patients at six weeks 
post partum, the correlation coefficient still did not 
approach significant levels (P>0.1). 
No correlation was ever demonstrated between 
platelet All binding and PRC (P>O;l). 
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Figure 5.7. 
Correlation between platelet All binding and plasma 
All concentration in the non-pregnant control group. 
Regression characteristics: log (platelet All 
binding) - 1.14 - 0.31 (plasma All concentration). 
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Haematological data. 
There were no significant differences in recovery 
of platelets from whole blood in any 
pregnant/postnatal group (47%-55%) when compared with 
the non-pregnant control group (56%). Contamination 
with leucocytes was <1% (1-5 x 103/pl) and no 
erythrocytes were detected. 
a) Normotensive patients. 
The median values of platelet count, mean platelet 
volume (MPV) and platelet distribution width (PDW) are 
summarised in Table 5.5. 
Kruskal-Wallis analysis of variables demonstrated a 
significant effect o( pregnancy on all three 
p a ~ a m e t e r s s (P<O.OOl in each case). 
A diminution in platelet count occurred during 
.pregnancy (Figure 5.8), with the fall from the values 
in the non-pregnant control group significant by the 
third trimester (P<O.Ol, Mann-Whitney U test). The 
values of platelet count remained low at 24 hours 
after delivery, but were significantly increased at 
six weeks after delivery, the platelet count of this 
group approximating to that of the non-pregnant 
control group." 
MPV increased in pregnancy, the increase from the 
values in the non-pregnant control group became 
significant by the third trimester (P<O.OOl), and 
remained high at 24 hours af ter deli very. Al though 
the values of MPV at six weeks after delivery fell 
_significantly as compared to the third trimester group 
(P<O.Ol), these values remained significantly higher 
than those of the non-pregnant control group (P<O.Ol). 
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Table 5.5 
1 st trimester 2nd trimester 3rd . trimester 24hrs PN 6/52 PN 
Platelet count 220 198 183 170 167 243 
( x 109 /L) (175-274) (180-238) : (163-209) (150-194) (156-232) (206-271 ) 
Mean platelet 7.8 7.8 7.9 8.7 8.4 8.2 
, 
volume (fl) (7.3-8.2) (7.6-8.1 ) (7.5-8.6) (7.9-9.1) ( 7 . 5 - 8 ~ 7 ) ) (7.8-8.7) 
Platelet distribution 15.5 16.2 15.7 . 17.1 16.4 16.0 
width (15.0-16.7) (15.3-17.0) (14.9-16.5) (16.4-18.5) (15.2-17.5) (15.1-16.7) 
Yield 56 51 52 52 55 51 
(%) (48-62) (48-63) (51-58) (49-58) ( 5 ~ - 6 0 ) ) (47-54) 
Figure 5.8. 
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A similar pattern was found when POW was considered, 
the increase from the non-pregnant control group 
becoming significant by the third trimester (P<O.OOl). 
Values of POW fell postpartum, with values at six 
weeks post delivery approximating to those of the non-
pregnant control group. 
There was no significant correlation in any group 
between any of the platelet parameters and platelet 
All binding, when assessed using .Spearman correlation 
coefficients. 
b) Hypertensive patients. 
The median values of platelet count, MPV and. POW 
are summarised in Table 5.6. 
There were no significant differences in. p i a t e l e ~ ~
count (Figure 5.9) and POW between any of the groups, 
although the difference in platelet count between the 
patients with non-proteinuric PIH and those with pre-
eclampsia approached significance (P-O.04, Mann-
Whitney U test). One of the 14 pre-eclampsia patients 
was thrombocytopaenic (defined as a platelet count of 
less than 100 x 109/L). MPV was significantly higher 
in the patients with PIH as compared to . the 
normotensive third trimester group (P<O.OOl), no 
significant d;ifference being found between non-
proteinuric PIHand the pre-eclampsia patients 
(P>O.l). 
No significant correlation between any of the 
platelet parameters and platelet All binding was found 
in any of the groups of hypertensive patients, when 
assessed using Spearman correlation coefficients. 
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Table 5.6. 
Platelet data from the normotensive and hypertensive 
third trimester patients. 
Median values are shown, with the interquartile range 
in brackets. 
The PIH patients have been subdivided on the basis of 
significant proteinuria. The overall data from the 
PIH group and the subdivided data are shown, with the 
normotensive subjects included for comparison. 
Table 5.6 
3rd trimester PIH Non-proteinuric PIH P r e ~ e c l a m p s i a a
n=25 n=25 n=11 n=14 
Platelet count 170 188 219 146 
(x 109 /L) ( 1 5 0 ~ 1 9 4 ) ) (130-226) (145-283) (123-247) 
Mean platelet 8.7 10.1 10.0 10.8 
volume' (fI) (7.9-9.1) (9.4-11.3) (9.2-11.1) ( 9 . 4 ~ 1 2 . 6 ) )
Platelet distribution 17.1 17.3 17.1 17.6 
width (16.4-18.5) (16.9-18.1) (16.8-17.5) (17.0-18.3) 
Yield 52 47 49 47 
(%) (49-58) (37·52) (45-5'5 ) (36-52) 
~ ~
Table. 5.7. 
Biochemical data from the normotensive pregnant ~ n d d
non-pregnant patients. 
Median values are shown, with the interquartile range 
in brackets. 
Table 5.7 
Non- 1 st trimester 2nd trimester 3rd trimester I 24hrs PN 6/52 PN 
Sodium 140 137 137 137 138 140 
(mmol/L) (138-141) (136-138) (136-138) (136-139) (138-139) (139-142) 
Potassium 4.2 4.2 4.0 4.1 4.2 4.3 
(mmollL) (4.0-4.5) (4.0-4.2) (3.7-4.2) (3.9-4.3) (4.0-4.4) (4.1-4.5) 
Urea 4.f 3.0 3.0 3.0 3.4 5.4 
(mmo/L) (3.6-4.8) (2.3-3.7) (2.5-3.4) (2.2-3.7) (3.0-4.0) (4.1-5.9) 
Creatinine 87 66 71 71 72 86 
(umoI/L) (83-92) (63-72) (63-83) (68-77) (65-84) (79-93) 
Urate 202 159 193 212 244 280 
(umoIlL) (180-229) (140-178) (149-204 ) (171-245) (230-315) (249-321 ) 
Osmolality 282 273 273 275 280 285 
(Os mIL) (277-285) (270-275) (270-276) (274-279) (276-282) (283-287) 
; 
Biochemical data. 
a) Normotensive patients. 
The median values of serum sodium, potassium, urea, 
creatinine, urate and osmolality are summarised in 
Table 5.7. 
Kruskal-Wallis analysis of variance demonstrated a 
significant effect of pregnancy on the values of serum 
sodium, urea, creatinine, urate and osmolality 
(P<O.OOl in each case). 
When the first trimester group were compared with 
the n o n . ~ p r e g n a n t t control group, significantly lower 
levels of serum sodium, u r e a ~ ~ c ~ e a t i n i n e , , urate and 
osmolality were found (P<O.OOl in each case, Mann-
Whitney u test). No further significant changes in 
any of these' parameters occurred during pregnancy. 
Values of serum sodium, urate and osmolality at 24 
hours after delivery were significantly higher than 
those of the third trimester group (P<O.Ol in each 
case). Significant i ~ c r e a s e s s in serum concentrations 
of sodium (P<O.Ol), urea (P<O.OOl), creatinine 
(P<O.OOl) and osmolality (P<O.OOl) were found when 
the samples obtained six weeks after delivery were 
compared with the 24 hours after delivery group. 
There were significant differences between the non-
pregnant control group and the women studied six weeks 
after delivery when the values of serum urea (P(O.Ol) 
and urate . (P<O.OOl) were compared. Potassium 
concentrations were not significantly different across 
the sample groups studied. 
There was no correlation in any group between any 
of these biochemical .parameters and platelet All 
-159-
binding when assessed using Spearman correlation 
coefficients. 
b) Hypertensive patients. 
The median values of serum sodium, potassium, urea, 
creatinine, urate and osmolality are summarised in 
Table 5.8. 
There were no significant differences in the 
concentrations of serum sodium, potassium, urea and 
osmolality between any of the groups, although in 
comparisons of concentrations of urea, the difference 
between the non-proteinuric PIH patients and those 
with pre-eclampsia approached significance (P-O.02, 
Mann-Whitney U test). Significantly higher values of 
serum creatinine were found in the pre-eclampsia 
subgroup as c O n : t p a ~ e d d t.O those patients wfth non-
proteinuric PIR (P<O.Ol). The values of serum urate 
were significantly higher in the patients with PIH a ~ ~
compared to the. normotensive 
( P < O . O O O l ) ~ ~ there being no 
between the non-proteinuric 
subgroups (Figure 5.10). 
third trimester· group 
significant difference 
and the pre-eclamptic 
Again, no correlation was found between any of the 
biochemical p a ~ a m e t e r s s and platelet All binding 
(Spearman correlation coefficients). 
Discriminant analysis. 
. Discriminant analysis is a statistical test in 
which linear combinations of variables are used to 
distinguish between two or more categories of cases. 
The variables 'discriminate' between groups of cases 
and predict into which category or group a case falls, 
based on the values of the variables [SPSS-X, 1988]. 
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Table 5.8. 
Biochemical data from the normotensive and 
hypertensive third trimester patients. 
Median values are shown, with the interquartile range 
in brackets. 
The PIH patients have been subdivided on the basis of 
significant proteinuria. The overall data from the 
PIH group and the subdivided data are shown, with the 
normotensive subjects included for comparison. 
Table 5.8 
3rd trimester PIH Non-protelnuric PIH Pre-eclampsia . 
n=25 n=25 n=ll n=14 
Sodium 137 137 137 138 
(mmoIlL) (136-139) (135-138) (135-138) . (134-138) 
Potassium 4.1 : 4.1 4.0 4.1 
(mmoIlL) (3.9-4.3) (3.9-4.3) (3.9-4.3) (4.0-4.4) 
Urea, 3.0 3.7 2.8 3.9 
(mmo/L) (2.2-3.7) (2.8-4.3) (2.4-4.1) (3.5-4.6) 
Creatinine 71 79 75 85 
(umoIlL) (68-77) (73-89) (61-80) (76-104) 
Urate 212 318 317 339 
(umoIlL) (171-245) (260-412) (239-408) (277-422) 
Osmolality 275 278 ~ ~ 276 278 
(Osm/L) (274-279) (274-280) (274-280) (274-280) 
Urinary protein * * . 0.55 . 0.10 1.90 
(g/24hrs) (0.1.0-2.20) (0.10-0.20) (1.05-3.20) 
Figure 5.10. 
Serum urate concentrations in the normotensive and 
hypertensive third trimester pregnant patients. 
Median values are shown, with the interquartile range 
marked. 
Serum urate concentrations were significantly higher 
in the PIH patients as compared to the normotensive 
women (P<O.OOl). 
The PIH patients have been subdivided on the basis of 
significant proteinuria. The overall data from the 
PIH group and the subdivided data are shown, with the 
normotensive subjects included for comparison. 
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The use of platelet All binding to discriminate 
between normotensive and hypertensive third trimester 
patients was thus assessed using canonical 
discriminant analysis. There was a false positive 
rate of 42% and a false negative rate of 18%, 70% of 
patients being correctly classified. When the 
hormonal, platelet, and biochemical parameters 
measured in this study were used to discriminate 
between the two groups of third trimester patients, 
the only parameters which correctly classified more 
patients were serum urate and MPV (correct 
classification in 80% of patients in both cases). The 
results of such discriminant analysis were not 
improved when MPV and platelet All binding were 
combined (74% of patients correctly "classified)" but 
when platelet All binding and se,rum urate were 
combined there ~ a s s a false positive rate of 24% and a 
false negative"' rate of 10%, 83% of patients being 
correctly classified. 
Discussion. 
The cross-sectional study thus provided evidence of 
a reduction in platelet All binding in normotensive 
pregnancy, the change being apparent by the first' 
trimester. It was therefore decided to pertorm a 
prospective longitudinal study (discussed in the next 
chapter) in order to determine whether these findings 
would be confirmed when a cohort of women were 
followed through pregnancy. Pregnancy-induced changes 
in platelet All binding, and in the hormonal, platelet 
and biochemical parameters will also be studied in the 
longitudinal study. To avoid unnecessary repetition, 
a discussion of these changes, found in the cross-
sec tiona1 study and in the 10ngi tudina1 study, is 
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included at the end of the next chapter. This 
discussion will only address the problems specific to 
the cross-sectional study. 
On analysing the data from the cross-sectional 
study, certain deficiencies were evident. One of 
these was the inclusion in the first trimester group, 
of women attending for termination of pregnancy. At 
the hospital in which the women· were studied, 
(University Hospital, Nottingham), the first antenatal 
clinic visit for the majority of women is at eighteen 
weeks gestation. It was thus logistically easier ,. to 
recruit women attending for termination of pregnancy. 
However, the demographic differences between the first 
trimester patients and b o t ~ ~ the non-pregnant control 
group and the other pregnant/postnatal groups, which 
resulted from their inclusion, provide an important 
caveat in making other comparisons between the groups •. 
This problem will be resolved by the longitudinal 
study. 
The patients in the six weeks postnatal group were 
recruited randomly from the hospital postnatal'clinic. 
However, the majority of six week postnatal 
attendances are at the General Practitioner's surgery, 
hospital postnatal attendances being restricted to 
pregnancies cClmplicated antenatally or at delivery. 
This accounted for the high incidence of delivery by 
caesarean section in the six weeks postnatal group. 
It mus t be rei tera ted tha t none of the pregnancies 
were complicated by either PIH or intrauterine growth 
retardation, the majority of the caesarean sections 
being for failure to progress in the first stage of 
labour or for fetal distress. However, because of the 
large proportion of operative deliveries in the 
sample, these individuals may not be representative of 
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the puerperal population as a whole. Again, the 
longitudinal study will address this problem. 
It may be three months post partum before the 
changes consequent upon the renal alterations of 
normal pregnancy resolve [Davison and Lindheimer, 
1984]. This was reflected in the significant 
differences in serum urea and serum urate found 
between the non-pregnant control group and the 
subjects studied six weeks after delivery. The time 
period of six weeks after delivery may not have been 
long enough to re-es tablish the inverse correlation 
between plasma All. concentration' and platelet All 
binding. In the longitudinal study 'patients will thus 
be followed until three months after delivery. 
In the cross-sectional study. the absence of 
proteinuria in the non-pregnant and the normotensive 
pregnant groups was assessed using urinary dipsticks, 
a method deemed by some [e.g. Davey, 1986] to be 
inaccurate. In order to obtain a quantitative 
measurement of urinary protein, and also' to further 
investigate the relationship between platelet All· 
binding and both electrolyte balance and renal 
function (no correlation having been found between 
platelet All binding and any of the serum biochemical 
parameters measured), the longitudinal study will 
incorporate 24 hour urine collections from every 
subject on each occasion platelet All binding is 
measured. 
In addition to a longitudinal study, with the 
diminution in platelet All binding in the first 
trime"ster indicating that a study of early pregnancy 
would be particularly relevant, the results of the 
cross-sectional study suggest other lines of 
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investigation. One of these is a larger comparison of 
normotensive and hypertensive third trimester 
patients, there being a significant difference in 
platelet All binding between the two groups in the 
cross-sectional study, despite the small sample size. 
Moreover, if such a study included follow up of both 
groups in the puerperium it would determine whether 
any such differences resolve after delivery. Further 
study of platelet All binding in women with 
hypertensive diseases of pregnancy is included in 
Chapter 7. 
The use of -canonical discriminant analysis to 
discriminate between normotensive primigravidae and 
patients with established PIH indicates that the 
potential use of platelet All binding as a marker for 
PIH is limited, with b o t ~ ~ both MPV and serum urate 
estimations pr"oving better at discriminating between 
the two groups of third trimester women. The 
potential use of the technique as a screening test for 
PIH may however be greater, and this possibility is 
discussed further in Chapters 7 and 8. 
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Chapter 6. 
LONGITUDINAL STUDY. 
Platelet All binding in normotensive pregnancy. 
Chapter 5 describes a preliminary study 
investigating the changes in platelet angiotensin II 
(All) binding in normotensive pregnancy. Although 
useful information was obtained, cross-sectional 
studies such as this are inherently weak, as they 
investigate different individuals at differing time 
points. A formal prospective study investigating the 
changes in platelet All binding in normotensive 
pregnancy was therefore performed. 
Statis·tical analysis. 
The statis.tical analysis used in this s t ~ d y y differs 
from that used in the other studies included in the 
thesis, .In that the nature of, a longitudinal study 
enables more powerful statistical tests to be used •. 
In assessing the ·overall effect of pregnancy on any 
given parameter, the Friedman non-parametric analysis 
of v a ~ i a n c e e has been used. This technique calculates 
the mean rank for each parameter over all the time 
points, (in this study: gestational ages), for each 
case [SPSS-X, 1988], instead of assessing the data as 
being from different individuals at different time 
points (as in the Kruskal-Wallis analysis of 
variance). When values of any parameter at any two 
gestations are compared, the data can be regarded as 
paired, thus the Wilcoxon matched-pairs signed-ranks 
test has been used. With the exception of the early 
.. 
pregnancy subgroup, the subjects in the non-pregnant 
control group differ from those in the other groups, 
thus 'in comparisons . including this group, the Mann-
Whitney U test has been used. 
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In determining whether there was a significant 
correlation between platelet All binding and any of 
the parameters measured in pregnancy (for example the 
serum All concentration), stepwise regression analysis 
has been used. This necessitated the use of 
parametric statistics, in a c c ~ r d d with statistical 
advice received, there being no non-parametric 
equivalent technique. Using this method, the effect 
of gestation, which may exert an effect on both 
parameters and thus produce a falsely positive 
correlation between them (the Durbin-Watson effect), 
can be excluded [SPSS-X, 1988]. 
,Regression analysis is a highly." sophisticated 
technique. In an effort· to ensure that no trends 
between platelet All binding and any of the measured 
parameters were missed, preliminary analysis of the 
data was performed as follows. The subjects were 
divided into two groups on the basis of levels of 
platelet All binding above or below the median for 
each gestation. At each gestation, the two groups 
were compared using the Mann-Whitney U test, in order. 
to determine whether significant differences in any of 
th,e parameters measured existed between subjects with 
'low binding' and those with 'high binding'. However, 
no trends were suggested that were not confirmed using 
regression analysis, and the results of the 
preliminary analysis above, will not be referred to in 
the text. 
Study sample. 
The cross-sectional study described in the previous 
chapter highlighted the need to study the changes in 
platelet All binding in early pregnancy. At the onset 
of the study, thirty pre-conceptual, nulliparous, 
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normotensive women were recruited to the study. These 
subjects were referred by local general practitioners 
and practice nurses and included women attending for 
advice regarding pre-conceptual health care, such as 
checking of rubella immune status. No subject had 
been taking hormonal contraception for at least six 
months, or had any recent history of menstrual 
disorder. All subjects were investigated between days 
5-9 of the menstrual cycle, and were advised that 
after they conceived they would be studied both 
throughout their pregnancy and in the puerperium. 
This group thus formed the non-pregnant control g r o ~ p . .
Out of the thirty patients recruited, only seven 
were pregnant one year into my allotted research time; 
It was thus decided to recruit a further 25 
primiparous women, who were investigated from eleven 
weeks gestation and throughout their pregnancies. The 
first antenatal clinic visit of patients referred to 
the hospital used in the study (University Hospital, 
Nottingham) is usually at eighteen weeks gestation. A 
random selection was made from patients who were 
referred by their general practitioners at an early 
gestation (less than nine weeks). These patients were 
asked to participate in the study, and to attend for 
an additional antenatal clinic visit at eleven weeks 
gestation. Two of these subjects . developed 
hypertension during their pregnancy (one of whom had 
been studied preconceptually), and were thus excluded 
from this l?ngitudinal study of normotensive pregnancy 
(they are discussed in the next chapter). The 
pregnancy cohort group therefore consisted of thirty 
patients studied from eleven weeks gestation until 
twelve weeks post delivery. 
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None of the women included in this study were known 
to be suffering from renal, metabolic or 
cardiovascular disease. No subject was taking any 
medication except iron supplementation. All the 
pregnancies remained normotensive throughout, with no 
patient having significant prot.einuria (>0.3g / 24 
hour urine collection) at any time. All subjects were 
receiving sodium intake ad libitum and had normal 
serum urea, creatinine and electrolyte estimations. 
The gestational age of each subject was confirmed by 
an ultrasound scan at eighteen weeks gestation. 
The median age of the non:-pregnant control group 
was 27 years (interquartile range 25-28) and of the 
pregnant cohort group was 25 years (22-27). The 
difference in age between the two groups approached 
statistical significance (p - 0.03, Mann-Whitney U 
-test). By chance all subjects were C a u c ~ s i a n , ,
although no positive discrimination was practised. 
One of the thirty patients (3%) in each group was a 
smoker. 
The median maternal weight"s and systemic arterial 
blood pressures of the two groups are shown in Table 
6.1. There was no significant difference in'maternal 
weight when the non-pregnant control group was 
compared with Ehe pregnant. cohort group at 11 weeks 
gestation (P>0.5, Mann-Whitney U test). Friedman 
analysis of variance indicated a significant effect of 
pregnancy (P<O.OOl), with significant increases 
between 18 and 28 weeks gestation (P<O.OOl) and 
between 28 and 36 weeks gestation (P<O.Ol) being found 
(Wilcoxon·· matched-pairs signed-ranks test). There 
were significant decreases in maternal weight from 36 
weeks gestation to 6 weeks post delivery (P<O.OOl, 
Wilcoxon matched-pairs signed-ranks test) and from 6 
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Table 6.1. 
Maternal weights' and systemic blood pressures of the 
non-pregnant control group and the pregnant cohort 
group. 
Median values are shown, with the interquartile range 
in brackets. 
. Table 6.1 
Non-pregnant GESTATION (weeks) 
control group 11 18 28 36 . I 6 weeks PN 12 weeks PN 
Weight 53.9 60.8 62.8 68.8 71.5 62.3 58.5 
, . 
(Kg) (56.8-65.4) (55.3-67.7) (56.3-69.6 (61.0-74.3) (64.5-78.6) (60.0-69.5) (55.3-68.3) 
Systolic blood 115 110 110 110 110 120 115 
pressure (mmHg.) (110-120) (100-110) (100-120) (100-120) (110-120) (110-120) (110-120) 
Diastolic blood 70 70 60 70 70 70 70 
pressure (mmHg.) (70-75) (60-70) (60-70) (60-70) (61-70) (60-70) (60-70) 
-
to 12 weeks post delivery (P<O.Ol). When the pregnant 
cohort group were weighed at either 6 or 12 weeks 
following delivery there were no significant 
differences as compared to the non-pregnant control 
group (P>0.5, Mann-Whitney U test). 
There were no significant differences in systolic 
blood pressure between either group or between any 
gestation (P>0.05). There was a significantly lower 
diastolic blood pressure in the pregnant cohort group 
at 11 weeks gestation as compared to the non-pregnant 
control· group (P<O.Ol). There was no significant 
effect of pregnancy on diastolic blood pressure 
(P>O.l) and no significant changes in diastolic blood 
pressure following delivery. However, the diastolic 
blood pressure of the pregnant cohort group at 12 
weeks post partum was significantly lower than' that of 
the non-pregnarit control group (P<O.Ol). 
No significant correlations were found between 
platelet All binding and any of the above parameters 
in either the non-pregnant control group (P>O.l, 
Spearman correlation coefficient) or the pregnant 
cohort group (P>O.l, stepwise regressional analysis 
when pregnant, Spearman correlation coefficient 
following delivery) • 
.-
The median birthweight in the pregnant cohort group 
was 3.44 Kg (interquartile range 3.04-3.75) and the 
median gestational age at delivery was 40 weeks (39-
41). None of the birthweights were below the 3rd 
centile for gestational age. 20 (66%) had a 
spontaneous vaginal delivery, 5 (17%) were delivered 
using forceps, and 5 (17%) by caesarean section. Two 
caesarean sections were for delay in the first stage 
of labour, one was for a breech presentation with poor 
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pelvimetry, and two were for fetal distress (although 
in each case the subsequent cord pH was normal). 16 
(53%) infants were male, 14 (47%) were female, and 
none were admitted to the neonatal unit for any 
reason. 18 (60%) of the infants were breast-fed and 
12 (40%) bottle fed. At six weeks following delivery 
only two (7%) of the women had menstruated, and at 
twelve weeks only 8 (27%) had menstruated. 
Early pregnancy. 
In addition to the seven preconceptual patients who 
conceived in the first year of the study, a further 
seven preconceptual women subsequently conceived. 
These women were asked to contact the hospital at as 
early a gestation as possible. Two of the women 
suffered a spontaneous abortion. Analysis of the 
changes in early pregnancy in the, remaining twelve 
women is included in this chapter. One of the twelve 
patients developed pregnancy induced hypertension 
(discussed further in the next ~ h a p t e r , , p. 198). In 
view of the small sample size, the ranges of values 
will be quoted rather than the 25th and 75th centiles. 
Despite the small sample size, some limited 
statistical analysis has been performed using the data 
obtained from this subgroup. 
The median age of the g ~ o u p p was 27 years (24-33). 
Median maternai weight increased from 58.9 Kg' (47.2-
75.8) when non-pregnant to 60.0 Kg (47.0-77.5) at 5-8 
weeks gestation, 62.1 Kg (50.1-79.0) at 11 weeks 
gestation and 65.9 Kg (52.8-84.0) at 18 weeks 
gestation. Friedman analysis of v a r ~ a n c e e indicated a 
significant effect of early pregnancy on maternal 
w e i g ~ t t in this subgroup (P<O.Ol), the difference 
between 11 and 18 weeks gestation being significant 
(P<O.Ol, Wilcoxon matched-pairs s i g n e d ~ r a n k s s test). 
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Median systemic blood pressure was 110/70 mmHg 
(110/60-125/75) when non-pregnant, 110/70 mmHg 
(110/60-120/70) at 5-8 weeks gestation, 110/70 mmHg 
(100/60-120/75) at 11 weeks gestation and 105/65 mmHg 
(95/60-120/70) at 18 weeks gestation. There was no 
significant effect of early pregnancy of either 
systolic or diastolic blood pressure on this subgroup 
(P>0.05). 
Platelet Angiotensin II (All) binding data. 
" 
The median value of platelet All binding in the 
non-pregnant .control group was 5.1 fmol/l09 cells 
(interquartile range 2.5-12.8), with marked individual 
variability being found (Figure 6.1). There w a ~ ~
significantly lower bi:nding it} the pregnant cohort 
group at 11 weeks gestation (2.1 fmol/l09 cells, 0.3-
4.1, P<O.Ol, Mann-Whitney U test), with an apparent 
reduction in variability. The effect of pregnancy on 
platelet All binding approached significance (P=0.02, 
Friedman analysis of' variance) with significantly 
lower bindin'g at 18 weeks gestation (0.3 fmol/l09 
cells, 0-1.6) than at 11 weeks gestation (P<O.Ol, 
Wilcoxon matched-pairs signed-ranks test). There were 
no subsequent significant changes in pregnancy 
(P>0.05), w i ~ h h the median value of platelet All 
binding remaining low (0.8 fmol/l09 cells, 0 . 3 ~ 3 . 5 , , at 
28 weeks gestation and 0.7 fmol/l09 cells, 0-2.8, at 
36 weeks gestation). There was significantly higher 
binding at 6 weeks following delivery (3.9' fmol/l09 
cells, 1.6-6.9, P<O. 01) as compared to the samples 
taken at 36 weeks gestation, but there was no further 
significant change at 12 weeks after delivery (3.9 
fmol/l09 cells, 0-6.5, P>O.l). There were no 
significant differences between the values of platelet 
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Figure 6.1. 
Platelet All binding in the non-pregnant control 
group and the pregnant cohort group. 
The median values of platelet All binding are 
indicated by horizontal bars. 
Figure 6.2. 
Platelet All binding in the early pregnancy subgroup. 
The median values of platelet All binding are 
indicated by h o r i z o n t a ~ ~ bars. 
Platelet All binding fell in all the patients except 
one, (who subsequently developed pregnancy-induced 
hypertension. 
Figure 6.1. 
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All binding in the non-pregnant control group and 
those of the pregnant cohort group at either 6 or 12 
weeks after delivery (P>0.05, Mann-Whitney U test). 
Early pregnancy group. 
Friedman analysis of variance indicated a 
significant effect of early pregnancy on platelet All 
binding in this subgroup (P<O. 01). The difference 
between platelet All binding before conception (median 
value 3.4 fmol/109 cells) to that at 5-8 weeks 
gestation (1.2 fmol/109 cells) approached significance 
(P-0.02, Wilcoxon matched-pairs signed-ranks test),as 
did the difference between platelet All binding at 11 
weeks gestation (1.5 fmol/10 9 cells) and that,:, at 18 
weeks gestation (0.0 fmol/109 cells, P-0.02)., These 
changes are illustrated in Figure 6 ~ 2 . .
Hormonal' da ta. 
The m e d ~ a n n values of plasma angiotensin II (All), 
,plasma renin concentration (PRe) and plasma renin 
substrate (PRS) are summarised in Table 6.'2. 
Higher All levels were found in the pregnant 'cohort 
group at 11 weeks gestation as compared to the non-
pregnant control group (P<O.OOl, Mann-Whitney U test) 
(Figure 6.3). "Within the pregnant cohort group there 
was no effect of pregnancy on plasma All concentration 
(P>O.l, Friedman analysis of variance), but there was 
a significant fall in the levels of the peptide at 6 
weeks following delivery as compared to those at 36 
weeks gestation (P<O.OOl, Wilcoxon matched-pairs 
signed-ranks test). There was no significant 
difference between the values of plasma All at 12 
weeks following delivery as compared to 6 weeks 
following delivery (P>0.5), and no significant 
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Table 6.2. 
Hormonal data from the non-pregnant control group and 
the pregnant cohort group. 
Median values are shown, with the interquartile range 
in brackets. 
The concentrations of all three hormones were 
significantly elevated in pregnancy. 
Table 6.2 
Non-pregnant GESTATION (weeks) 
control group 1 1 18 28 36 . I 6 weeks PN 12 weeks PN 
Angiotensin II 10.7 29.4 27.8 33.3 30.9 12.5 11.7 
(pg/ml) (5.2-25.8) (22.0-38.6) (20.6-35.2) (23.6-42.8) (20.6-44.4) (8.8-16.1) (9.0-15.5) 
P.R.C. . 1.3 5.7 6.0 6.6 6.5 2.0 2.9 
(ng Allhr/ml) (0.9-1.9) (4.5-7.5) (4.5-8.4) (4.8-8.7) (4.3-9.6) (1.1-2.8) (1.0-3.8) 
P.R.S. 1.2 2.3 3.0 3.3 3.5 1.3 1.2 
(ug Allml) (0.9-1.6) (1.9-2.9) (2.6-3.4) (2.8-4.0) (3.2-4.0) (0.9-1.7) (1.0-1.9) 
differences between the values of plasma All in the 
non-pregnant control group and those of the pregnant 
cohort group at either 6 or 12 weeks post partum 
(P>0.5, Mann-Whitney U test). 
Increased values of PRe and PRS were also found in 
pregnancy (Figure 6.3). Values of both PRe and PRS 
were significantly higher in the pregnant cohort group 
at 11 weeks gestation as compared to the non-pregnant 
control group (P<O.OOl in each case). There was no 
subsequent effect of pregnancy on PRe within the 
pregnant cohort group (P>0.5), but there was a 
significant effect on PRS (P<O.OOOl), with significant 
increases between 11 and 18 weeks g e s t a t ~ o n n (P<O.OOOl) 
and between 18 and 28 weeks gestation (P<O.Ol). The 
values of both PRe and PRS Were significantly lower at 
6 weeks following delivery' as compared to 36 weeks 
gestation (P<O.OOl in each case). There were no 
significant differences between the values of either 
PRe. or PRS at 12 weeks·following delivery as compared 
to those at 6 weeks following delivery (P>O.l), and no 
significant differences between the values of either 
PRe or PRS in the non-pregnant control group as 
compared to the pregnant cohort group ~ t t either 6 or 
12 weeks post partum. (The difference in PRe between 
the non-pregnant control 
group at 1 ~ ~ weeks 
significance, P-O.Oll). 
group and the pregnant cohort 
after delivery approached 
In twenty pregnant women, plasma oestradiol 
concentration was measured at 36 weeks gestation. The 
median concentration was 66,000 ··,.pmol/L (34,000-
85,000). 
In the non-pregnant control group the inverse 
correlation between platelet All binding and plasma 
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Figure 6.3. 
Plasma angiotensin II (All), plasma renin substrate 
(PRS) , . and plasma renin concentration (PRe) .i!! the 
non-pregnant control group and the pregnant cohort' 
group. 
Median values are shown, with the interquartile range 
marked. 
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All approached statistical significance (P= 0.03, 
Spearman correlation coefficient rs= 0.40). There was 
no correlation between platelet All binding and either 
PRe or PRS (P)O.l). 
When women from between 11 to·36 weeks gestation in 
the pregnant cohort group were considered, there were 
significant inverse correlations found between 
platelet All binding and all of the .. above hormonal 
parameters; plasma All (stepwise regression analysis, 
T= -2.61, P<O.Ol), PRe (T= -3.40, P<O.OOl), PRS (T= -
2.95, P<O.Ol). Moreover, the correlations b e t w ~ e n n
both PRe and PRS w i t ~ ~ platelet All binding were 
independent of any cor.relation between platelet All 
binding and All; PRe (T- -3.10, P(O.Ol), P ~ S S .(T- -
2.84, P<O.()1). At both 6 and 12 weeks following 
delivery, no correlation between platelet All binding 
and plasma All, PRC or PRS was found (P>O.l). In the 
subgroup of twenty pregnant women at 36 weeks 
gestation, there was no correlation between platelet 
All binding and plasma oestradiol concentration 
(P)0.5, Spearman correlation coeff;cient) (Figure 
6.4). 
Early pregnancy group. 
The median values of plasma All, PRC and PRS in 
this subgroup ,are summarised in Table 6.3. 
Friedman analysis of variance indicated that the 
effect of early pregnancy on plasma All was not 
significant (P)O.05), although the difference between 
the values of the subgroup when non-pregnant and at 5-
8 weeks" gestation approached significance (P=0.014, 
Wilcoxon matched-pairs signed ranks test). The effect 
of early pregnancy on. PRS was significant (P(O.Ol), 
with significant increases in the levels of PRS 
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Figure 6.4. 
The absence £! any correlation between platelet All 
binding and the serum oestradiol concentration. 
(p>o.s, rs= -0.18) 
Figure 6.5. 
Plasma angiotensin II (All), plasma renin substrate 
(PRS), and plasma' renin concentration (PRe) in the 
early pregnancy subgroup. 
Median values are shown, with the range marked. 
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between 5-8 weeks gestation and 11 weeks gestation and 
between 11 weeks gestation and 18 weeks gestation 
(P<O.Ol in each case) (Figure 6.5). A significant 
effect of early pregnancy on PRC was also found 
(P<O.Ol), with the increase in levels measured when 
the subgroup were non-pregnant" to those at 5-8 weeks 
being significant (P<O.Ol). 
Haematological data. 
Contamination of the prepared platelet suspension 
by leucocytes was <1% (1-5 x .103Ipl) and. no 
erythrocytes were detected. 
The m e ~ i a n n values of platelet count,. mean platelet 
volume (MPV) , platelet distribution width (POW), 
recovery of platelets from whole blood (yield), 
haemoglobin concentration and white cell count (WCC) 
are summarised in Table 6.4. 
There were no significant differences in the values 
of platelet count, MPV and POW between the non-
pregnant control group and the pregnant cohort group 
at 11 weeks gestation (P>O.l, Mann-Whitney U test). 
Although there was no significant effect of pregnancy 
on platelet count (P>0.05, Friedman analysis of 
variance), there was a significant increase. in MPV 
(P<O.OOOl) and the increase in PDW approached 
significance (p .... 0.015). The largest increases were 
between 28 weeks gestation and 36 weeks gestation, 
when both MPV (P<O.OOl, Wilcoxon matched-pairs signed-
ranks test) and POW (p.... 0.02) .'. were considered. 
Following delivery there was a significant diminution 
in MPV between 36 weeks gestation and 6 weeks post 
partum (P<O.Ol, Wilcoxon matched-pairs signed-ranks 
test), but no other significant changes in platelet 
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Table 6.3. 
Hormonal data from the early pregnancy subgroup. 
Median values are shown, with the range in brackets. 
Table 6.5. 
Platelet data from the early pregnancy subgroup. 
Median values are shown, with the range in brackets. 
Table 6.3 
GESTATION (weeks) 
o 5-8 11 18 
Angiotensin II 12.1 40.3 30.2 25.0 
(pg/ml) (2.8-26.3) (14.8-59.2) (24.7-71.7) (15.8-87.8) 
P.R.C. 1.9 6.0 7.4 6.7 
eng Al/hr/ml) (0.7-7.2) (3.3-12.9), (4_4-11.1) (4.0-12.9) 
P.R.S. 1.5 1.5 2.4 3.1 
(ug AI/ml) (0.9-3.7) (0.9-3.3) (1.7-3.5) (2.6-4.2) 
Table 6.5, 
Platelet count 207 218 216 199 
(x 109 /L) (137-337) (183-326) (168-281 ) (173-275) 
Mean platelet 7.5 8.0 7.8 8.2 
volume (tl) (7.2-8.9) (7.2-9.8) (6.0-8.6) (6.8-9.0) 
Platelet distrib- 14.6 15.2 15.3 15.8 
ution width (13.8-16.8) (13.8-16.9) (14.2-17.4) (13.8-18.0) 
Table 6.4. 
Haematological data. from the non-pregnant control 
group and the pregnant cohort group. 
Median values are shown, with the interquartile range 
in brackets. 
Table 6.4 
I 
Non-pregnant I' GESTATION (weeks) 
11 18 28 36 6 weeks PN 12 weeks PN 
Platelet count 209 . 227 207 212 208 226 235 
( x l09/L) (182-270) (198-265) (191-239) (195-250) (174-244 ) (187-259) (211-278) 
Mean platelet 8.1 7.9 8.0 8.0 8.5 " 8.1 8.0 
volume (n) (7.5-8.4) (7.5-8.3) (7.7-8.3) (7.7-8.4) (8.2-8.9) . (7.7-8.6) (7.8-8.4) 
Platelet distribution I 15.8 15.4 15.4 15.7 16.1 15.6 15.3 
width (14.7-16.7) (14.6-16.4) (14.7-16.0) (14.6-16.2) 05.4-16.9) (14.8-16.1) (14.9-16.4 ) 
Yield 54 58 59 51 43 57 53 
(%) (47-64) (50-68) (46-78) (37-71 ) (35-58) (36-75) . (35-79) 
Haemoglobin 13.3 13.1 12.1 11.8 11.8 12.6 12.8 
, 
(g/dl) (12.8-14.0) (12.4-14.1) (11.8-12.7) (10.7-12.6) (1=0.0-12.5 ) (12.1-13.3) (12.3-13.3) 
White cell count 6.3 8.3 8.9 8.6 8.3 5.5 5.8 
: 
(x 10 IL) (5.4-7.3) (7.1-9.0) . (7.1-9.9) (7.8-10.4) (7.4-10.2) (4.8-6.9) (4.6-6.7) 
count, MPV or PDW (P>O.OS). There were no significant 
differences between the values of platelet count, MPV 
and PDW in the non-pregnant control group and those of 
the pregnant cohort group at either 6 or 12 weeks 
after delivery (P>O.l, Mann-Whitney U test). 
Platelet yield in the pregnant cohort group at 11 
weeks gestation did not differ significantly from that 
of the non-pregnant control group (P>O.l). However, a 
significant effect of pregnancy was found (P<O.Ol), 
with significant diminutions in yield between 18 and 
28 weeks gestation (P<O.Ol) and between 28 and 36 
weeks gestation (P<O.Ol). The platelet yield at 6 
weeks post partum was significantly g r e ~ t e r r than at 36 
weeks gestation (P<q.01). There were no significant 
differences between the yield at 6 weeks after 
delivery and at 12 weeks after delivery (P>O.l)., or 
between the yield in the non-pregnant control group 
and at either 6 weeks or 12 weeks after delivery 
(P>O.S). 
At 11 weeks gestation, a s i g n i f i c a n ~ ~ change iri wee 
(P<O.OOl) but not in haemoglobin concentration (P>O.S) 
was found, as compared to the non-pregnant control 
group. Although there was no significant effect of 
pregnancy on wee (P>O.l), there was a significant 
diminution i'n haemoglobin concentration (P<O.OOl), 
with the decreases between 11 and 18 weeks gestation 
(P<O.OOl) and between 18 and 28 weeks gestation being 
significant (P<O.OOl). Following delivery, the values 
of both wee and haemoglobin concentration at 6 weeks 
post partum were significantly altered as compared to 
those at 36 weeks gestation (P<O.OOl in each case). 
There were no significant differences between either 
wee or haemoglobin concentration at 6 weeks after 
delivery and at 12 weeks after delivery (P>O.l in each 
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case), or between wee in the non-pregnant control 
group and at either 6 weeks or 12 weeks ges ta tion 
(P>0.1). However, the haemoglobin concentration was 
significantly higher in the non-pregnant control group 
in comparison with the pregnant cohort group at 6 
weeks after delivery (P<0.01). ,This difference ceased 
to be significant when the comparison was with the 
pregnant cohort group at 12 weeks gestation. 
There was no correlation between ,platelet All 
binding and any of the haematological parameters at 
any gestation, in any group (P>0.1, s t e p ~ i s e e
r e g r e s s i ~ n n analysis when pregnant, Spearman 
correlation coefficient in the non-pregnant control 
group and following delivery). 
Early pregnancy group.-
The 'median values of platelet count, MPV and PDW of 
this subgroup are summarised in Table 6.5. 
There was ,no significant effect of early pregnancy 
on either platelet count (P>0.1) or MPV (P>0.1), 
a l t h o u g h ~ t h e e increase in PDW approached significance 
(p- 0.04). 
Biochemical data. 
The median values of serum sodium, potassium, urea, 
creatinine, urate and osmolality are summarised in 
Table 6.6. 
There were significantly lower', levels of serum 
sodium (P<0.001, Mann-Whitney U test), urea 
(P<O.0001), urate (P<0.01), creatinine (P<0.0001) and 
osmolality (P<0.0001) in the pregnant cohort group at 
11 weeks gestation as compared to the non-pregnant 
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Table 6.6. 
Serum biochemical data from the non-pregnant control 
group and the pregnant cohort group. 
Median values are shown, with the interquartile range 
in brackets. 
Table 6.6 
Non-pregnant GESTATION (weeks) 
SERUM control group 11 18 28 36 6 weeks PN 12 weeks PN 
Sodium 139 137 137 135 136 139 140 
(mmoIlL) (138-141) (136-138) (134-138) (133-136) (133-137) (138-140) (139-141) 
Potassium 4.3 4.3 4.2 4.2 4.4 4.3 4.3 
(mmoIlL) (4.0-4.6) (4.1-4.4) (3.9-4.4) (4.1-4.4) (4.1-4.6) (4.1-4.6) (4.2-4.7) 
Urea 3.9 3.1 2.7 2.2 2.1 4.2 4.1 
(mmoIlL) (3.5-4.5) (2.7-3.4) (2.1-3.3) (2.0-2.9) "(1.9-2.6) (3.1-5.3) (3.2-4.6) 
Creatinine 87 61 53 52 57 75 70 
(umoIlL) (81-91) ( 5 5 ~ 6 9 ) ) ( 48-65) (46-56) (49-65) (67-81) (66-77) 
Urate 201 153 189 208 259 271 250 
(umoIlL) (173-222) (137-198) (171-212) (177-226) ~ ~(211-289) (244-312) (220-281) 
Osmolality 281 277 276 278 276 284 284 
(Osm/L) (279-284) (273-279) (274-279) (275-280) (275-279) (282-287) (281-288) 
, 
control group. Friedman analysis of variance 
demonstrated a significant effect of pregnancy on 
serum sodium (P<0.01) (with a significant decrease 
occurring between 18 and 28 weeks gestation, P<0.01, 
Wilcoxon matched-pairs signed-ranks test), serum urea 
(P<0.001) (a significant decrease occurring between 18 
and 28 weeks gestation, P<0.01), serum urate 
(P<0.0001) (significant increases occurring between 11 
and 18 weeks ges ta tion and between 28 and 36 weeks 
gestation, P<0.001) and serum creatinine (P<0.0001) 
(significant decreases occurring between 11 and 18 
weeks gestation, P<O.01, and between 28 and 36 ~ e e k s s
gestation, P<0.001). The changes in serum urate are 
illustrated in Figure 6.6. Following delivery, there 
were significant increases from 36 weeks gestation to' 
6 weeks post partum in levels of serum sodium, urea" 
osmolality and creatinine- (P<q.001 in each case, 
Wilcoxon matched-pairs signed-ranks test). There were 
no further significant changes in any of the 
biochemical parameters from 6,weeks post partum to 12 
weeks pos t partum,. although the diminution in serum 
creatinine approached significance (P= 0.03). There 
were significant differences between the values of 
serum urate (P<0.0001, Mann-Whitney U test), 
osmolality (P<0.01) and creatinine (P<O.001) in the 
non-pregnant control group and those of the pregnant 
cohort grouR at 6 weeks 'after delivery. S i ~ n i f i c a n t t
differences in serum urate (P<O.OOl) and in serum 
creatinine (P<0.001) remained when the non-pregnant 
control group were compared with the cohort group at 
12 weeks after delivery. There were no differences in 
serum potassium at any gestation (P>O.l). 
"The median values of urinary sodium, potassium, 
urea, creatinine, urate, osmolality, protein and 
volume are summarised in Table 6.7. 
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Figure 6.6. 
Serum urate concentrations in the non-pregnant 
control group and the pregnant cohort group. . 
Median values are shown, with the interquartile range 
marked. 
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Table 6.7. 
Urinary biochemical data from the non-pregnant 
control group and the pregnant cohort group. 
Median values are shown, with the interquartile range 
in brackets. 
Table 6.7 
Non-pregnant GESTATION (weeks) 
URINARY I control group 11 18 28 36 6 weeks PN 12 weeks PN 
Sodium 88 103 100 100 100 120 121 
(mmoIlL) (78-98) (73-130) (78-125) (82-132) . (76-118) (96-151) (110-149) 
Potassium 49 57 54 49 45 61 56 
(mmoIlL) (44-61) (44-66) (42-68) (40-72) (36-53) (4.4-78) (43-68) 
Urea 20 23 22 21 17 25 25 
(mmollL) (16-23) (19-29) . (16-29) (17-25) (14-21 ) (18-31) (19-27) 
Creatinine 8.2 7.9 8.7 8.0 7.6 9.5 0.0 
(umoI/L) (6.1-9.9) (6.7-9.3) (5.4-10.6) (5.3-10.5) (6.3-9.8) (7.8-11.0) (7.1-9.5) 
Urate 1.6 2.1 2.1 2.3 2.4 2.3 2.1 
(umoIlL) (1.2-2.3) (1.8-2.6) (1.6-2.7) (1.8-3.2) (1.8-3.1) (1.7-3.0) (1.6-2.8) 
Osmolality 496 583 543 547 506 686 617 
(mmol/kg) (396-530) (457-719) (448-684) ( 460-680) (459-628) (533-802) (452-696) 
~ ~
Protein 0.09 . 0.10 0.1Q. 0.09 0.07 0.05 0.03 
(gIL) (0.05-0.12) (0.04-0.17) (0.00-0.17) (0.05-0.16) (0.03-0.09) (0-0.10) (0-0.08) 
Volume 1.3 1.3 1.2 1.3 1.3 1.0 0.6 
(l) (1.1-1.0) (1.0-1.7) (1.0-1.7) (0.9-1.6) (1.0-1.5) (0.7-1.1) (0.4-0.8) 
There were no significant changes in any of the 
measured urinary biochemical parameters in the 
pregnant cohort group at 11 weeks gestation as 
compared to the non-pregnant group (P)0.05). There 
was no significant effect of pregnancy on any of the 
measured urinary parameters, although the changes in 
urinary urea es tima tions approached significance (P= 
0.04). Following delivery, there were significant 
increases in urinary sodium (P<O.Ol) and urinary urea 
(P<O.Ol) from 36 weeks gestation to 6 weeks post 
partum, with the changes in urinary creatinine (P= 
0.02) and urinary osmolality approaching significance 
(P= 0.03). The only significant change between 6 
weeks and 12 weeks post partum was a ~ a l l l in urine 
volume (P<O. 01) • There we1;'e significant differences 
between the non-pregnant control group and the 
pregnant cohort group at 6 -weeks after delivery when 
urinary sodium (P<O.OOl), urea (P<O.Ol), osmolality 
(P<O.Ol) and volume (P<O.OOOl) were considered. The 
significant differences in urinary sodium (P<O.OOl) 
. and' urinary volume (P<O.OOOl) remained when the non-
pregnant control group were compared to the pregnant 
cohort group at 12 weeks after delivery. 
·In the non-pregnant control group there was no 
correlation found between platelet All binding and any 
of the serum"or urinary biochemical parameters (P)O.l, 
Spearman correlation coefficient). Howe'ver, in 
pregnancy there were significant correlations between 
platelet All binding and serum sodium (P<O.Ol, T= 2.8, 
stepwise regression analysis), serum urea (P<O.Ol, T= 
2.9) and serum osmolality (P<O.Ol, ~ = = 3.2). Moreover, 
these correlations were independent of any inverse 
correlation between platelet All binding and plasma 
All (serum sodium P<O.Ol T- 2.8, serum urea P<O.Ol T= 
2.7 and serum osmolality P<O.Ol T- 2.9). There were 
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no correlations found in pregnancy between platelet 
All binding and any of the other serum parameters or 
between platelet All binding and any of the urinary 
parameters, including the urinary sodium/urinary 
creatinine ratio (P(O.OS). Following delivery, there 
was no correlation found between platelet All binding 
and any of the serum or urinary biochemical parameters 
at either 6 weeks or 12 weeks post partum (P>O.l). 
The following derived values for renal function 
were calculated: ([] denotes concentration) 
Urinary sodium/urinary creatinine ratio, 
Glomerular filtration rate (GFR) 
GFR - urinary[creatinine] x urine volume 
plasma[creatinine] x collection time (mins) 
Fractional excretion of sodium (FeNa) 
FeNa _ urinary[sodium] x plasma[creatinine] 
urinary[creatinine] x plasma[sodium] x 10 
Fractional excretion of potassium(FeK) 
FeK _ urinary[potassium] x plasma[creatinine] 
urinary[creatinine] x plasma[potassium] x 10 
Osmolar clearance (Cosm) 
Cosm 
_ u urinary volume x urinary osmolality 
plasma osmolality x collection time (mins) 
Water clearance (Urine flow - Cosm) 
.. 
However, there was no significant correlation found 
bet'.¥een platelet All binding and any of the above 
derived values for renal function in either the non-
pregnant control group or the pregnant cohort group, 
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at any gestation (in each case P>O.OS, Spearman 
correlation coefficient or stepwise regression 
analysis as appropriate). 
Early pregnancy group. 
The median values of serum sodium, potassium, urea, 
creatinine, urate and osmolality in this subgroup are 
summarised in Table 6.8. 
There was a significant effect of early pregnancy 
on serum urea, creatinine and osmolality (P(O.Ol in 
each case, Friedman analysis of variance), and the 
effect on serum urate approached s ~ g n i f i c a n c e e (P= 
0.02). 
Discussion. 
In the following discussion of the results of the 
cross-sectional and the longitudinal study, the order 
used in the text above will be adhered to. The 
discussion thus commences with a consideration of the 
study sample, before reviewing the changes in platelet 
All binding, and then the changes in the hormonal, 
haematological and biochemical parameters measured. 
The longitudinal study is weaker than if all the 
pregnant women had been' investigated prior ,to their 
pregnancy and used as their own controls. However, it' 
was not logistically possible to obtain a large enough 
pregnant cohort using this method. Fortunately a 
sufficient number of the preconceptual subjects 
conceived, therefore the early pregnancy subgroup did 
act as their own controls. One of the major flaws in 
the' cross-sectional study, the demographic differences 
between the first trimester group and the non-pregnant 
control group, was thus corrected. 
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Table 6.8. 
Serum biochemical data from the early pregnancy 
subgroup. 
Median values are shown, with the range in brackets. 
Table 6.8 
GESTATION (weeks) 
SERUM o 5-8 11 12 
Sodium 139 137 137 137 
(mmoIlL) (137-142) (135-140) (134-140) (135-139) 
Potassium 4.3 4.2 4.2 4.2 
(mmoIlL) (3.9-4.7) (3.9-4.4) (3.7-4.5) (3.9-4.5) 
Urea 3.8 3.0 2.8 2.8 
(mmoI/L) (3.0-4.6) (2.0-3.4) (2.0-3.3) (2.2-3.1) 
Creatinine 83 64 55 52 
(umol/L) (61-92) (48-74) (41-69) (45-58) 
Urate 220 189 172 190 
(umoIlL) (164-241 ) (171-212) (148-197) (152-215) 
Osmolality 280 278 277 276 
(Osm/L) (278-284) (275-280) (273-279) (275-279) 
Many of the deficiencies in the cross-sectional 
study have been discussed at the end of the previous 
chapter (p. 162). Certain more subtle deficiencies in 
the longitudinal study did, however, become apparent. 
There was a bias in the selection of the non-pregnant 
control group, which only included well-motivated 
women who attended their general practitioner or 
practice nurse for advice regarding pre-pregnancy 
health care, and who were prepared to attend the 
hospital and have a sample of blood sample taken. 
This bias may account for the difference in age 
between the non-pregnant control group and the 
pregnant cohort g r o ~ p p which approached statistical 
significance. In or4er to concentrate on the changes 
in platelet All binding in early p r e g n a ~ c y , , the 
l o n g i t u d ~ n a l l pregnant cohort group were selected 
randomly" from women referred at an early gestation by 
their general practitioners. A further source of bias 
is thus incorporated, as women who present late in 
pregnancy, and would thus be excluded from the study, 
tend to be younger than average, and of a lower socio-
economic class [Birch,1989]. 
In the discussion following the cross-sectional 
study, the differences between the non-pregnant 
control group and those women studied six weeks after 
delivery, particularly as regards renal ,function, 
were considered. The longitudinal' study emphasises 
the dangers in assuming that at twelve weeks post 
partum a woman has returned to her pre-pregnant state. 
The haematological data agrees with both this 
supposition and previous studies [Louden, 1988, Kilby, 
1990]. However, at twelve weeks following delivery, 
22-of the pregnant cohort g r o ~ p p had not menstruated, 
all of the women having had regular menstrual periods 
prior to their pregnancies. This finding is in accord 
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with previous work which suggests that even in bottle-
feeding mothers, menstruation does not typically occur 
until fourteen weeks after delivery [reviewed by 
Howie, 1988]. In addition there were significant 
differences in certain of the urinary biochemical 
parameters between the non-pregnant control group and 
the subjects studied twelve weeks after delivery. 
The principal 
longi tudinal study 
finding of 
of platelet 
the 
All 
prospective 
binding in 
normotensive pregnancy was that a reduction in binding 
occurred, the reduction occurring early in p r e g n ~ n c y . .
Study of the early pregnancy subgroup suggests that 
the diminished plat'elet All binding, with lower levels 
" d e m o n s ~ r a t e d d at 5-8 weeks gestation, may represent a 
continuation of the low binding found in -the luteal 
phase "of the menstrual cycle (see chapter 4), the 
return' to follicular levels not o c c ~ r r i n g g if the woman 
conceives. 
The results of the longitudinal study confirm those 
of the provisional cross-sectional study, and suggest 
that the fall in platelet All binding in pregnancy 
parallels the diminution in pressor responsiveness to 
infused All, that also occurs in pregnancy [Gant, 
Daley, Chand, Whalley and MacDonald, 1973]. This 
finding s u p p ~ . r t s s the use ,of platelets as a accessible 
model of vascular smooth muscle in, pregnant women, in 
order to study All binding site changes. 
In both the cross-sectional and the longitudinal 
studies, there were certain subjects in whom the 
values of platelet All binding were elevated, even in 
the" third trimester of pregnancy. In the longitudinal 
study, individuals in whom values of platelet All 
binding were well above the median at 36 weeks 
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gestation also tended to have elevated levels at 18 
and at 28 weeks gestation. The explanation for the 
high levels of binding in these women is unclear; in 
the cross-sectional study the four women with the 
highest values of platelet All binding, at 36 weeks 
gestation all delivered male infants but this was not 
the case in the longitudinal study, (although it was 
interesting to note that 11/15 of the women with 
values of platelet All binding above the median at 36 
weeks gestation subsequently delivered male infants). 
In all of these women the blood pressure recordings 
were well below pathological levels throughout their 
p r ~ g n a n c i e s , , and' plasma All concentrations did not 
differ markedly from the median values. 
The studies discussed in this thesis were the first 
cross-sectional and the first longitudinal studies of 
platelet All binding in pregnancy. However, Pawlak 
and Macdonald [1990] have recently presented 
preliminary data from a cross-sectional study of 
platelet All binding sites in pregnancy. The numbers 
in the study w e r ~ ~ small (16 non-pregnant controls and 
16 women in the first and third trimesters), the nOn-
pregnant control group was of mixed parity and was 
tested at various stages of the menstrual cycle, and 
parametric statistical analysis was inappropriately 
used. .Nevertheless; Pawlak and Macdonald 
demonstrated a diminution in platelet All binding site 
capacity in pregnancy, with binding site capacity in 
the first trimester subjects being significantly lower 
than in the non-pregnant control group. 
The cross-sectional study, the longitudinal study 
and the early pregnancy subgroup all demonstrated 
increases in plasma All, PRe, and PRS in pregnancy. 
In the longitudinal study all six samples from each 
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patient were assayed on the same day, thus minimising 
laboratory errors. There were, however, very few 
differences between the longitudinal and cross-
sectional studies, with both plasma All and PRe 
increasing markedly in early pregnancy, (the early 
pregnancy subgroup demonstrating elevated levels at 5-
8 weeks gestation), and then increasing slightly 
towards term. These increases thus occur at a similar 
gestation to the diminution in platelet All binding. 
In contrast, there were gradual increases in PRS 
throughout pregnancy. These findings are in accord 
with the consensus from recent studies [discussed in 
the Introduction, p. 40, reviewed by Broughton Pipkin, 
1988]. 
Both the cross-sectional and the longitudinal 
studies, and the cross-sectional study of Pawlak and 
Macdonald [1990], demonstrated an inverse correlation 
between platelet All binding and plasma All in the 
non-pregnant control subjects which approached 
statistical significance. This lends support to the 
contention t h ~ t t platelet All binding is down-regulated 
by plasma II in non-pregnant women [Moore, Taylor and 
. Williams, 1984, Ding, Kenyon and Semple, 1985]. 
In pregnancy, the cross-sectional study described 
in this thesis and that described by P ~ w l a k k and 
Macdonald [1990] found no correlation between platelet 
All binding and any of the hormonal parameters. There 
have been no other studies. of All binding in human 
pregnancy, although studies using animals suggest 
several other possible r e g u l a t o r y · ~ n f l u e n c e s s upon All 
receptor concentration (these are discussed in detail 
in' the Introduction, p. 79). 
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One such possibility is the serum level of 
oestradiol; changes in rat and rabbit uterine All 
receptors in the ovarian cycle having been found to be 
directly proportional to serum oestradiol estimation 
[Schirar, Capponi and Cat.t, 1980]. However, there are 
differences in All receptor' regulation in uterine 
tissue as compared to vascular smooth muscle tissue. 
For example, in in vitro studies with rat tissue, 
sodium increases All binding to mesenteric artery 
homogenates [Wright, Alexander, Ekstein and Gimbrone, 
1982] but has no effect on All binding to uterine 
homogenates [Bennett and Snyder, 1980]. Only twenty 
of the pregnant patients in the longitudinal study had 
serum oestradiol levels measured. Nevertheless, the 
absence of any correlation between platelet All 
binding and serum oestradiol in these patients 
suggests that such a regulatory mechanism is unlikely. 
Alternatively, the divalent cations, Mn+2, Mg+2 and 
Ca+2 have been found to increase rat mesenteric artery 
All receptor concentrations in in vitro studies 
[Mcqueen, Murray and Semple, 1984]. Plasma calcium 
concentrations were not measured in this study. 
However, in a longitudinal study of subjects drawn 
from the same population as those of this study, and 
using identical entry criteria, Kilby [1990] found 
that serum calcium concerttrations, when c o r r ~ c t e d d for 
albumen binding, were unchanged during normotensive 
pregnancy. In contrast, platelet intracellular free 
Ca+2 concentrations have been reported to rise during 
pregnancy, although the increase only reached 
statistical significance in t h ~ ~ third trimester 
[Kilby, Broughton Pipkin, Cockbill, Heptinstall and 
Symonds, 1990]. However, when platelet intracellular 
free Ca+2 was measured in third trimester subjects, in 
conjunction with platelet All binding, no correlation 
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between the two parameters was found (Chapter 3, 
Characterisation of binding, p. 131). 
In contrast to the cross-sectional studies, the 
longitudinal study did suggest inverse correlations in 
pregnancy between platelet All 'binding and plasma All, 
PRS and PRC. This was probably due to the greater 
statistical power of the longitudinal study being 
required to demonstrate the inverse correlations. As 
in the non-pregnant women, these hormonal parameters 
thus seem to be likely regulatory influences of 
platelet All binding in pregnancy. Interestingly 
however, All infusion studies have suggested . that 
after the first trimester of pregnancy, pressor 
sensitivity to All is also independent of endogenous 
plasma All concentration [Broughton Pipkin, Hunter, 
Turner and O'Brien, 1984], and other regulatory 
influences may well affect platelet All binding in 
pregnancy. 
In both the longi tudinal and the cross-sectional 
studies, there was no correlation between plasma All 
and platelet All binding in the women studied after 
delivery. In the cross-sectional study, a rapid fall 
in plasma All, PRC and PRS, evident at 24 hours after 
delivery, was accompanied by a more gradual return to 
non-pregnant" levels of platelet All . binding, 
confirming the dissociation between platelet All 
binding and the hormonal parameters. The median 
values of both platelet All binding and plasma All at 
six and twelve weeks post partum approximate to those 
of the nulliparous non-pregnan't control group, 
although the Scatter of platelet All binding data was 
narrower when the subjects were studied after 
delivery. The dangers in regarding women at twelve 
weeks after delivery as having returned to the non-
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pregnant state has been discussed above, the reduced 
post partum variability may be related to the delay in 
es tablishing ovulatory cycles. It seems unlikely 
that a different mechanism regulates platelet All 
binding in parous as compared to nulliparous women, 
and it would be interesting to study these women at 
progressively longer intervals after delivery, in 
order to determine if and when an inverse correlation 
between platelet All binding and plasma All returns. 
The conflicting reports of the changes in platelet 
count in pregnancy [e.g. Sill and Lind, 1985, Fenton, 
Saunders and Cavill, 1977] have already been discussed 
in the Introduction (p. 99). This thesis'. provides 
further conflicting evidence. The longitudinal study, 
in keeping with .the majority of previous longitudinal 
. 
studies, found no change in platelet. count.. In 
'contrast, the' cross-sectional study demonstrated a 
highly significant fall in platelet count with 
gestational age. In certain of the previoua reports 
in which a fall in platelet count was found, the 
exclusion of patients ~ i t h h pregnancy-induced 
hypertension has been questioned [e.g. Fay, Hughes and 
Farron, 1983]. This criticism cannot be applied to 
the cross-sectional study described in Chapter 5, and 
the reason for the discrepancy in the results of the 
two s t u d i e s ~ ~ is u n c l e a r ~ ~ The dangers in. drawing 
conclusions from cross-sectional studies alone' are 
thus illustrated. 
Both the cross-sectional and longitudinal studies 
demonstrated pregnancy-induced increases in mean 
platelet volume and platelet distribution width, with 
the majority of the increases occurring in the third 
trimester. These findings are in agreement with the 
majority of previous studies [e.g. Sill and Lind, 
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1985] (discussed in the Introduction, p. 100). Letsky 
[1985] has demonstrated that platelets become 
progressively smaller with age, thus this data is 
consistent with a pregnancy-induced increase in 
platelet turnover. Values of platelet All binding are 
expressed per cell; the maximal increase in mean 
platelet volume was of the order of 6%, thus the 
results would be similar if expressed per unit 
membrane protein. 
A progressive reduction in platelet yield (the 
proportion of the platelets in whole blood that 
remained after platelet preparation) was found in 
pregnancy, in both the cross-sectional and 
longitudinal studies. This may well be due to the 
well-documented changes in platelet reactivity 
[Yamazaki, Motomiya, Kikutani, S a k a k ~ b a r a , , W ~ t a n e b e , ,
N u m a t ~ ~ and, 'Noguchi, 1979], outlined in the 
introductory chapter (p. 102). The most contemporary 
experimental evidence is provided by a prospective 
study from this 'centre, . in· which both platelet 
aggregation (in response to arachidonic acid and 
adrenaline) and adrenaline-induced platelet exocytosis 
(as measured by radioimmunoassay of 14C-serotonin) 
were found to increase significantly by the third 
trimester, in comparison to the non-pregnant state 
[Louden, B r q ~ g h t o n n Pipkin, Heptinstall, Fox, Mitchell 
and Symonds, 1990]. Increased platelet aggregation 
would be expected to diminish the number of platelets 
in the platelet-rich plasma obtained after 
centrifugation. 
It is possible that pregnancy-induced platelet 
changes per !,!, may be responsible for altered 
platelet All binding, ,which would thus not reflect All 
binding to vascular smooth muscle. This possibility 
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seems unlikely; the maximal platelet changes occur in 
the third trimester, whereas those of platelet AII 
binding occur in the first trimester, and at no 
gestation, in any study, was a correlation between 
platelet AII binding and any of the platelet 
parameters found. The finding of no consistent 
alteration in platelet All binding following blood 
transfusion, when the platelet parameters were 
markedly altered, provides further evidence to refute 
such a hypothesis (Chapter 2, p. 125). 
The longitudinal 
pregnancy . induced 
study also 
a fall in 
demonstrated that 
the haemoglobin 
concentration and an increase in white cell count. 
Both of these phenomena are well described [Letsky, 
1980], the former being due to haemodilution, and . the 
latter being due.to ~ ~ direct ~ f f e c t t of oestrogens.-
The marked changes in serum urea and electrolytes, 
creatinine and urate conc;entrations, particularly in 
the first trimester of pregnancy, which were 
demonstrated in both the longitudinal and the cross-
sectional studies, are also in accord with phenomena 
previously well described [Wood, 1977]. 
Mineralocorticoid and vasopressin secretion are 
increased in normotensive pregnancy. Increased plasma 
progesterone u concentrations in pregnancy cause a 
hyperventilation which results in a lowering of the 
serum bicarbonate concentration. This is balanced by 
a fall in serum sodium concentration. Water retention 
is thus achieved despite an increase in the glomerular 
filtration rate and is reflected in a reduced plasma 
osmolality [Wood, 1977]. Although substantial renal 
tubular absorption of urea 
pregnancy, the net effect 
excretion, thus leading to 
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is thought to occur in 
is of increased urea 
a fall in serum urea 
concentration with gestation. A complex process 
maintains serum urate concentration, involving both 
secretion and reabsorption in the proximal renal 
tubule and then further reabsorption in the distal 
tubules [Wood, 1977]. In normotensive pregnancy the 
serum urate concentration - falls initially with 
gestation and then rises to reach almost non-pregnant 
concentrations at the end of the last trimester 
[Dunlop and Davison, 1977]. All these changes are 
reflected in the results of the studies described 
above. 
In the longitudinal study, significant correlations 
were found in pregnancy, between platelet All binding 
and the values of plasma sodium, urea and osmolality. 
It may well be that the greater numbers. and 
. 
statistical power, of the longitudinal study is 
responsible for the identification of correlations not 
found in the cross-sectional study. Decreases in the 
rate of delivery of sodium to the distal tubule may be 
effecting reductions in platelet All binding via 
alterations in the renin-angiotensin system, the 
altered delivery being detected at the macula densa 
and signalling reciprocal renin release [Vander and 
Miller, 1964] (outlined in the Introduction, p. 22). 
However, use of s t ~ p w i s e e regression analysis suggested 
that these correlations acted independently 9f changes 
in plasma All concentration. Further evidence to 
suggest that the plasma sodium concentration may exert 
a key regulatory influence on levels of platelet All 
binding will be presented in Chapters 7 and 8. 
Consideration of possible regulatory mechanisms 
whereby the plasma sodium concentration exerts such an 
irifluence is included in the General Discussion at the 
end of the thesis (p. 239). 
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In an effort 
between platelet 
the longitudinal 
to study further the relationship 
All binding and electrolyte balance, 
study incorporated the collection of 
24 hour urine samples. The difficulties in using such 
collections 
graphically 
obtained on 
illustrated. 
an out-patient basis are 
. Patients found that 
providing serial samples whilst pregnant was a 
considerable drawback to participating in the study. 
Even women who collected their' samples with an almost 
missionary zeal whilst pregnant became less compliant 
when coping with a newborn infant. This almost 
certainly accounted for the volumes of several samples 
in the puerperium being consistent with a c u ~ e e renal 
failure (less than 400ml I day, [Warrell, 1 9 8 ~ ] ) , , and 
for the highly significant differences in urine 
volumes obtained at six and twelve weeks post partum 
compared to those of the non-pregnant control group. 
. . 
The results of 'the urinary biochemical parameters must 
thus be treated with some scepticism, although even 
when the derived values for renal function were 
considered, no correlations were found with platelet 
AII·binding. 
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Chapter 7. 
Platelet All binding in women with hypertensive 
diseases of pregnancy. 
This chapter describes the differences in platelet 
angiotensin II (All) binding of primiparous women 
whose pregnancies were complicated by hypertension as 
compared to primiparous women whose pregnancies were 
normotensive throughout. All definitions used in this 
chapter have been described in detail in the 
Introduction (Section 1, p. 9). This part of the 
thesis is essentially a cross-sectional study, 
although all the subjects were investigated prior to 
delivery and then studied prospectively after 
delivery, at both six and twelve weeks post partum. 
Thus when comparisons are made within groups, between 
samples taken before and after delivery and between 
six and twelve weeks post partum, the data has been 
treated as paired data. 
Study·sample. 
67 third trimester primiparous patients whose 
pregnancies were complicated by hypertension were 
included in the study. 61 of these patients had 
pregnancy induced hypertension (PIH), as defined by 
Davey and MacGillivray [1987] (Introduction, p. 9). 
These patients were subdivided into 30 patients with 
non-proteinuric PIH and 31 patients with proteinuric 
PIH or p r e - e ~ l a m p s i a , , with respect of the presence or 
absence of ',significant proteinuria' (>0.3g/24 hour 
urine collection), as illustrated in Figure 7.1. Two 
of these patients were o r ~ g i n a l l y y in the longitudinal 
pregnancy cohort group (described in the previous 
chapter). All subjects with PIH were followed up in 
the postnatal:period and all were normotensive with no 
significant proteinuria at twelve weeks after 
delivery. In addition 6 patients whose blood pressure 
remained elevated at twelve weeks after delivery are 
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Figure 7.1. 
Quantitative urinary protein content in the' PIH 
patients in the third trimester. 
Median values are shown, with the interquartile range 
marked. 
The PIH group have been subdivided into non-
proteinuric PIH patients (n=30) and patients with 
pre-eclampsia (n-31) on the basis of significant 
proteinuria (>0.3g / 24hours). The overall data from 
the PIH group and the subdivided data are shown, with 
the normotensive-subjects included for comparison. 
Figure 7.2. 
Diastolic and systolic blood pressures of the lli 
patients in the third trimester. 
Median values are ~ h o w n , , with the interquartile range 
marked. In certain groups, the 25th or 75th centiles 
-, 
were equal to the median. 
The PIH group have been subdivided on the basis of 
significant proteinuria. The overall data from the 
PIH group and the, subdivided data are shown, with the 
normotensive subjects included for comparison. 
. 
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included in the study as an essential hypertension 
group. None of the essential hypertension group had 
significant proteinuria at any time. (In view of the 
small size of the essential hypertension group, the 
range of values has been quoted, rather than the 25th 
_ and 75th centiles, and these'- patients have not been 
included in statistical comparisons.) At the time of 
investigation all the subjects were hospital 
inpatients, hypertension in pregnancy having been 
diagnosed. However, all samples were taken prior to 
any antihypertensive medication having been commenced. 
These sample groups. were compared in a cross-
sectional manner to the .30 normotensive 'primigravidae 
of the pregnancy cohort group (described .in. the 
previous chapter) when they attended the antenatal 
clinic at 36 weeks gestation. 
All subjects were receiving sodium intake ad 
libitum' and the gestational age of each subject had 
been confirmed by an eighteen week ultrasound scan. 
The median age of the normotensive primigravidae 
was 25 years (interquartile range 22-27) and of the 
PIH patients was 24 years (21-27). When the latter 
group was subdivided, the median age of the non-
proteinuricaPIH patienti was 24 years (21-27) and of 
the p r e - e c l a ~ p s i a a group was 23 years (21-28). The 
median age of the 6 essential hypertensive women was 
25 years (range 21-36). There were no significant 
differences in maternal age between any of the groups 
(P>O.l, Mann-Whitney U test). All'of the normotensive 
p r i m i g r a v i d a ~ ~ and all of the pre-eclampsia g r o u ~ ~ were 
Ca'ucasian. Two of the non-proteinuric PIH patients 
(7%) and one of the essential hypertensive women were 
Asian, the remainder being Caucasian. One of the 
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normotensive primigravidae (3%) was a smoker, as were 
two of the non-proteinuric PIH patients (7%), three of 
the pre-eclampsia group (10%) and two of the essential 
hypertensive women. 
There was no significant 'difference between the 
values of gestational age at the time of investigation 
of the PIH patients (median 36 weeks, 32-38) and those 
of the normotensive primigravidae (36 weeks, 35-36, 
P>O.l, Mann-Whitney U test). However when the PIH 
group was subdivided, the gestational ages of the non-
proteinuric PIH patients (38 weeks, 36-39) " were 
significantly g r ~ a t e r r than t'hose of both the 
normotensive primigravidae (P(O.Ol), and those of the 
pre-eclampsia group (35 weeks, 31-37, P(O.Ol). The 
, ,. 
mediap gestational age at the time of investigation of 
the essential hypertensive subjects was 38 weeks 
(range 34-40). -. 
The median maternal weights and systemic blood 
pressures of the normotensive primigravidae, of the 
PIH patients and of the essential hypertensive women, 
at initial investigation and at six and twelve weeks 
post partum, are summarised in Table 7.1. At initial 
investigation, the maternal weights of the PIH 
patients were significantly greater than those of the 
normotensive primigravidae (P(O.Ol, M a n n - ~ h i t n e y y U 
test). When the former group ,was subdivided, the 
maternal weights of the non-proteinuric PIH patients 
were significantly greater than those of both the 
normotensive primigravidae (P(O.OOl) and the pre-
eclamptic group (P(O.Ol). There' was no significant 
difference in maternal weight between the normotensive 
primigravidae and the pre-eclampsia group (P>O.l). 
The median maternal, weights of all the groups fell 
after delivery. Nevertheless, the same statistically 
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Table 7.1. 
Maternal weights and systemic blood pressures in the 
third trimester and at six and twelve weeks after 
delivery. 
Median values are shown, with the interquartile range 
in brackets. 
The PIH patients have been subdivided on the basis of 
significant proteinuria. The overall data from the 
PIH group and the subdivided data are shown, with the 
normotensive subjects and the essential hypertensive 
women included for comparison. 
Table 7.1 Third trl mester groups 
Normotensive PIH Non protein- Pre- Essential 
uric PIH eclampsia hypertensive 
(n=30) (n=61 ) (n-30) (n=31 ) (n=6) 
Weight 71.5 79.5 89.0 76.0 87.5 
(Kg) (64.5-78.6) (70.6-93.0) (77.8-99.5) (69.0-80.5) 
Systolic blood 110 140 140 145 140 
pressure (mmHg) (110-120) (140-150) (140-150) (145-150) 
Diastolic blood 70 95 90 95 90 
pressure (mmHg) (61-70) (90-100) (90-100) (92-100) 
6 week postnatal groups 
Normotensive PIH Non protein- Pre- Essential 
uric PIH eclampsia hypertensive 
Weight 62.3 71.0 78.0 68.1 79.4 
(Kg) (60.0-69.5) (61.2-85.9) (70.0-91.8) (60.6-72.4) 
Systolic blood 120 120 120 120 135 
pressure (mmHg) (110-120) (115-130) (115-125) (115-130) 
Diastolic blood 70 75 75 75 90 
pressure (mmHg) (60-70) (70-80) (70-80) (65-80) 
12 week postnatal groups 
Normotensive PIH Non protein- Pre- Essential 
uric PIH e c l a m ~ s i a a hypertensive 
Weight 58.5 69.5 76.0 66.1 76.1 
(Kg) (55.3-68.3) (61.5-77.4) (68.3-90.5) (58.9-71.3) 
Systolic blood 115 ~ ~ 120 120 119 140 
pressure (mmHg) (110-120) (110-120) (110-120) (110-120) 
Diastolic blood 70 70 70 70 90 
pressure (mmHg) (60-70) (70-75) (69-78) (67-72) 
significant differences between the groups persisted 
at both six and twelve weeks after delivery. 
By definition, at initial investigation there were 
significant differences in both the systolic 
(P(O.OOOl) and diastolic (P(O.OOOl) blood pressures of 
the PIH patients as compared to the normotensive 
primigravidae (Figure 7.2). The differences between 
the non-proteinuric PIH patients and the pre-eclampsia 
group were not significant (P)O.l). The systolic and 
diastolic blood pressures of both the non-proteinuric 
PIH patients and the pre-eclampsia group were 
significantly lower at 12 weeks after delivery as 
compared to those at the initial investigation (P(O.Ol 
in each case, Wilcoxon matched-pairs signed-ranks 
test), and at twel've 'weeks after delivery there,' were 
no significant differences in systolic and diastolic 
blood pressures between any of the groups (P)O.OS). 
No significant correlations were found between 
platelet All binding and any of the above parameters 
in any of the groups (P)O.l, Spearman correlation 
coefficient). 
The birthweights in the normotensive primigravidae 
(median 3.44 Kg, 3.04-3.75) were significantly greater 
than thoseuof the PIH ~ a t i e n t s s (2.87 Kg, 2.32-3.27, 
P(O. 0001, Mann-Whi tney Utes t) • When the la't ter group 
was subdivided, the difference between the 
birthweights of the pre-eclampsia group (2.60 Kg, 
1.74-3.34) and ~ h o s e e of the non-proteinuric PIH 
patients (3.08 Kg, 2.63-3.26) approached significance 
(p- 0.03). .. The median birthweight of the essential 
hypertension group was 2.64 Kg. 
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The gestational ages at delivery of the 
normotensive primigravidae (median 40 weeks, 39-41) 
were significantly greater than those of the PIH 
patients (38 weeks, 36-39, P<O.OOOl). When the latter 
group was subdivided, the gestational ages at delivery 
of the non-proteinuric PIH patients (38 weeks, 36-39) 
were significantly greater than those of the pre-
eclampsia group (37 weeks, 34-38, P<O.Ol). The median 
gestational age at delivery of the essential 
hypertension group was 37 weeks. 
5 (17%) of the normotensive primigravidae, were 
delivered by caesarean section, as compared to 25 
(41%) of the PIH patients (17 of the 25 wer,e patients 
with pre-eclampsia). The ratio of male:female infants 
was 1.1:1 in the normotensive primigravidae and 1.9:1 
in the PIH p ~ t ~ e n t s s (1.7:1 in the non-proteinuric PIR 
patients and 2.1:1 in the pre-eclampsia group). 18 
(60%) of the normotensive primigravidae breast-fed 
their infants, as compared to 26 (43%) of the PIH 
patients (17 (57%) of the non-proteinuric PIH patients 
and 9 (29%) of the pre-eclampsia group). . At twelve 
weeks after delivery, only 8 (27%) of the normotensive 
primigravidae and 15 (25%) of the PIH patients had 
menstruated. 
In addi teion to the 'above subjects, pla,telet All 
binding was also measured in 6 subjects with 
'fulminating pre-eclampsia'. This was defined as 
patients with pre-eclampsia, in whom the diastolic 
blood pressure was greater than 110 mmHg., +++ 
proteinuria was present on d i p ~ t i c k k testing of a 
random sample, and in whom delivery was necessary 
b ~ f o r e e 24 hours after a d m i s ~ i o n n (in most cases a 
caesarean section was performed as soon as the blood 
pressure was controlled by anti-hypertensive 
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medication). In 5 of the 6 cases, blood was taken 
for assay prior to antihypertensive medication being 
administered. In the remaining case, blood was taken 
only a few minutes after intravenous hydrallazine had 
been commenced. All 6 patients were primiparous, the 
median gestational age of these subjects was 31 weeks 
and the median platelet count was 97 x 109/L. 
Platelet Angiotensin II (All) binding data. 
At the time of initial investigation, median 
platelet All binding in the PIH patients w a ~ ~ 4.4 
fmol/l09 cells (interquartile range 2.0-7.6) (Figure 
7.3). Platelet All binding in the PIH patients was 
thus s.ignificantly higher than in the normotensive 
primigravidae, studied at 36 weeks gestation (median 
9 . 
value 0.7 fmol/l0 cells, 0-2.8,. P<O. 0001, Mann-
Whitney U· test). When the PIH patients were 
subdivided, although platelet All binding was higher 
.in the pre-eclampsia group (5.3 f m o l / l 0 ~ ~ cells, 3.5-
16.3) than in the non-proteinuric PIH patients (3.9 
fmol/109 cells, 1.8-6.1), the difference was not 
significant (p- 0.08). In addition, whereas several 
of the normotensive primigravidae had undetectable 
levels of platelet All binding at 36 weeks gestation, 
this was not. the case when any of. the patients with 
pre-eclampsiJl were studied. The median value of 
platelet All binding in the essential hypertension 
group was 0.4fmol/l09 cells). 
The median value of platelet All binding in the 6 
patients with fulminating pre-eclampsia was 4.0 
fmol/109 cells (range 2.9-6.1). The values of 
platelet All binding in the two PIH patients who had 
been studied longitudinally are illustrated in Figure 
7.4. The median values found in the longitudinal 
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Figure 7.3. 
Platelet All binding in the PIH patients in the third 
trimester. 
The median values of platelet All binding are 
indicated by horizontal bars. 
Platelet All binding was significantly higher in the 
PIH patients as compared to the· normotensive women 
(P(O.OOOl). 
The· PIH group have been subdivided on the basis of 
significant proteinuria. The overall data from the 
PIH group and the subdivided data are shown, with the 
normotensive subjects included for comparison. 
Figure 7.4. 
Platelet All binding in the two PIH patients studied 
longitudinally prior to the development of PIH. 
The median values. of platelet All binding found in· 
the longitudinal study of normotensive pregnant 
subjects are shown for comparison. 
Figure 7.3. 
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study of normotensive pregnancy (Chapter 6) are also 
indicated in Figure 7.4. Neither of the PIH patients 
demonstrated the early-pregnancy fall in platelet All 
binding that was found in the normotensive pregnant 
subjects. 
As discussed in the previous chapter (p. 171), in 
the normotensive primigravidae, platelet All binding 
was significantly increased at six weeks post partum 
(3.9 fmol/l09 cells, 1.6-6.9, P<O.Ol, Wilcoxon 
matched-pairs signed ranks test), with no further 
significant change at twelve weeks post partum (3.9 
fmol/l09 cells, 0-6.5, P>O.l). In contrast, platelet 
All binding in the PIH patients had not s ~ g n i f i c a n t l y y
changed at either six weeks post partum (3.8 fmol/l09 
cells, 1.7-6.0, P)O.l) or twelve weeks post partum 
(4.2 f m o l / l ~ 9 9 cells, 0.8-6.9, P>0.5). When the PIH 
patients were subdivided, there were no significant 
changes in platelet All binding at either six or 
twelve weeks post partum in the non-proteinuric PIH 
patients (3.7 fmol/l09 cells, 1.3-6.1, and 5.3 
fmol/l09 cells, 0.5-8.4, respectively), or .in the preo-
eclampsia group (4.0 fmol/l09 cells, 1.9-6°.4, and 3.1 
fmol/l09 cells, 0.9-7.1, respectively) (in each case, 
P>O.l, Wilcoxon matched-pairs signed ranks test). 
There were no significant differences between any of 
the groups" at either' six or twelve ° weeks after 
delivery (in each case, P>O.5, Mann-Whitney U test). 
In the essential hypertension group the median 
value of platelet All binding was 3.9 fmol/109 cells 
at six weeks post partum and 1 ~ 0 0 0 fmol/109 cells at 
twelve weeks post partum. 
, 
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Hormonal data. 
The median values of plasma angiotensin II (All), 
plasma renin concentration (PRe) and plasma renin 
substrate (PRS) in the third trimester, and at six and 
twelve weeks after delivery, ,are summarised in Table 
7.2. 
In the third trimester, although the values of PRe 
were significantly higher in the normotensive 
primigravidae as compared to the PIH patients, there 
were no significant differences in the values of 
plasma Allor PRS between the two groups (P>0.05, 
Mann-Whitney U test). However, when the PIH patients 
were subdivided" further signiticant differences 
became apparent (Figure 7.5). The values of all three 
hormonal parameters were lower in the pre-eclampsia 
'. ' group as compared to ,the non-proteinuric PIH patients, 
with the differences approaching statistical' 
significance in each case (p- 0.01-0.04). In the non-
proteinuric PIH patients the values of plasma All, PRe 
and PRS approximated to those of the normotensive 
primigravidae, with no significant differences between 
the two groups (although for PRe the difference 
approached significance, P- 0.02). In contrast," the 
values of PRe (P<O.OOOl) and PRS (P<O.Ol) were 
significan..tly lower in the pre-eclampsia. group as 
compared to the normotensive primigravidae, with the 
difference between the values of plasma All 
approaching significance (p- 0.02). 
In the normotensive primigravidae, there were 
significant falls in the levels of all three hormones 
from 36 weeks gestation to six weeks post partum (in 
each case P<O.OOl, chapter 6, p. 172, Figure 6.3), 
with no further significant changes from six to twelve 
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Table 7.2. 
Values of the hormonal parameters in the third 
trimester and at six and twelve weeks after delivery. 
Median values are shown, with the interquartile range 
in brackets. 
The PIR patients have been subdivided on the basis of 
significant proteinuria. The overall data from the 
PIR group and the subdivided data are shown, with the 
normotensive subjects and the essential hypertensive 
women included for comparison. 
Table 7.2 Third trimester groups 
Normotensive PIH Non protein- Pre- Essential 
uric PIH eclampsia hypertensive 
(n=30) (n=61 ) (n.30) (n=31) (n=6) 
Angiotensin II 30.9 21.7 . 32.4 10.7 25.3 
(pg/ml) (20.6-44.4) (8.7-66.2) (16.0-81. 7) (7.8-55.9) 
P.RC. 6.5 2.5 4.2 1.7 3.8 
(ng Allhr/ml) (4.3-9.6) (1.3-4.8) (2.0-9.2) (0.9-2.5) 
P.R.S. 3.5 3.0 3.0 3.0 3.2 
(ug AI/m/) (3.2-4.0) (2.6-3.6) ( 2 . 7 ~ 3 . 9 ) ) (2.3-3.3) 
6 week postnatal groups 
Normotensive PIH Non protein- Pre- Essential 
uric PIH eclampsia hypertensive 
Angiotensin II 12.5 16.4 18.8 14.5 14.3 
(pg/m/) (8.8-16.1) (10.5-22.7) (9.9-24.1 ) (9.2-23.9) 
P.R.C. 2.0 2.1 2.7 1.9 1.5 
(ng AI/hr/ml) (1.1-2.8) (1.1-1.9) (1.1-3.9) (1.1-2.8) 
P.R.S. 1.3 1.2 1.1 1.2 1.6 
(ug AI/m/) (0.9-1.7) (1.1-1.9) (0.8-1.6) (0.7-1.7) 
12 week postnatal groups 
Normotensive PIH Non protein- Pre- Essential 
uric PIH eclampsia hypertensive 
Angiotensin II 11.7 16.0 16.6 14.8 16 
(pg/ml) (9.0-15.5) (9.5-28.0) (9.0-29.4) (9.5-28.8) 
P.RC. 2.9 1.9 2.2 1.9 1.6 
(ng AI/hr/ml) (1.0-3.8) (1.4-2.8) .<1.5-3.3) (1.3-2.7) 
P.R.S. 1.2 1.1 1.0 1.3 1.5 
.. (ug AI/ml) (1.0-1.9) (0.8-1.8) . (0.8-1.7) (0.8-2.8) 
Figure 7.5. 
Plasma angiotensin II (All), plasma renin substrate 
(PRS) z and plasma renin concentration (PRe) in the 
PIH patients in the third trimester. 
Median values are shown, with the interquartile range 
marked. 
The PIH patients have been subdivided on the basis of 
significant proteinuria. The overall data from the 
PIH group and the subdivided data are shown, with the 
normotensive subjects included for comparison. 
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weeks post partum. In the PIH patients, there were no 
significant changes in the values of plasma Allor PRe 
(although the fall in the values of plasma All from 36 
weeks gestation to six weeks post partum approached 
significance, P= 0.03, Wilcoxon matched-pairs signed 
ranks test), and there was a significant fall in PRS 
from 36 weeks gestation to six weeks post partum 
(P(O.Ol). When the PIH patients were subdivided, in 
the non-proteinuric PIH patients, as in the 
normotensive primigravidae, there were significant 
falls in the levels of all three hormones from 36 
weeks gestation to six weeks after delivery (in each 
case P(O.Ol), with no further significant changes from 
six to twelve weeks post partum. In the pre-
eclampsia group, whilst the levels of PRS fell 
significantly from 36 weeks gestation to six weeks 
post partum (P(O.Ol), the l ~ v e i s s of .plasma All and PRe 
were increased after delivery, with the rise in plasma 
All approaching significance (P= 0.04). There were no 
significant changes in the l e v e ~ s s of plasma All, PRe 
and PRS in the p ~ e - e c l a m p s i a a group from six to twelve 
weeks after d e l i ~ e r y y (in each case P)O.l) • 
. At six and at twelve weeks after delivery, there 
were no significant differences in the values of any 
of the hormonal parameters between any of the groups 
(P)O.OS). 
In the normotensive primigravidae, the significant 
inverse correlations between platelet All binding and 
the hormonal parame ters have been discussed in the 
previous chapter (p. 187). There' were no correlations 
found between platelet All binding and the hormonal 
p'arameters when the PIH patients were investigated in 
the third trimester (P)O.l, Spearman correlation 
coefficient). However, there was a significant 
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inverse correlation between platelet All binding and 
plasma All (P<O.Ol, rs= -0.44) at six weeks post 
partum, and at twelve weeks post partum the inverse 
correlation approached significance (P= 0.04, r s- -
0.29). When the PIH patients were subdivided, there 
was a significant inverse correlation between plasma 
All and platelet All binding in the pre-eclampsia 
group at six weeks post partum (P<O.Ol, rs· -0.53). 
This correlation was not present at twelve weeks post 
partum (P>O.l), and was not present at either six or 
twelve weeks after delivery when the non-proteinuric 
PIH patients were considered (P>O.l). There were no 
correlations at any time between platelet All binding 
and either PRC or PRS in any of the PIH groups (in 
each case P>O.l). 
Haematological data. 
Contamination of the platelet concentrate by 
leucocytes was <1% (1-5 x 103/pl) and no erythrocytes 
were detected. 
The median values of platelet count, mean platelet 
volume (MPV) and platelet distribution volume (PDW) , 
in the third trimester and at both six and twelve 
weeks a f t e ~ ~ delivery are summarised in Table 7.3. 
In the third trimes ter, the MPV and the PDW were 
significantly greater in the PIH patients as compared 
to the normotensive primigravidae (P<O.OOOl and 
P<O.OOl respectively, Mann-Whitney U test). The 
difference in platelet count between the two groups 
approached significance (p. 0.04). When the PIH 
patients were subdivided, the difference in the 
platelet count between the non-proteinuric PIH 
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Table 7.3. 
Values of the platelet parameters -in the third 
trimester and at six and twelve weeks after delivery. 
Median values are shown, with the interquartile range 
in brackets. 
The PIH patients have been subdivided on the basis of 
significant proteinuria. The overall data from the 
PIH group and the subdivided data are shown, with the 
normotensive subjects and the essential hypertensive 
women included for comparison. 
Table 7.3 Third trl mester groups 
Normotensive PIH Non protein- Pre- Essential 
uric PIH eclampsia hypertensive 
(n=30) (n .. 61 ) (n==30) J!1&311 I n = ~ ~
Platelet count 208 190 221 173 213 
(x 1091L) (174-244) (154-232) (162-258) (128-209) 
Mean platelet 8.5 9.4 9.2 9.7 8.5 
volume (fI) (8.2-8.9) (8.6-10.1 ) (7.9-10.0) (9.1-10.2) 
Platelet distrib- 16.1 17.1 16.9 17.3 16.3 
ution width (15.4-16.9) (16.1-18.1) (15.1-17.7) (17.0-18.0) 
6 week postnatal groups. 
Normotensive PIH Non protein- Pre- Essential 
uric PIH e c l a m ~ s i a a l'!Yi:>.ertensive 
Platelet count 226 246 240 246 311 
(x 109 /L) (187-259) (209-278) (199-283) (209-270) 
Mean platelet 8.1 8.3 8.1 8.4 7.8 
volume (fl) (7.7-8.6) (7.8-9.1 ) (7.8-8.9) (7.9-9.6) 
Platelet. distrib- 15.6 15.9 16.0 15.S 15.4 
ution width (14.8-16.1) (15.2-16.3) (15.2-16.1 ) (15.3-17.0) 
12 week postnatal groups 
Normotensive PIH Non protein- Pre- Essential 
uric PIH e c l a m ~ s i a a h y ~ e r t e n s i v e e
Platelet count 235 238 246 223 297 
(x 109/L) (211-278) (211-272) (202-269) (210-261 ) 
Mean platelet 8.1 8.3 8.3 8.4 7.9 
volume (tI) (7.7-8.6) (7.9-8.8) (7.8-8.7) (S.0-9.1 ) 
Platelet distrib- 15.6 15.8 15.S 15.S 15.2 
ution width (14.9-16.4) (15.2-16.4) (15.2-16.5) (15.2-16.5) 
patients and the pre-eclampsia group approached 
significance (P= 0.02) (Figure 7.6). Moreover, when 
the non-proteinuric PIH patients were compared with 
the normotensive primigravidae the only significantly· 
different platelet parameter was the MPV (P(O.OOl), 
whereas when the pre-eclampsia group were compared 
with the normotensive primigravidae there were 
significant differences in the platelet count 
(P(O. 01) , the MPV (P(O. 0001) and. the PDW (P(O. 001) 
(Figure 7.7). 
In the normotensive primigravidae, the changes in 
the platelet parameters following delivery have 
already been discussed in the previous chapter (p. 
188). In the PIH patients there was a significant 
rise in platelet count (P(O.Ol, Wilcoxon matched-pairs 
signed-ranks test) at six weeks after delivery. as 
co'mp'ared to at 36 weeks gestation, with significant 
falls in MPV (P(O.OOl) and PDW (P(O.OOOl). When the 
PIH patients were subdivided, the changes in al1. three 
parameters were significant in the pre-eclampsia group 
(P(O.OOl in each case), whereas when' the non-
proteinuric patients were considered only the fall in 
MPV was significant (P(O.OOl). There were no 
significant changes from six to twelve weeks post 
partum in any of the PIH groups (P)O.l). There were 
no s i g n i f ~ c a n t t differences in any of the platelet 
parameters between any of the groups at either six or 
twelve weeks after delivery (P)0.05, Mann-Whitney U 
test). 
In the third trimester, there was no significant 
difference in the proportion of platelets in whole 
blood that were recovered in the prepared platelet 
suspension (platelet yield) between the PIH patients 
(47%, 38-55) and the normotensive primigravidae (43%, 
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Figure 7.6. 
Platelet count in the PIH patients in the third 
trimester. 
Median values are shown, with the interquartile range 
marked. 
The PIH patients have been subdivided on the basis of 
significant proteinuria. The overall data from the 
PIH group and the subdivided data are shown, with the 
normotensive subjects included for comparison. 
Figure 7.7. 
Mean platelet volume (MPV) and platelet distribution 
width (PDW) in the PIH patients in the third 
trimester. 
Median values are shown, with the interquartile range 
marked. 
The PIH patients have been subdivided on the basis of 
significant proteinuria. The overall data from the 
PIH group and the subdivided data are shown, with the 
normotensive subjects included for comparison. 
Hid 
-lsdw_I08 0IAnul8loAd 
S d n O I : : l ~ ~
A81S8WIJI pAt: A81S8WIAI pAt: 
--w - ~ I " " I " ~ I U U --".,---.-___ ,'1 
~ ~ ~ ~ D?7.))j i.... ~ ~ fZ;)'JZI b»7Z11 , .. -" .7»>:;1 I 0 
Mad 
Ad., ~ ~
S d n O I : : l ~ ~
Hid 
: , ; , ~ ~ ~
, , -: 
' , ~ , ' . , J J
, , ". , , ... 
, , ". , , ... 
, , ". 
, , " 
, , ". , , " 
, , ". 
, , " 
, , ". , , ... 
, , '" 
" " ". , , '" 
" " '. , , " 
" " '. , , ", 
" " " 
',',"" , , ,,1 
" " ,I ~ ~ , ". 
" " .t , , ". 
" " ., 
· , ". 
" " ·t 
· , ", 
" " ., 
· , ,,1 
" " ". · , ".
" " ., 
· , ". 
" " ., 
· , ". 
" " " ,',',1 
,','.: 
,','.: 
, , I 
" " ,I , , I 
" " .1 , , I 
, , . 
, , 
, , 
, , 
, , 
, , 
_ladw_lo8 0IAnu1810Ad A81S8WIAI pAt: A81S8WIAI pAt 
-8Jd -UON Hid 8AlsU8,OWAON 
8 
OL 
ZL 
trL 
9L 
8L 
~ ~
i: 
CI) 
Do) 
::s 
"g 
iii 
-Q.!. 
_. CI> 
u..-
-::2. < 
C70 
c-
_c 
0'3 
::s CI) 
:e-
_. i: 
Q."'O 
:r,s 
--"'0= C ~ ~
~ " ' O O
iii 
S-
a; 
-
'L'L 8mB!.:! 
(77777] '''''''If] 0777771 '777771 10 
os 
"'0 
iii 
-
OOL CI) 
a; 
-(') 
0 
C OSL ::s 
-
->C 
~ ~ ... 
C) 
• 
-r-
-osz 
GOt 
'9' L 8mB!.:! 
35-58, P>O. 5, Mann-Whi tney Utes t). No significant 
differences were revealed when the PIH patients were 
subdivided. Similarly, there were no significant 
differences in platelet yield between any of the 
groups at either six or twelve weeks after delivery 
(P)0.1), with values in the PIR patients of SS% at 
six weeks post par tum and 50% at twelve weeks post 
partum. 
In the third trimester PIH patients, 'values of 
haemoglobin concentration (12.2 g/dl, 11.4-12.8) and 
white cell count (wee) (9.1 x 109/L, 7.8-11.2) were 
higher than· in the normotensive primigravidae' (11.8 
g/dl, 10.0-12.S, and 8.3 x 109/L, 7.4-10.2), but these 
differences were not significant (P>0.1). No 
significant differences were revealed when the PIH 
patients were s u b d i v ~ d e d . . . In the PIH patients 
f o l l ~ w i n g g delivery there were no significant changes 
in haemoglobin concentration, although the wee at six 
weeks post partum (6.3. x 109/L, S.2-7.1) was 
significantly lower than that at 36 weeks gestation 
(P<O.Ol). There were no significant differences in 
either parameter between any of the groups at six 
weeks or at twelve weeks post partum. 
There was no correlation between platelet All 
binding and any of the haematological parameters in 
the PIH patients in the 'third trimester, at 'six weeks 
post partum or at twelve weeks post partum (P>0.1, 
Spearman correlation coefficient). 
Biochemical data. 
The median'values of serum sodium, 
creatinine, urate and osmolality 
trimester are summarised in Table 7.4. 
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potassium, urea, 
in the third 
Table 7.4. 
Serum biochemical data in the third trimester. 
Median values are shown, with the interquartile range 
in brackets. 
The PIH patients have been subdivided on the basis of 
significant proteinuria. The overall data from the 
PIH group and the subdivided data are shown, with the 
normotensive subjects and the essential hypertensive 
women included for comparison. 
. Table 7.4 
Normotensive PIH Non-protelnurlc Pre-eclampsia Essential hypertension' 
SERUM (n=30) (n=61 ) (n=30) (n=31 ) (n=6) 
Sodium 136 137 137 138 134 
(mmoIlL) . ( 1 3 3 ~ 1 3 7 ) ) (135-138) (135-138) (135-139) 
Potassium 4.4 4.2 4.3 4.2 4.3 
(mmoIlL) (4.1-4.6) (4.0-4.6) (4.0-4.7) (4.0-4.5) 
Urea 2.1 3.3 II 2.9 3.7 2.3 (mmoIlL) (1.9-2.6) (2.6-4.1 ) (2.4-3.9) (3.0-4.4) 
Creatinine 57 75 67 8'2 60 
(umoI/L) (49-65) (63-83) (59-78) (73-90) 
Urate 259 317 308 339 281 
(umoIlL) (211-289) (256-398) (219-408) (291-398) 
Osmolality 276 279 II 278 27'9 278 (Osm/L) (275-279 ) (276-280 ) (278-282) (277-280) 
In the third trimester, the values of serum urea, 
creatinine and urate were significantly higher in the 
PIH patients as compared to the normotensive 
primigravidae (in each case P<O.OOOl, Mann-Whitney U 
test), and the differences in serum sodium (p- 0.02) 
and serum osmolality (P= 0.01) approached 
" 
significance. The differences in serum urate are 
illustrated in Figure 7.8. When the PIH patients were 
subdivided, the differences in serum sodium (P= 0.04), 
urea (p- 0.03) and creatinine (p- 0.02) approached 
significance. However, at both six weeks and at 
twelve weeks after delivery, there were no significant 
differences in any of the serum biochemical parameters 
b e t ~ e e n n any of the groups (P>O.OS). 
The correlations between platelet All ~ i n d i n g g and 
the serum b i o ~ h e m i c a l . . parameters in the normotensive 
primigravidae have been discussed in the previous 
chapter (p. 191). In the third trimester PIH patients' 
there was a significant correlation between platelet 
All binding and serum sodium concentration (P<O.Ol, 
r s-,O.37, Spearman correlation coefficient). When the 
PIH patients were subdivided, there was no such 
correlation in the pre-eclampsia group (P>O.l), 
although in the non-proteinuric PIH patients the 
correlation approached significance (p. 0.03, rs. 
0.44). There were no correlations found in the PIH 
patients, between platelet All binding and 'any of the 
other serum biochemical parameters. 
At six weeks after delivery, there were no 
correlations found between p l a t ~ l e t t All binding and 
any of the serum biochemical par'ameters when the PIH 
group as a whole was considered. However, in the non-
proteinuric PIH subgroup, the correlation between 
platelet All binding and serum sodium concentration 
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.. Figure 7.8. 
Serum urate concentrations in the PIH patients in the 
third trimester. 
Median values are shown, with the interquartile range 
marked. 
Serum urate concentrations were significantly higher 
in the PIH patients as compared to the normotensive 
women (P<O.OOOl). 
The PIH patients have been subdivided on the basis of 
significant proteinuria. The overall data from the 
PIH group and the subdivided data are shown, with the 
.normotensive subjects included for comparison. 
Figure 7.9. 
Glomerular filtration rate in the PIH patients in the 
third trimester. 
Median values are shown, with the interquartile range 
marked. 
The PIH patients have been subdivided on the basis of 
significant proteinuria. The overall data from the 
PIH group and the subdivided data are shown, with the 
normotensive subjects included for comparison. 
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again approached significance (P= 0.04, rs= 0.41). At 
twelve weeks after delivery, the only correlation with 
platelet All binding to approach significance in the 
PIH group was that with serum sodium concentration (P= 
0.04, rs= 0.30). No correlations with platelet All 
binding were found when the PIH patients were 
subdivided. 
The median values of urinary sodium, potassium, 
urea, creatinine, urate, osmolality, protein and 
volume in the third trimester are summarised in Table 
7.5. 
By definition, the values of urinary protein in the 
third trimester were significantly higher in the pre-
eclampsia group than in both the normotensive 
primigravidae (P(O.OOOl, 'Mann-Whitney U test) and the, 
non-proteinuric PIH patients (P(O.OOOl). These 
differences are illustrated in Figure 7.1. There were·· 
no other significant differences in any of the 
measured urinary biochemical parameters (in each case 
P>0.05). 
The following derived values for' renal function 
were calculated: urinary sodium/urinary creatinine 
ratio, glomerular filtration rate, fractional 
excretion of sodium, fractional excretion of 
potassium, "osmolar clearance and water clearance (as 
outlined in Chapter 6, p. 180). There were 
significant differences between the groups in the 
derived values of glomerular filtration rate, with 
significantly higher values found in the normotensive 
primigravidae as compared to the PIH patients (P(O.Ol, 
Mann-Whitney"U test), and significantly higher values 
found in non-proteinuric PIH patients as compared to 
the pre-eclampsia group (P(O.OOl) (Figure 7.9). There 
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Table 7.5. 
Urinary biochemical data in the third trimester. 
Median values are shown, with the interquartile"range 
in brackets. 
The PIH patients have been subdivided on the basis of 
significant proteinuria. The overall data from the 
PIH group and the subdivided data are shown, with the 
normotensive subjects and the essential hypertensive 
women included for comparison. 
Table 7.5 . 
Normotensive PIH Non-proteJnurlc P,H Pre-eclampsIa Essential hypertension 
URINARY (n=30) (n=61) (n=30) (n=31) (n=6) 
SodIum 100 98 91 1.10 92 
, (mmoIlL) (76-118) (70-131) (67-125) (69-132) 
Potassium 45 53 47 57 50 
(mmoIlL) (36-53) (40-66) (44-49) (43-73) 
Urea 17 20 18 22 18 
(mmoIlL) (14-21) (16-26) (16-27) (16-26) 
Creatinine 7.6 8.3 8.1 9.4 7.5 
(umoI/L) (6.3-9.8) (6.3-10.3) (6.1-9.7) (6.5-12.5) 
Urate 2.4 2.2 2.0 2.5 2.4 
(umoI/L) (1.8-3.1 ) (1.8-2.9) (1.4-2.8) ( 2 ~ 0 - 4 . 1 1 ) 
Osmolality 506 543 497 554 555 
(mmollkg) (459-628) (417-688) (394-677) (435-739) 
Protein 0.07 0.42 0.13 1.43 0.92 
(gIL) (0.03-0.09) (0.13-1.48) (0.07-0.20) (0.65-3.15 ) 
Volume 1.3 1.2 1.4 0.9 1.4 
(L/24hrs) (1.0-1.5) (0.8-1.7) (0.9-1.9) (0.7-1.3) 
Fractional excretion 0.49 0.59 0.56 0.69 0.51 
of sodium (0.43-0.65) (0.44-0.82) (0.46-0.72) (0.43-0.87) 
were no other significant differences between the 
groups although the difference in the urinary 
sodium/urinary creatinine ratios between the pre-
eclampsia group and the normotensive primigravidae 
approached significance (p-. 0.02), as did the 
differences in fractional excretion of sodium between 
the normotensive primigravidae as compared to both the 
total PIH group and the pre-eclampsia patients . (p-
0.03 and P- 0.02 respectively). The values of 
fractional excretion of sodium in each of the groups 
are given in Table 7.5. 
At six and at twelve week_s post partum, - the only 
significant difference in e i t ~ e r r the measured· urinary 
parameters or the derived values of renal function 
between the groups was a significantly greater urinary 
volume in all the PIH groups as compared to the 
normotensive primigravidae (P(O.Ol). 
There were no significant correlations found 
between any of the measured urinary parameters and 
platelet All binding, in any group, at any time 
(P>0.05). The only derived value of· renal function 
for which a correlation with platelet All binding 
approached significance was the fractional excretion 
of sodium, when the PIH group as a whole was 
considered, in the third trimester (p- 0.02, Spearman 
correlation' coefficient-rs- 0.33). 
Discriminant analysis. 
.-
The use of platelet All binding to discriminate 
between the' normotensive primigravidae and the PIH 
pitients, in the third trimester, was assessed using 
canonical discriminant analysis (discussed on p. 160). 
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There was a false positive rate of 42% and a false 
negative rate of 14%, 67% of patients being correctly 
classified. When the hormonal, haema tological and 
biochemical parameters measured in this study were 
used to discriminate between the two groups of third 
trimester patients, the only parameters which 
correctly classified more patients were serum urate 
and MPV (correct classification in 76% and 75% of 
cases respectively). The results of such discriminant 
analysis were not markedly improved when platelet All 
binding was combined with either serum urate (68% of 
patients correctly classified) or MPV (77% of patients 
correctly classified).' However, when all.. three 
p a r a m e t e r . ~ ~ were combined· there was a false positive 
rate of 27% and a false negative rate of 1%, 81% of 
. .. 
patients being correctly classified. 
When the above parameters were used to discriminate 
between the normotensive primigravidae and the pre-. 
eclampsia group, in the third trimester, similar 
results were obtained. With platelet All binding as 
the discriminant, there was a false positive rate of 
48% and a false negative rate of 14%, 68% of patients 
being correctly classified. Serum urate and MPV both 
correctly classified 80% of patients. Platelet All 
binding combined with serum urate resulted in correct 
classification of 80% of patients and combined with 
MPV resulted in correct classification .of 81% of 
patients. When all three parameters were combined, 
there was a false positive rate of 26% and a false 
negative rate of 4%, 85% of patients being correctly 
classified. 
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Discussion 
The results of this study of platelet All binding 
in normotensive and hypertensive primigravidae are 
similar to those of the small pilot study described in 
Chapter 5. The two studies will thus be discussed 
together. 
This study provides further evidence to support the 
use of platelet All binding as a model of vascular 
responsiveness to All. Just as the fall of platelet 
All binding in early pregnancy (described in the 
p r ~ v i o u s s chapter) parallels the diminution in pressor 
response to infused All [Gant, Daley, Chand, Whalley 
and Macdonald, 1973], i.n ~ I H H the increased levels of 
platelet All binding in comparison with normotensive 
primigravidae parallels the increased All pressor 
responsiveness found in PIH [Gant et. a1.,'1973]. 
The pilot study was the first reported study of 
platelet All binding in patients with PIH. 
Subsequently, P a ~ l a k k and Macdonald [1990] reported the 
preliminary results of a study of platelet All binding 
sites in hypertensive p r ~ g n a n c y . . Although the numbers 
in their study were small (16 in each group) and the 
definition of PIH used was an increase in diastolic 
blood pressure of 20 mmHg. or more, Pawlak and 
Macdonald also found that whilst platelet All binding 
in women with PIH was lower than that of non-pregnant 
women, it was significantly .greater than that of 
normotensive women in the third trimester of 
pregnancy. 
Only two of the patients who developed PIH had been 
studied on a longitudinal basis. However, the results 
from these two women support the hypothesis that the 
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elevated levels of platelet All binding in women with 
PIH as compared to the normotensive primigravidae are 
not due to a rise in platelet All binding towards the 
end of pregnancy in PIH patients, but instead, are due 
to the early pregnancy fall in platelet All binding 
found in normotensive pregnancy, not occurring. 
Although platelet All binding was. higher in the 
pre-eclampsia group than in the patients wi th non-
proteinuric PIH, the difference was not significant. 
This is in marked contrast to the significant 
differences in certain of the haematological, 
biochemical and in particular the. hormonal parameter,s 
(all discussed below). Moreover, there were highly 
s i g ~ i f ~ c a n t t differences in platelet All bindin'g 
between the normotensive primigravidae and both of the 
PIH subgroups. As discussed in the Introduction 
(Sections 1 and ·3), the majority of the 
haematological, biochemical and hormonal differences· 
between normotensive and hypertensive pregnant women 
are only apparent shortly before, or indeed after, the 
rise in blood pressure. If the differences in 
platelet All binding are more fundamental, occurring 
at a much earlier gestation, this suggests a link 
between the aetiology of non-proteinuric PIH and pre-
eclampsia. The finding that in women with fulminating 
pre-eclampsia, the levels of platelet All binding were 
no higher bhan in the other PIR patients also supports 
this suggestion. 
Only a small number of women with essential 
hypertension were included • In the study. 
Nevertheless, the finding that the values of platelet 
AII binding:in this group approximated to those of the 
normotensive primigravidae and were much lower than 
those of the PIH patients suggests that essential 
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hypertension in pregnancy is an entirely different 
condition to pregnancy-induced hypertension, and 
provides further evidence to support the concept that 
platelet All binding is central to the development of 
pregnancy-induced hypertension. A study of non-
pregnant individuals also found that values of 
platelet All binding in normotensive subjects were 
similar to those of individuals with essential 
hypertension [Ding, Kenyon and Semple, 1985]. 
As outlined in the Introduction (Section 3, p. 49), 
there is some consensus that in pre-eclampsia, 
activity of the renin-angiotensin system is-suppressed 
[e.g. Symonds and Andersen, 1974], whilst in mild non-
proteinuric PIH, activity is increased [e.g. Symonds, 
Broughton Pipkin and Craven, 1975]. The results of 
this study confirm that the renin-angiotensin s y s t e ~ ~
is suppressed' in pre-eclampsia, and although no 
evidence of activation in non-proteinuric PIH was 
found, differences between the two PIH subgroups were, . 
indeed, demonstrated. 
The two studies described in this thesis, and that 
of Pawlak and Macdonald [1990], all failed to 
demonstrated any correlation between platelet All 
binding and any of the hormonal parameters, in the PIH 
patients in the third trimester. This is in contrast 
to the correlations, discussed in the- previous 
chapter, found in normotensive third trimester 
subjects. That in these women, regulation of platelet 
All binding must be more complex than straightforward 
down-regulation by plasma All, i.s emphasised by the 
non-proteinuric PIH patients. Although the median 
value of platelet All binding in this group was almost 
six times that of the normotensive third trimester 
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subjects, plasma All levels in the two groups were 
similar. 
Platelet pathophysiology in pregnancy-induced 
hypertension has been discussed in the Introduction 
(Section 7, p 103). The decreased platelet number, 
increased MPV and increased PDW found in pre-eclamptic 
patients in this study, have previously been 
demonstrated on numerous occasions [e.g. Giles and 
Inglis, 1981], the increased MPV and increased 
megakaryocytes found in the bone marrow [Thiagarajah, 
Bourgeois, Harbert and Candle, 1984] indicating 
increased platelet turnover. Only one of the PIH 
patients was thrombocytopaenic (defined as a platelet 
count of less than 100 x 109/L). This probably 
reflects . the exclusion of the most severely affected 
individuals, who were delivered b.efore t h ~ ~ twenty four 
hours necessary to make the diagnosis. 
It seems most unlikely that d i f f e ~ e n c e s s in any of 
the measured p l a t e l e ~ ~ parameters between the two 
groups were responsible for -the differences in 
platelet All binding. -No correlation between platelet 
All binding and any of the platelet parameters was 
found in any of the groups. In addition, values of 
platelet All binding were not a ~ f e c t e d d by donation of 
large volumes of blood, another situation in which 
platelet turnover is increased (Chapter 2, p. 125). 
Louden, Heptinstall, Broughton Pipkin, Mitchell and 
Symonds [1988] demonstrated that adrenaline-induced 
platelet aggregation was increased in both non-
proteinuric PIH patients and women with pre-eclampsia. 
This finding is consistent with the elevated levels of 
platelet.AII binding in these groups, Poplawski [1970] 
and Ding, MacIntyre, Kenyon and Semple [1985] having 
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demonstrated a potentiation of the adrenaline-induced 
platelet aggregation by All. 
A possible mechanism by which platelet All binding 
is increased in PIH has been suggested by Gleeson, 
Ahmed, Rice-Evans and Elder [1990]. Gleeson et. ale 
[1990] have sugges ted that' the pla tele t membrane in 
women with pre-eclampsia has an inherited or acquired 
defect, perhaps due to a change in the phospholipid 
content ratio and glycocalyx structure on the surface 
of the platelet membrane, which causes an increase in 
membrane viscosity. It is believed that alterations 
in cell membrane fluidity can affect the accessibility 
of cell membrane proteins which act as binding sites. 
Increasing the viscosity of a cell membrane decreases 
its capacity to solubilise integral proteins, 
displacing the proteins t ~ w a r d s s tpe aqueous phase on 
e i t ~ e r r side of'the membrane [Borochov and Shinitzky, 
1976]. This 'vertical displacement' of membrane' 
proteins may thus allow previo,usly concealed binding 
sites to be unmasked. 
Platelet membrane fluidity can be modified in vivo 
and in vitro. Dietary n-3 polyunsaturated fatty 
acids, which decrease membrane viscosity, inhibit 
platelet aggregation [Vas Dias, Gibney and Taylor, 
1982] and enrichment of platelet membranes with 
cholesterol· in vitro increases membrane viscosity and 
sensitises platelets to aggregation by ADP and 
adrenaline [Shattil and Cooper, 1976]. In a small 
pilot study, Gleeson et. ale [1990] determined the 
relative membrane viscosity in .. platelets from six 
pregnant women, three of whom had PIH, and three of 
whom were "normotensive controls. They found 
significantly higher platelet membrane viscosity in 
the PIH patients. 
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In this study, the pre-eclampsia group were noted 
to have a significantly lower median creatinine 
clearance (reflecting a reduced glomerular filtration 
rate) than either the normotensive primigravidae or 
the non-proteinuric PIH patients. This finding has 
been noted in the past, with glomerular filtration 
rate and effective renal plasma flow being reduced by 
30% and 20% respectively in pre-eclamptic women 
[Lindheimer, Chesley, Taylor, Spargo and Katz, 1987], 
and may be due to increase4 intrarenal sensitivity to 
All, All having a potent vasoconstricting effect on 
renal vascular smooth muscle [reviewed by Mendelsohn, 
1985, discussed in the Introduction, p. 36J. The 
elevated serum urea and uric acid concentrations, 
found· in this study in the PIH p ~ t i e n t s , , have· also 
been well described previously, being thought to 
reflect a decline in renal function [Redman, Beilin 
. . 
and Bonnar, 1976]. 
In the .pregnant normotensive primigravidae there 
·vas a direct correlation between platelet All binding 
and and the serum sodium concentration (discussed in 
the previous chapter, p. 191). In the third trimester 
PIH patients this correlation was again found, and the 
possibility remains that in pregnancy, it is the serum 
sodium concentration rather than the plasma All level 
which regulates platelet All binding. Consideration 
of possible mechanisms by which such regulation may 
act is included in the General Discussion (Chapter 9, 
p. 239). 
There were very few differences found between any 
of the groups at either. six'or twelve weeks post 
partum (although by definition, the values of systemic 
'"blood pressure were higher in the women with essential 
hypertension). However, the volumes of the 24 hour. 
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urinary collections were significantly lower in the 
normotensive primigravidae than in either of the PIH 
groups. Whils t there may have been poor compliance 
amongst the normotensive primigravidae (discussed in 
the previous chapter, p. 192), suffering a 
complica tion of their pregnancy presumably increased 
the motivation of the PIH patients. 
The use of canonical discriminant analysis 
confirmed the finding of the pilot study, in that 
platelet All binding appears to have only limited 
potential as a marker for PIH. Although combining the 
three parameters produced the highes t proportion of 
correctly predicted outcomes, both MPV a n ~ ~ serum urate 
estimations proving better at discriminating between 
normotensive third trimester women and those with 
establi,shed PIH. Interestingly, these results when 
platelet All binding is used in discriminating between 
normotensive primigravidae and women with established 
PIH . are very similar to those achieved when the All 
infusion test (discussed in the Introduction, p. 14)· 
was used to predict whether PIH would develop in 
pregnancy. Oney and Kaulhausen [1982] found a false 
positive rate of 55% in European women using the All 
infusion test, although the false negative rate was 
only 5%. 
In normotensive pregnancy, the diminution in 
platelet All binding parallels closely the diminution 
in pressor sensitivity to All [Gant, Daley, Chand, 
Whalley and Macdonald, 1973, discussed in the 
Introduction p. 14 and p. 50]. If the same is true of 
pregnancies complicated byPIH, "and the data from the 
two longitudinal patients whose pregnancies were 
-complicated by PIH suggests that this is so, then the 
increased platelet All binding as compared to 
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normotensive pregnant women should be detectable well 
before the clinical development of PIH. The potential 
use of the technique as a screening test for PIH may 
thus be much greater. 
To investigate this possibility, it was decided to 
perform both the platelet All binding estimation and 
the All pressor sensitivity test in a group of 
normotensive, primiparous pregnant women, in order to 
establish whether co-linearity between the two methods 
existed, and to assess the success of each test in 
predicting the outcomes of the pregnancies. This 
study is described in.the next chapter. 
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Chapter 8. 
PARALLEL STUDIES OF PLATELET All BINDING AND 
All PRESSOR RESPONSIVENESS. 
This chapter describes a study of the relationship 
between platelet angiotensin II (All) binding and the 
pressor responsiveness to All (as indicated by the All 
sensitivity test, discussed in the Introduction, p. 
14). This relationship was studied in a group of 
pregnant women, and in a smaller group of non-pregnant 
women. By comparing the results of the two techniques 
obtained from the pregnant subjects, and by following-
up the outcomes of the pregnancies, the potential of 
the two methods as screening tests for pregnancy-
induced hypertension (PIH) could also be assessed. 
Study sample. 
Pregnant subjects. 
Primiparous pregnant women, in whom an initial 
diastolic blood pressure recording of 80-85 mmHg. was 
made at their second antenatal clinic visit (at the· 
University Hospital, Nottingham this is at 28-32 weeks 
gestation), were asked if they would participate in 
the study. 37 patients were thus recruited. However, 
the arterial blood pressure of three subjects failed 
to stabilise prior to the All infusion (as detailed in 
the protocol below), and these patients were excluded 
from the study. The diastolic blood pressures of all 
the remaining 34 pregnant subjects settled to <70 
mmHg. p r i o ~ ~ to the All infusion. 
None of the 34 pregnant women were known to be 
suffering from renal, metabolic or cardiovascular 
disease. All subjects were receiving sodium intake ad 
libitum and had normal urea, creatinine and 
e l e c t ~ o l y t e e s t i m a t i o n s . . The gestational age of each 
subject was confirmed by an ultrasound scan at 
eighteen weeks gestation. 
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10 of the 34 women developed PIH subsequent to the 
All sensitivity test and the platelet All binding 
estimation (subsequent PIH group). Six of the 
subsequent PIH group developed pre-eclampsia and four 
developed non-proteinuric PIH, the definitions used 
being those described in detail in the Introduction 
(p. 9) • The 0 ther 24 pregnancies remained 
normotensive throughout (normotensive group). In 
order to minimise bias, the results of the experiments 
were not available to the obstetricians responsible 
for the medical care of the patients, and the outcome 
of the pregnancies was assessed by a colleague who 
likewise did not have access to the experimental 
results. 
All of the patients, apart from one Asian subject 
in the normotensive group, were Caucasian. None of· 
the subsequent PIH group were taking any medication 
apart from iron supplementation. Of the normotensive 
group, two patients were using antacids, one was 
taking oral antibiotics and one occasionally used a 
salbutamol inhaler. Two (20%) of the subsequent PIH 
group and three (13%) of the normotensive group 
continued to smoke whilst pregnant. Five patients 
(50%) in the subsequent PIH group gave a history of 
essential hypertension in a first degree relative as 
compared to seven (29%) in the normotensive group. 
Four (40%) of the subjects in the subsequent PIH group 
stated that their mothers had suffered PIH as compared 
to 5 (21%) in the normotensive g r o u p ~ ~
The median maternal ages, b,ooking visit systemic 
blood pressures (at the University Hospital, 
Nottingham, this is at eighteen weeks gestation), 
gestational ages at the time of the infusion, maternal 
weights at the time of the infusion and the systemic 
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blood pressures immediately prior to the infusion, of 
both the normotensive and the subsequent PIH groups, 
are summarised in Table 8.1. 
There were no significant differences in any of 
these parameters when measured at the time of the 
infusion (P)0.05, Mann-Whitney U test). However, the 
booking visit systolic blood pressure was 
significantly higher in the subsequent PIH group 
(P<O.Ol), and the difference· in booking visit 
diastolic blood pressures approached significance (p-
0.02). 
The gestational ages at delivery of the subsequent 
PIH group_ (median 37.5 weeks, 34-39) were 
significantly lower than those of the normotensive 
group (median 40 weeks, 39-41, P<O.Ol, Mann-Whitney U 
. 
test). Of the normotensive group, seven women (29%) 
had a forceps delivery, and two women (8%) were 
. ,." 
delivered by caesarean section (both for fetal 
distress in the first stage of labour); the remainder 
had spontaneous vaginal deliveries. In contrast, in 
the subsequent PIH group, only three women (30%) had 
vaginal deliveries (forceps being used in one case), 
the remainder being delivered by caesarean section. 
The birthweights of the subsequent PIH group (median 
2.86 Kg., 2.29-3.20) ,were significantly lower than 
those of "the normotensive group (median' 3.42 Kg., 
3.19-3.54, P<O.Ol). Ten (42%) of the birthweights in 
the normotensive group were below the 50th centile for 
gestational age, as compared to seven (70%) of the 
birthweights in the subsequent PIH group. Eight (80%) 
of the infants in the subsequent PIH group were male, 
as were fourteen infants (58%) in the normotensive 
group. 
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Table 8.1. 
Maternal ages, booking 
pressures, gestational ages, 
prior !£ the infusion, and 
visit systemic blood 
systemic blood pressures 
maternal weights·!! the 
infusion, of the pregnant subjects. 
The pregnant subjects have been subdivided into those 
patients who remained normotensive following 
investigation, and those who subsequently developed 
PIH. 
Despite the small number of subjects in the PIH 
group, in order to aid comparison between the two 
groups, the interquartile range is quoted in addition 
to the median. 
Table 8.2. 
Ages, systemic blood pressures prior to the 
infusion, and body weights at the infusion, of .the 
non-pregnant subjects. 
Median values are shown, with the range in brackets. 
Table 8.1 
Maternal age 
(years) 
Booking visit systolic 
blood pressure (mmHg.) 
Booking visit diastolic 
blood pressure (mmHg.) 
Gestational age at 
Infusion (weeks) 
Systolic blood pressure 
prior to InfuSion (mmHg.) 
Diastolic blood pressure 
prior to Infusion (mmHg.) 
Maternal weight at Infusion 
(Kg) 
Table 8.2 
Age 
(years) 
Systolic blood pressure 
prior to Infusion (mmHg.) 
DiastOlic blood pressure 
prior to InfUSion (mmHg.) 
Body weight at Infusion 
(Kg) 
Normotensive group 
n=24 
Subsequent PIH group. 
n=10 
24.0 
(21.5-27.0) 
115 
(110-120) 
70 
(60-70) 
32.0 
(31.5-32.5 ) 
117 
(114-122) 
65 
(60-69) 
75.0 
(65.5-82.1 ) 
Non-pregnant group 
n=24 
27.0 
(16.0-44.0) 
115 
(109-129) 
68 
(58-76) 
57.5 
(52.0-73.0) 
24.0 
(19.5-31.5) 
125 
(120-133) 
77 
(70-80) 
30.5 
(28.0-32.0) 
121 
(115-124) 
66 
(61-70) 
78.8 
(71.2-88.4) 
Non-pregnant subjects. 
Ten nulliparous, normotensive Caucasian women were 
recruited into the study. The blood pressure of o.ne 
subject failed to stabilise prior to the i n f u s i o n ~ ~
Nine subjects were thus included in the study. They 
were all investigated between days 5-9 of the 
menstrual cycle. No subject was taking any 
medication, including hormonal contraception. All 
subjects were normotensive and had no history of 
renal, metabolic or cardiovascular disease. All 
subjects were receiving sodium intake ad libitum and 
had normal urea, creatinine and electrolytes. Their 
ages, body weights and systemic blood pressures, at 
the time of the infusions, are summa.rised in Table 
8.2. In view of t h ~ ~ small sample size, the range of 
values are quoted rather . than the 25th and 75.th 
centiles. 
Protocol. 
The protocol used was that of Broughton Pipkin, 
Hunter, Turner and O'Brien [1982], with only minor 
modifications. It is described in brief below. 
The subjects lay supine throughout the experiment, 
a pillow being placed under the pregnant subjects to 
support a right l a t e r ~ . l l tilt. Indwelling cannulas 
(Venflon, 16G on the left side and 18G on' the right 
side) were placed in both antecubital fossae. Normal 
saline solution was infused continuously at 
approximately 30 drops/minute via the right arm. The 
cannula in the left arm was used solely for blood 
sampling. Arterial blood pressure was measured at 2 
minute intervals from the left arm using a Dinamap 
automatic blood ·pressure recorder (Critikon Ltd., 
Ascot, U.K.). 
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Arterial blood pressure was allowed to stabilize 
for a minimum of 30 minutes after setting up, until 
random fluctuations in diastolic blood pressure had 
been within 6 mmHg. for 10 minutes. An initial blood 
sample, for measurement of platelet All binding, 
plasma All, plasma renin concentration (PRC), plasma 
renin substrate (PRS), serum urea, creatinine and 
electrolytes and full blood count, was taken at this 
point. (Details of the determination of these 
parameters are included in Chapter 2, p. 118). 
After a further 10 minutes, provided that the blood 
pressure had r e s t a b i l i ~ e d , , All was infused 
intravenously via a needle connection into the 
indwelling cannula of the ~ i g h t t arm, so that it was 
flushed in by the saline infusion. The All was made 
up freshly each 'day from dry ampoules of 2.5 mg; the 
stock solution was then stored on "ice. This was 
infused with a Vickers pump (Vickers Medical Ltd., 
Basingstoke, U.K.). Doses of All given were 4, 8, 16, 
32,48 and 64 ng/kg/minute to p ~ e g n a n t ' p a t i e n t s s and 1, 
2, 4, 8 and 16 ng/kg/minute to non-pregnant subjects. 
Each infusion step lasted 10 minutes. At the end of 
the third step a further blood sample was taken for 
plasma All, PRC and PRS estimation. The All infusion 
was discontinued after the last planned infusion step, 
or earlier if a 20 mmHg. rise in' diastolic blood 
pressure h ~ d d been achieved. After a period of 30 
minutes recovery and stabilisation of blood pressure, 
a third blood sample was obtained, again for plasma 
All, PRC and PRS estimation. 
Infusion parameter calculations • 
.. The basal systolic and diastolic blood pressures 
were calculated using the stable blood pressures 
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bracketing the infusion. The pressor response to All 
was calculated as the mean systolic or diastolic blood 
pressure over the last six minutes of each infusion 
step. The absolute evoked change was than calculated 
by comparison with the baseline. 
,-
Response thresholds were calculated for both 
diastolic and systolic blood pressures, for each 
patient, as being the doses of All required to evoke 
both a 5 mmHg.' and a 20 mmHg. rise in blood pressure. 
For this purpose the linear relationship between 
log10AII infused and evoked rise in blood pressure: 
y == a + bx 
was used, where y == evoked r e s p ~ : > n s e e (mmHg.), Ii == 
intercept on the y axis, b == slope from the curve 
relating pressor response to the infused dose of All, 
and x == infused dose of All (10g10). This method has 
previously been used by other workers investigating 
the pressor effect of All [Chinn and Dusterdieck,-
1972]. 
Figure 8.1 provides an illustration, using. one 
representative subject, of the calculation of the 
doses of All required to produce a 20 mmHg. rise in 
systolic blood pressure (TS20), and in diastolic blood 
pressure (TD20). Figure 8.1 also demonstrates the 
calculation of the slope from the curve relating 
pressor response (systolic 5L05, diastolic, 5LOD),. to 
the infused dose of All. 
RESULTS. 
Hormonal data. 
Pregnant subjects. 
The median values of plasma angiotensin II (All), 
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Figure 8.1. 
Calculations derived from the All infusion pressor 
dose response curves. 
This figure illustrates, using one representative 
subject, the calculation of the doses of All required 
to produce a 20 mmHg. rise in systolic blood pressure 
(TS20), and in diastolic blood pressure (TD20). The 
figure also demonstrates the calculation of the slope 
from the curve relating pressor response (systolic 
SLOS, diastolic SLOD), to the infused dose of All. 
Figure 8.1 
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plasma renin concentration (PRe) and plasma renin 
substrate (PRS), immediately prior to the infusion, at 
the third infusion step, and following the infusion, 
are summarised in Table 8.3. 
There was a significant rise in plasma All levels 
as a result of the 16 ng All/kg/min infusion in both 
the subsequent PIH group (P(O.Ol, Wilcoxon matched-
pairs signed-ranks test) and the normotensive group 
(P(O.OOl). Plasma All levels following the infusion 
were significantly lower than those at the 16 ng 
All/kg/min infusion step in the normotensive group 
(P(O.OOl), with the difference approaching 
significance in the subsequent PIH group (p- 0.015). 
There were no significant differences between the 
plasma All levels measured immediately prior to the 
infusion as compared to those found f o l l o ~ i n g g the 
infusion (for each group P>O.l). These changes in 
plasma All levels are illustrated in Figure 8.2. 
There were no significant changes in the levels of 
PRe or PRS in either group, although' in the 
normotensive group, the fall in PRe from that 
immediately prior to the infusion to that at the 1.6 ng 
All/kg/min infusion step approached significance (p-
0.04). 
There were no significant differences between the 
levels of any of the hormonal parameters in the 
subsequent PIH group as compared to the normotensive 
group, at any stage (P>O.l, Mann-Whitney U test). 
Non-pregnant subjects. 
The median values of plasma All, 
immediately prior to the infusion, 
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PRe and 
at the 4 
PRS 
ng 
Table 8.3. 
Values of the hormonal parameters in the pregnant 
subjects, prior to the infusion, at the third 
infusion step, and following the infusion. 
The pregnant subjects have been subdivided into those 
patients who remained normotensive following 
investigation, and those who subsequently developed 
PIH. 
Despite the small number of subjects in the PIH 
group, in order. to aid comparison between the two 
groups, the interquartile range is quoted in addition 
to the median. 
Table 8.4. 
Values of the hormonal parameters in the non-pregnant 
subjects, prior to the infusion, at the third 
infusion step, and following the infusion. 
Median values are shown, with the range in brackets. 
Table 8.3 
Normotensive group Subsequent PIH group 
All {Rg/mll 
Prior to Infusion 34.1 
At 16 ng All/kg/min 107.5 
Following Infusion 19.5 
PRC eng Allhr/mll 
Prior to Infusion 
At 16 ng All/kg/min 
Following Infusion 
PRS (ug Allml) 
Prior to Infusion 
At 16 ng AIl/kg/min 
Following InfUSion 
Table 8.4 
All (Rg/mn 
Prior to Infusion 
At ~ ~ ng AIl/kg/min 
Following Infusion 
PRC (ng Allhr/mll 
Prior to Infusion 
At 4 ng All/kg/min 
Following infusion 
PRS (ug AI/mil 
Prior to Infusion 
At 4 ng AIl/kg/min 
Following infusion 
3.8 
2.8 
3.0 
3.3 
3.0 
3.1 
n=24 
(19.4-48.9) 36.2 
(58.0-205.0) 146.1 
(15.8-43.0) 14.2 
(3.5-6.2) 3.1 
(2.4-4.4) 2.1 
(2.3-4.0) . 2.8 
(2.8-3.7) 3.2 
(2.6-3.6) 3.4 
(2.6-3.5) 3.8 
Non-pregnant subjects 
n=9 
15.4 (9.9-28.8) 
52.3 (34.5-106.7) 
15.8 (10.0-35.0) 
2.8 (0.7-3.5) 
1.5 (0.5-2.5) 
1.5 (0.4-2.3) 
1.0 (0.6-1.2) 
1.1 (0.5-1.5) 
0.8 (0.7-1.3) 
n=10 
(16.0-49.1 ) 
(70.1-193.0) 
(9.6-83.3) 
(2.2-6.9) 
(1.7-3.9) 
(2.4-3.3) 
(2.4-3.9) 
(2.8-3.9) 
(3.0-4.3) 
Figure 8.2. 
Plasma Angiotensin II (All) levels prior ~ ~ during, 
and following the All infusion, in the pregnant 
subjects. , 
Median values are shown, with the interquartile range 
marked. 
The pregnant subjects have been subdivided into those 
patients who remained normotensive following 
investigation, and those who subsequently developed 
PIH. 
Figure 8.3. 
Plasma Angiotensin II (All) levels prior ~ ~ during, 
and following the All infusion, in the non-pregnant 
subjects. 
Median values are shown, with 'the range marked. 
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AII/kg/min infusion step and following the infusion, 
are summarised in Table 8.4. 
The levels of plasma All at the 4 ng All/kg/min 
infusion step were significantly higher than both 
those measured before the infusion (P<O.Ol, Wilcoxon 
signed-ranks matched pairs test), and those measured 
following the infusion (P<O.Ol). The levels of plasma 
All found following the infusion did not differ 
significantly from those measured prior to the 
infusion (P)O.5). These changes in plasma AII levels 
are illustrated in Figure 8.3. There were no 
significant changes in the levels of PRe or PRS 
(P)O.l). 
Haematological and biochemical data. 
~ r e g n a n t t subjects. 
The median values of platelet count, mean platelet 
volume (MPV), platelet distribution ·width (PDW) , 
haemoglobin concentration (Hb) and haematocrit at the 
time of the infusion are summarised in Table 8.5. 
There were no significant differences between the 
subsequent PIH group and the normotensive group in any 
of the haematological parameters (P)O.OS). 
The median values of serum sodium, potassium, urea, 
creatinine,) urate and 'osmolality at the time of the 
infusion are summarised in Table 8.6. There were no 
significant differences between the subsequent PIH 
group and the normotensive group in any of the serum 
biochemical parameters (in each case P)O.2, Mann-
Whitney U test). 
Non-pregnant subjects. 
The median values (range) of platelet count, MPV, 
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Table 8.5. 
Values of the haematological parameters in the 
pregnant subjects. 
The pregnant subjects have been subdivided into those 
patients who remained normotensive following 
investigation, and those who subsequently developed 
PIH. 
Despi te the small number of subjects in the PIH 
group, in order to aid comparison between the two 
groups, the interquartile range is quoted in addition 
to the median. 
Table 8.6. 
Values of the biochemical parameters in the pregnant 
subjects. 
The'pregnant subjects have been subdivided into those 
patients who remained normotensive following 
investigation, and' those who subsequently developed 
PIH. 
Despite the small number of subjects in the PIH 
group, in order to aid comparison' between the two 
groups, the interquartile range is quoted in addition 
to the median. 
Table 8.5 
Normotensive group Subsequent PIH group 
n=24 n=10 
Platelet count 186.0 189.0 
(x 109 IL) (157-242) (149-226 ) 
Mean platelet volume 8.1 8.6 
(f1 ) (7.9-8.8) (7.7-9.3) 
Platelet distribution 16.0 17.4 
width (15.2-16.5) (15.4-17.9) 
Haemoglobin concentration 10.6 11.0 
(g/dl) (10.1-11.3) (10.5-11.6) 
Haematocrlt 0.32 0.33 
(0.30-0.34) (0.31-0.35) 
Table 8.6 
Normotensive group Subsequent PIH group 
n=24 n=10. 
Sodium 136 137 
(mmoIlL) (134-138) (136-137) 
Potassium 4.0 4.0 
(mmoi/L) (3.8-4.2) (3.8-4.1 ) 
Urea 2.3 2.0 
(mmol/l) (1.9-3.3) (1.1-2.7) 
Creatinine 57 59 
(umol/I) (49-66) (52-72) 
Urate 206 197 
(umolll) (171-259 ) (195-273) 
Osmolality 277 278 
(osm/L) (274-280) (278-280) 
PDW, Rb and haematocrit at the time of the infusion 
are summarised in Table 8.7. The median values 
(range) of serum sodium, potassium, urea, creatinine, 
urate and osmolality at the time of the infusion are 
summarised in Table 8.8. 
Platelet All binding data. 
Pregnant subjects. 
The median value of platelet All binding in the 
normotensive group was 1.0 fmol/l09 cells (0-3.4). 
Platelet All binding was significantly higher in the 
subsequent.PIR group (6.7 fmol/l09 cells, 3 . 3 - ~ 1 . 3 , , P-
0.001, Mann-Whitney U test). The differing values of 
platelet Ail binding in the two groups are illustrated 
in Figure 8.4. 
. . 
No significant correlations were found in either 
group, between platelet All binding and any of the 
hormonal, haematological. or biochemical parameters, 
although in the subsequent PIR group the inverse 
correlation between platelet All binding and PRe 
approached significance (P<0.02, rs· -0.75, Spearman 
correlation coefficient). 
No significant differences were found in platelet 
All binding when the pregnant subjects were divided on 
the basis "of infant sex (P)0.05, Mann-Whitney U test) 
or on the basis of birthweight below either the 50th 
centile (P)O.l) or the 10th centile (P)O.l). 
Non-pregnant subjects. 
The median value of platelet All binding was 4.9 
fmol/l09 cells (range 0.7-8.5). The only significant 
correlation between platelet All binding and any of 
the hormonal, haematological or biochemical parameters 
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Table 8.7. 
Values of the haematological parameters in the non-
pregnant subjects. 
Median values are shown, with the range in brackets. 
Table 8.8. 
Values of the biochemical parameters in the non-
pregnant subjects. 
" 
Median values are shown, with the range in brackets. 
Table 8.7 
Platelet count 
(x 109 IL) 
Mean platelet volume 
(fl) 
Platelet distribution 
width 
Haemoglobin concentration 
(g/dl) 
Haematocrlt 
Table 8.8. 
Sodium 
(mmol/I) 
Potassium 
.-
(mmol/I) 
Urea 
(umolll) 
Creatinine 
(umol/I) 
Urate 
(umol/I) 
Osmolality 
(osmll) 
Non-pregnant group 
n=24 
197.0 
(156.272) 
7.8 
(7.5-9.2) 
15.3 
(14.0-17.0) 
11.4 
(9.9-12.2) 
0.33 
(0.29-0.35) 
Non-pregnant group 
n=24 
139 
(134-141 ) 
4.1 
(3.6-4.2) 
4.5 
(3.1-6.0) . 
69 
(58-80) 
250 
(182-294) 
282 
(277·286) 
Figure 8.4 •. 
Comparison of platelet All binding in those pregnant 
patients· who remained normotensive and those who 
subsequently developed PIH. 
Median values are indicated by a horizontal bar. 
Platelet All binding correctly classified 79%' of 
patients. 
Figure 8.5. 
Comparison of the 
(SLOO) in those 
normotensive and 
PIH. 
slope of 
pregnant 
those who 
I . 
the pressor response 
patients who remained 
subsequently developed 
Median values are indicated by a horizontal bar. 
The slope of the diastolic pressor response correctly 
classified 63% of patients. 
Figure 8.4 
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was between platelet All binding and MPV (P<O.Ol, rs= 
0.81, Spearman correlation coefficient), although the 
correlation with serum sodium concentration approached 
significance (P= 0.04, rs= 0.67). 
All infusion parameters. 
Pregnant subjects. 
The median values of the rises in systolic and 
diastolic blood pressure at 16 ng All/kg/min, the 
slopes of the curves relating pressor response to 
infused All (systolic SLOS, diastolic SLOD) , and the 
doses of All required to produce both a 5 mmHg. rise 
in blood pressure (systolic TS5, diastolic TD5) and a 
20 m m H g ~ ~ rise in blood pressure (systolic TS20, 
diastolic TD20), are summarised in Table 8.9, with the 
values of the SLOD being illustrated in Figure 8.5. A 
. 
20mmHg. rise in systolic blood pressure was achieved 
in 13 (54%) of the normotensive group and 6 (60%) of 
the subsequent· PIH group, with a 20 mmHg. rise in 
diastolic blood pressure being achieved in 12 (50%) of 
the normotensive group and 7 (70%) of the subsequent 
PIH group. 
There were no significant differences between the 
subsequent PIH group and the normotensive group when 
any of the infusion parameters were considered (P>O.l, 
Mann-Whi tney Utes t) •. 
When all the pregnant patients were considered, 
there was a significant correlation between platelet 
All binding and the SLOD ( P < O . ~ l , , rs· 0.54, Spearman 
correlation coefficient), with the correlation between 
platelet All binding and the SLOS approaching 
"significance (p. 0.03, rs= 0.41). When the pregnant 
patients were subdivided, in the normotensive group, 
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Table 8.9. 
Values of the infusion parameters in the pregnant 
subjects." 
The pregnant subjects have been subdivided into those 
patients who remained normotensive following 
investigation, and those who subsequently developed 
PIH. 
Despite the small number of subjects in the PIR 
group, in order to aid comparison between the two 
groups, the interquartile range is quoted in addition 
to the median. 
Table 8.9 
Systolic BP rise at 
16 ng All/kg/min (mmHg.) 
Diastolic BP rise at 
16 ng All/kg/min (mmHg.) 
SLOS 
SLOD 
TSS 
(ng All/kg/min) 
TS20 
(ng All/kg/min) 
TDS 
(ng All/kg/min) 
TD20 
(ng All/kg/min) 
Normotensive group 
n=24 
10.7 
(7.3-14.1) 
13.4 
(7.9-16.0) 
17.6 
(13.2-22.5) 
13.5 
(11.5-22.2) 
5.8 
(4.1-8.3) 
30.8 
(20.4-S2.1 ) 
3.5 
(1.8-6.7) 
27.3 
(12.6-39.7) 
Subsequent PIH group 
n=10 
12.1 
(6.5-17.1) 
12.7 
(10.3-23.1) 
18.5 
(16.2-27.7) 
18.9 
(15.3-22.4) 
6.4 
(4.4-7.3) 
29.8 
(15.3-36.1) 
4.9 
(3.6-7.2) 
28.9 
(14.2-31.3) 
the correlations between platelet All binding and both 
the,SLOD (p. 0.03, rs· 0.49) and the SLOS (p. 0.02, 
rs· 0.51) approached significance. In the subsequent 
PIH group there was a significant correlation between 
platelet All binding and the SLOD (P(O.Ol, rs· 0.86), 
with the correlation between platelet All binding and 
the rise in systolic blood pressure at 16 ng 
All/kg/min approaching significance (p. 0.04, rs· 
0.70). No other correlations between platelet All 
binding and any of the infusion parameters were found 
(P)O.l). 
Non-pregnant subjects. 
,The median values of the rises in, sys tolic and 
diastolic blood pressure· at 4 ng All/kg/min, the 
.slopes of the curves rel.ating pressor response to 
infused All (systolic SLOS, diastolic SLOD) , and the 
doses of All required to produce both a 5 mmHg. rise 
in blood pressure (systolic TS5, diastolic TD5) and a 
20· mmHg. rise in blood pressure (systolic TS20, 
diastolic TD20), are summarised in Table 8.10. A 20 
mmHg. rise in systolic blood pressure was achieved in. 
6 (66%) subjects with a 20 mmHg. r i s ~ ~ in diastolic 
blood pressure being achieved in 7 (78%) subjects. 
No correlations were found between platelet All 
binding and any of the infusion parameters (in each 
case P)O. 2') • 
Discriminant analysis. 
The use of platelet All binging as a prospective 
screening test, i.e. to predict the subsequent 
development of PIH, was assessed using canonical 
discriminant analysis (discussed on p.160). There was 
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Table 8.10. 
Values of the infusion parameters in the non-pregnant 
subjects. 
Median values are shown, with the range in brackets. 
Table 8.10 
Systolic BP rise at 
. 4 ng All/kg/min (mmHg.) 
Diastolic BP rise at 
4 ng All/kg/min (mmHg.) 
SLOS 
SLOD 
' .. 
TS5 
(ng All/kg/min) 
TS20 
(ng All/kg/min) 
TD5 
(ng All/kg/min) 
TD20 
(ng All/kg/min) 
Non-pregnant subjects 
n=9 
9.7 
(4.8-16.9) 
12.9 
(5.8-18.7) 
18.8 
. (14.4-40.2) 
13.2 
(7.5-22.2) 
1.8 
(1.1-4.5) 
11.2 
(3.8-17.8) 
0.8 
(0.2-1.8) 
12.5 
(3.6-20.4) 
a false positive rate of 40% and a false negative rate 
of 16%, 77% of patients being correctly classified. 
When the hormonal, haematological and biochemical 
parameters measured at the time of the infusion were 
used to discriminate between those patients who would 
subsequently develop PIH and those who would remain 
normotensive, in each case, less than 60% of patients 
were correctly classified. In particular, serum urate 
and MPV correctly classified only 51% and 59% of 
patients correctly. The systemic blood pressure 
measured at the time of the infusion was also 
unsuccessful in discriminating between the two groups. 
However, when the booking ~ i s i i t sys tolie blood 
pressure was, used to discriminate between the two 
groups, there was,a false positive rate of ~ O % % and a 
f?lse negative rate of 50%, 62% of patients being· 
correctly classified, and when the booking visit 
diastolic blood pressure was used, there was a false 
positive rate of 40% and a false negative rate of 21%, 
74% of p a t i e ~ t s s being correctly ·'classified. The 
results of such discriminate ~ n a l y s i s s were improved 
when platelet All binding was combined with either the 
booking visit systolic blood pressure (89% .correct 
classification, 30% false positive rate, . 4% false 
negative rate) or the booking visit diastolic blood 
pressure (79% correct classification, 30% false 
positive rate, 17% false negative rate). 
None of the infusion parameters was as effective in 
discriminating between the two groups as platelet All 
binding, the most successful .?eing the SLOD (63% 
correct classification, 37% false negative and false 
posi tive rates). However, combining the TS20 with 
~ l a t e l e t t All binding produced the highest proportion 
of correctly classified patients of any parameter or 
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combination of parameters (90% correct classification, 
16% false positive rate, 7% false negative rate). 
Discussion. 
Two important conclusions can be drawn from the 
parallel studies of All pressor sensitivity and 
platelet All binding. The first concerns the close 
correlation which was found between platelet All 
binding and the slopes of both the diastolic and the 
systolic pressor responses to All, in the pregnant 
subjects. T ~ i s s correlation" provides support for the 
use of p l a t e ~ e t t All binding 'as a model for vascular 
smooth muscle sensitivity. Sec9ndly, although a 
marked overlap was found when platelet All binding was 
used as a predictive test fo+ PIH, the results using 
platelet All btnding were better than those u s i n g ~ n i i
of the parameters derived from the ~ I I I sensitivity 
test. 
The incidence of PIH a m ~ n g s t t primigravid women in 
this centre (University Hospital, Nottingham), using 
the definition detailed in the Introduction (p. 9), 
has been found to be as low as 5% [Baker and Kilby, 
unpublished data]. In an effort to increase the 
proportion of patients studied, who subsequently 
developed "PIH, women' in whom a diastolic blood 
pressure of 80-85 mmHg. was initially recorded at 
their second antenatal clinic visit, were selected. 
The previous work of Friedman and Neff [1977], who 
suggested that a diastolic blood pressure greater than 
75 mmHg. led to an increased incidence of PIH, was 
therefore confirmed; approximately one third of the 
patients entered into this study subsequently 
developed PIH. The selection of this particular 
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population could be criticised, in that at the time of 
recruitment to the study, the definitions of PIH used 
by certain authors [e.g. Chesley, 1976] had already. 
been fulfilled. However, it must be stressed that 
prior to the infusion, the blood pressures of all the 
subjects settled to levels well below any pathological 
thresholds, that two thirds of the patients 
subsequen tly had uncomplicated pregnancies and tha t 
none of the platelet counts, serum urate estimations 
etc. were found to be elevated. It thus seems likely 
that the subjects studied are representative of the 
primigravid pregnant population, but a much larger 
study would be needed to confirm this. Furthermore, 
the selected patient. group do represent a particular 
clinical problem, i.e. whether to ignore an. initial 
elevated blood pressure recording if the blood 
pressure s u b s e q u ~ n t l y y s ~ t t 1 e s . . This study suggests 
that this group of patients is at a high .risk of 
developing PIH and should be offered any suitable 
screening test. 
When this study was commenced, the implications of 
the studies discussed earlier in the thesis, that 
differences in platelet All binding in normotensive 
and hypertensive pregnant women might be apparent at a 
much earlier ges.tation, had not become fully apparent. 
If the fall in. platelet All binding in normotensive 
pregnancy" does occur by eighteen w e e k ~ ~ gestation 
(Chapter 6, p. 171), and if the elevated levels of 
platelet All binding in PIH are due to this early 
gestation diminution in binding not occurring (Chapter 
7, p. 210), then a study of platelet All binding at 
the antenatal booking visit might be more appropriate. 
The rationale for the use of platelets as a model 
for vascular myocytes has been outlined in the 
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Introduction (p. 108). The correlations found in 
pregnant women, between platelet All binding and the 
slopes of the pressor response to All support the use 
of platelet All binding as a model of vascular smooth 
muscle, and suggest that the elevated platelet All 
binding in PIH does reflect elevated myocyte All 
binding. That the strongest correlations were found 
with the slopes of the curves relating pressor 
response to the infused dose of All is perhaps not 
surprising. Considerable debate had arisen from 
previous studies [Nakamura, Ito, Matsui, Yoshimura, 
Kawasaki and Maeyama, 1986, Dekker, Makovitz and 
Wallenburg, 1990], as to the most appropriate 
threshold rise in blood pressure. Use of the slopes 
of the pressor responses resolves this, uncertainty. 
Moreover, in this study, some of the subjects failed 
to attain the 20 mmHg. threshold rise in blood 
pressure. 
The results ootained from the parallel studies in 
the non-pregnant women appear to conflict with other 
results presented in the thesis, and presumably were 
as a consequence of the very small sample size of this 
group. No significant correlations were found between 
platelet All binding and the infusion parameters, and 
it would be difficult to postulate a model whereby 
platelet All binding reflected vascular smooth muscle 
All 'pressor responsiveness in pregnant women but not 
in non-pregnant women. In addition, the significant 
correlation that was found, that between platelet All 
binding and mean platelet volume (MPV) , was not found 
in any of the larger studies .. of pregnant· or non-
pregnant women presented in earlier chapters, with 
changes inMPV resulting from blood donation not being 
associated with changes in platelet All binding (see 
p. 125). The entry criteria for the non-pregnant 
-231-
subjects in this study were exacting, and it proved 
more difficult to recruit subjects than had been 
anticipated. Nevertheless, parallel studies involving 
a larger number of non-pregnant subjects are 
necessary, even if this requires a relaxation of 
certain of the entry criteria. 
From a pragmatic viewpoint, the most important 
conclusion that can be drawn from this study, is the 
confirmation of the potential use of platelet All 
binding as a screening test for PIH. The false 
positive and false negative rates obtained when 
platelet All binding was u s ~ d d as a prospective 
discriminant were very similar t . ~ ~ those obtained when 
platelet All binding was used .to discriminate women 
with established PIa from normotensive primigravidae. 
However, the potential use of the technique .as a 
screening test"-is greater than its potential use as a 
marker for PIH, because parameters such as. MPV and 
serum urate which effectively discriminated women with 
established PIH from normotensive pregnant women, were 
not effective on a prospective basis. 
As discussed in the Introduction (p. 52), the All 
sensitivity test is widely regarded as one of the most 
accurate predictors of PIH [e.g. Wallenburg, Dekker, 
Makovitz and Rotmans, 1986]. However, a search of the 
literature revealed only five small studies [Morris, 
O'Grady, Hamilton and Davidson, 1978, Orozco, Pinsker, 
Hernandez and Karchmer, 1979, Oney and Kaulhausen, 
1982, Nakamura, Ito, Matsui, Yoshimura, Kawasaki and 
Maeyama, 1986, Dekker, Makovitz and Wallenburg, 1990] 
which assessed the validity of'· the original work by 
Gant, Daley, Chand, Whalley and MacDonald [1973]. All 
"of these studies found a considerable false positive 
rate, with, depending on. the thresholds used, typical 
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rates of 45-55%, the exception being the study of 
Morris et. ale [1978], in which the false positive 
rate was 93%. In this study, using SLOD, the 
parameter derived from the infusion studies which was 
found to be the most effective discriminant, the false 
positive rate was 37%. In contrast, the 37% false 
negative rate for the All 'sensitivity test found in 
this study was higher than that of any of the previous 
studies, with all the studies except that of Morris 
et. ale [1978] finding a false' negative rate rate 
below 10%. 
None of the above studies were able to duplicate 
the very low false positive a n ~ ~ false negative rates 
found ~ n n t h ~ ~ original report [Gant et. al., 1973], 
which as discussed in the Introduction (p. 5q), may be 
due to the particular Dallas population studied. Even' 
aLfter achieving' considerably better results with the 
All sensitivity test than those of this study, Oney 
and Kaulhausen [1982]' concluded that the, test could 
not be recommended for routine screening for PIH. In 
our hands, as in those of Morr'-s et. al" [1978], the 
assessment of the risk of PIH using the All 
sensitivity test was patently unreliable. T h ~ ~ reason 
for the discrepancy between the results of this study 
and those of Orozco et. ale [1979], Oney and 
Kaulhausen [1982], Nakamura et. ale [1986] and Dekker 
et. al.' [1.990] is unclear. The population in this 
study was similar to that investigated by Oney and 
Kaulhausen [1982] and Dekker et. ale [1990]. The 
studies differ in that not all the above workers 
generated pressor dose response, curves. The use of 
such curves would, however, 'be anticipated to increase 
the predictive accuracy of the test. 
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Nakamura et. ale [1986] argued that that it was 
imprudent to predict the outcome of pregnancy on only 
one performance of the All sensitivity test, and that 
it was preferable to perform the test serially in the 
same patient for accurate evaluation. Whilst this may 
well be a valid criticism of our study the logistical 
difficulties of performing the All sensitivity test on 
one occasion are considerable. Moreover, the high 
platelet All binding coefficients of variation found 
(see p. 126) suggest that the predictive accuracy of 
this technique might also be improved by serial 
estimations. 
The predictive accuracy of platelet All binding in 
assessing the risk of developing PIH was at least as 
great as that previously derived using the All 
sensitivity test (with the exception of the original 
. 
report by Gant et. ale [1973]). Moreover, by 
including the booking visit systemic blood pressure; 
(information readily available), almost a 90% correct 
classification was achieved. Furthermore, unlike the 
measurement of platelet All binding, the All 
sensitivity test had the disadvantage that the failure 
of the blood pressures of certain patients to 
stabilise prior to the infusion caused the test to be 
abandoned in these patients. This problem was also 
reported by Morris et. ale [1978]. 
Therefore, there is an urgent need for a much 
larger study to assess the prospective use of platelet 
All binding in determining the risk of developing PIH. 
Serial estimations of platelet .. AII binding would be 
preferable, as these might i n c r ~ a s e e the accuracy of 
the e v a l u a ~ i o n , , and would indicate the optimal 
gestation to perform the test if a single estimation 
were deemed to be the most cost effective. If the 
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results of such a study were to confirm those of this 
study, then the more invasive, more expensive and more 
time-consuming All sensitivity test would surely be 
redundant. 
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Chapter 9. 
GENERAL DISCUSSION. 
The characterisation studies performed using blood 
from non-pregnant subjects confirmed that human 
platelets possess a single class of angiotensin II 
(All) binding sites which are of high affinity, 
specific, saturable and reversible. The higher 
variability of platelet AIr binding found in the non-
pregnant subjects relative to previous reports [e.g. 
Moore and Williams, 1981] may have resulted from all 
the subjects being female and at day 5-9 of the 
menstrual cycle, maximal variability having been 
demonstrated at this stage of the cycle. Although the 
pregnant subjects in whom characterisation .. studies 
were performed may not have been representative of the 
normotensive population, the preliminary results of 
Pawlak and Macdonald [personal communication] also 
indicate that platelet All binding sites are of high 
. 
affinity, with a dissociation constant similar to that 
of non-pregnant subjects. Although a positive trend 
was suggested, (p. 131, Figure 3.10), no correlation 
was demonstrated between platelet All binding and' the" 
rise in intracellular free calcium after ex vivo All 
--. 
infusion, thus validation of the high affinity 
affinity platelet All binding sites as receptors was 
not achieved. 
The cross-sectional and longitudinal studies of 
platelet" All binding in n o r m o t e n s i v ~ ~ pregnancy 
demonstrated a marked reduction in binding. That this 
diminution in binding occurred at an early gestation 
was confirmed by study of the early pregnancy 
subgroup, with lower levels demonstrable at 5-8 weeks 
gestation. These levels may represent a continuation 
of the low binding found in the luteal phase of the 
"menstrual cycle. These results suggest that the fall 
in platelet All binding in pregnancy parallels the 
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pregnancy-induced fall in All pressor responsiveness 
[Gant, Daley, Chand, Whalley and MacDonald, 1973], and 
. support the use of platelets as a,n accessible model of 
vascular smooth muscle in pregnant women. 
Changes in binding site occupancy are unlikely to 
account for the changes in platelet All binding, the 
All infusions having little effect on levels of 
binding. Changes in platelet All binding due to 
synthesis or degradation of new binding sites seem 
improbable as platelets possess no nuclei and minimal 
protein synthesis capacity. However, the suggestion 
that altered platelet All binding results ··from the 
exposure or concealment of .... presynthesised binding 
sites on the cell membrane would be consistent with. 
the data, with the 'vertical displacement' theory of 
Borochov and S h i ~ i t z k y y [1976] being one possibility 
(discussed in detail in Chapter 7, p. 213). The down-
regulation of insulin receptors has been related to 
this type of· binding site mechanism [Krupp and Lane, 
1981]. 
The fall in platelet All binding levels from those 
of the non-pregnant women to those in pregnancy, which 
were between five and ten fold, put into perspective 
the relatively high coefficients of variation of the 
technique, that were ,reported in the Methods chapter. 
Even in" non-pregnant subjects, the data from this 
study suggests that the number of binding sites per 
platelet is less than ten, (similar numbers of binding 
sites per cell having been reported previously, e.g. 
Ding,Kenyon and Semple [1985]). In view of this low 
c o n c e n t r a ~ i o n n of binding sites per platelet, the 
limi ted reproducibility of the technique, which 
persisted throughout the study, was perhaps not 
unexpected. 
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Once the platelet preparation and platelet binding 
studies had been modified and validated, one advantage 
of the technique used was that the laboratory methods 
were straightforward and easily learnt. Three medical 
students worked in the department at various intervals 
during the study (measuring platelet All binding in 
neonatal platelets), and all three were able to obtain 
satisfactory results, with similar reproducibility to 
that of this study, within a short time period. 
Analysis of the data obtained from the binding 
studies was handicapped by the necessity to use 
distribution-free or non-parametric statistics. 
Although over recent decades there h a ~ ~ been a dramatic 
and expansive development of parametric statistical 
analysis, there have been few developments of non-
parametric statistical tests [Lehmann, 1975]. Very 
. 
considerable statistical advice was received regarding 
each of the studies included in the thesis, in order 
tha t the mos t appropria te non-parame tric tes ts. were 
selected. Nevertheless, there was a loss of 
statistical power as a consequence of the use of n o n ~ ~
parametric statistical analysis; anticipated 
development of non-parametric tests should result in 
·this loss being minimised in future studies. 
The study of the non-pregnant subjects provided 
further ~ y i d e n c e e for -down-regulation of platelet All 
binding by plasma All concentration. The longitudinal 
study of platelet All binding in normotensive 
pregnancy utilised greater statistical power than that 
of the cross-sectional study and suggested that this 
mechanism may also be a factor ~ n n pregnancy. The All 
infusion studies and the lack of any significant 
changes in platelet All binding at 24 hours after 
delivery when the plasma All levels were significantly 
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elevated, suggest that down-regulation by plasma All 
concentration does not exert a short term effect. 
Animal studies using various tissues have provided 
conflicting results. Whereas Schiffrin, Gutkowska and 
Genest [1984] found that short-term All infusions 
reduced All receptor concentrations in mesenteric 
artery fractions, Chevillotte, Rouzaire-Dubois, 
Devynck and Meyer [1976] found that acute pressor 
intravenous injection of All did not affect the number 
of uterine All receptors. Chevillotte et. al. [1976] 
reported that after 24 hours All infusion, the uterine 
All receptor concentration was reduced, and diminished 
A I ~ ~ binding in r a ~ ~ bladder particulate fractions have 
als.o been demonstrated after 2-4 days [Aguilera and 
Catt, 1981]. These differences serve to illustrate 
the dangers of drawing conclusions regarding All 
binding from studies using differing ti.ssues from 
differing species. 
Other regulatory factors may·influence platelet All 
binding in normotensive pregnancy and undoubtedly 
influence binding in pregnancies complica ted by 
pregnancy-induced hypertension (PIH). For example, 
although plasma All concentrations were higher in 
women with non-proteinuric PIH as compared to 
normotensive primigravidae, the same was true of 
platelet All binding in these patients. 
One other possible regulatory factor is the serum 
sodium concentration, a . direct correlation 
persistently being demonstrated in the various studies 
included in the thesis. Indee.d,if the data from the 
cross-sectional, longitudfnal normotensive, 
longitudinal hypertensive and infusion studies are 
"pooled, then amongst subjects in the third trimester 
of pregnancy (n-181), the direct correlation between 
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platelet All binding and serum sodium concentration 
approaches statistical significance (p- 0.15, rs· 
0.19). In contrast, there is no significant inverse 
correlation between platelet All binding and plasma 
All concentration (P>0.05, rs· 0.10). 
As discussed in the Introduction (p. 81), many 
workers [e.g. Aguilera and Catt, 1981] have concluded 
that the effects of alterations in sodium balance on 
All pressor sensitivity [Brunner, Chang, Wallach, 
Sealey and Laragh, 1972] and on vascular smooth muscle 
cell receptor concentrations [Aguilera and ,Catt, 
1981], result from changes in, the renin-angiotensin 
system. (Sodium depletion increases All p r o d u c t . ~ o n n by 
stimulating renin release, as . outlined in the 
I n t r o d u c ~ i o n , , p. 22). This concept is supported by 
the findings. of Cowley and Lohmeir [1977], who 
. 
demonstrated that short term alterations in sodium 
balance by haemodialysis in nephrectomised dogs did 
not affect· vascular All sensitivity, whereas Oliver 
'and Cannon [1978] noted diminished sensitivity during 
acute'sodium depletion by frusemide administration in 
dogs, a condition characterised by markedly increased 
All levels,. 
However, the results of the regression analysis 
performed on data from the longitudinal study of 
normotensive pregnancy (Chapter 6), i n d i ~ a t e d d that the 
correlation between platelet All binding and serum 
sodium concentration was independent of plasma All 
levels. It remains possible that there is a direct 
effect of the serum sodium concentration on both All 
binding and vascular sensitivity. Whilst' there have 
been several studies of the effect of dietary sodium 
restriction on both vascular reactivity and All 
binding site concentration, as above" variations in 
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serum sodium levels have not been observed during 
dietary sodium restriction, and there have been very 
few studies of the effect of changes in extracellular 
sodium concentration. In one such study, intra-
arterial infusion of high concentration saline 
solutions via the brachial artery of male subjects 
resulted in alterations in-extracellular sodium levels 
which were directly proportional to changes in 
vascular responsiveness to All [Heistad, Abboud and 
Ballard, 1971]. 
Sodium and water retention in a blood vessel wall 
would increase wall thickness [Friedman and ~ ~ i e d m a n , ,
1967], and perhaps alter vascular reactivity. 
~ o w e v e r , , the results of in vitro experiments in which 
the sodium ion concentration influences the binding of 
agonists to a diverse variety of binding sites, 
including dopamine [Usdin, Cree.e and Snyder, 1980}, 
opiate [Pert and Snyder, 1974], muscarinic cholinergic 
[Rosenberger, Yamamura and Roeske [1980] and All 
receptors [Wright, Alexander, Ekstein and Gimbr<?ne, 
1982], suggests a more complex mechanism. 
There is conflicting evidence from in vitro studies 
regarding the effect of sodium ion concentration on 
smooth muscle cell All binding. In the rabbit uterus 
[Bennett and Snyder, 1980] and the rabbit aorta 
[Devynck, and Meyer, '1976], alterations in sodium ion 
concentration have not been found to influence All 
binding. However, as discussed in the Introduction 
(p. 71), binding sites in these tissues may not be 
representative of those in tissue from resistance 
vessels. Wright et. al. [1982] demonstrated that rat 
mesenteric artery All binding was increased by 
"increases in sodium ion concentration, whereas 
increases in other monovalent cations (including 
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lithium, potassium and ammonium) resulted in reduced 
All binding. 
Wright eta ale [1982] suggested the existence ofa 
membrane monovalent cation site closely related to the 
vascular smooth muscle All receptor. A similar 
membrane site was proposed'to explain the stimulatory 
effect of increasing sodium ion concentration on 
adrenal cortical All binding [Glossman, Baukal and 
Catt, 1974], and is in keeping with the two-state 
model of receptor binding [e.g. Koshland,' 1964] 
outlined in the Introduction (p. 66). 
An alternative e ~ p l a n a t i o n n for the regulatory 
influence of sodium ion concentration on AIL binding 
involves.a direct effect on the conformation of the 
radioligand, since interaction be,tween All and 
artificial lipid membranes have been demonstrated by 
Elliott and Goodfriend [1979]. These interactions 
were '. sensitive to cation concentrations (including 
calcium and magnesium), although a specific effect of 
sodium ion concentration was not investigated. 
However, regula tion . of binding by' the sodium ion 
concentration appears' to be a general phenomenon, as 
above, involving agonists as diverse as peptides and 
o p i a t e s ~ ~ Thus, it seems more likely that sodium ion 
concentration changes act through sodium ion-sensitive 
membrane sites common'to many hormone binding sites, 
rather than by a specific physical alteration in the 
All molecule. 
In in vitro studies, guanine nucleotides have been 
found to inhibit All binding' [Devynck and Meyer, 
1976], discussed in the Introduction (p.82). Wright 
eta ala [1982] demonstrated that the effect of guanine 
nucleotides in inhibiting All binding varied with the 
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ambient sodium ion concentration. The guanine 
nucleotide-sensitive site is thus one locus where 
effects of alterations in sodium ion concentrations 
may be mediated. 
Robdell [1980] has suggested that membrane guanine 
nucleotide-binding proteins play a pivotal role in the 
transduction of signals from a variety of surface 
receptors. The theory was originally derived from 
data on adenylate cyclase coupled receptors, 
particularly the beta-adrenergic receptors [Robdell, 
1980], although it has since been extended to other 
guanine nucleotid"e sensitive receptors ,. [Catt, 
Mendelsohn, Millan and Aguilera, i984]. An agonist, 
. . 
l;>ut not an antagonist, induces the formation of a 
complex between the receptor and a membrane nucleotide 
regulatory protein. In the absence of guanine 
nucleotides, the receptor binds the agonist with high 
affinity. When guanine nucleotides bind to sites on 
the regulatory protein, simultaneous (or sequential)' 
development of low affinity states for the agonist and 
coupling of the regulatory unit to the catalytic unit 
of adenylate cyclase lead to the activation, or 
inhibition of the enzyme. 
Wright et." ale [1982] suggested that sodium ions 
facilitated the formation of a receptor-nucleotide 
regulatol:lY protein complex of high affinity for All. 
When guanine nucleotides bind to the complex, All 
binding is inhibited. Since All does not stimulate 
adenylate cyclase activity, but rather has an 
inhibitory effect on the enzyme [Woodcock and Johnson, 
1982], All binding sites must interact with the 
i n h i b i t o r y ~ ~ form of the g u ~ n y l - n u c l e o t i d e e regulatory 
"protein (Ni) that is involved in the actions of 
several ligands,.. including the alpha2-agonists 
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[reviewed by Gilman, 1984] 
In p a t i ~ n t s s with PIH increased levels of platelet 
All binding in comparison with normotensive 
primigravidae were found. The increased levels 
paralleled the increased All pressor response found in 
patients with PIH [Gant et. a1., 1973]. There would 
seem to be a limited application for the technique as 
a marker for PIH in patients with the established 
disease, possibly as an adjunct to the biochemical and 
haemato1ogica1 parameters more commonly measured. 
However, values of platelet All binding in patients 
who deve1"oped fulminating pre-eclampsia were no higher 
than those of the other pre-eclampsia subjects. 
Moreover, the va1qe of platelet All binding" in the 
single patient who developed eclampsia was· below the. 
median value of the PIH group. 
The hypothesis, supported by the two patients 'from 
the longitudinal study who developed PIH,. that 
platelet All binding also parallels All pressor 
sensitivi,ty in pregnancies complicated by PIH, would 
suggest that differences in platelet All binding 
between normotensive pregnant women and PIH patients 
should be apparent well before the clinical 
development of the disease. The potential application 
of the technique as a screening test for PIH was 
emphasised in the previous chapter; the results using 
platelet All binding as a predictive test for PIH not 
only being better than· those of the biochemical and 
haematological parameters measured, but also being 
better than those using any of the parameters derived 
from the All sensitivity test. . 
A much larger prospective study is needed to 
confirm the potential use of platelet All binding as a 
-244-
screening test for PIH. However, with recent studies 
suggesting measures which prevent the development of 
the disease, the need for such a practical and 
minimally invasive technique to determine those at 
risk of PIH, has never been greater. 
Dietary salt restriction, as advocated by Nakamura, 
Ito, Matsui, Yoshimura, Kawasaki and Maeyama [1986], 
was suggested as a prophylactic measure as early as 
the 18th century [Zuckert, 1767]. Although the 
geographical incidence of eclampsia has been reported 
as varying with the dietary intake of salt [deSnoo and 
Remmelts, 1938], there is little evidence to support 
the use of salt restriction as a prophylactic measure, 
with Robinson [1958] reporting an increased incidence 
of PIH .in patients advised to restrict their salt 
intake, as compared to patients told to increase 
dietary salt consumption. Similar conclusions should 
be drawn regarding the prophylactic administration of 
diuretic therapy. Finnerty and Bepko [1966] reported 
"that 'vasoconstriction', (diagnosed on the basis of 
ei ther a 10% or more rise in mean arterial blood 
pressure or the appearance of proteinuria), d e ~ e l o p e d d
three time,s as often in untreated women as compared to 
patients treated prophylactically with chlorothiazide. 
However, not only was the study poorly controlled, but 
many of the patients in whom the mean arterial blood 
pressure .... rose by '10% did not have dia,stolic blood 
pressures above 70 mmHg. In contrast, Chesley [1976] 
reviewed six double-blind studies of diuretic drugs as 
preventatives of pre-eclampsia; five of the six 
studies indicated essentially no effect, and the one 
exception was based on only 74·cases. The use of both 
fish-oil dietary supplementation and low-dose aspirin 
" administration offer much greater promise. 
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A large number of diseases have been considered to 
be preventable or curable by fish-oil [Gibson, 1988], 
but it has only recently been suggested that fish-oil 
supplementation might lessen the occurrence of 
obstetric complications such as pre-eclampsia [Romero, 
Lockwood, Oyarzun and Hobbins, 1988]. The possible 
preventative effect of fil:lh-oil in pre-eclampsia is 
supported indirectly by the controlled study 
undertaken by the People's League of Health [1946] 
during 1938-39 in London. Over five thousand pregnant 
women were allocated alternately to treatment with a 
dietary supplement which included halibut liver oil, 
or to no treatment. The group receiving the 
supplement had less 'toxaemia' than the control group. 
The beneficial effect of fish-oil seems to be 
associated mainly with its long chain n-3 fatty a c i d ~ , ,
which together- with the·n-6 fatty acids derived 
primarily from vegetables, represent the main 
·polyunsaturated fatty acids in our diet. As discussed 
in the introduction (p. 52), PIH is associated with 
decreased pros tacyc1in synthesis [ Y 1 i ~ o r k a 1 a a and 
Maki1a, 1985] and increased thromboxane A2 synthesis, 
which contributes to· the thrombocyte aggregation and 
vasoconstriction seen in the disease [Walsh, 1985].· 
Secher and Olsen [1990] suggested that the beneficial 
effect of fish-oil supplementation was due to a change 
in haemos ta tic balance resulting from the increased 
~ ~ . 
prostacyclin production and the inhibition of 
thromboxane A2 production that is found after intake 
of long chain n-3 fatty acids [Leaf and Weber, 1988]. 
However, dietary n-3 polyunsaturated fatty acids 
are also known to decrease platelet membrane viscosity 
'" [Vas Dias, Gibney and Taylor, 1982]. This provides an 
alternative explanation of the beneficial effect of 
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fish-oil supplementation, in that supplementation may 
reduce the elevated platelet membrane viscosity found 
in pre-eclampsia [Gleeson, Ahmed, Rice-Evans and 
Elder, 1990]. Such an alteration in cell membrane 
fluidity would reduce the accessibility of cell 
membrane proteins which act as binding sites 
(discussed in detail in ,Chapter 7, p. 213). A 
reduction in All binding would thus be anticipated and 
it is interesting to note that the All pressor 
response is reduced after fish-oil intake [Leaf and 
Weber, 1988]. This is clearly an area in which 
further studies are required. The results of a 
prospective analysis. of both the efficacy of 
administering fish-oil supplementation to women with 
high values of platelet All binding in reducing the 
incidence. of pre-eclampsia, and the assessment of the 
effect o( fish-oil on platelet All binding, would be 
particularly interesting. 
The incidence of PIH has been found to be decreased 
in women given low-dose aspirin. In a controlled 
trial by Beaufils, Uzan, Donsimoni and Colau [1985], 
aspirin (150 mg/day) combined with dipyridamole (300 
mg/day) was administered to women from the first 
trimester of pregnancy. The treatment regimen 
conferred a clear benefit, both in terms of the 
occurrence of PIH and intra-uterine growth 
retardation, and in perinatal survival. These 
" 
subjects were selected on the basis of a previous 
obstetric history indicating that they were likely· to 
develop PIH.· A clear advantage of the subsequent 
study by Wallenburg, Dekker, Makovitz and Rotmans 
[1986] was that patients were-selected to participate 
in ., their, study on the basis of an increased blood 
" pressure response to infused All. 23 women received 
60 mg aspirin daily, and the same number received 
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matching placebo until delivery. In the placebo group 
PIB, pre-eclampsia, and eclampsia developed in four, 
seven and one cases, respectively, whereas only two 
women in the aspirin group developed mild PIH. 
Several larger studies of the effect of low-dose 
aspirin in pregnancy, such as the Collaborative Low-
dose Aspirin Study in Pregnancy (CLASP), have been 
commenced. In an overview of the resul ts of these 
studies thus far available, Grant [1990] reported that 
meta-analysis of the data indicated that there was an 
80% reduction in pre-eclampsia. as a consequence of 
low-dose aspirin adminis tra tion, a1 though no 
significant reduction in the perinatal mortality rate 
was demonstrated. 
There is some concern as to the safety of aspirin 
. ingestion in pregnancy. Some human studies [e.g. 
McNeil, 1973]· ·suggest that there is an increase in 
congenital malformations when aspirin is given in high 
doses in early p·regnancy. Animal data has shown that 
aspirin (55-90 mg/Kg) may cause constriction of the 
fetal ductus arteriosus [Heymann and Rudolph, 1976], 
and increased incidences of both ante-partum and post-
partum haemorrhages have been described following 
aspirin ingestion in pregnancy [Collins and Turner, 
1975]. Such fears may well prove to be unfounded, 
with large studies having found no association between 
aspirin ingestion and either congenital malformations 
[Slone,' Siskind, Heineman, Manson" Kaufman and 
Shapiro, 1976], or persistent pulmonary hypertension 
[Shapiro, Siskind, Manson, 'Heineman, Kaufman and 
Slone, 1976]. Nevertheless, if platelet All binding 
does prove to be an effective and practical screening 
test, then restricting low-dose aspirin administration 
to those deemed to be at high risk of developing PIH 
has obvious merit. 
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It would be interesting to determine the effect of 
low-dose aspirin on platelet All binding. Spitz, 
Magness, Cox, Brown, Rosenfeld and Gant [1988] 
demonstrated that the administration of low-dose 
aspirin to women in the third trimester of pregnancy 
with increased All pressor sensitivity caused them to 
become more refractory to infused All. These women 
did not, however, become as refractory to infused All 
as normal pregnant women. In view of this finding, a 
reduction in platelet All binding as a consequence of 
low-dose aspirin administration might be anticipated. 
The finding of the close correlations between 
platelet All 'binding and the slopes of the diastolic 
and systolic p r ~ s s ~ r r response to infused All 
strengthen the other conclusions of the thesis, in 
that the correlations provide support for the use of 
platelet All b-inding as a model of' vascular smooth 
'muscle sensitivity. 
Further support for such a model has been provided 
by comparis?ns of neonatal platelet All binding and 
the in vitro response of chorionic plate arterial 
strips to All [Cook, Farquhar, Baker, Broughton 
Pipkin, unpublished data]. A significant inverse 
correlation was found between the response of the 
arterial strips to 10-7 M All and the values of 
neonatal platelet All binding. Assuming that there is 
.-
a direct relationship. between All bInding and the 
degree of contraction, as, demonstrated in the rabbit 
aorta by Baudouin, Meyer and Worcel [1971], this 
suggests that the levels of platelet All binding 
reflect those of vascular tissue. 
There are many possible areas 
investigation of platelet All binding. 
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of further 
Perhaps the 
most important would be a large prospective study 
assessing the use of the technique as a screening 
test. The effect of fish oil administration and low 
dose aspirin therapy on levels of platelet All binding 
would also be a valuable study •. Platelet All binding 
levels have not been measured in multigravid pregnant 
women, and it would be interesting to determine levels 
in women whose previous pregnancies were complicated 
by PIH. Other possible avenues of investigation 
include isolation and characterisation studies of 
platelet All binding sites, particularly on platelets 
. from normotensive pregnant and hypertensive pregnant 
women, and further efforts to correlate .a cellular 
response with binding site concentrations •.... 
"To a ,scientist there is no absolute truth; truth 
' .. 
is a relative term. A hypothesis becomes more 
probably true the more often it stands up to 
experiment, and the more' rigorous these experiments 
are."· [Pickering, 1964]. 
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Appendix A. 
Materials and disposable equipment : 
Acetone : obtained from BDH Chemicals Ltd., 
Poole, England. 
Acetylsalicylic acid • • obtained from Sigma 
Chemicals Co., St. Louis, U.S.A. 
Angiotensin II : 2.5 mg ampoules of 
Hypertensin Ciba were obtained from Ciba-Geigy 
Ltd., Basle, Switzerland. 
Angiotensin II analogues : Angiotensin I, 
[Sar1 Ala8] angiotensin II, [des-Asp1] angiotensin 
II (angiotensin III) were obtained from ,Sigma 
Chemicals C o . ~ ~ S ~ . . Louis, U.S.A. 
Apyrase : obtained from Sigma Chemicals Co., 
St. Louis, U.S.A. 
Bacitracin : obtained 
. 
from Sigma Chemicals 
Co., St. Louis, U.S.A. 
Bovine serum albumin : obtained from Sigma 
Chemicals Co., St. Louis, U.S.A. 
C a ~ c i u m m chloride (CaCI2) : obtained from Sigma 
Chemicals Co., St. Louis, U.S.A. 
Citric acid : obtained from BDH Chemicals 
Ltd., Poole, England. 
CO2 : compressed gas was obtained from BOC 
Ltd., Guildford, Surrey. 
Earles 199 medium : obtained from Flow 
Laboratories, Irvine, Scotland. 
EDTA (Diaminoethaneteta-acetic acid) : 
obtained from Fisons Scientific Apparatus Ltd., 
Loughborough, England. 
Glucose : obtained 'from May and Baker Ltd., 
Dagenham, England. 
Hydrochloric acid (HCI): obtained from May 
and Baker Ltd., Dagenham, England. 
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125I-Angiotensin II : (2000 Ci/mmol, 74 
TBq/mmol) was obtained from Amersham International 
plc, Amersham, Bucks, England. 
Liquipipettes : 5 ml plastic liquipipettes 
were obtained from Elkay, Eireann, Costelloe, Co. 
Galway, Ireland. 
Magnesium sulphate (MgS04) : 
Fisons Scientific Apparatus Ltd., 
England. 
obtained from 
Loughborough, 
Medi-Swab : containing 70% v/v isopropyl 
alcohol and 0.5% w/w chlorhexidine acetate, 
obtained from Smith and Nephew Medical Ltd. 
Microcentrifuge tubes : 400 ul polyethylene 
microcentrifuge t"ubes were obtained from Beckman, 
U.S.A. 
Minoton solution • • isotonic salt solution 
obtained from ABX, Montpellier, France. 
" -
Nylon gauze : 20 um Nylon gauze was obtained 
from Henry Simon, Stockport, England. 
Percoll : obtained from Sigma Chemicals Co., 
St. Louis, U.S.A. 
O-Phenanthroline • • obtained 
Chemicals Co., St. Louis, U.S.A. 
from Sigma 
Polypropylene test tubes were round bottomed 
and disposable. 3 ml, and 10 ml tubes were 
obtained from L.I.P. Ltd., Yorkshire, England. 
Graduated 10 ml tubes were obtained from Sarstedt 
Lt4,., Leicester,' England. Appropriate stoppers 
were supplied by L.I.P. Ltd., and "Sarstedt. Ltd. 
respectively. 
Pthalate solutions : dibutyl pthalate and 
dionyl pthalate obtained from BDH Chemicals Ltd., 
Poole, England. 
Tris : obtained from BDH Chemicals Ltd., 
Poole, England. 
Trisodium citrate obtained from Hopkin and 
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Williams Ltd., Chadwell Heath. 
Vacutainer tubes : obtained from Becton 
Dickinson Vacutainer Systems, Cowley, Oxford. 
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Appendix B. 
The figures below have been provided by Mr. N. 
S. Brown (Top grade biochemist) of the Clinical 
Chemistry department, University Hospital, 
Nottingham. The table indicates the between-batch 
coefficients of variation for both serum and urine 
biochemistry. 
Between-batch C.V. (%). 
SERUM. 
Sodium 1.0 " 
Potassium . 3.0 «3mmol/l); 1.5 (>3mmol/l) 
Urea .2.5 «10mmal/l); 1.5 (>10mmol/l) 
Creatinine 4.0 «200umol/l); 1.5 (>200umol/l) 
Osmolality 0.5 
Urate 2.5 
URINE. 
Sodium 4.0 
Potassium 3.0 
Urea 3.0 
Creatinine 3.0 
O s ~ o l a l i t y y 0.5 
Urate 2.5 
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Appendix C. 
Derivation of association and dissociation 
constants from kinetic data using two ligand 
concentrations. [Gunther, 1980a]. 
For the reaction of ,a drug/hormone (D) binding 
reversibly with a single class of receptor sites 
(R) to form a receptor-bound complex B : 
D + R B 
When 'the initial free drug/hormone conceritration 
Do » Ro: 
D-o Dt , for all times (t). 
Thus the rate of change of concentration 
drug/hormone (dB/dt) is approximated by: 
dB/dt - K1Do(Ro - B) - K_1B 
- K1DoRo - B(K1Do + K_1) 
The solution to the general equation: 
p(x)y + Q(x) is 
ye(p(x)dx _ 
whereZ is a constant. 
Th\ls : 
SQe(p(X)dX dx 
of bound 
dy/dx + 
+ Z 
Be(K1Do +K_1)t 
- K1DoRo .e(KiDo + K_1)t + Z 
K1Do + K_1 
When taO, B-O and 
o - + Z 
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Thus . • 
Bt 
- K1DoRo .[1 _ e-(K1Do + K_l)t] 
K1Do + K_l 
When t - infinity, B - Beq 
-
K1DoRo 
K1Do +K_l 
Thus • • 
Beg - B 
-
e";'(K1Do + K_l)t 
or : 
Beq 
Beg - B 
Beq r-
When plotted graphically, the slope (S) of: 
ln [Beg - Bl agains t time 
Beq J 
determines the value of -(K1Do + K_l) 
If two different concentrations of 
and Do' a ~ e e used: -(K1Do + K_l) 
and -(K1Do' + K_l) - S' 
.Kl - S - S' and K_l,-
Do' - Do 
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drug/hormone Do 
- S 
S'Do - SDo' 
D • - D o 0 
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